# EDGAR Filing Document

**Accession Number:** 0000917952
**File Stem:** 0001104659-23-037527
**Filing Date:** 2023-3
**Character Count:** 532123
**Document Hash:** fd9633a26f4152dc747cb7502ce807dc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-037527.hdr.sgml**: 20230328

**ACCESSION NUMBER**: 0001104659-23-037527

**CONFORMED SUBMISSION TYPE**: N-VPFS

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230328

**DATE AS OF CHANGE**: 20230328

**EFFECTIVENESS DATE**: 20230328

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Brighthouse Variable Annuity Account B
- **CENTRAL INDEX KEY:** 0000917952
- **IRS NUMBER:** 133690700
- **STATE OF INCORPORATION:** NY
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-VPFS
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-08306
- **FILM NUMBER:** 23766973

**BUSINESS ADDRESS:**
- **STREET 1:** BRIGHTHOUSE LIFE INSURANCE CO OF NY
- **STREET 2:** 285 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 6175783514

**MAIL ADDRESS:**
- **STREET 1:** BRIGHTHOUSE LIFE INSURANCE CO OF NY
- **STREET 2:** 285 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** First MetLife Investors Variable Annuity Account One
- **DATE OF NAME CHANGE:** 20120712

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FIRST METLIFE INVESTORS VARIABLE ANNUITY ACCOUNT ONE
- **DATE OF NAME CHANGE:** 20010416

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FIRST COVA VARIABLE ANNUITY ACCOUNT ONE
- **DATE OF NAME CHANGE:** 19960515

## Series and Classes Contracts Data

### Brighthouse Variable Annuity Account B (Series ID: S000005137)

| Class ID   | Class Name                                                                 | Ticker Symbol   |
|:---|:---|:---|
| C000014059 | Class VA (offered between June 15, 2001 and October 7, 2011)               |  |
| C000014060 | PrimElite III                                                              |  |
| C000014061 | Marquis Portfolios (offered between November 7, 2005 and April 30, 2012)   |  |
| C000014062 | Protected Equity Portfolio (PEP)                                           |  |
| C000014063 | Class C (offered between September 4, 2001 and October 7, 2011)            |  |
| C000014064 | Class AA                                                                   |  |
| C000014065 | Class B                                                                    |  |
| C000014066 | Class A                                                                    |  |
| C000014067 | Class XC                                                                   |  |
| C000014068 | Class L                                                                    |  |
| C000014069 | Class L - 4 Year (offered between November 22, 2004 and October 7, 2011)   |  |
| C000014070 | Vintage XC                                                                 |  |
| C000014071 | Vintage L                                                                  |  |
| C000021946 | First COVA VA                                                              |  |
| C000039423 | Class S (offered between April 30, 2007 and October 7, 2011)               |  |
| C000040657 | PrimElite IV                                                               |  |
| C000062199 | Pioneer PRISM XC                                                           |  |
| C000069430 | Class XTRA                                                                 |  |
| C000075156 | Class XTRA 6                                                               |  |
| C000078063 | Simple Solutions/SM/                                                       |  |
| C000094883 | Class VA-4 (offered between May 1, 2011 and October 7, 2011)               |  |
| C000106652 | Class S (offered between October 7, 2011 and May 1, 2016)                  |  |
| C000106653 | Class VA-4 (offered between October 7, 2011 and May 1, 2016)               |  |
| C000106661 | Class VA (offered between October 7, 2011 and May 1, 2016)                 |  |
| C000106662 | Class L - 4 Year (offered between October 7, 2011 and April 28, 2013)      |  |
| C000106663 | Class C (offered on and after October 7, 2011)                             |  |
| C000108044 | Class S - L Share Option (offered between October 7, 2011 and May 1, 2016) |  |
| C000110905 | Class O (offered between April 30, 2012 and September 20, 2015)            |  |
| C000112437 | Marquis Portfolios (offered on and after April 30, 2012)                   |  |
| C000125464 | Class L - 4 Year (offered on and after April 29, 2013)                     |  |
| C000159767 | Class O (offered on and after September 21, 2015)                          |  |
| C000168028 | Class VA-4 (offered on and after May 2, 2016)                              |  |
| C000168029 | Class VA (offered on and after May 2, 2016)                                |  |
| C000168035 | Class S (offered on and after May 2, 2016)                                 |  |
| C000168036 | Class S - L Share Option (offered on and after May 2, 2016)                |  |
| C000186121 | Brighthouse Prime Options                                                  |  |

**REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

To the Contract Owners of<br>Brighthouse Variable Annuity Account B<br>and Board of Directors of<br>Brighthouse Life Insurance Company of NY

**Opinion on the Financial Statements and Financial Highlights**

We have audited the accompanying statements of assets and liabilities of Brighthouse Variable Annuity Account B (the "Separate Account") of Brighthouse Life Insurance Company of NY (the "Company") comprising each of the individual Sub-Accounts listed in Note 2.A as of December 31, 2022, the related statements of operations for the year then ended, the statements of changes in net assets for each of the two years in the period then ended, and the financial highlights in Note 8 for each of the five years in the period then ended for the Sub-Accounts, except for the Sub-Accounts included in the table below; the related statements of operations, changes in net assets, and the financial highlights for the Sub-Accounts and periods indicated in the table below; and the related notes. In our opinion, the financial statements and financial highlights present fairly, in all material respects, the financial position of each of the Sub-Accounts constituting the Separate Account of the Company as of December 31, 2022, and the results of their operations for the year then ended (or for the periods listed in the table below), the changes in their net assets for each of the two years in the period then ended (or for the periods listed in the table below), and the financial highlights for each of the five years in the period then ended (or for the periods listed in the table below), in conformity with accounting principles generally accepted in the United States of America.

---

| | | | |
|:---|:---|:---|:---|
| **Individual Sub-Accounts** <br> **Comprising the Separate**<br> **Account** | **Statement of**<br> **Operations** | **Statements of** <br> **Changes in** <br> **Net Assets** | **Financial Highlights** |
| BHFTI AB International Bond Sub-Account | For the year ended December 31, 2022 | For the years ended December 31, 2022 and 2021 | For the years ended December 31, 2022, 2021, 2020, and the period from April 29, 2019 (commencement of operations) through December 31, 2019 |
| BHFTI SSGA Emerging Markets Enhanced Index Sub-Account | For the year ended December 31, 2022 | For the years ended December 31, 2022 and 2021 | For the years ended December 31, 2022, 2021, 2020, and the period from April 29, 2019 (commencement of operations) through December 31, 2019 |
| Janus Henderson Global Sustainable Equity Sub-Account | For the period from April 29, 2022 (commencement of operations) through December 31, 2022 | For the period from April 29, 2022 (commencement of operations) through December 31, 2022 | For the period from April 29, 2022 (commencement of operations) through December 31, 2022 |

---

**Basis for Opinion**

These financial statements and financial highlights are the responsibility of the Separate Account's management. Our responsibility is to express an opinion on the Separate Account's financial statements and financial highlights based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Separate Account in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

------

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement, whether due to error or fraud. The Separate Account is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Separate Account's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements and financial highlights, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements and financial highlights. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements and financial highlights. Our procedures included confirmation of investments owned as of December 31, 2022, by correspondence with the custodian or mutual fund companies. We believe that our audits provide a reasonable basis for our opinion.

/s/ DELOITTE & TOUCHE LLP

Tampa, Florida<br>March 24, 2023

We have served as the Separate Account's auditor since 2000.

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B <br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF ASSETS AND LIABILITIES**

**December 31, 2022**

---

| | |
|:---|:---|
| | **American Funds<sup>®</sup>** <br> **Global Growth** <br> **Sub-Account** |
| **Assets:** | **Assets:** |
| Investments at fair value | $20852209 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |
| Total Assets | 20852209 |
| **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 53 |
| Total Liabilities | 53 |
| **Net Assets** | $20852156 |
| **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $20851807 |
| Net assets from contracts in payout | 349 |
| Total Net Assets | $20852156 |

---

The accompanying notes are an integral part of these financial statements.<br>1

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF ASSETS AND LIABILITIES — (Continued)**

**December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **American Funds<sup>®</sup>** <br> **Global Small** <br> **Capitalization** <br> **Sub-Account** | **American Funds<sup>®</sup>** <br> **Growth** <br> **Sub-Account** | **American Funds<sup>®</sup>** <br> **Growth-Income**<br> **Sub-Account** | **American Funds<sup>®</sup>** <br> **The Bond** <br> **Fund of America** <br> **Sub-Account** | **BHFTI AB Global** <br> **Dynamic Allocation** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $3136702 | $38543661 | $22633179 | $6955792 | $90348944 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 3136702 | 38543661 | 22633179 | 6955792 | 90348944 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 30 | 47 | 57 | 23 | 46 |
| Total Liabilities | 30 | 47 | 57 | 23 | 46 |
| **Net Assets** | $3136672 | $38543614 | $22633122 | $6955769 | $90348898 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $3127223 | $38511296 | $22583702 | $6955769 | $90348898 |
| Net assets from contracts in payout | 9449 | 32318 | 49420 |  |  |
| Total Net Assets | $3136672 | $38543614 | $22633122 | $6955769 | $90348898 |

---

The accompanying notes are an integral part of these financial statements.<br>2

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTI AB** <br> **International Bond** <br> **Sub-Account** | **BHFTI** <br> **Allspring** <br> **Mid Cap Value** <br> **Sub-Account** | **BHFTI** <br> **American Funds<sup>®</sup>** <br> **Balanced Allocation** <br> **Sub-Account** | **BHFTI** <br> **American Funds<sup>®</sup>** <br> **Growth Allocation** <br> **Sub-Account** | **BHFTI** <br> **American Funds<sup>®</sup>** <br> **Growth** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $1370741 | $16121568 | $196621488 | $110709842 | $76530592 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 1370741 | 16121568 | 196621488 | 110709842 | 76530592 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 8 | 31 | 44 | 32 | 40 |
| Total Liabilities | 8 | 31 | 44 | 32 | 40 |
| **Net Assets** | $1370733 | $16121537 | $196621444 | $110709810 | $76530552 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $1370733 | $16081985 | $196185426 | $110671419 | $76530552 |
| Net assets from contracts in payout |  | 39552 | 436018 | 38391 |  |
| Total Net Assets | $1370733 | $16121537 | $196621444 | $110709810 | $76530552 |

---

The accompanying notes are an integral part of these financial statements.<br>3

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF ASSETS AND LIABILITIES — (Continued)**

**December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTI** <br> **American Funds<sup>®</sup>** <br> **Moderate Allocation** <br> **Sub-Account** | **BHFTI** <br> **BlackRock Global** <br> **Tactical Strategies** <br> **Sub-Account** | **BHFTI** <br> **BlackRock** <br> **High Yield** <br> **Sub-Account** | **BHFTI** <br> **Brighthouse** <br> **Asset** <br> **Allocation 100** <br> **Sub-Account** | **BHFTI** <br> **Brighthouse** <br> **Balanced Plus** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $98772195 | $170129744 | $53734648 | $92559796 | $329714285 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 98772195 | 170129744 | 53734648 | 92559796 | 329714285 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 41 | 59 | 47 | 49 | 47 |
| Total Liabilities | 41 | 59 | 47 | 49 | 47 |
| **Net Assets** | $98772154 | $170129685 | $53734601 | $92559747 | $329714238 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $98719795 | $170129685 | $53733837 | $92364819 | $329714238 |
| Net assets from contracts in payout | 52359 |  | 764 | 194928 |  |
| Total Net Assets | $98772154 | $170129685 | $53734601 | $92559747 | $329714238 |

---

The accompanying notes are an integral part of these financial statements.<br>4

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTI** <br> **Brighthouse** <br> **Small Cap Value** <br> **Sub-Account** | **BHFTI** <br> **Brighthouse/**<br> **abrdn Emerging** <br> **Markets Equity** <br> **Sub-Account** | **BHFTI** <br> **Brighthouse/**<br> **Eaton Vance** <br> **Floating Rate** <br> **Sub-Account** | **BHFTI** <br> **Brighthouse/**<br> **Franklin Low** <br> **Duration** <br> **Total Return** <br> **Sub-Account** | **BHFTI** <br> **Brighthouse/**<br> **Templeton** <br> **International** <br> **Bond** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $24116137 | $22036170 | $12290996 | $12905543 | $2290439 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 24116137 | 22036170 | 12290996 | 12905543 | 2290439 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 37 | 60 | 34 | 43 | 23 |
| Total Liabilities | 37 | 60 | 34 | 43 | 23 |
| **Net Assets** | $24116100 | $22036110 | $12290962 | $12905500 | $2290416 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $24115844 | $21996900 | $12285059 | $12905500 | $2290416 |
| Net assets from contracts in payout | 256 | 39210 | 5903 |  |  |
| Total Net Assets | $24116100 | $22036110 | $12290962 | $12905500 | $2290416 |

---

The accompanying notes are an integral part of these financial statements.<br>5

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF ASSETS AND LIABILITIES — (Continued)**

**December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTI** <br> **Brighthouse/**<br> **Wellington** <br> **Large Cap** <br> **Research** <br> **Sub-Account** | **BHFTI CBRE** <br> **Global** <br> **Real Estate** <br> **Sub-Account** | **BHFTI** <br> **Harris Oakmark** <br> **International** <br> **Sub-Account** | **BHFTI Invesco** <br> **Balanced-Risk** <br> **Allocation** <br> **Sub-Account** | **BHFTI Invesco** <br> **Comstock** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $1517073 | $14342051 | $42520415 | $32681340 | $31709751 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 1517073 | 14342051 | 42520415 | 32681340 | 31709751 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 19 | 63 | 51 | 39 | 69 |
| Total Liabilities | 19 | 63 | 51 | 39 | 69 |
| **Net Assets** | $1517054 | $14341988 | $42520364 | $32681301 | $31709682 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $1517054 | $14326103 | $42512385 | $32681301 | $31691527 |
| Net assets from contracts in payout |  | 15885 | 7979 |  | 18155 |
| Total Net Assets | $1517054 | $14341988 | $42520364 | $32681301 | $31709682 |

---

The accompanying notes are an integral part of these financial statements.<br>6

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTI Invesco** <br> **Global Equity** <br> **Sub-Account** | **BHFTI Invesco** <br> **Small Cap** <br> **Growth** <br> **Sub-Account** | **BHFTI** <br> **JPMorgan** <br> **Core Bond** <br> **Sub-Account** | **BHFTI** <br> **JPMorgan** <br> **Global Active** <br> **Allocation** <br> **Sub-Account** | **BHFTI** <br> **JPMorgan** <br> **Small Cap** <br> **Value** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $3132934 | $34367537 | $27532926 | $52280119 | $3225595 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 3132934 | 34367537 | 27532926 | 52280119 | 3225595 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 38 | 117 | 26 | 49 | 33 |
| Total Liabilities | 38 | 117 | 26 | 49 | 33 |
| **Net Assets** | $3132896 | $34367420 | $27532900 | $52280070 | $3225562 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $3132896 | $34354997 | $27514876 | $52280070 | $3224369 |
| Net assets from contracts in payout |  | 12423 | 18024 |  | 1193 |
| Total Net Assets | $3132896 | $34367420 | $27532900 | $52280070 | $3225562 |

---

The accompanying notes are an integral part of these financial statements.<br>7

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF ASSETS AND LIABILITIES — (Continued)**

**December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTI** <br> **Loomis Sayles** <br> **Global Allocation** <br> **Sub-Account** | **BHFTI** <br> **Loomis Sayles** <br> **Growth** <br> **Sub-Account** | **BHFTI** <br> **MetLife** <br> **Multi-Index** <br> **Targeted Risk** <br> **Sub-Account** | **BHFTI MFS<sup>®</sup>** <br> **Research** <br> **International** <br> **Sub-Account** | **BHFTI** <br> **Morgan Stanley** <br> **Discovery** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $17095405 | $43988484 | $37616145 | $24998849 | $8373747 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 17095405 | 43988484 | 37616145 | 24998849 | 8373747 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 41 | 91 | 34 | 63 | 42 |
| Total Liabilities | 41 | 91 | 34 | 63 | 42 |
| **Net Assets** | $17095364 | $43988393 | $37616111 | $24998786 | $8373705 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $17079583 | $43971480 | $37616111 | $24993912 | $8373705 |
| Net assets from contracts in payout | 15781 | 16913 |  | 4874 |  |
| Total Net Assets | $17095364 | $43988393 | $37616111 | $24998786 | $8373705 |

---

The accompanying notes are an integral part of these financial statements.<br>8

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTI** <br> **PanAgora** <br> **Global** <br> **Diversified Risk** <br> **Sub-Account** | **BHFTI** <br> **PIMCO Inflation** <br> **Protected Bond** <br> **Sub-Account** | **BHFTI** <br> **PIMCO** <br> **Total Return** <br> **Sub-Account** | **BHFTI** <br> **Schroders** <br> **Global** <br> **Multi-Asset** <br> **Sub-Account** | **BHFTI SSGA** <br> **Emerging Markets** <br> **Enhanced Index** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $78195615 | $48728457 | $100619410 | $29726951 | $821690 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 78195615 | 48728457 | 100619410 | 29726951 | 821690 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 41 | 46 | 52 | 46 | 11 |
| Total Liabilities | 41 | 46 | 52 | 46 | 11 |
| **Net Assets** | $78195574 | $48728411 | $100619358 | $29726905 | $821679 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $78195574 | $48697351 | $100486941 | $29726905 | $821679 |
| Net assets from contracts in payout |  | 31060 | 132417 |  |  |
| Total Net Assets | $78195574 | $48728411 | $100619358 | $29726905 | $821679 |

---

The accompanying notes are an integral part of these financial statements.<br>9

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF ASSETS AND LIABILITIES — (Continued)**

**December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTI SSGA** <br> **Growth and** <br> **Income ETF** <br> **Sub-Account** | **BHFTI SSGA** <br> **Growth ETF** <br> **Sub-Account** | **BHFTI T. Rowe** <br> **Price Large** <br> **Cap Value** <br> **Sub-Account** | **BHFTI T. Rowe** <br> **Price Mid** <br> **Cap Growth** <br> **Sub-Account** | **BHFTI Victory** <br> **Sycamore Mid** <br> **Cap Value** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $78281883 | $43083228 | $55541146 | $53143439 | $17809469 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 78281883 | 43083228 | 55541146 | 53143439 | 17809469 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 47 | 39 | 91 | 32 | 69 |
| Total Liabilities | 47 | 39 | 91 | 32 | 69 |
| **Net Assets** | $78281836 | $43083189 | $55541055 | $53143407 | $17809400 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $77901442 | $43048615 | $55535731 | $53139483 | $17809400 |
| Net assets from contracts in payout | 380394 | 34574 | 5324 | 3924 |  |
| Total Net Assets | $78281836 | $43083189 | $55541055 | $53143407 | $17809400 |

---

The accompanying notes are an integral part of these financial statements.<br>10

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTI** <br> **Western Asset** <br> **Management** <br> **Government Income** <br> **Sub-Account** | **BHFTII Baillie** <br> **Gifford** <br> **International** <br> **Stock** <br> **Sub-Account** | **BHFTII** <br> **BlackRock** <br> **Bond Income** <br> **Sub-Account** | **BHFTII** <br> **BlackRock** <br> **Capital** <br> **Appreciation** <br> **Sub-Account** | **BHFTII** <br> **BlackRock** <br> **Ultra-Short** <br> **Term Bond** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $27754382 | $11036463 | $15688420 | $12954640 | $44372066 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 27754382 | 11036463 | 15688420 | 12954640 | 44372066 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 43 | 31 | 78 | 45 | 159 |
| Total Liabilities | 43 | 31 | 78 | 45 | 159 |
| **Net Assets** | $27754339 | $11036432 | $15688342 | $12954595 | $44371907 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $27754339 | $11036432 | $15680362 | $12954595 | $44355681 |
| Net assets from contracts in payout |  |  | 7980 |  | 16226 |
| Total Net Assets | $27754339 | $11036432 | $15688342 | $12954595 | $44371907 |

---

The accompanying notes are an integral part of these financial statements.<br>11

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF ASSETS AND LIABILITIES — (Continued)**

**December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTII** <br> **Brighthouse** <br> **Asset** <br> **Allocation 20** <br> **Sub-Account** | **BHFTII** <br> **Brighthouse** <br> **Asset** <br> **Allocation 40** <br> **Sub-Account** | **BHFTII** <br> **Brighthouse** <br> **Asset** <br> **Allocation 60** <br> **Sub-Account** | **BHFTII** <br> **Brighthouse** <br> **Asset** <br> **Allocation 80** <br> **Sub-Account** | **BHFTII** <br> **Brighthouse/**<br> **Artisan** <br> **Mid Cap Value** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $11945879 | $214540228 | $398629349 | $298347026 | $11294411 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 11945879 | 214540228 | 398629349 | 298347026 | 11294411 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 45 | 65 | 55 | 85 | 88 |
| Total Liabilities | 45 | 65 | 55 | 85 | 88 |
| **Net Assets** | $11945834 | $214540163 | $398629294 | $298346941 | $11294323 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $11936665 | $213958488 | $398230867 | $298149059 | $11294082 |
| Net assets from contracts in payout | 9169 | 581675 | 398427 | 197882 | 241 |
| Total Net Assets | $11945834 | $214540163 | $398629294 | $298346941 | $11294323 |

---

The accompanying notes are an integral part of these financial statements.<br>12

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTII** <br> **Brighthouse/**<br> **Dimensional** <br> **International** <br> **Small Company** <br> **Sub-Account** | **BHFTII** <br> **Brighthouse/**<br> **Wellington** <br> **Core Equity** <br> **Opportunities** <br> **Sub-Account** | **BHFTII** <br> **Frontier** <br> **Mid Cap Growth** <br> **Sub-Account** | **BHFTII** <br> **Jennison Growth** <br> **Sub-Account** | **BHFTII** <br> **Loomis Sayles** <br> **Small Cap Core** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $4247329 | $70228569 | $9392796 | $60088432 | $716072 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 4247329 | 70228569 | 9392796 | 60088432 | 716072 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 31 | 169 | 33 | 47 | 16 |
| Total Liabilities | 31 | 169 | 33 | 47 | 16 |
| **Net Assets** | $4247298 | $70228400 | $9392763 | $60088385 | $716056 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $4210467 | $70206376 | $9366519 | $60032990 | $716056 |
| Net assets from contracts in payout | 36831 | 22024 | 26244 | 55395 |  |
| Total Net Assets | $4247298 | $70228400 | $9392763 | $60088385 | $716056 |

---

The accompanying notes are an integral part of these financial statements.<br>13

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF ASSETS AND LIABILITIES — (Continued)**

**December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTII** <br> **Loomis Sayles** <br> **Small Cap** <br> **Growth** <br> **Sub-Account** | **BHFTII** <br> **MetLife** <br> **Aggregate** <br> **Bond Index** <br> **Sub-Account** | **BHFTII MetLife** <br> **Mid Cap Stock Index** <br> **Sub-Account** | **BHFTII MetLife** <br> **MSCI EAFE<sup>®</sup> Index** <br> **Sub-Account** | **BHFTII MetLife** <br> **Russell 2000<sup>®</sup> Index** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $420285 | $29840232 | $10797679 | $8395729 | $12531366 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 420285 | 29840232 | 10797679 | 8395729 | 12531366 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 14 | 40 | 38 | 30 | 37 |
| Total Liabilities | 14 | 40 | 38 | 30 | 37 |
| **Net Assets** | $420271 | $29840192 | $10797641 | $8395699 | $12531329 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $420271 | $29808901 | $10788070 | $8386413 | $12456097 |
| Net assets from contracts in payout |  | 31291 | 9571 | 9286 | 75232 |
| Total Net Assets | $420271 | $29840192 | $10797641 | $8395699 | $12531329 |

---

The accompanying notes are an integral part of these financial statements.<br>14

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTII MetLife** <br> **Stock Index** <br> **Sub-Account** | **BHFTII** <br> **MFS<sup>®</sup> Total Return** <br> **Sub-Account** | **BHFTII** <br> **MFS<sup>®</sup> Value** <br> **Sub-Account** | **BHFTII Neuberger** <br> **Berman Genesis** <br> **Sub-Account** | **BHFTII** <br> **T. Rowe Price** <br> **Large Cap Growth** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $77419237 | $5553407 | $26172002 | $9821697 | $41326309 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 77419237 | 5553407 | 26172002 | 9821697 | 41326309 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 60 | 83 | 59 | 49 | 30 |
| Total Liabilities | 60 | 83 | 59 | 49 | 30 |
| **Net Assets** | $77419177 | $5553324 | $26171943 | $9821648 | $41326279 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $77359217 | $5521361 | $26171943 | $9806678 | $41326279 |
| Net assets from contracts in payout | 59960 | 31963 |  | 14970 |  |
| Total Net Assets | $77419177 | $5553324 | $26171943 | $9821648 | $41326279 |

---

The accompanying notes are an integral part of these financial statements.<br>15

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF ASSETS AND LIABILITIES — (Continued)**

**December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTII** <br> **T. Rowe Price** <br> **Small Cap Growth** <br> **Sub-Account** | **BHFTII VanEck** <br> **Global Natural** <br> **Resources** <br> **Sub-Account** | **BHFTII Western** <br> **Asset Management** <br> **Strategic Bond** <br> **Opportunities** <br> **Sub-Account** | **BHFTII Western** <br> **Asset Management** <br> **U.S. Government** <br> **Sub-Account** | **BlackRock Global** <br> **Allocation V.I.** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $356819 | $3271323 | $53472812 | $24326746 | $5106653 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 356819 | 3271323 | 53472812 | 24326746 | 5106653 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 11 | 31 | 115 | 60 | 10 |
| Total Liabilities | 11 | 31 | 115 | 60 | 10 |
| **Net Assets** | $356808 | $3271292 | $53472697 | $24326686 | $5106643 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $356808 | $3260842 | $53332542 | $24251260 | $5106643 |
| Net assets from contracts in payout |  | 10450 | 140155 | 75426 |  |
| Total Net Assets | $356808 | $3271292 | $53472697 | $24326686 | $5106643 |

---

The accompanying notes are an integral part of these financial statements.<br>16

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Fidelity<sup>®</sup> VIP** <br> **Contrafund<sup>®</sup>** <br> **Sub-Account** | **Fidelity<sup>®</sup> VIP** <br> **Equity-Income** <br> **Sub-Account** | **Fidelity<sup>®</sup> VIP** <br> **Mid Cap** <br> **Sub-Account** | **FTVIPT Franklin** <br> **Income VIP** <br> **Sub-Account** | **FTVIPT Franklin** <br> **Mutual Shares VIP** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $17299622 | $14077 | $11059141 | $16476684 | $2170122 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 17299622 | 14077 | 11059141 | 16476684 | 2170122 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 62 | 6 | 31 | 37 | 26 |
| Total Liabilities | 62 | 6 | 31 | 37 | 26 |
| **Net Assets** | $17299560 | $14071 | $11059110 | $16476647 | $2170096 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $17297679 | $14071 | $11040833 | $16424503 | $2157139 |
| Net assets from contracts in payout | 1881 |  | 18277 | 52144 | 12957 |
| Total Net Assets | $17299560 | $14071 | $11059110 | $16476647 | $2170096 |

---

The accompanying notes are an integral part of these financial statements.<br>17

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF ASSETS AND LIABILITIES — (Continued)**

**December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **FTVIPT Franklin** <br> **Small Cap Value VIP** <br> **Sub-Account** | **FTVIPT Templeton** <br> **Foreign VIP** <br> **Sub-Account** | **FTVIPT Templeton** <br> **Global Bond VIP** <br> **Sub-Account** | **Invesco V.I.** <br> **Equity and Income** <br> **Sub-Account** | **Invesco V.I. EQV** <br> **International Equity** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $2751765 | $9492205 | $5828793 | $12081576 | $6357086 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 2751765 | 9492205 | 5828793 | 12081576 | 6357086 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 23 | 32 | 22 | 27 | 35 |
| Total Liabilities | 23 | 32 | 22 | 27 | 35 |
| **Net Assets** | $2751742 | $9492173 | $5828771 | $12081549 | $6357051 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $2738917 | $9486202 | $5819355 | $12072239 | $6354072 |
| Net assets from contracts in payout | 12825 | 5971 | 9416 | 9310 | 2979 |
| Total Net Assets | $2751742 | $9492173 | $5828771 | $12081549 | $6357051 |

---

The accompanying notes are an integral part of these financial statements.<br>18

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Invesco** <br> **V.I. Main Street** <br> **Small Cap<sup>®</sup>** <br> **Sub-Account** | **Janus Henderson** <br> **Global** <br> **Sustainable Equity** <br> **Sub-Account** | **LMPVET** <br> **ClearBridge Variable** <br> **Appreciation** <br> **Sub-Account** | **LMPVET** <br> **ClearBridge Variable** <br> **Dividend Strategy** <br> **Sub-Account** | **LMPVET** <br> **ClearBridge Variable** <br> **Large Cap Growth** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $2800157 | $12068 | $22295264 | $12615137 | $226084 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 2800157 | 12068 | 22295264 | 12615137 | 226084 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 28 | 2 | 64 | 46 | 10 |
| Total Liabilities | 28 | 2 | 64 | 46 | 10 |
| **Net Assets** | $2800129 | $12066 | $22295200 | $12615091 | $226074 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $2797758 | $12066 | $22295200 | $12615091 | $221666 |
| Net assets from contracts in payout | 2371 |  |  |  | 4408 |
| Total Net Assets | $2800129 | $12066 | $22295200 | $12615091 | $226074 |

---

The accompanying notes are an integral part of these financial statements.<br>19

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF ASSETS AND LIABILITIES — (Continued)**

**December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **LMPVET** <br> **ClearBridge Variable** <br> **Large Cap Value** <br> **Sub-Account** | **LMPVET** <br> **ClearBridge Variable** <br> **Small Cap Growth** <br> **Sub-Account** | **LMPVET Franklin** <br> **Multi-Asset Variable** <br> **Conservative Growth** <br> **Sub-Account** | **LMPVET Franklin** <br> **Multi-Asset** <br> **Variable Growth** <br> **Sub-Account** | **LMPVET Franklin** <br> **Multi-Asset Variable** <br> **Moderate Growth** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $221481 | $5865941 | $1064103 | $1053714 | $28961 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 221481 | 5865941 | 1064103 | 1053714 | 28961 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 13 | 41 | 16 | 12 | 5 |
| Total Liabilities | 13 | 41 | 16 | 12 | 5 |
| **Net Assets** | $221468 | $5865900 | $1064087 | $1053702 | $28956 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $221468 | $5865900 | $1064087 | $1053702 | $28956 |
| Net assets from contracts in payout |  |  |  |  |  |
| Total Net Assets | $221468 | $5865900 | $1064087 | $1053702 | $28956 |

---

The accompanying notes are an integral part of these financial statements.<br>20

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **LMPVIT Western** <br> **Asset Variable** <br> **Global High** <br> **Yield Bond** <br> **Sub-Account** | **PIMCO VIT** <br> **High Yield** <br> **Sub-Account** | **PIMCO VIT** <br> **Low Duration** <br> **Sub-Account** | **Pioneer** <br> **Mid Cap Value VCT** <br> **Sub-Account** | **Putnam VT** <br> **Large Cap Value** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $6316868 | $69324 | $39455 | $1694861 | $15933 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |  |  |  |
| Total Assets | 6316868 | 69324 | 39455 | 1694861 | 15933 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 36 | 5 | 5 | 26 | 4 |
| Total Liabilities | 36 | 5 | 5 | 26 | 4 |
| **Net Assets** | $6316832 | $69319 | $39450 | $1694835 | $15929 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $6316832 | $69319 | $39450 | $1694835 | $15929 |
| Net assets from contracts in payout |  |  |  |  |  |
| Total Net Assets | $6316832 | $69319 | $39450 | $1694835 | $15929 |

---

The accompanying notes are an integral part of these financial statements.<br>21

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF ASSETS AND LIABILITIES — (Concluded)**

**December 31, 2022**

---

| | | |
|:---|:---|:---|
| | **Putnam VT** <br> **Sustainable Leaders** <br> **Sub-Account** | **TAP 1919** <br> **Variable Socially** <br> **Responsive** <br> **Balanced** <br> **Sub-Account** |
| **Assets:** | **Assets:** | **Assets:** |
| Investments at fair value | $367687 | $197481 |
| Due from Brighthouse Life Insurance<br>Company of NY |  |  |
| Total Assets | 367687 | 197481 |
| **Liabilities:** | **Liabilities:** | **Liabilities:** |
| Due to Brighthouse Life Insurance<br>Company of NY | 3 | 7 |
| Total Liabilities | 3 | 7 |
| **Net Assets** | $367684 | $197474 |
| **Contract Owners' Equity** | **Contract Owners' Equity** | **Contract Owners' Equity** |
| Net assets from accumulation units | $367684 | $197474 |
| Net assets from contracts in payout |  |  |
| Total Net Assets | $367684 | $197474 |

---

The accompanying notes are an integral part of these financial statements.<br>22

------

This page is intentionally left blank.

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF OPERATIONS**

**For the year ended December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **American Funds<sup>®</sup>** <br> **Global Growth** <br> **Sub-Account** | **American Funds<sup>®</sup>** <br> **Global Small** <br> **Capitalization** <br> **Sub-Account** | **American Funds<sup>®</sup>** <br> **Growth** <br> **Sub-Account** | **American Funds<sup>®</sup>** <br> **Growth-Income** <br> **Sub-Account** | **American Funds<sup>®</sup>** <br> **The Bond** <br> **Fund of America** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $146391 | $— | $141735 | $306729 | $215709 |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 286936 | 29429 | 570513 | 339756 | 88348 |
| Administrative charges | 54488 | 8194 | 111070 | 60855 | 17336 |
| Total expenses | 341424 | 37623 | 681583 | 400611 | 105684 |
| Net investment income (loss) | (195033) | (37623) | (539848) | (93882) | 110025 |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)** <br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)** <br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)** <br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)** <br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)** <br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)** <br> **on Investments:** |
| Realized gain distributions | 2550359 | 1129801 | 6425610 | 2510710 | 91493 |
| Realized gains (losses) on sale of <br>investments | 287652 | 5330 | 583941 | 727392 | (191396) |
| Net realized gains (losses) | 2838011 | 1135131 | 7009551 | 3238102 | (99903) |
| Change in unrealized gains (losses) <br>on investments | (10125723) | (2390890) | (24167323) | (8565719) | (1238954) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (7287712) | (1255759) | (17157772) | (5327617) | (1338857) |
| Net increase (decrease) in net assets <br>resulting from operations | $(7482745) | $(1293382) | $(17697620) | $(5421499) | $(1228832) |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>24

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTI AB Global** <br> **Dynamic Allocation** <br> **Sub-Account** | **BHFTI AB** <br> **International Bond** <br> **Sub-Account** | **BHFTI** <br> **Allspring**<br> **Mid Cap Value** <br> **Sub-Account** | **BHFTI**<br> **American Funds<sup>®</sup>** <br> **Balanced Allocation** <br> **Sub-Account** | **BHFTI** <br> **American Funds<sup>®</sup>** <br> **Growth Allocation** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $4440011 | $157035 | $65634 | $2964725 | $1303349 |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 1249168 | 14994 | 233276 | 2676922 | 1604991 |
| Administrative charges | 257566 | 3415 | 42526 | 523432 | 302339 |
| Total expenses | 1506734 | 18409 | 275802 | 3200354 | 1907330 |
| Net investment income (loss) | 2933277 | 138626 | (210168) | (235629) | (603981) |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)** <br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)** <br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)** <br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)** <br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)** <br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)** <br> **on Investments:** |
| Realized gain distributions | 7453895 | 13388 | 3077910 | 27856058 | 18916838 |
| Realized gains (losses) on sale of <br>investments | (681765) | (29308) | 244582 | 234091 | (435991) |
| Net realized gains (losses) | 6772130 | (15920) | 3322492 | 28090149 | 18480847 |
| Change in unrealized gains (losses) <br>on investments | (36495467) | (386913) | (4394847) | (72232007) | (46610178) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (29723337) | (402833) | (1072355) | (44141858) | (28129331) |
| Net increase (decrease) in net assets <br>resulting from operations | $(26790060) | $(264207) | $(1282523) | $(44377487) | $(28733312) |

---

The accompanying notes are an integral part of these financial statements.<br>25

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF OPERATIONS — (Continued)**

**For the year ended December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTI**<br> **American Funds<sup>®</sup>** <br> **Growth** <br> **Sub-Account** | **BHFTI** <br> **American Funds<sup>®</sup>** <br> **Moderate Allocation** <br> **Sub-Account** | **BHFTI** <br> **BlackRock Global** <br> **Tactical Strategies** <br> **Sub-Account** | **BHFTI** <br> **BlackRock** <br> **High Yield** <br> **Sub-Account** | **BHFTI**<br> **Brighthouse**<br> **Asset**<br> **Allocation 100** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $467116 | $1820418 | $4492686 | $2817747 | $1366599 |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 1044327 | 1331148 | 2353649 | 636556 | 1408612 |
| Administrative charges | 203506 | 260271 | 482676 | 136233 | 252927 |
| Total expenses | 1247833 | 1591419 | 2836325 | 772789 | 1661539 |
| Net investment income (loss) | (780717) | 228999 | 1656361 | 2044958 | (294940) |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions | 17439012 | 10976688 | 7175818 |  | 9014464 |
| Realized gains (losses) on sale of<br>investments | 143384 | (535616) | (2185543) | (619936) | (214400) |
| Net realized gains (losses) | 17582396 | 10441072 | 4990275 | (619936) | 8800064 |
| Change in unrealized gains (losses)<br>on investments | (49376596) | (29620820) | (52510688) | (8611976) | (34904564) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (31794200) | (19179748) | (47520413) | (9231912) | (26104500) |
| Net increase (decrease) in net assets<br>resulting from operations | $(32574917) | $(18950749) | $(45864052) | $(7186954) | $(26399440) |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>26

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTI** <br> **Brighthouse**<br> **Balanced Plus** <br> **Sub-Account** | **BHFTI** <br> **Brighthouse** <br> **Small Cap Value** <br> **Sub-Account** | **BHFTI**<br> **Brighthouse/abrdn**<br> **Emerging** <br> **Markets Equity** <br> **Sub-Account** | **BHFTI** <br> **Brighthouse/**<br> **Eaton Vance** <br> **Floating Rate** <br> **Sub-Account** | **BHFTI** <br> **Brighthouse/**<br> **Franklin Low** <br> **Duration** <br> **Total Return** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $9080181 | $159232 | $172086 | $441167 | $387814 |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 4409455 | 355873 | 317344 | 147558 | 191166 |
| Administrative charges | 930804 | 64534 | 58786 | 30653 | 35980 |
| Total expenses | 5340259 | 420407 | 376130 | 178211 | 227146 |
| Net investment income (loss) | 3739922 | (261175) | (204044) | 262956 | 160668 |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions | 35438440 | 4463115 | 3502864 |  |  |
| Realized gains (losses) on sale of<br>investments | (3572318) | 355166 | 4179 | (112054) | (363467) |
| Net realized gains (losses) | 31866122 | 4818281 | 3507043 | (112054) | (363467) |
| Change in unrealized gains (losses)<br>on investments | (139536531) | (8821765) | (11234038) | (540923) | (808436) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (107670409) | (4003484) | (7726995) | (652977) | (1171903) |
| Net increase (decrease) in net assets<br>resulting from operations | $(103930487) | $(4264659) | $(7931039) | $(390021) | $(1011235) |

---

The accompanying notes are an integral part of these financial statements.<br>27

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF OPERATIONS — (Continued)**

**For the year ended December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTI**<br> **Brighthouse/**<br> **Templeton**<br> **International**<br> **Bond**<br> **Sub-Account** | **BHFTI**<br> **Brighthouse/**<br> **Wellington** <br> **Large Cap** <br> **Research** <br> **Sub-Account** | **BHFTI CBRE** <br> **Global** <br> **Real Estate** <br> **Sub-Account** | **BHFTI**<br> **Harris Oakmark** <br> **International** <br> **Sub-Account** | **BHFTI Invesco** <br> **Balanced-Risk** <br> **Allocation** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $— | $9423 | $655728 | $968553 | $2281208 |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 30586 | 25161 | 217269 | 597715 | 418151 |
| Administrative charges | 6047 | 4190 | 39893 | 109366 | 88390 |
| Total expenses | 36633 | 29351 | 257162 | 707081 | 506541 |
| Net investment income (loss) | (36633) | (19928) | 398566 | 261472 | 1774667 |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions |  | 371168 | 1534418 | 2436968 | 2172579 |
| Realized gains (losses) on sale of<br>investments | (138259) | 23871 | 201870 | (446523) | (540648) |
| Net realized gains (losses) | (138259) | 395039 | 1736288 | 1990445 | 1631931 |
| Change in unrealized gains (losses)<br>on investments | 19360 | (786143) | (7269850) | (11084705) | (8728095) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (118899) | (391104) | (5533562) | (9094260) | (7096164) |
| Net increase (decrease) in net assets<br>resulting from operations | $(155532) | $(411032) | $(5134996) | $(8832788) | $(5321497) |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>28

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTI Invesco** <br> **Comstock** <br> **Sub-Account** | **BHFTI Invesco** <br> **Global Equity** <br> **Sub-Account** | **BHFTI Invesco** <br> **Small Cap** <br> **Growth** <br> **Sub-Account** | **BHFTI**<br> **JPMorgan** <br> **Core Bond** <br> **Sub-Account** | **BHFTI** <br> **JPMorgan** <br> **Global Active** <br> **Allocation** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $616233 | $— | $— | $732135 | $1443612 |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 413406 | 37235 | 463529 | 389908 | 664819 |
| Administrative charges | 80634 | 8267 | 91867 | 74599 | 145837 |
| Total expenses | 494040 | 45502 | 555396 | 464507 | 810656 |
| Net investment income (loss) | 122193 | (45502) | (555396) | 267628 | 632956 |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions | 4698269 | 475808 | 13216282 |  | 7342942 |
| Realized gains (losses) on sale of<br>investments | 1278944 | 923 | (1389874) | (459702) | (554168) |
| Net realized gains (losses) | 5977213 | 476731 | 11826408 | (459702) | 6788774 |
| Change in unrealized gains (losses)<br>on investments | (6376704) | (1854985) | (29109339) | (4583343) | (20508235) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (399491) | (1378254) | (17282931) | (5043045) | (13719461) |
| Net increase (decrease) in net assets<br>resulting from operations | $(277298) | $(1423756) | $(17838327) | $(4775417) | $(13086505) |

---

The accompanying notes are an integral part of these financial statements.<br>29

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF OPERATIONS — (Continued)**

**For the year ended December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTI** <br> **JPMorgan** <br> **Small Cap** <br> **Value** <br> **Sub-Account** | **BHFTI** <br> **Loomis Sayles** <br> **Global Allocation** <br> **Sub-Account** | **BHFTI** <br> **Loomis Sayles** <br> **Growth** <br> **Sub-Account** | **BHFTI**<br> **MetLife**<br> **Multi-Index** <br> **Targeted Risk** <br> **Sub-Account** | **BHFTI MFS<sup>®</sup>** <br> **Research**<br> **International** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $41175 | $— | $— | $752458 | $464974 |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 52456 | 247378 | 657841 | 481556 | 351613 |
| Administrative charges | 9019 | 46604 | 118605 | 105644 | 64242 |
| Total expenses | 61475 | 293982 | 776446 | 587200 | 415855 |
| Net investment income (loss) | (20300) | (293982) | (776446) | 165258 | 49119 |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions | 1193815 | 2605759 | 4479631 | 3923265 | 1776477 |
| Realized gains (losses) on sale of<br>investments | 28266 | (54594) | (139140) | (587910) | 138907 |
| Net realized gains (losses) | 1222081 | 2551165 | 4340491 | 3335355 | 1915384 |
| Change in unrealized gains (losses)<br>on investments | (1811817) | (7967290) | (21524231) | (15035888) | (7886301) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (589736) | (5416125) | (17183740) | (11700533) | (5970917) |
| Net increase (decrease) in net assets<br>resulting from operations | $(610036) | $(5710107) | $(17960186) | $(11535275) | $(5921798) |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>30

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTI**<br> **Morgan Stanley** <br> **Discovery** <br> **Sub-Account** | **BHFTI**<br> **PanAgora**<br> **Global**<br> **Diversified Risk** <br> **Sub-Account** | **BHFTI**<br> **PIMCO Inflation** <br> **Protected Bond** <br> **Sub-Account** | **BHFTI** <br> **PIMCO** <br> **Total Return** <br> **Sub-Account** | **BHFTI**<br> **Schroders**<br> **Global**<br> **Multi-Asset**<br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $— | $10094191 | $3349430 | $3245920 | $462438 |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 128644 | 722656 | 711733 | 1424390 | 383193 |
| Administrative charges | 23791 | 149808 | 132983 | 275102 | 82220 |
| Total expenses | 152435 | 872464 | 844716 | 1699492 | 465413 |
| Net investment income (loss) | (152435) | 9221727 | 2504714 | 1546428 | (2975) |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions | 5070807 | 6004698 |  |  | 2175171 |
| Realized gains (losses) on sale of<br>investments | (623419) | (1289736) | (264494) | (2099822) | (197291) |
| Net realized gains (losses) | 4447388 | 4714962 | (264494) | (2099822) | 1977880 |
| Change in unrealized gains (losses)<br>on investments | (15332025) | (31051666) | (10006009) | (19392140) | (10515168) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (10884637) | (26336704) | (10270503) | (21491962) | (8537288) |
| Net increase (decrease) in net assets<br>resulting from operations | $(11037072) | $(17114977) | $(7765789) | $(19945534) | $(8540263) |

---

The accompanying notes are an integral part of these financial statements.<br>31

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF OPERATIONS — (Continued)**

**For the year ended December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTI SSGA** <br> **Emerging Markets** <br> **Enhanced Index** <br> **Sub-Account** | **BHFTI SSGA** <br> **Growth and** <br> **Income ETF** <br> **Sub-Account** | **BHFTI SSGA** <br> **Growth ETF** <br> **Sub-Account** | **BHFTI T. Rowe** <br> **Price Large** <br> **Cap Value** <br> **Sub-Account** | **BHFTI T. Rowe** <br> **Price Mid** <br> **Cap Growth** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $18395 | $2533554 | $1283423 | $934697 | $— |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 7954 | 1056034 | 572087 | 767745 | 728799 |
| Administrative charges | 1865 | 209374 | 115811 | 144070 | 142460 |
| Total expenses | 9819 | 1265408 | 687898 | 911815 | 871259 |
| Net investment income (loss) | 8576 | 1268146 | 595525 | 22882 | (871259) |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions |  | 13847683 | 7912512 | 7197069 | 11113514 |
| Realized gains (losses) on sale of<br>investments | (11780) | (355128) | (141764) | 1057492 | (750768) |
| Net realized gains (losses) | (11780) | 13492555 | 7770748 | 8254561 | 10362746 |
| Change in unrealized gains (losses)<br>on investments | (173073) | (30728242) | (17572169) | (12443704) | (26182136) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (184853) | (17235687) | (9801421) | (4189143) | (15819390) |
| Net increase (decrease) in net assets<br>resulting from operations | $(176277) | $(15967541) | $(9205896) | $(4166261) | $(16690649) |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>32

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTI Victory**<br> **Sycamore Mid** <br> **Cap Value** <br> **Sub-Account** | **BHFTI**<br> **Western Asset** <br> **Management**<br> **Government Income** <br> **Sub-Account** | **BHFTII Baillie** <br> **Gifford** <br> **International** <br> **Stock** <br> **Sub-Account** | **BHFTII**<br> **BlackRock** <br> **Bond Income** <br> **Sub-Account** | **BHFTII**<br> **BlackRock**<br> **Capital**<br> **Appreciation**<br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $307985 | $700709 | $98304 | $454610 | $— |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 238762 | 345940 | 154143 | 190483 | 153948 |
| Administrative charges | 46080 | 74130 | 29071 | 40490 | 33413 |
| Total expenses | 284842 | 420070 | 183214 | 230973 | 187361 |
| Net investment income (loss) | 23143 | 280639 | (84910) | 223637 | (187361) |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions | 2241670 |  | 1072307 | 20435 | 4013380 |
| Realized gains (losses) on sale of<br>investments | 602925 | (897741) | (81226) | (370230) | (122196) |
| Net realized gains (losses) | 2844595 | (897741) | 991081 | (349795) | 3891184 |
| Change in unrealized gains (losses)<br>on investments | (3745353) | (4759750) | (5375526) | (2854382) | (10595662) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (900758) | (5657491) | (4384445) | (3204177) | (6704478) |
| Net increase (decrease) in net assets<br>resulting from operations | $(877615) | $(5376852) | $(4469355) | $(2980540) | $(6891839) |

---

The accompanying notes are an integral part of these financial statements.<br>33

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF OPERATIONS — (Continued)**

**For the year ended December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTII**<br> **BlackRock**<br> **Ultra-Short**<br> **Term Bond** <br> **Sub-Account** | **BHFTII**<br> **Brighthouse**<br> **Asset** <br> **Allocation 20** <br> **Sub-Account** | **BHFTII**<br> **Brighthouse**<br> **Asset** <br> **Allocation 40** <br> **Sub-Account** | **BHFTII** <br> **Brighthouse** <br> **Asset** <br> **Allocation 60** <br> **Sub-Account** | **BHFTII** <br> **Brighthouse** <br> **Asset** <br> **Allocation 80** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $— | $358764 | $6056101 | $9277746 | $5904538 |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 574647 | 151745 | 3112710 | 5562474 | 4541564 |
| Administrative charges | 108016 | 28931 | 588021 | 1082677 | 823405 |
| Total expenses | 682663 | 180676 | 3700731 | 6645151 | 5364969 |
| Net investment income (loss) | (682663) | 178088 | 2355370 | 2632595 | 539569 |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions |  | 362127 | 12816911 | 33399887 | 31190789 |
| Realized gains (losses) on sale of<br>investments | (118383) | (72684) | (3770084) | (6096887) | (4477098) |
| Net realized gains (losses) | (118383) | 289443 | 9046827 | 27303000 | 26713691 |
| Change in unrealized gains (losses)<br>on investments | 623943 | (2240953) | (52512213) | (113977855) | (103687059) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | 505560 | (1951510) | (43465386) | (86674855) | (76973368) |
| Net increase (decrease) in net assets<br>resulting from operations | $(177103) | $(1773422) | $(41110016) | $(84042260) | $(76433799) |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>34

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTII**<br> **Brighthouse/**<br> **Artisan** <br> **Mid Cap Value** <br> **Sub-Account** | **BHFTII**<br> **Brighthouse/**<br> **Dimensional**<br> **International** <br> **Small Company** <br> **Sub-Account** | **BHFTII**<br> **Brighthouse/**<br> **Wellington**<br> **Core Equity** <br> **Opportunities** <br> **Sub-Account** | **BHFTII**<br> **Frontier** <br> **Mid Cap Growth** <br> **Sub-Account** | **BHFTII**<br> **Jennison Growth** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $88338 | $106456 | $980862 | $— | $— |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 172834 | 59136 | 999745 | 131905 | 877023 |
| Administrative charges | 31628 | 11370 | 185631 | 25502 | 172749 |
| Total expenses | 204462 | 70506 | 1185376 | 157407 | 1049772 |
| Net investment income (loss) | (116124) | 35950 | (204514) | (157407) | (1049772) |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions | 1896603 | 494898 | 13613946 | 3579402 | 17022342 |
| Realized gains (losses) on sale of<br>investments | 270992 | (122989) | 1421741 | (249298) | (714277) |
| Net realized gains (losses) | 2167595 | 371909 | 15035687 | 3330104 | 16308065 |
| Change in unrealized gains (losses)<br>on investments | (4073602) | (1453187) | (20778263) | (6923547) | (52643998) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (1906007) | (1081278) | (5742576) | (3593443) | (36335933) |
| Net increase (decrease) in net assets<br>resulting from operations | $(2022131) | $(1045328) | $(5947090) | $(3750850) | $(37385705) |

---

The accompanying notes are an integral part of these financial statements.<br>35

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF OPERATIONS — (Continued)**

**For the year ended December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTII**<br> **Loomis Sayles** <br> **Small Cap Core** <br> **Sub-Account** | **BHFTII**<br> **Loomis Sayles** <br> **Small Cap** <br> **Growth** <br> **Sub-Account** | **BHFTII**<br> **MetLife**<br> **Aggregate** <br> **Bond Index** <br> **Sub-Account** | **BHFTII MetLife**<br> **Mid Cap Stock Index** <br> **Sub-Account** | **BHFTII MetLife** <br> **MSCI EAFE<sup>®</sup> Index** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $— | $— | $784794 | $93630 | $299202 |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 11814 | 4327 | 386657 | 135940 | 106469 |
| Administrative charges | 1886 | 1131 | 78286 | 27938 | 21458 |
| Total expenses | 13700 | 5458 | 464943 | 163878 | 127927 |
| Net investment income (loss) | (13700) | (5458) | 319851 | (70248) | 171275 |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions | 154862 | 113601 |  | 1883273 | 232008 |
| Realized gains (losses) on sale of<br>investments | (5033) | (12318) | (631092) | 11503 | 89871 |
| Net realized gains (losses) | 149829 | 101283 | (631092) | 1894776 | 321879 |
| Change in unrealized gains (losses)<br>on investments | (287331) | (233796) | (4821917) | (3623564) | (2059678) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (137502) | (132513) | (5453009) | (1728788) | (1737799) |
| Net increase (decrease) in net assets<br>resulting from operations | $(151202) | $(137971) | $(5133158) | $(1799036) | $(1566524) |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>36

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTII MetLife** <br> **Russell 2000<sup>®</sup> Index** <br> **Sub-Account** | **BHFTII MetLife** <br> **Stock Index** <br> **Sub-Account** | **BHFTII** <br> **MFS<sup>®</sup> Total Return** <br> **Sub-Account** | **BHFTII** <br> **MFS<sup>®</sup> Value** <br> **Sub-Account** | **BHFTII Neuberger** <br> **Berman Genesis** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $101862 | $878565 | $98649 | $407714 | $— |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 157354 | 1002508 | 75910 | 326578 | 148479 |
| Administrative charges | 32773 | 204067 | 15194 | 66977 | 27231 |
| Total expenses | 190127 | 1206575 | 91104 | 393555 | 175710 |
| Net investment income (loss) | (88265) | (328010) | 7545 | 14159 | (175710) |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions | 2422562 | 7718638 | 603369 | 3914427 | 1904842 |
| Realized gains (losses) on sale of<br>investments | (51741) | 1707819 | 40236 | 222971 | 311102 |
| Net realized gains (losses) | 2370821 | 9426457 | 643605 | 4137398 | 2215944 |
| Change in unrealized gains (losses)<br>on investments | (5594056) | (27821423) | (1442661) | (6442795) | (4900749) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (3223235) | (18394966) | (799056) | (2305397) | (2684805) |
| Net increase (decrease) in net assets<br>resulting from operations | $(3311500) | $(18722976) | $(791511) | $(2291238) | $(2860515) |

---

The accompanying notes are an integral part of these financial statements.<br>37

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF OPERATIONS — (Continued)**

**For the year ended December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BHFTII** <br> **T. Rowe Price** <br> **Large Cap Growth** <br> **Sub-Account** | **BHFTII**<br> **T. Rowe Price** <br> **Small Cap Growth** <br> **Sub-Account** | **BHFTII VanEck** <br> **Global Natural** <br> **Resources** <br> **Sub-Account** | **BHFTII Western** <br> **Asset Management** <br> **Strategic Bond** <br> **Opportunities** <br> **Sub-Account** | **BHFTII Western** <br> **Asset Management** <br> **U.S. Government** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $— | $— | $92900 | $3485125 | $524454 |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 589031 | 5867 | 50826 | 717145 | 328218 |
| Administrative charges | 116946 | 968 | 9434 | 146599 | 60024 |
| Total expenses | 705977 | 6835 | 60260 | 863744 | 388242 |
| Net investment income (loss) | (705977) | (6835) | 32640 | 2621381 | 136212 |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions | 10201255 | 81134 |  |  |  |
| Realized gains (losses) on sale of<br>investments | (770001) | (3267) | 374892 | (1314854) | (709240) |
| Net realized gains (losses) | 9431254 | 77867 | 374892 | (1314854) | (709240) |
| Change in unrealized gains (losses)<br>on investments | (35287598) | (184896) | (69498) | (13666366) | (2463664) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (25856344) | (107029) | 305394 | (14981220) | (3172904) |
| Net increase (decrease) in net assets<br>resulting from operations | $(26562321) | $(113864) | $338034 | $(12359839) | $(3036692) |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>38

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BlackRock Global** <br> **Allocation V.I.** <br> **Sub-Account** | **Fidelity<sup>®</sup> VIP** <br> **Contrafund<sup>®</sup>** <br> **Sub-Account** | **Fidelity<sup>®</sup> VIP** <br> **Equity-Income** <br> **Sub-Account** | **Fidelity<sup>®</sup> VIP** <br> **Mid Cap** <br> **Sub-Account** | **FTVIPT Franklin** <br> **Income VIP** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $— | $70647 | $246 | $31014 | $829253 |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 54262 | 253774 | 184 | 137499 | 226559 |
| Administrative charges | 12711 | 44710 | 36 | 27554 | 41403 |
| Total expenses | 66973 | 298484 | 220 | 165053 | 267962 |
| Net investment income (loss) | (66973) | (227837) | 26 | (134039) | 561291 |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions | 79705 | 928033 | 494 | 806683 | 336598 |
| Realized gains (losses) on sale of<br>investments | (51793) | 401990 | 140 | 78671 | 100517 |
| Net realized gains (losses) | 27912 | 1330023 | 634 | 885354 | 437115 |
| Change in unrealized gains (losses)<br>on investments | (957620) | (7778585) | (1749) | (3040018) | (2277755) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (929708) | (6448562) | (1115) | (2154664) | (1840640) |
| Net increase (decrease) in net assets<br>resulting from operations | $(996681) | $(6676399) | $(1089) | $(2288703) | $(1279349) |

---

The accompanying notes are an integral part of these financial statements.<br>39

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF OPERATIONS — (Continued)**

**For the year ended December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **FTVIPT Franklin** <br> **Mutual Shares VIP** <br> **Sub-Account** | **FTVIPT Franklin** <br> **Small Cap Value VIP** <br> **Sub-Account** | **FTVIPT Templeton** <br> **Foreign VIP** <br> **Sub-Account** | **FTVIPT Templeton** <br> **Global Bond VIP** <br> **Sub-Account** | **Invesco V.I.** <br> **Equity and Income** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $41845 | $28038 | $305014 | $— | $187930 |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 26732 | 33204 | 151211 | 72031 | 158664 |
| Administrative charges | 5657 | 6704 | 24957 | 14641 | 30186 |
| Total expenses | 32389 | 39908 | 176168 | 86672 | 188850 |
| Net investment income (loss) | 9456 | (11870) | 128846 | (86672) | (920) |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions | 252706 | 529103 |  |  | 1734112 |
| Realized gains (losses) on sale of<br>investments | (9627) | (25955) | (226014) | (380789) | 327175 |
| Net realized gains (losses) | 243079 | 503148 | (226014) | (380789) | 2061287 |
| Change in unrealized gains (losses)<br>on investments | (486280) | (859494) | (932074) | 30249 | (3418929) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (243201) | (356346) | (1158088) | (350540) | (1357642) |
| Net increase (decrease) in net assets<br>resulting from operations | $(233745) | $(368216) | $(1029242) | $(437212) | $(1358562) |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>40

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Invesco V.I. EQV** <br> **International Equity**<br> **Sub-Account** | **Invesco V.I.** <br> **Main Street** <br> **Small Cap<sup>®</sup>** **Sub-Account** | **Janus Henderson**<br> **Global Sustainable**<br> **Equity**<br> **Sub-Account (a)** | **LMPVET**<br> **ClearBridge Variable** <br> **Appreciation** <br> **Sub-Account** | **LMPVET**<br> **ClearBridge Variable** <br> **Dividend Strategy** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $94814 | $7642 | $66 | $229454 | $160471 |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 74318 | 35523 | 51 | 286759 | 160000 |
| Administrative charges | 15793 | 7396 | 11 | 53531 | 29997 |
| Total expenses | 90111 | 42919 | 62 | 340290 | 189997 |
| Net investment income (loss) | 4703 | (35277) | 4 | (110836) | (29526) |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions | 740300 | 358068 |  | 1116292 | 1107757 |
| Realized gains (losses) on sale of<br>investments | 59839 | 91247 | (4) | 1294858 | 579279 |
| Net realized gains (losses) | 800139 | 449315 | (4) | 2411150 | 1687036 |
| Change in unrealized gains (losses)<br>on investments | (2395955) | (1069128) | (910) | (6121163) | (3065686) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (1595816) | (619813) | (914) | (3710013) | (1378650) |
| Net increase (decrease) in net assets<br>resulting from operations | $(1591113) | $(655090) | $(910) | $(3820849) | $(1408176) |

---

The accompanying notes are an integral part of these financial statements.<br>41

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF OPERATIONS — (Continued)**

**For the year ended December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **LMPVET** <br> **ClearBridge Variable** <br> **Large Cap Growth** <br> **Sub-Account** | **LMPVET**<br> **ClearBridge Variable** <br> **Large Cap Value** <br> **Sub-Account** | **LMPVET** <br> **ClearBridge Variable** <br> **Small Cap Growth** <br> **Sub-Account** | **LMPVET Franklin**<br> **Multi-Asset Variable** <br> **Conservative Growth** <br> **Sub-Account** | **LMPVET Franklin** <br> **Multi-Asset Variable** <br> **Growth** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $— | $3023 | $— | $24866 | $34868 |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 3645 | 3585 | 76172 | 15144 | 13949 |
| Administrative charges | 633 | 577 | 12752 | 3147 | 2800 |
| Total expenses | 4278 | 4162 | 88924 | 18291 | 16749 |
| Net investment income (loss) | (4278) | (1139) | (88924) | 6575 | 18119 |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions | 17658 | 8773 | 131502 | 67195 | 93872 |
| Realized gains (losses) on sale of<br>investments | 2854 | 4201 | 12970 | 7814 | 4466 |
| Net realized gains (losses) | 20512 | 12974 | 144472 | 75009 | 98338 |
| Change in unrealized gains (losses)<br>on investments | (128153) | (33238) | (2397200) | (306752) | (327160) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (107641) | (20264) | (2252728) | (231743) | (228822) |
| Net increase (decrease) in net assets<br>resulting from operations | $(111919) | $(21403) | $(2341652) | $(225168) | $(210703) |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>42

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **LMPVET Franklin** <br> **Multi-Asset Variable** <br> **Moderate Growth** <br> **Sub-Account** | **LMPVIT Western** <br> **Asset Variable** <br> **Global High** <br> **Yield Bond** <br> **Sub-Account** | **PIMCO VIT** <br> **High Yield** <br> **Sub-Account** | **PIMCO VIT** <br> **Low Duration** <br> **Sub-Account** | **Pioneer** <br> **Mid Cap Value VCT** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $554 | $423451 | $3696 | $680 | $24881 |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 421 | 82454 | 868 | 487 | 21878 |
| Administrative charges | 75 | 14048 | 181 | 99 | 4181 |
| Total expenses | 496 | 96502 | 1049 | 586 | 26059 |
| Net investment income (loss) | 58 | 326949 | 2647 | 94 | (1178) |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions | 2206 |  |  |  | 735289 |
| Realized gains (losses) on sale of<br>investments | (139) | (165358) | (268) | (42) | (1424) |
| Net realized gains (losses) | 2067 | (165358) | (268) | (42) | 733865 |
| Change in unrealized gains (losses)<br>on investments | (7940) | (1305538) | (11899) | (3077) | (877943) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (5873) | (1470896) | (12167) | (3119) | (144078) |
| Net increase (decrease) in net assets<br>resulting from operations | $(5815) | $(1143947) | $(9520) | $(3025) | $(145256) |

---

The accompanying notes are an integral part of these financial statements.<br>43

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF OPERATIONS — (Concluded)**

**For the year ended December 31, 2022**

---

| | | | |
|:---|:---|:---|:---|
| | **Putnam VT** <br> **Large Cap Value** <br> **Sub-Account** | **Putnam VT** <br> **Sustainable Leaders** <br> **Sub-Account** | **TAP 1919** <br> **Variable Socially** <br> **Responsive** <br> **Balanced** <br> **Sub-Account** |
| **Investment Income:** | **Investment Income:** | **Investment Income:** | **Investment Income:** |
| Dividends | $231 | $3228 | $1486 |
| **Expenses:** | **Expenses:** | **Expenses:** | **Expenses:** |
| Mortality and expense risk and <br>other charges | 78 | 4929 | 2941 |
| Administrative charges | 38 | 590 | 528 |
| Total expenses | 116 | 5519 | 3469 |
| Net investment income (loss) | 115 | (2291) | (1983) |
| **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** | **Net Realized and Change in** <br> **Unrealized Gains (Losses)**<br> **on Investments:** |
| Realized gain distributions | 1340 | 57427 | 10284 |
| Realized gains (losses) on sale of<br>investments | 33 | 1179 | 249 |
| Net realized gains (losses) | 1373 | 58606 | 10533 |
| Change in unrealized gains (losses)<br>on investments | (2125) | (170986) | (64961) |
| Net realized and change in <br>unrealized gains (losses) <br>on investments | (752) | (112380) | (54428) |
| Net increase (decrease) in net assets<br>resulting from operations | $(637) | $(114671) | $(56411) |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>44

------

This page is intentionally left blank.

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF CHANGES IN NET ASSETS**

**For the years ended December 31, 2022 and 2021**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **American Funds<sup>®</sup> Global Growth**<br> **Sub-Account** | **American Funds<sup>®</sup> Global Growth**<br> **Sub-Account** | **American Funds<sup>®</sup>** **Global Small Capitalization**<br> **Sub-Account** | **American Funds<sup>®</sup>** **Global Small Capitalization**<br> **Sub-Account** | **American Funds<sup>®</sup> Growth**<br> **Sub-Account** | **American Funds<sup>®</sup> Growth**<br> **Sub-Account** | **American Funds<sup>®</sup> Growth-Income**<br> **Sub-Account** | **American Funds<sup>®</sup> Growth-Income**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $(195033) | $(347139) | $(37623) | $(52419) | $(539848) | $(808713) | $(93882) | $(147196) |
| Net realized gains (losses) | 2838011 | 3499200 | 1135131 | 486536 | 7009551 | 14085410 | 3238102 | 1657034 |
| Change in unrealized gains <br>(losses) on investments | (10125723) | 802629 | (2390890) | (163175) | (24167323) | (2721277) | (8565719) | 4389873 |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (7482745) | 3954690 | (1293382) | 270942 | (17697620) | 10555420 | (5421499) | 5899711 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 374834 | 657001 | 10715 | 46617 | 79581 | 146507 | 384080 | 619462 |
| Net transfers (including fixed <br>account) | 1206721 | 230790 | 600679 | (227051) | 2230772 | (3587604) | (473099) | (633321) |
| Contract charges | (176059) | (170298) | (29089) | (30093) | (304006) | (313771) | (178996) | (166913) |
| Transfers for contract benefits <br>and terminations | (1928856) | (3543142) | (333874) | (531538) | (3613562) | (7127415) | (2711529) | (3102235) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (523360) | (2825649) | 248431 | (742065) | (1607215) | (10882283) | (2979544) | (3283007) |
| Net increase (decrease) <br>in net assets | (8006105) | 1129041 | (1044951) | (471123) | (19304835) | (326863) | (8401043) | 2616704 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 28858261 | 27729220 | 4181623 | 4652746 | 57848449 | 58175312 | 31034165 | 28417461 |
| End of year | $20852156 | $28858261 | $3136672 | $4181623 | $38543614 | $57848449 | $22633122 | $31034165 |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>46

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **American Funds<sup>®</sup>** **The Bond Fund of America**<br> **Sub-Account** | **American Funds<sup>®</sup>** **The Bond Fund of America**<br> **Sub-Account** | **BHFTI**<br> **AB Global Dynamic Allocation**<br> **Sub-Account** | **BHFTI**<br> **AB Global Dynamic Allocation**<br> **Sub-Account** | **BHFTI AB International Bond**<br> **Sub-Account** | **BHFTI AB International Bond**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $110025 | $3066 | $2933277 | $(1588979) | $138626 | $(18221) |
| Net realized gains (losses) | (99903) | 428640 | 6772130 | 9760400 | (15920) | 5764 |
| Change in unrealized gains <br>(losses) on investments | (1238954) | (585246) | (36495467) | 1352142 | (386913) | (34170) |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (1228832) | (153540) | (26790060) | 9523563 | (264207) | (46627) |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 388557 | 666056 | 389475 | 571240 | 165349 | 543668 |
| Net transfers (including fixed <br>account) | 232013 | 1054191 | (147401) | (928806) | (28270) | 138436 |
| Contract charges | (83736) | (71648) | (1510309) | (1531274) | (22087) | (12007) |
| Transfers for contract benefits <br>and terminations | (1341475) | (1377911) | (8174114) | (10998732) | (79039) | (32393) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (804641) | 270688 | (9442349) | (12887572) | 35953 | 637704 |
| Net increase (decrease) <br>in net assets | (2033473) | 117148 | (36232409) | (3364009) | (228254) | 591077 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 8989242 | 8872094 | 126581307 | 129945316 | 1598987 | 1007910 |
| End of year | $6955769 | $8989242 | $90348898 | $126581307 | $1370733 | $1598987 |

---

The accompanying notes are an integral part of these financial statements.<br>47

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF CHANGES IN NET ASSETS — (Continued)**

**For the years ended December 31, 2022 and 2021**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTI**<br> **Allspring Mid Cap Value**<br> **Sub-Account** | **BHFTI**<br> **Allspring Mid Cap Value**<br> **Sub-Account** | **BHFTI American Funds<sup>®</sup>** **Balanced Allocation**<br> **Sub-Account** | **BHFTI American Funds<sup>®</sup>** **Balanced Allocation**<br> **Sub-Account** | **BHFTI American Funds<sup>®</sup>** **Growth Allocation**<br> **Sub-Account** | **BHFTI American Funds<sup>®</sup>** **Growth Allocation**<br> **Sub-Account** | **BHFTI American Funds<sup>®</sup> Growth**<br> **Sub-Account** | **BHFTI American Funds<sup>®</sup> Growth**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $(210168) | $(191921) | $(235629) | $(868796) | $(603981) | $(1061206) | $(780717) | $(1456412) |
| Net realized gains (losses) | 3322492 | 463823 | 28090149 | 12346426 | 18480847 | 7962722 | 17582396 | 12089499 |
| Change in unrealized gains <br>(losses) on investments | (4394847) | 4366796 | (72232007) | 12709635 | (46610178) | 11061078 | (49376596) | 6589105 |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (1282523) | 4638698 | (44377487) | 24187265 | (28733312) | 17962594 | (32574917) | 17222192 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 126366 | 160076 | 7019598 | 9467700 | 2147676 | 5598494 | 7812947 | 12276422 |
| Net transfers (including fixed <br>account) | (1405681) | (1482936) | 899784 | (356963) | 1951298 | 4250815 | 5235582 | (7055531) |
| Contract charges | (134653) | (127860) | (2353084) | (2201243) | (1427422) | (1172283) | (963464) | (723861) |
| Transfers for contract benefits <br>and terminations | (1128965) | (1707273) | (14192868) | (17879296) | (7294855) | (9236625) | (4698878) | (9226472) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (2542933) | (3157993) | (8626570) | (10969802) | (4623303) | (559599) | 7386187 | (4729442) |
| Net increase (decrease) <br>in net assets | (3825456) | 1480705 | (53004057) | 13217463 | (33356615) | 17402995 | (25188730) | 12492750 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 19946993 | 18466288 | 249625501 | 236408038 | 144066425 | 126663430 | 101719282 | 89226532 |
| End of year | $16121537 | $19946993 | $196621444 | $249625501 | $110709810 | $144066425 | $76530552 | $101719282 |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>48

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTI American Funds<sup>®</sup>** **Moderate Allocation**<br> **Sub-Account** | **BHFTI American Funds<sup>®</sup>** **Moderate Allocation**<br> **Sub-Account** | **BHFTI BlackRock**<br> **Global Tactical Strategies**<br> **Sub-Account** | **BHFTI BlackRock**<br> **Global Tactical Strategies**<br> **Sub-Account** | **BHFTI BlackRock High Yield**<br> **Sub-Account** | **BHFTI BlackRock High Yield**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $228999 | $(19412) | $1656361 | $(260472) | $2044958 | $1313747 |
| Net realized gains (losses) | 10441072 | 5186685 | 4990275 | 11066077 | (619936) | 68756 |
| Change in unrealized gains <br>(losses) on investments | (29620820) | 3603234 | (52510688) | 7845690 | (8611976) | 474519 |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (18950749) | 8770507 | (45864052) | 18651295 | (7186954) | 1857022 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 8488540 | 6768871 | 747469 | 2725014 | 8635618 | 15429218 |
| Net transfers (including fixed <br>account) | 36594 | 121343 | (2088501) | (3157066) | (6437013) | 5182210 |
| Contract charges | (1173098) | (1079439) | (2802146) | (2815725) | (774683) | (464896) |
| Transfers for contract benefits <br>and terminations | (6406264) | (9898564) | (13863243) | (20078824) | (2641404) | (3032577) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | 945772 | (4087789) | (18006421) | (23326601) | (1217482) | 17113955 |
| Net increase (decrease) <br>in net assets | (18004977) | 4682718 | (63870473) | (4675306) | (8404436) | 18970977 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 116777131 | 112094413 | 234000158 | 238675464 | 62139037 | 43168060 |
| End of year | $98772154 | $116777131 | $170129685 | $234000158 | $53734601 | $62139037 |

---

The accompanying notes are an integral part of these financial statements.<br>49

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF CHANGES IN NET ASSETS — (Continued)**

**For the years ended December 31, 2022 and 2021**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTI**<br> **Brighthouse Asset Allocation 100**<br> **Sub-Account** | **BHFTI**<br> **Brighthouse Asset Allocation 100**<br> **Sub-Account** | **BHFTI**<br> **Brighthouse Balanced Plus**<br> **Sub-Account** | **BHFTI**<br> **Brighthouse Balanced Plus**<br> **Sub-Account** | **BHFTI**<br> **Brighthouse Small Cap Value**<br> **Sub-Account** | **BHFTI**<br> **Brighthouse Small Cap Value**<br> **Sub-Account** | **BHFTI Brighthouse/abrdn**<br> **Emerging Markets Equity**<br> **Sub-Account** | **BHFTI Brighthouse/abrdn**<br> **Emerging Markets Equity**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $(294940) | $(635332) | $3739922 | $4262816 | $(261175) | $(242514) | $(204044) | $(459892) |
| Net realized gains (losses) | 8800064 | 12242901 | 31866122 | 22900466 | 4818281 | 1277397 | 3507043 | 1274221 |
| Change in unrealized gains <br>(losses) on investments | (34904564) | 6476300 | (139536531) | 923081 | (8821765) | 6739477 | (11234038) | (2780398) |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (26399440) | 18083869 | (103930487) | 28086363 | (4264659) | 7774360 | (7931039) | (1966069) |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 491573 | 1895894 | 1390806 | 2779431 | 623696 | 569523 | 212390 | 709538 |
| Net transfers (including fixed <br>account) | 1818173 | (3867340) | (112149) | 776154 | (838610) | (3271898) | 1995395 | 877044 |
| Contract charges | (815973) | (769674) | (5073526) | (5206650) | (200434) | (185328) | (220760) | (231755) |
| Transfers for contract benefits <br>and terminations | (5974308) | (7347871) | (30595461) | (45148995) | (1539451) | (2347891) | (1694965) | (2830979) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (4480535) | (10088991) | (34390330) | (46800060) | (1954799) | (5235594) | 292060 | (1476152) |
| Net increase (decrease) <br>in net assets | (30879975) | 7994878 | (138320817) | (18713697) | (6219458) | 2538766 | (7638979) | (3442221) |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 123439722 | 115444844 | 468035055 | 486748752 | 30335558 | 27796792 | 29675089 | 33117310 |
| End of year | $92559747 | $123439722 | $329714238 | $468035055 | $24116100 | $30335558 | $22036110 | $29675089 |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>50

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTI Brighthouse/Eaton**<br> **Vance Floating Rate**<br> **Sub-Account** | **BHFTI Brighthouse/Eaton**<br> **Vance Floating Rate**<br> **Sub-Account** | **BHFTI Brighthouse/Franklin**<br> **Low Duration Total Return**<br> **Sub-Account** | **BHFTI Brighthouse/Franklin**<br> **Low Duration Total Return**<br> **Sub-Account** | **BHFTI Brighthouse/Templeton**<br> **International Bond**<br> **Sub-Account** | **BHFTI Brighthouse/Templeton**<br> **International Bond**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $262956 | $166333 | $160668 | $51638 | $(36633) | $(42586) |
| Net realized gains (losses) | (112054) | (17024) | (363467) | (121415) | (138259) | (36771) |
| Change in unrealized gains <br>(losses) on investments | (540923) | 49336 | (808436) | (161028) | 19360 | (107203) |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (390021) | 198645 | (1011235) | (230805) | (155532) | (186560) |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 973813 | 1128373 | 150908 | 428748 | 7487 | 3395 |
| Net transfers (including fixed <br>account) | 1132652 | 1227701 | (1373429) | 2879945 | (198038) | 462901 |
| Contract charges | (143695) | (93776) | (172448) | (185779) | (30208) | (28978) |
| Transfers for contract benefits <br>and terminations | (523758) | (578767) | (1066547) | (1293318) | (131951) | (177986) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | 1439012 | 1683531 | (2461516) | 1829596 | (352710) | 259332 |
| Net increase (decrease) <br>in net assets | 1048991 | 1882176 | (3472751) | 1598791 | (508242) | 72772 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 11241971 | 9359795 | 16378251 | 14779460 | 2798658 | 2725886 |
| End of year | $12290962 | $11241971 | $12905500 | $16378251 | $2290416 | $2798658 |

---

The accompanying notes are an integral part of these financial statements.<br>51

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF CHANGES IN NET ASSETS — (Continued)**

**For the years ended December 31, 2022 and 2021**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTI Brighthouse/Wellington**<br> **Large Cap Research**<br> **Sub-Account** | **BHFTI Brighthouse/Wellington**<br> **Large Cap Research**<br> **Sub-Account** | **BHFTI**<br> **CBRE Global Real Estate**<br> **Sub-Account** | **BHFTI**<br> **CBRE Global Real Estate**<br> **Sub-Account** | **BHFTI**<br> **Harris Oakmark International**<br> **Sub-Account** | **BHFTI**<br> **Harris Oakmark International**<br> **Sub-Account** | **BHFTI**<br> **Invesco Balanced-Risk Allocation**<br> **Sub-Account** | **BHFTI**<br> **Invesco Balanced-Risk Allocation**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $(19928) | $(19697) | $398566 | $244660 | $261472 | $(529729) | $1774667 | $601157 |
| Net realized gains (losses) | 395039 | 270790 | 1736288 | 587687 | 1990445 | 725609 | 1631931 | 1257655 |
| Change in unrealized gains <br>(losses) on investments | (786143) | 142194 | (7269850) | 4624996 | (11084705) | 3498449 | (8728095) | 1171260 |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (411032) | 393287 | (5134996) | 5457343 | (8832788) | 3694329 | (5321497) | 3030072 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 4716 | 360 | 280358 | 409501 | 827557 | 1865866 | 203512 | 649367 |
| Net transfers (including fixed <br>account) | (26245) | (71298) | 114970 | (1532778) | 1147108 | (2453046) | 3402164 | 181552 |
| Contract charges | (17983) | (15293) | (132575) | (126039) | (404686) | (386594) | (488728) | (429528) |
| Transfers for contract benefits <br>and terminations | (86579) | (97915) | (1223244) | (1993367) | (2865778) | (4495759) | (3697674) | (3510407) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (126091) | (184146) | (960491) | (3242683) | (1295799) | (5469533) | (580726) | (3109016) |
| Net increase (decrease) <br>in net assets | (537123) | 209141 | (6095487) | 2214660 | (10128587) | (1775204) | (5902223) | (78944) |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 2054177 | 1845036 | 20437475 | 18222815 | 52648951 | 54424155 | 38583524 | 38662468 |
| End of year | $1517054 | $2054177 | $14341988 | $20437475 | $42520364 | $52648951 | $32681301 | $38583524 |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>52

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTI Invesco Comstock**<br> **Sub-Account** | **BHFTI Invesco Comstock**<br> **Sub-Account** | **BHFTI Invesco Global Equity**<br> **Sub-Account** | **BHFTI Invesco Global Equity**<br> **Sub-Account** | **BHFTI Invesco Small Cap Growth**<br> **Sub-Account** | **BHFTI Invesco Small Cap Growth**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $122193 | $134232 | $(45502) | $(58061) | $(555396) | $(700685) |
| Net realized gains (losses) | 5977213 | 1404050 | 476731 | 418354 | 11826408 | 10004585 |
| Change in unrealized gains <br>(losses) on investments | (6376704) | 7921328 | (1854985) | 184051 | (29109339) | (6920466) |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (277298) | 9459610 | (1423756) | 544344 | (17838327) | 2383434 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 1758507 | 2497258 | 99779 | 58632 | 2984769 | 7055731 |
| Net transfers (including fixed <br>account) | (2828435) | (3054461) | 372867 | 969 | 4534762 | (1076613) |
| Contract charges | (278597) | (218969) | (24035) | (23123) | (393518) | (304758) |
| Transfers for contract benefits <br>and terminations | (3069617) | (4950054) | (184046) | (306365) | (1984339) | (3542343) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (4418142) | (5726226) | 264565 | (269887) | 5141674 | 2132017 |
| Net increase (decrease) <br>in net assets | (4695440) | 3733384 | (1159191) | 274457 | (12696653) | 4515451 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 36405122 | 32671738 | 4292087 | 4017630 | 47064073 | 42548622 |
| End of year | $31709682 | $36405122 | $3132896 | $4292087 | $34367420 | $47064073 |

---

The accompanying notes are an integral part of these financial statements.<br>53

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF CHANGES IN NET ASSETS — (Continued)**

**For the years ended December 31, 2022 and 2021**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTI JPMorgan Core Bond**<br> **Sub-Account** | **BHFTI JPMorgan Core Bond**<br> **Sub-Account** | **BHFTI**<br> **JPMorgan Global Active Allocation**<br> **Sub-Account** | **BHFTI**<br> **JPMorgan Global Active Allocation**<br> **Sub-Account** | **BHFTI**<br> **JPMorgan Small Cap Value**<br> **Sub-Account** | **BHFTI**<br> **JPMorgan Small Cap Value**<br> **Sub-Account** | **BHFTI**<br> **Loomis Sayles Global Allocation**<br> **Sub-Account** | **BHFTI**<br> **Loomis Sayles Global Allocation**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $267628 | $253415 | $632956 | $(625374) | $(20300) | $(25183) | $(293982) | $(170807) |
| Net realized gains (losses) | (459702) | 9934 | 6788774 | 5238054 | 1222081 | 358582 | 2551165 | 2717963 |
| Change in unrealized gains <br>(losses) on investments | (4583343) | (1280127) | (20508235) | 869259 | (1811817) | 823401 | (7967290) | 61130 |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (4775417) | (1016778) | (13086505) | 5481939 | (610036) | 1156800 | (5710107) | 2608286 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 880660 | 1773429 | 1632867 | 4176368 | 633 | 614 | 420098 | 1953297 |
| Net transfers (including fixed <br>account) | (1374175) | 3962163 | (480103) | 2394342 | (205066) | (457964) | 436696 | 1045956 |
| Contract charges | (367303) | (316936) | (806582) | (757834) | (29046) | (26749) | (191670) | (158717) |
| Transfers for contract benefits <br>and terminations | (1813828) | (2210350) | (5060601) | (8762000) | (269816) | (324638) | (1416709) | (1960361) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (2674646) | 3208306 | (4714419) | (2949124) | (503295) | (808737) | (751585) | 880175 |
| Net increase (decrease) <br>in net assets | (7450063) | 2191528 | (17800924) | 2532815 | (1113331) | 348063 | (6461692) | 3488461 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 34982963 | 32791435 | 70080994 | 67548179 | 4338893 | 3990830 | 23557056 | 20068595 |
| End of year | $27532900 | $34982963 | $52280070 | $70080994 | $3225562 | $4338893 | $17095364 | $23557056 |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>54

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTI Loomis Sayles Growth**<br> **Sub-Account** | **BHFTI Loomis Sayles Growth**<br> **Sub-Account** | **BHFTI**<br> **MetLife Multi-Index Targeted Risk**<br> **Sub-Account** | **BHFTI**<br> **MetLife Multi-Index Targeted Risk**<br> **Sub-Account** | **BHFTI**<br> **MFS<sup>®</sup> Research International**<br> **Sub-Account** | **BHFTI**<br> **MFS<sup>®</sup> Research International**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $(776446) | $(864869) | $165258 | $203168 | $49119 | $(214904) |
| Net realized gains (losses) | 4340491 | 3489802 | 3335355 | 2500186 | 1915384 | 2030652 |
| Change in unrealized gains <br>(losses) on investments | (21524231) | 5572940 | (15035888) | 1500645 | (7886301) | 1240528 |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (17960186) | 8197873 | (11535275) | 4203999 | (5921798) | 3056276 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 293885 | 538761 | 1006060 | 1874005 | 528783 | 409301 |
| Net transfers (including fixed <br>account) | 3038027 | 17844750 | (1906769) | (750925) | 705028 | 540379 |
| Contract charges | (401956) | (363920) | (589983) | (601164) | (215870) | (203094) |
| Transfers for contract benefits <br>and terminations | (3313529) | (5751931) | (3491589) | (3986989) | (1775361) | (3195841) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (383573) | 12267660 | (4982281) | (3465073) | (757420) | (2449255) |
| Net increase (decrease) <br>in net assets | (18343759) | 20465533 | (16517556) | 738926 | (6679218) | 607021 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 62332152 | 41866619 | 54133667 | 53394741 | 31678004 | 31070983 |
| End of year | $43988393 | $62332152 | $37616111 | $54133667 | $24998786 | $31678004 |

---

The accompanying notes are an integral part of these financial statements.<br>55

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF CHANGES IN NET ASSETS — (Continued)**

**For the years ended December 31, 2022 and 2021**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTI Morgan Stanley Discovery**<br> **Sub-Account** | **BHFTI Morgan Stanley Discovery**<br> **Sub-Account** | **BHFTI**<br> **PanAgora Global Diversified Risk**<br> **Sub-Account** | **BHFTI**<br> **PanAgora Global Diversified Risk**<br> **Sub-Account** | **BHFTI**<br> **PIMCO Inflation Protected Bond**<br> **Sub-Account** | **BHFTI**<br> **PIMCO Inflation Protected Bond**<br> **Sub-Account** | **BHFTI PIMCO Total Return**<br> **Sub-Account** | **BHFTI PIMCO Total Return**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $(152435) | $(284471) | $9221727 | $(93542) | $2504714 | $(509772) | $1546428 | $349765 |
| Net realized gains (losses) | 4447388 | 12989952 | 4714962 | 616936 | (264494) | 183514 | (2099822) | 5511689 |
| Change in unrealized gains <br>(losses) on investments | (15332025) | (14302671) | (31051666) | (182815) | (10006009) | 2548475 | (19392140) | (9684757) |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (11037072) | (1597190) | (17114977) | 340579 | (7765789) | 2222217 | (19945534) | (3823303) |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 252279 | 1654277 | 244878 | 198808 | 1902146 | 2484315 | 1892258 | 3831049 |
| Net transfers (including fixed <br>account) | 4443871 | (3187719) | 94190464 | 704609 | (1692609) | 7451585 | (3024659) | 16530974 |
| Contract charges | (90024) | (111776) | (1127159) | (80363) | (557143) | (479154) | (1227339) | (1129884) |
| Transfers for contract benefits <br>and terminations | (854275) | (2801767) | (4606441) | (467421) | (3665710) | (6606348) | (7764016) | (13351653) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | 3751851 | (4446985) | 88701742 | 355633 | (4013316) | 2850398 | (10123756) | 5880486 |
| Net increase (decrease) <br>in net assets | (7285221) | (6044175) | 71586765 | 696212 | (11779105) | 5072615 | (30069290) | 2057183 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 15658926 | 21703101 | 6608809 | 5912597 | 60507516 | 55434901 | 130688648 | 128631465 |
| End of year | $8373705 | $15658926 | $78195574 | $6608809 | $48728411 | $60507516 | $100619358 | $130688648 |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>56

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTI**<br> **Schroders Global Multi-Asset**<br> **Sub-Account** | **BHFTI**<br> **Schroders Global Multi-Asset**<br> **Sub-Account** | **BHFTI SSGA**<br> **Emerging Markets Enhanced Index**<br> **Sub-Account** | **BHFTI SSGA**<br> **Emerging Markets Enhanced Index**<br> **Sub-Account** | **BHFTI**<br> **SSGA Growth and Income ETF**<br> **Sub-Account** | **BHFTI**<br> **SSGA Growth and Income ETF**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $(2975) | $(458523) | $8576 | $(471) | $1268146 | $247975 |
| Net realized gains (losses) | 1977880 | 826478 | (11780) | 16600 | 13492555 | 5663800 |
| Change in unrealized gains <br>(losses) on investments | (10515168) | 3593784 | (173073) | (41056) | (30728242) | 4541725 |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (8540263) | 3961739 | (176277) | (24927) | (15967541) | 10453500 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 290857 | 644705 | 229983 | 504445 | 3353475 | 3569616 |
| Net transfers (including fixed <br>account) | 156513 | (1892415) | 35060 | 34680 | (577780) | (1237685) |
| Contract charges | (459050) | (477831) | (9858) | (2580) | (983916) | (941432) |
| Transfers for contract benefits <br>and terminations | (2650034) | (4637504) | (6224) | (6919) | (4523688) | (7130590) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (2661714) | (6363045) | 248961 | 529626 | (2731909) | (5740091) |
| Net increase (decrease) <br>in net assets | (11201977) | (2401306) | 72684 | 504699 | (18699450) | 4713409 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 40928882 | 43330188 | 748995 | 244296 | 96981286 | 92267877 |
| End of year | $29726905 | $40928882 | $821679 | $748995 | $78281836 | $96981286 |

---

The accompanying notes are an integral part of these financial statements.<br>57

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF CHANGES IN NET ASSETS — (Continued)**

**For the years ended December 31, 2022 and 2021**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTI SSGA Growth ETF**<br> **Sub-Account** | **BHFTI SSGA Growth ETF**<br> **Sub-Account** | **BHFTI**<br> **T. Rowe Price Large Cap Value**<br> **Sub-Account** | **BHFTI**<br> **T. Rowe Price Large Cap Value**<br> **Sub-Account** | **BHFTI**<br> **T. Rowe Price Mid Cap Growth**<br> **Sub-Account** | **BHFTI**<br> **T. Rowe Price Mid Cap Growth**<br> **Sub-Account** | **BHFTI**<br> **Victory Sycamore Mid Cap Value**<br> **Sub-Account** | **BHFTI**<br> **Victory Sycamore Mid Cap Value**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $595525 | $(15776) | $22882 | $184616 | $(871259) | $(1042131) | $23143 | $(86212) |
| Net realized gains (losses) | 7770748 | 3579877 | 8254561 | 1449007 | 10362746 | 7447686 | 2844595 | 1578281 |
| Change in unrealized gains <br>(losses) on investments | (17572169) | 4233748 | (12443704) | 11540519 | (26182136) | 1782233 | (3745353) | 3735854 |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (9205896) | 7797849 | (4166261) | 13174142 | (16690649) | 8187788 | (877615) | 5227923 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 959741 | 412071 | 2318144 | 2872715 | 3461128 | 5682435 | 515552 | 679030 |
| Net transfers (including fixed <br>account) | (633847) | (68516) | (3266058) | (2575152) | 52728 | (995125) | (1358418) | (1796267) |
| Contract charges | (539459) | (523139) | (483743) | (393126) | (604571) | (481353) | (183592) | (152421) |
| Transfers for contract benefits <br>and terminations | (2248558) | (3245507) | (3651334) | (5238496) | (3295212) | (4300660) | (1054612) | (1716149) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (2462123) | (3425091) | (5082991) | (5334059) | (385927) | (94703) | (2081070) | (2985807) |
| Net increase (decrease) <br>in net assets | (11668019) | 4372758 | (9249252) | 7840083 | (17076576) | 8093085 | (2958685) | 2242116 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 54751208 | 50378450 | 64790307 | 56950224 | 70219983 | 62126898 | 20768085 | 18525969 |
| End of year | $43083189 | $54751208 | $55541055 | $64790307 | $53143407 | $70219983 | $17809400 | $20768085 |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>58

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTI Western Asset**<br> **Management Government Income**<br> **Sub-Account** | **BHFTI Western Asset**<br> **Management Government Income**<br> **Sub-Account** | **BHFTII**<br> **Baillie Gifford International Stock**<br> **Sub-Account** | **BHFTII**<br> **Baillie Gifford International Stock**<br> **Sub-Account** | **BHFTII BlackRock Bond Income**<br> **Sub-Account** | **BHFTII BlackRock Bond Income**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $280639 | $277539 | $(84910) | $(136108) | $223637 | $215989 |
| Net realized gains (losses) | (897741) | 133749 | 991081 | 2393760 | (349795) | 362304 |
| Change in unrealized gains <br>(losses) on investments | (4759750) | (1790954) | (5375526) | (2583830) | (2854382) | (900901) |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (5376852) | (1379666) | (4469355) | (326178) | (2980540) | (322608) |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 469251 | 519878 | 309575 | 769962 | 1527651 | 2982041 |
| Net transfers (including fixed <br>account) | 88337 | 1110504 | 1086729 | 355228 | (608077) | 2255249 |
| Contract charges | (465966) | (474102) | (129353) | (130867) | (197466) | (135850) |
| Transfers for contract benefits <br>and terminations | (2726929) | (5617687) | (749962) | (1772408) | (1050417) | (1294680) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (2635307) | (4461407) | 516989 | (778085) | (328309) | 3806760 |
| Net increase (decrease) <br>in net assets | (8012159) | (5841073) | (3952366) | (1104263) | (3308849) | 3484152 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 35766498 | 41607571 | 14988798 | 16093061 | 18997191 | 15513039 |
| End of year | $27754339 | $35766498 | $11036432 | $14988798 | $15688342 | $18997191 |

---

The accompanying notes are an integral part of these financial statements.<br>59

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF CHANGES IN NET ASSETS — (Continued)**

**For the years ended December 31, 2022 and 2021**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTII**<br> **BlackRock Capital Appreciation**<br> **Sub-Account** | **BHFTII**<br> **BlackRock Capital Appreciation**<br> **Sub-Account** | **BHFTII**<br> **BlackRock Ultra-Short Term Bond**<br> **Sub-Account** | **BHFTII**<br> **BlackRock Ultra-Short Term Bond**<br> **Sub-Account** | **BHFTII**<br> **Brighthouse Asset Allocation 20**<br> **Sub-Account** | **BHFTII**<br> **Brighthouse Asset Allocation 20**<br> **Sub-Account** | **BHFTII**<br> **Brighthouse Asset Allocation 40**<br> **Sub-Account** | **BHFTII**<br> **Brighthouse Asset Allocation 40**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $(187361) | $(196260) | $(682663) | $(716775) | $178088 | $188940 | $2355370 | $3144096 |
| Net realized gains (losses) | 3891184 | 2084301 | (118383) | (202952) | 289443 | 246148 | 9046827 | 10819058 |
| Change in unrealized gains <br>(losses) on investments | (10595662) | 477254 | 623943 | (47334) | (2240953) | (163407) | (52512213) | 2308216 |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (6891839) | 2365295 | (177103) | (967061) | (1773422) | 271681 | (41110016) | 16271370 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 2415010 | 3820262 | 1212532 | 2745276 | 532655 | 1042313 | 2489478 | 1916201 |
| Net transfers (including fixed <br>account) | 1383904 | (75506) | 5680779 | 10617902 | 923109 | 1851341 | (2733112) | (1711130) |
| Contract charges | (174637) | (112738) | (573168) | (642839) | (108382) | (107079) | (2495616) | (2578457) |
| Transfers for contract benefits <br>and terminations | (388456) | (478777) | (8692863) | (14560595) | (733766) | (1207109) | (21327096) | (29162354) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | 3235821 | 3153241 | (2372720) | (1840256) | 613616 | 1579466 | (24066346) | (31535740) |
| Net increase (decrease) <br>in net assets | (3656018) | 5518536 | (2549823) | (2807317) | (1159806) | 1851147 | (65176362) | (15264370) |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 16610613 | 11092077 | 46921730 | 49729047 | 13105640 | 11254493 | 279716525 | 294980895 |
| End of year | $12954595 | $16610613 | $44371907 | $46921730 | $11945834 | $13105640 | $214540163 | $279716525 |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>60

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTII**<br> **Brighthouse Asset Allocation 60**<br> **Sub-Account** | **BHFTII**<br> **Brighthouse Asset Allocation 60**<br> **Sub-Account** | **BHFTII**<br> **Brighthouse Asset Allocation 80**<br> **Sub-Account** | **BHFTII**<br> **Brighthouse Asset Allocation 80**<br> **Sub-Account** | **BHFTII Brighthouse/**<br> **Artisan Mid Cap Value**<br> **Sub-Account** | **BHFTII Brighthouse/**<br> **Artisan Mid Cap Value**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $2632595 | $2977551 | $539569 | $184135 | $(116124) | $(129812) |
| Net realized gains (losses) | 27303000 | 29748546 | 26713691 | 30339014 | 2167595 | 909798 |
| Change in unrealized gains <br>(losses) on investments | (113977855) | 13334104 | (103687059) | 18639586 | (4073602) | 2477157 |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (84042260) | 46060201 | (76433799) | 49162735 | (2022131) | 3257143 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 6283668 | 8740787 | 1329964 | 1540537 | 292000 | 409978 |
| Net transfers (including fixed <br>account) | 97303 | 519923 | (1480447) | (2704264) | (761881) | (1078085) |
| Contract charges | (4224994) | (4207886) | (2919837) | (2958086) | (96133) | (86213) |
| Transfers for contract benefits <br>and terminations | (33926542) | (49493815) | (28778516) | (32708849) | (1250436) | (1258147) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (31770565) | (44440991) | (31848836) | (36830662) | (1816450) | (2012467) |
| Net increase (decrease) <br>in net assets | (115812825) | 1619210 | (108282635) | 12332073 | (3838581) | 1244676 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 514442119 | 512822909 | 406629576 | 394297503 | 15132904 | 13888228 |
| End of year | $398629294 | $514442119 | $298346941 | $406629576 | $11294323 | $15132904 |

---

The accompanying notes are an integral part of these financial statements.<br>61

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF CHANGES IN NET ASSETS — (Continued)**

**For the years ended December 31, 2022 and 2021**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTII Brighthouse/Dimensional**<br> **International Small Company**<br> **Sub-Account** | **BHFTII Brighthouse/Dimensional**<br> **International Small Company**<br> **Sub-Account** | **BHFTII Brighthouse/Wellington**<br> **Core Equity Opportunities**<br> **Sub-Account** | **BHFTII Brighthouse/Wellington**<br> **Core Equity Opportunities**<br> **Sub-Account** | **BHFTII Frontier Mid Cap Growth**<br> **Sub-Account** | **BHFTII Frontier Mid Cap Growth**<br> **Sub-Account** | **BHFTII Jennison Growth**<br> **Sub-Account** | **BHFTII Jennison Growth**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $35950 | $(303) | $(204514) | $(250687) | $(157407) | $(190298) | $(1049772) | $(1320438) |
| Net realized gains (losses) | 371909 | 307100 | 15035687 | 6428607 | 3330104 | 2201973 | 16308065 | 20417657 |
| Change in unrealized gains <br>(losses) on investments | (1453187) | 342817 | (20778263) | 10812848 | (6923547) | (583678) | (52643998) | (6904084) |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (1045328) | 649614 | (5947090) | 16990768 | (3750850) | 1427997 | (37385705) | 12193135 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 48538 | 229669 | 1154939 | 1580371 | 692872 | 1029794 | 4647543 | 11666330 |
| Net transfers (including fixed <br>account) | (129774) | (447370) | (6897134) | (1502645) | 543390 | (418863) | 6931681 | (3946982) |
| Contract charges | (47466) | (43865) | (612984) | (530784) | (85835) | (72101) | (680664) | (536929) |
| Transfers for contract benefits <br>and terminations | (239821) | (233951) | (5570384) | (7387218) | (505004) | (1106983) | (4141621) | (5278920) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (368523) | (495517) | (11925563) | (7840276) | 645423 | (568153) | 6756939 | 1903499 |
| Net increase (decrease) <br>in net assets | (1413851) | 154097 | (17872653) | 9150492 | (3105427) | 859844 | (30628766) | 14096634 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 5661149 | 5507052 | 88101053 | 78950561 | 12498190 | 11638346 | 90717151 | 76620517 |
| End of year | $4247298 | $5661149 | $70228400 | $88101053 | $9392763 | $12498190 | $60088385 | $90717151 |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>62

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTII**<br> **Loomis Sayles Small Cap Core**<br> **Sub-Account** | **BHFTII**<br> **Loomis Sayles Small Cap Core**<br> **Sub-Account** | **BHFTII**<br> **Loomis Sayles Small Cap Growth**<br> **Sub-Account** | **BHFTII**<br> **Loomis Sayles Small Cap Growth**<br> **Sub-Account** | **BHFTII**<br> **MetLife Aggregate Bond Index**<br> **Sub-Account** | **BHFTII**<br> **MetLife Aggregate Bond Index**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $(13700) | $(17397) | $(5458) | $(6954) | $319851 | $293684 |
| Net realized gains (losses) | 149829 | 97217 | 101283 | 76562 | (631092) | (20752) |
| Change in unrealized gains <br>(losses) on investments | (287331) | 89705 | (233796) | (22275) | (4821917) | (1512236) |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (151202) | 169525 | (137971) | 47333 | (5133158) | (1239304) |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 180 | 240 |  |  | 3312899 | 5551461 |
| Net transfers (including fixed <br>account) | (7144) | (104917) | 5689 | (26496) | (2325519) | 3095843 |
| Contract charges | (9456) | (9221) | (3712) | (3575) | (398567) | (319449) |
| Transfers for contract benefits <br>and terminations | (20399) | (68674) | (15204) | (15252) | (1926030) | (2316754) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (36819) | (182572) | (13227) | (45323) | (1337217) | 6011101 |
| Net increase (decrease) <br>in net assets | (188021) | (13047) | (151198) | 2010 | (6470375) | 4771797 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 904077 | 917124 | 571469 | 569459 | 36310567 | 31538770 |
| End of year | $716056 | $904077 | $420271 | $571469 | $29840192 | $36310567 |

---

The accompanying notes are an integral part of these financial statements.<br>63

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF CHANGES IN NET ASSETS — (Continued)**

**For the years ended December 31, 2022 and 2021**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTII**<br> **MetLife Mid Cap Stock Index**<br> **Sub-Account** | **BHFTII**<br> **MetLife Mid Cap Stock Index**<br> **Sub-Account** | **BHFTII**<br> **MetLife MSCI EAFE<sup>®</sup> Index**<br> **Sub-Account** | **BHFTII**<br> **MetLife MSCI EAFE<sup>®</sup> Index**<br> **Sub-Account** | **BHFTII**<br> **MetLife Russell 2000<sup>®</sup> Index**<br> **Sub-Account** | **BHFTII**<br> **MetLife Russell 2000<sup>®</sup> Index**<br> **Sub-Account** | **BHFTII MetLife Stock Index**<br> **Sub-Account** | **BHFTII MetLife Stock Index**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $(70248) | $(69629) | $171275 | $1449 | $(88265) | $(100523) | $(328010) | $(118206) |
| Net realized gains (losses) | 1894776 | 1082125 | 321879 | 232960 | 2370821 | 1592033 | 9426457 | 8795111 |
| Change in unrealized gains <br>(losses) on investments | (3623564) | 1132423 | (2059678) | 579586 | (5594056) | 198353 | (27821423) | 11195919 |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (1799036) | 2144919 | (1566524) | 813995 | (3311500) | 1689863 | (18722976) | 19872824 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 1733602 | 1405489 | 366582 | 613475 | 979224 | 2434480 | 6201122 | 9273280 |
| Net transfers (including fixed <br>account) | (285456) | (651533) | (36900) | (51310) | 507100 | (920085) | (1234368) | (2803322) |
| Contract charges | (121123) | (94512) | (105809) | (87478) | (159155) | (116364) | (760068) | (631861) |
| Transfers for contract benefits <br>and terminations | (625962) | (897861) | (458573) | (693845) | (563214) | (1547360) | (3804845) | (5324810) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | 701061 | (238417) | (234700) | (219158) | 763955 | (149329) | 401841 | 513287 |
| Net increase (decrease) <br>in net assets | (1097975) | 1906502 | (1801224) | 594837 | (2547545) | 1540534 | (18321135) | 20386111 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 11895616 | 9989114 | 10196923 | 9602086 | 15078874 | 13538340 | 95740312 | 75354201 |
| End of year | $10797641 | $11895616 | $8395699 | $10196923 | $12531329 | $15078874 | $77419177 | $95740312 |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>64

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTII MFS<sup>®</sup> Total Return**<br> **Sub-Account** | **BHFTII MFS<sup>®</sup> Total Return**<br> **Sub-Account** | **BHFTII MFS<sup>®</sup> Value**<br> **Sub-Account** | **BHFTII MFS<sup>®</sup> Value**<br> **Sub-Account** | **BHFTII**<br> **Neuberger Berman Genesis**<br> **Sub-Account** | **BHFTII**<br> **Neuberger Berman Genesis**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $7545 | $15671 | $14159 | $(25961) | $(175710) | $(230362) |
| Net realized gains (losses) | 643605 | 580199 | 4137398 | 867731 | 2215944 | 1798572 |
| Change in unrealized gains <br>(losses) on investments | (1442661) | 232473 | (6442795) | 4940401 | (4900749) | 580055 |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (791511) | 828343 | (2291238) | 5782171 | (2860515) | 2148265 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 4782 | 15334 | 1334401 | 1311300 | 186401 | 924312 |
| Net transfers (including fixed <br>account) | (256597) | 137234 | (631240) | (1249011) | (940772) | (1492106) |
| Contract charges | (45980) | (43795) | (290252) | (229519) | (97962) | (88234) |
| Transfers for contract benefits <br>and terminations | (519905) | (677404) | (1329752) | (1467920) | (990552) | (1067683) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (817700) | (568631) | (916843) | (1635150) | (1842885) | (1723711) |
| Net increase (decrease) <br>in net assets | (1609211) | 259712 | (3208081) | 4147021 | (4703400) | 424554 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 7162535 | 6902823 | 29380024 | 25233003 | 14525048 | 14100494 |
| End of year | $5553324 | $7162535 | $26171943 | $29380024 | $9821648 | $14525048 |

---

The accompanying notes are an integral part of these financial statements.<br>65

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF CHANGES IN NET ASSETS — (Continued)**

**For the years ended December 31, 2022 and 2021**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTII**<br> **T. Rowe Price Large Cap Growth**<br> **Sub-Account** | **BHFTII**<br> **T. Rowe Price Large Cap Growth**<br> **Sub-Account** | **BHFTII**<br> **T. Rowe Price Small Cap Growth**<br> **Sub-Account** | **BHFTII**<br> **T. Rowe Price Small Cap Growth**<br> **Sub-Account** | **BHFTII**<br> **VanEck Global Natural Resources**<br> **Sub-Account** | **BHFTII**<br> **VanEck Global Natural Resources**<br> **Sub-Account** | **BHFTII Western Asset Management**<br> **Strategic Bond Opportunities**<br> **Sub-Account** | **BHFTII Western Asset Management**<br> **Strategic Bond Opportunities**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $(705977) | $(906596) | $(6835) | $(8180) | $32640 | $(25718) | $2621381 | $1555806 |
| Net realized gains (losses) | 9431254 | 8552998 | 77867 | 66376 | 374892 | 214737 | (1314854) | 494914 |
| Change in unrealized gains <br>(losses) on investments | (35287598) | 2082416 | (184896) | (15546) | (69498) | 519647 | (13666366) | (1196323) |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (26562321) | 9728818 | (113864) | 42650 | 338034 | 708666 | (12359839) | 854397 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 2632317 | 4547867 |  |  | 82840 | 14142 | 2093180 | 4761066 |
| Net transfers (including fixed <br>account) | 7080632 | (3131673) | 10148 | (6880) | (919116) | (619548) | (719437) | 9324484 |
| Contract charges | (550614) | (466461) | (4306) | (4241) | (47699) | (42848) | (605228) | (504399) |
| Transfers for contract benefits <br>and terminations | (2204685) | (4377323) | (10933) | (6889) | (199803) | (419629) | (5259584) | (11220972) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | 6957650 | (3427590) | (5091) | (18010) | (1083778) | (1067883) | (4491069) | 2360179 |
| Net increase (decrease) <br>in net assets | (19604671) | 6301228 | (118955) | 24640 | (745744) | (359217) | (16850908) | 3214576 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 60930950 | 54629722 | 475763 | 451123 | 4017036 | 4376253 | 70323605 | 67109029 |
| End of year | $41326279 | $60930950 | $356808 | $475763 | $3271292 | $4017036 | $53472697 | $70323605 |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>66

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTII Western Asset**<br> **Management U.S. Government**<br> **Sub-Account** | **BHFTII Western Asset**<br> **Management U.S. Government**<br> **Sub-Account** | **BlackRock Global Allocation V.I.**<br> **Sub-Account** | **BlackRock Global Allocation V.I.**<br> **Sub-Account** | **Fidelity<sup>®</sup> VIP Contrafund<sup>®</sup>** **Sub-Account** | **Fidelity<sup>®</sup> VIP Contrafund<sup>®</sup>** **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $136212 | $305144 | $(66973) | $(17704) | $(227837) | $(345719) |
| Net realized gains (losses) | (709240) | (28315) | 27912 | 952390 | 1330023 | 4567498 |
| Change in unrealized gains <br>(losses) on investments | (2463664) | (1245014) | (957620) | (762918) | (7778585) | 1010067 |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (3036692) | (968185) | (996681) | 171768 | (6676399) | 5231846 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 1046619 | 3362528 | 574790 | 1994956 | 920394 | 1565305 |
| Net transfers (including fixed <br>account) | (238195) | 4084454 | 130787 | 459889 | 471209 | (833653) |
| Contract charges | (332526) | (245509) | (76265) | (38295) | (147087) | (128078) |
| Transfers for contract benefits <br>and terminations | (3536759) | (3687622) | (105054) | (35863) | (1709074) | (2792896) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (3060861) | 3513851 | 524258 | 2380687 | (464558) | (2189322) |
| Net increase (decrease) <br>in net assets | (6097553) | 2545666 | (472423) | 2552455 | (7140957) | 3042524 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 30424239 | 27878573 | 5579066 | 3026611 | 24440517 | 21397993 |
| End of year | $24326686 | $30424239 | $5106643 | $5579066 | $17299560 | $24440517 |

---

The accompanying notes are an integral part of these financial statements.<br>67

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF CHANGES IN NET ASSETS — (Continued)**

**For the years ended December 31, 2022 and 2021**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Fidelity<sup>®</sup> VIP Equity-Income**<br> **Sub-Account** | **Fidelity<sup>®</sup> VIP Equity-Income**<br> **Sub-Account** | **Fidelity<sup>®</sup> VIP Mid Cap**<br> **Sub-Account** | **Fidelity<sup>®</sup> VIP Mid Cap**<br> **Sub-Account** | **FTVIPT Franklin Income VIP**<br> **Sub-Account** | **FTVIPT Franklin Income VIP**<br> **Sub-Account** | **FTVIPT**<br> **Franklin Mutual Shares VIP**<br> **Sub-Account** | **FTVIPT**<br> **Franklin Mutual Shares VIP**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $26 | $21 | $(134039) | $(153582) | $561291 | $592048 | $9456 | $39886 |
| Net realized gains (losses) | 634 | 2100 | 885354 | 3404712 | 437115 | 146447 | 243079 | 44484 |
| Change in unrealized gains <br>(losses) on investments | (1749) | 1106 | (3040018) | (117053) | (2277755) | 1925315 | (486280) | 368618 |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (1089) | 3227 | (2288703) | 3134077 | (1279349) | 2663810 | (233745) | 452988 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners |  |  | 535787 | 1015586 | 1010210 | 646864 | 37143 | 89424 |
| Net transfers (including fixed <br>account) | (1099) | (1114) | (276053) | (1592904) | (1148619) | 396517 | (26972) | (84542) |
| Contract charges | (103) | (97) | (90223) | (83072) | (128905) | (112195) | (17937) | (16498) |
| Transfers for contract benefits <br>and terminations | (2) | (3) | (1315611) | (2442341) | (1584729) | (2529323) | (274902) | (444078) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (1204) | (1214) | (1146100) | (3102731) | (1852043) | (1598137) | (282668) | (455694) |
| Net increase (decrease) <br>in net assets | (2293) | 2013 | (3434803) | 31346 | (3131392) | 1065673 | (516413) | (2706) |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 16364 | 14351 | 14493913 | 14462567 | 19608039 | 18542366 | 2686509 | 2689215 |
| End of year | $14071 | $16364 | $11059110 | $14493913 | $16476647 | $19608039 | $2170096 | $2686509 |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>68

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **FTVIPT**<br> **Franklin Small Cap Value VIP**<br> **Sub-Account** | **FTVIPT**<br> **Franklin Small Cap Value VIP**<br> **Sub-Account** | **FTVIPT Templeton Foreign VIP**<br> **Sub-Account** | **FTVIPT Templeton Foreign VIP**<br> **Sub-Account** | **FTVIPT**<br> **Templeton Global Bond VIP**<br> **Sub-Account** | **FTVIPT**<br> **Templeton Global Bond VIP**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $(11870) | $(13248) | $128846 | $7255 | $(86672) | $(102976) |
| Net realized gains (losses) | 503148 | 186047 | (226014) | (19494) | (380789) | (523143) |
| Change in unrealized gains <br>(losses) on investments | (859494) | 604397 | (932074) | 302296 | 30249 | 126101 |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (368216) | 777196 | (1029242) | 290057 | (437212) | (500018) |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 128626 | 298595 | 11552 | 15917 | 72335 | 282408 |
| Net transfers (including fixed <br>account) | (126326) | (308046) | (300821) | 514359 | (116190) | 661633 |
| Contract charges | (23287) | (20435) | (75466) | (70669) | (69110) | (57746) |
| Transfers for contract benefits <br>and terminations | (348129) | (681410) | (761458) | (778959) | (735510) | (1447284) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (369116) | (711296) | (1126193) | (319352) | (848475) | (560989) |
| Net increase (decrease) <br>in net assets | (737332) | 65900 | (2155435) | (29295) | (1285687) | (1061007) |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 3489074 | 3423174 | 11647608 | 11676903 | 7114458 | 8175465 |
| End of year | $2751742 | $3489074 | $9492173 | $11647608 | $5828771 | $7114458 |

---

The accompanying notes are an integral part of these financial statements.<br>69

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF CHANGES IN NET ASSETS — (Continued)**

**For the years ended December 31, 2022 and 2021**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Invesco V.I. Equity and Income**<br> **Sub-Account** | **Invesco V.I. Equity and Income**<br> **Sub-Account** | **Invesco V.I. EQV** <br> **International Equity**<br> **Sub-Account** | **Invesco V.I. EQV** <br> **International Equity**<br> **Sub-Account** | **Invesco V.I. Main Street Small Cap<sup>®</sup>** **Sub-Account** | **Invesco V.I. Main Street Small Cap<sup>®</sup>** **Sub-Account** | **Janus Henderson**<br> **Global Sustainable**<br> **Equity**<br> **Sub-Account (a)** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022 (a)** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $(920) | $31151 | $4703 | $(26122) | $(35277) | $(49033) | $4 |
| Net realized gains (losses) | 2061287 | 1020763 | 800139 | 1026385 | 449315 | 752399 | (4) |
| Change in unrealized gains <br>(losses) on investments | (3418929) | 1445202 | (2395955) | (642645) | (1069128) | 56467 | (910) |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (1358562) | 2497116 | (1591113) | 357618 | (655090) | 759833 | (910) |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 285773 | 714655 | 138902 | 550081 | 26920 | 423400 | 12442 |
| Net transfers (including fixed <br>account) | (609153) | (1100019) | 424671 | 305115 | (82183) | 7289 | 536 |
| Contract charges | (115748) | (105437) | (58804) | (53853) | (28380) | (23066) |  |
| Transfers for contract benefits <br>and terminations | (1792094) | (2312988) | (800388) | (1624149) | (390205) | (981287) | (2) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (2231222) | (2803789) | (295619) | (822806) | (473848) | (573664) | 12976 |
| Net increase (decrease) <br>in net assets | (3589784) | (306673) | (1886732) | (465188) | (1128938) | 186169 | 12066 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 15671333 | 15978006 | 8243783 | 8708971 | 3929067 | 3742898 |  |
| End of year | $12081549 | $15671333 | $6357051 | $8243783 | $2800129 | $3929067 | $12066 |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>70

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **LMPVET ClearBridge**<br> **Variable Appreciation**<br> **Sub-Account** | **LMPVET ClearBridge**<br> **Variable Appreciation**<br> **Sub-Account** | **LMPVET ClearBridge**<br> **Variable Dividend Strategy**<br> **Sub-Account** | **LMPVET ClearBridge**<br> **Variable Dividend Strategy**<br> **Sub-Account** | **LMPVET ClearBridge**<br> **Variable Large Cap Growth**<br> **Sub-Account** | **LMPVET ClearBridge**<br> **Variable Large Cap Growth**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $(110836) | $(233372) | $(29526) | $(18297) | $(4278) | $(5447) |
| Net realized gains (losses) | 2411150 | 3037099 | 1687036 | 2270169 | 20512 | 39520 |
| Change in unrealized gains <br>(losses) on investments | (6121163) | 2550143 | (3065686) | 1012586 | (128153) | 25217 |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (3820849) | 5353870 | (1408176) | 3264458 | (111919) | 59290 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 1018767 | 1936288 | 666288 | 757188 |  |  |
| Net transfers (including fixed <br>account) | (1060325) | (855973) | (634365) | (400489) | 10717 | 5465 |
| Contract charges | (220180) | (178113) | (114827) | (99868) | (552) | (588) |
| Transfers for contract benefits <br>and terminations | (2055526) | (3200916) | (963924) | (2403352) | (7303) | (25483) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (2317264) | (2298714) | (1046828) | (2146521) | 2862 | (20606) |
| Net increase (decrease) <br>in net assets | (6138113) | 3055156 | (2455004) | 1117937 | (109057) | 38684 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 28433313 | 25378157 | 15070095 | 13952158 | 335131 | 296447 |
| End of year | $22295200 | $28433313 | $12615091 | $15070095 | $226074 | $335131 |

---

The accompanying notes are an integral part of these financial statements.<br>71

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF CHANGES IN NET ASSETS — (Continued)**

**For the years ended December 31, 2022 and 2021**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **LMPVET ClearBridge**<br> **Variable Large Cap Value**<br> **Sub-Account** | **LMPVET ClearBridge**<br> **Variable Large Cap Value**<br> **Sub-Account** | **LMPVET ClearBridge**<br> **Variable Small Cap Growth**<br> **Sub-Account** | **LMPVET ClearBridge**<br> **Variable Small Cap Growth**<br> **Sub-Account** | **LMPVET Franklin Multi-Asset**<br> **Variable Conservative Growth**<br> **Sub-Account** | **LMPVET Franklin Multi-Asset**<br> **Variable Conservative Growth**<br> **Sub-Account** | **LMPVET Franklin Multi-Asset**<br> **Variable Growth**<br> **Sub-Account** | **LMPVET Franklin Multi-Asset**<br> **Variable Growth**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $(1139) | $(1941) | $(88924) | $(107552) | $6575 | $27024 | $18119 | $34255 |
| Net realized gains (losses) | 12974 | 28507 | 144472 | 1508031 | 75009 | 146900 | 98338 | 108490 |
| Change in unrealized gains <br>(losses) on investments | (33238) | 27367 | (2397200) | (639472) | (306752) | (21493) | (327160) | 76284 |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (21403) | 53933 | (2341652) | 761007 | (225168) | 152431 | (210703) | 219029 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 1665 | 5000 | 531096 | 818987 | 1654 | 1154 | 1380 | 2380 |
| Net transfers (including fixed <br>account) | 1978 | (4075) | 638411 | (549503) | 3372 | (131683) | 2445 | (9915) |
| Contract charges | (1527) | (1396) | (66786) | (53666) | (7726) | (10643) | (2111) | (2186) |
| Transfers for contract benefits <br>and terminations | (25712) | (17183) | (480171) | (566018) | (240652) | (158282) | (80212) | (40287) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (23596) | (17654) | 622550 | (350200) | (243352) | (299454) | (78498) | (50008) |
| Net increase (decrease) <br>in net assets | (44999) | 36279 | (1719102) | 410807 | (468520) | (147023) | (289201) | 169021 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 266467 | 230188 | 7585002 | 7174195 | 1532607 | 1679630 | 1342903 | 1173882 |
| End of year | $221468 | $266467 | $5865900 | $7585002 | $1064087 | $1532607 | $1053702 | $1342903 |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>72

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **LMPVET Franklin Multi-Asset**<br> **Variable Moderate Growth**<br> **Sub-Account** | **LMPVET Franklin Multi-Asset**<br> **Variable Moderate Growth**<br> **Sub-Account** | **LMPVIT Western Asset**<br> **Variable Global High Yield Bond**<br> **Sub-Account** | **LMPVIT Western Asset**<br> **Variable Global High Yield Bond**<br> **Sub-Account** | **PIMCO VIT High Yield**<br> **Sub-Account** | **PIMCO VIT High Yield**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $58 | $891 | $326949 | $222861 | $2647 | $2336 |
| Net realized gains (losses) | 2067 | 4601 | (165358) | (26760) | (268) | 161 |
| Change in unrealized gains <br>(losses) on investments | (7940) | (139) | (1305538) | (215026) | (11899) | (850) |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (5815) | 5353 | (1143947) | (18925) | (9520) | 1647 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners |  |  | 444892 | 830469 |  |  |
| Net transfers (including fixed <br>account) |  |  | (33530) | 710149 | (2377) | 7611 |
| Contract charges | (39) | (55) | (70679) | (56299) | (458) | (364) |
| Transfers for contract benefits <br>and terminations | (1762) | (11112) | (501179) | (1057142) | (1095) | (1000) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (1801) | (11167) | (160496) | 427177 | (3930) | 6247 |
| Net increase (decrease) <br>in net assets | (7616) | (5814) | (1304443) | 408252 | (13450) | 7894 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 36572 | 42386 | 7621275 | 7213023 | 82769 | 74875 |
| End of year | $28956 | $36572 | $6316832 | $7621275 | $69319 | $82769 |

---

The accompanying notes are an integral part of these financial statements.<br>73

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>STATEMENTS OF CHANGES IN NET ASSETS — (Concluded)**

**For the years ended December 31, 2022 and 2021**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **PIMCO VIT Low Duration**<br> **Sub-Account** | **PIMCO VIT Low Duration**<br> **Sub-Account** | **Pioneer Mid Cap Value VCT** <br> **Sub-Account** | **Pioneer Mid Cap Value VCT** <br> **Sub-Account** | **Putnam VT Large Cap Value**<br> **Sub-Account** | **Putnam VT Large Cap Value**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $94 | $(398) | $(1178) | $(14438) | $115 | $51 |
| Net realized gains (losses) | (42) | 22 | 733865 | 57762 | 1373 | 19420 |
| Change in unrealized gains <br>(losses) on investments | (3077) | (653) | (877943) | 433433 | (2125) | (13637) |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (3025) | (1029) | (145256) | 476757 | (637) | 5834 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners |  |  | 35966 | 193341 |  |  |
| Net transfers (including fixed <br>account) | (28) | 2527 | (146211) | (98362) |  |  |
| Contract charges | (275) | (266) | (12038) | (8726) |  |  |
| Transfers for contract benefits <br>and terminations | (4) | (1382) | (126569) | (281882) | (2) | (65329) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | (307) | 879 | (248852) | (195629) | (2) | (65329) |
| Net increase (decrease) <br>in net assets | (3332) | (150) | (394108) | 281128 | (639) | (59495) |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 42782 | 42932 | 2088943 | 1807815 | 16568 | 76063 |
| End of year | $39450 | $42782 | $1694835 | $2088943 | $15929 | $16568 |

---

(a) For the period April 29, 2022 to December 31, 2022.

The accompanying notes are an integral part of these financial statements.<br>74

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Putnam VT Sustainable Leaders**<br> **Sub-Account** | **Putnam VT Sustainable Leaders**<br> **Sub-Account** | **TAP 1919 Variable**<br> **Socially Responsive Balanced**<br> **Sub-Account** | **TAP 1919 Variable**<br> **Socially Responsive Balanced**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** |
| **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** | **Increase (Decrease) in Net Assets:** |
| **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** | **From Operations:** |
| Net investment income (loss) | $(2291) | $(4693) | $(1983) | $(3003) |
| Net realized gains (losses) | 58606 | 43239 | 10533 | 24008 |
| Change in unrealized gains <br>(losses) on investments | (170986) | 48120 | (64961) | 15158 |
| Net increase (decrease) <br>in net assets resulting <br>from operations | (114671) | 86666 | (56411) | 36163 |
| **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** | **Contract Transactions:** |
| Purchase payments received <br>from contract owners | 7214 | 6703 |  |  |
| Net transfers (including fixed <br>account) | (1487) | (163) |  |  |
| Contract charges |  |  | (35) | (35) |
| Transfers for contract benefits <br>and terminations |  |  | (7) | (6) |
| Net increase (decrease) <br>in net assets resulting <br>from contract transactions | 5727 | 6540 | (42) | (41) |
| Net increase (decrease) <br>in net assets | (108944) | 93206 | (56453) | 36122 |
| **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** | **Net Assets:** |
| Beginning of year | 476628 | 383422 | 253927 | 217805 |
| End of year | $367684 | $476628 | $197474 | $253927 |

---

The accompanying notes are an integral part of these financial statements.<br>75

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS**

**1. ORGANIZATION**

Brighthouse Variable Annuity Account B (the "Separate Account"), a separate account of Brighthouse Life Insurance Company of NY (the "Company"), was established by the Company's Board of Directors on December 31, 1992 to support the Company's operations with respect to certain variable annuity contracts (the "Contracts"). The company is a wholly-owned subsidiary of Brighthouse Life Insurance Company, which is an indirect wholly-owned subsidiary of Brighthouse Financial, Inc. The Separate Account is registered as a unit investment trust under the Investment Company Act of 1940, as amended, and is subject to the rules and regulations of the U.S. Securities and Exchange Commission, as well as the New York State Department of Financial Services.

The Separate Account is divided into Sub-Accounts, each of which is treated as an individual accounting entity for financial reporting purposes. Each Sub-Account invests in shares of the corresponding fund, portfolio, or series (with the same name) of the registered investment management companies (the "Trusts"), which are presented below:

AIM Variable Insurance Funds (Invesco Variable Insurance Funds) ("Invesco V.I.")

American Funds Insurance Series<sup>®</sup> ("American Funds")

BlackRock Variable Series Funds, Inc. ("BlackRock")

Brighthouse Funds Trust I ("BHFTI")\*

Brighthouse Funds Trust II ("BHFTII")\*

Fidelity<sup>®</sup> Variable Insurance Products ("Fidelity<sup>®</sup> VIP")

Franklin Templeton Variable Insurance Products Trust ("FTVIPT")

Janus Aspen Series ("Janus")

Legg Mason Partners Variable Equity Trust ("LMPVET")

Legg Mason Partners Variable Income Trust ("LMPVIT")

Morgan Stanley Variable Insurance Fund, Inc. ("Morgan Stanley VIF")

PIMCO Variable Insurance Trust ("PIMCO VIT")

Pioneer Variable Contracts Trust ("Pioneer")

Putnam Variable Trust ("Putnam VT")

Russell Investment Funds ("Russell")

Trust for Advised Portfolios ("TAP")

\* See Note 5 for a discussion of additional information on related party transactions.

The assets of each of the Sub-Accounts of the Separate Account are registered in the name of the Company. Under applicable insurance law, the assets and liabilities of the Separate Account are clearly identified and distinguished from the Company's other assets and liabilities. The portion of the Separate Account's assets applicable to the Contracts is not chargeable with liabilities arising out of any other business the Company may conduct.

The COVID-19 pandemic has at times resulted in or contributed to significant financial market volatility, travel restrictions and disruptions, quarantines, an uncertain interest rate environment, elevated inflation, global business, supply chain, and employment disruptions affecting companies across various industries, government and central bank interventions, wide-ranging changes in consumer behavior, as well as general concern and uncertainty that has negatively affected the economic environment. At this time, it continues to not be possible to estimate (i) the severity or duration of the pandemic, including the severity, duration and frequency of any additional "waves" or emerging variants of COVID-19, or (ii) the efficacy or utilization of any therapeutic treatments and vaccines for COVID-19 or variants thereof. It likewise remains not possible to predict or estimate the longer-term effects of the pandemic, or any actions taken to contain or address the pandemic, on our business and financial condition, the financial markets, and economy at large. The Company has implemented risk management and contingency plans, and continues to closely monitor this evolving situation, including the impact on services provided by third-party vendors. However, there can be no assurance that any future impact from the COVID-19 pandemic will not be material to the Company, the Separate Account and/or the Separate Account's investments.

Significant market volatility and negative investment returns in the financial markets resulting from the COVID-19 pandemic and market conditions could have a negative impact on returns of the underlying mutual funds in which the Separate Account invests.

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**2. LIST OF SUB-ACCOUNTS**

**A.** Purchase payments, less any applicable charges applied to the Separate Account, are invested in one or more Sub-Accounts in accordance with the selection made by the contract owner. The following Sub-Accounts had net assets as of December 31, 2022:

American Funds<sup>®</sup> Global Growth Sub-Account (a)

American Funds<sup>®</sup> Global Small Capitalization Sub-Account (a)

American Funds<sup>®</sup> Growth Sub-Account

American Funds<sup>®</sup> Growth-Income Sub-Account (a)

American Funds<sup>®</sup> The Bond Fund of America Sub-Account (a)

BHFTI AB Global Dynamic Allocation Sub-Account

BHFTI AB International Bond Sub-Account

BHFTI Allspring Mid Cap Value Sub-Account

BHFTI American Funds<sup>®</sup> Balanced Allocation Sub-Account

BHFTI American Funds<sup>®</sup> Growth Allocation Sub-Account

BHFTI American Funds<sup>®</sup> Growth Sub-Account

BHFTI American Funds<sup>®</sup> Moderate Allocation Sub-Account

BHFTI BlackRock Global Tactical Strategies Sub-Account

BHFTI BlackRock High Yield Sub-Account (a)

BHFTI Brighthouse Asset Allocation 100 Sub-Account

BHFTI Brighthouse Balanced Plus Sub-Account

BHFTI Brighthouse Small Cap Value Sub-Account (a)

BHFTI Brighthouse/abrdn Emerging Markets Equity Sub-Account (a)

BHFTI Brighthouse/Eaton Vance Floating Rate Sub-Account

BHFTI Brighthouse/Franklin Low Duration Total Return Sub-Account

BHFTI Brighthouse/Templeton International Bond Sub-Account

BHFTI Brighthouse/Wellington Large Cap Research Sub-Account (a)

BHFTI CBRE Global Real Estate Sub-Account (a)

BHFTI Harris Oakmark International Sub-Account (a)

BHFTI Invesco Balanced-Risk Allocation Sub-Account

BHFTI Invesco Comstock Sub-Account

BHFTI Invesco Global Equity Sub-Account

BHFTI Invesco Small Cap Growth Sub-Account (a)

BHFTI JPMorgan Core Bond Sub-Account

BHFTI JPMorgan Global Active Allocation Sub-Account

BHFTI JPMorgan Small Cap Value Sub-Account (a)

BHFTI Loomis Sayles Global Allocation Sub-Account

BHFTI Loomis Sayles Growth Sub-Account (a)

BHFTI MetLife Multi-Index Targeted Risk Sub-Account

BHFTI MFS<sup>®</sup> Research International Sub-Account (a)

BHFTI Morgan Stanley Discovery Sub-Account (a)

BHFTI PanAgora Global Diversified Risk Sub-Account

BHFTI PIMCO Inflation Protected Bond Sub-Account

BHFTI PIMCO Total Return Sub-Account (a)

BHFTI Schroders Global Multi-Asset Sub-Account

BHFTI SSGA Emerging Markets Enhanced Index Sub-Account

BHFTI SSGA Growth and Income ETF Sub-Account

BHFTI SSGA Growth ETF Sub-Account

BHFTI T. Rowe Price Large Cap Value Sub-Account (a)

BHFTI T. Rowe Price Mid Cap Growth Sub-Account (a)

BHFTI Victory Sycamore Mid Cap Value Sub-Account (a)

BHFTI Western Asset Management Government Income Sub-Account

BHFTII Baillie Gifford International Stock Sub-Account

BHFTII BlackRock Bond Income Sub-Account (a)

BHFTII BlackRock Capital Appreciation Sub-Account (a)

BHFTII BlackRock Ultra-Short Term Bond Sub-Account (a)

BHFTII Brighthouse Asset Allocation 20 Sub-Account

BHFTII Brighthouse Asset Allocation 40 Sub-Account

BHFTII Brighthouse Asset Allocation 60 Sub-Account

BHFTII Brighthouse Asset Allocation 80 Sub-Account

BHFTII Brighthouse/Artisan Mid Cap Value Sub-Account

BHFTII Brighthouse/Dimensional International Small Company Sub-Account

BHFTII Brighthouse/Wellington Core Equity Opportunities Sub-Account (a)

BHFTII Frontier Mid Cap Growth Sub-Account

BHFTII Jennison Growth Sub-Account (a)

BHFTII Loomis Sayles Small Cap Core Sub-Account

BHFTII Loomis Sayles Small Cap Growth Sub-Account

BHFTII MetLife Aggregate Bond Index Sub-Account

BHFTII MetLife Mid Cap Stock Index Sub-Account

BHFTII MetLife MSCI EAFE<sup>®</sup> Index Sub-Account

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**2. LIST OF SUB-ACCOUNTS — (Concluded)**

BHFTII MetLife Russell 2000<sup>®</sup> Index Sub-Account

BHFTII MetLife Stock Index Sub-Account (a)

BHFTII MFS<sup>®</sup> Total Return Sub-Account (a)

BHFTII MFS<sup>®</sup> Value Sub-Account (a)

BHFTII Neuberger Berman Genesis Sub-Account (a)

BHFTII T. Rowe Price Large Cap Growth Sub-Account (a)

BHFTII T. Rowe Price Small Cap Growth Sub-Account (a)

BHFTII VanEck Global Natural Resources Sub-Account

BHFTII Western Asset Management Strategic Bond Opportunities Sub-Account (a)

BHFTII Western Asset Management U.S. Government Sub-Account (a)

BlackRock Global Allocation V.I. Sub-Account

Fidelity<sup>®</sup> VIP Contrafund<sup>®</sup> Sub-Account (a)

Fidelity<sup>®</sup> VIP Equity-Income Sub-Account

Fidelity<sup>®</sup> VIP Mid Cap Sub-Account

FTVIPT Franklin Income VIP Sub-Account

FTVIPT Franklin Mutual Shares VIP Sub-Account

FTVIPT Franklin Small Cap Value VIP Sub-Account

FTVIPT Templeton Foreign VIP Sub-Account (a)

FTVIPT Templeton Global Bond VIP Sub-Account

Invesco V.I. Equity and Income Sub-Account

Invesco V.I. EQV International Equity Sub-Account (a)

Invesco V.I. Main Street Small Cap<sup>®</sup> Sub-Account

Janus Henderson Global Sustainable Equity Sub-Account (b)

LMPVET ClearBridge Variable Appreciation Sub-Account (a)

LMPVET ClearBridge Variable Dividend Strategy Sub-Account (a)

LMPVET ClearBridge Variable Large Cap Growth Sub-Account

LMPVET ClearBridge Variable Large Cap Value Sub-Account

LMPVET ClearBridge Variable Small Cap Growth Sub-Account (a)

LMPVET Franklin Multi-Asset Variable Conservative Growth Sub-Account

LMPVET Franklin Multi-Asset Variable Growth Sub-Account

LMPVET Franklin Multi-Asset Variable Moderate Growth Sub-Account

LMPVIT Western Asset Variable Global High Yield Bond Sub-Account (a)

PIMCO VIT High Yield Sub-Account

PIMCO VIT Low Duration Sub-Account

Pioneer Mid Cap Value VCT Sub-Account

Putnam VT Large Cap Value Sub-Account

Putnam VT Sustainable Leaders Sub-Account (a)

TAP 1919 Variable Socially Responsive Balanced Sub-Account

(a) This Sub-Account may invest in two or more share classes within the underlying fund, portfolio, or series of the Trusts.

(b) This Sub-Account began operations during the period ended December 31, 2022.

**B.** The following Sub-Accounts had no net assets as of December 31, 2022:

BHFTI Brighthouse/Artisan International Sub-Account

BHFTI TCW Core Fixed Income Sub-Account

Morgan Stanley VIF Global Infrastructure Sub-Account

Pioneer Real Estate Shares VCT Sub-Account

Russell Global Real Estate Securities Sub-Account

Russell International Developed Markets Sub-Account

Russell Strategic Bond Sub-Account

Russell U.S. Small Cap Equity Sub-Account

Russell U.S. Strategic Equity Sub-Account

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**3. PORTFOLIO CHANGES**

The following Sub-Account ceased operations during the year ended December 31, 2022:

BHFTI PanAgora Global Diversified Risk II Sub-Account

The operations of the Sub-Accounts were affected by the following changes that occurred during the year ended December 31, 2022:

**Name Changes:**

<u>Former Name</u>

Invesco V.I. International Growth Fund

BHFTI Brighthouse/Aberdeen Emerging Markets Equity Portfolio

<u>New Name</u>

Invesco V.I. EQV International Equity Fund

BHFTI Brighthouse/abrdn Emerging Markets Equity Equity Portfolio

**Merger:**

<u>Former Portfolio</u>

BHFTI PanAgora Global Diversified Risk Portfolio II

<u>New Portfolio</u>

BHFTI PanAgora Global Diversified Risk Portfolio

**4. SIGNIFICANT ACCOUNTING POLICIES**

**Basis of Accounting**

The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") applicable for variable annuity separate accounts registered as unit investment trusts, which follow the accounting and reporting guidance in Financial Accounting Standards Board *Accounting Standards Codification Topic 946, Investment Companies*.

**Security Transactions**

Security transactions are recorded on a trade date basis. Realized gains and losses on the sales of investments are computed on the basis of the average cost of the investment sold. Income from dividends and realized gain distributions are recorded on the ex-distribution date.

**Security Valuation**

A Sub-Account's investment in shares of a fund, portfolio, or series of the Trusts is valued at fair value based on the closing net asset value ("NAV") or price per share as determined by the Trusts as of the end of the year. All changes in fair value are recorded as changes in unrealized gains (losses) on investments in the statements of operations of the applicable Sub-Accounts. The Separate Account defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Each Sub-Account invests in shares of open-end mutual funds which calculate a daily NAV based on the fair value of the underlying securities in their portfolios. As a result, and as required by law, shares of open-end mutual funds are purchased and redeemed at their quoted daily NAV as reported by the Trusts at the close of each business day.

**Federal Income Taxes**

The operations of the Separate Account form a part of the total operations of the Company and are not taxed separately. The Company is taxed as a life insurance company under the provisions of the Internal Revenue Code ("IRC"). Under the current provisions of the IRC, the Company does not expect to incur federal income taxes on the earnings of the Separate Account to the extent the earnings are credited under the Contracts. Accordingly, no charge is currently being made to the Separate Account for federal income taxes. The Company will periodically review the status of this policy in the event of changes in the tax law. A charge may be made in future years for any federal income taxes that would be attributable to the Contracts.

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**4. SIGNIFICANT ACCOUNTING POLICIES — (Concluded)**

**Annuity Payouts**

Net assets allocated to Contracts in the annuity payout period are computed according to industry standard mortality tables. The assumed investment return is between 3.0 and 4.0 percent. The mortality risk is fully borne by the Company and may result in additional amounts being transferred into the Separate Account by the Company to cover greater longevity of annuitants than expected. Conversely, if amounts allocated exceed amounts required, transfers may be made to the Company. Annuity payouts are reported as contract transactions on the statements of changes in net assets of the applicable Sub-Accounts.

**Purchase Payments**

Purchase payments received from contract owners by the Company are credited as accumulation units as of the end of the valuation period in which received, as provided in the prospectus for the Contracts, and are reported as Contract transactions on the statements of changes in net assets of the applicable Sub-Accounts.

**Net Transfers**

Assets transferred by the contract owner into or out of Sub-Accounts within the Separate Account or into or out of the fixed account, which is part of the Company's general account, are recorded on a net basis as net transfers in the statements of changes in net assets of the applicable Sub-Accounts.

**Use of Estimates**

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported herein. Actual results could differ from these estimates.

**5. EXPENSES AND RELATED PARTY TRANSACTIONS**

The following annual Separate Account charges are asset-based charges paid to the company and assessed through a daily reduction in unit values, which are recorded as expenses in the accompanying statements of operations of the applicable Sub-Accounts:

<u>Mortality and Expense Risk</u> — The mortality risk assumed by the Company is the risk that those insured may die sooner than anticipated and therefore, the Company will pay an aggregate amount of death benefits greater than anticipated. The expense risk assumed is the risk that expenses incurred in issuing and administering the Contracts will exceed the amounts realized from the administrative charges assessed against the Contracts. In addition, the charge compensates the Company for the risk that the investor may live longer than estimated and the Company would be obligated to pay more in income payments than anticipated.

<u>Administrative</u> — The Company has responsibility for the administration of the Contracts and the Separate Account. Generally, the administrative charge is related to the maintenance, including distribution, of each contract and the Separate Account.

<u>Optional Death Benefit Rider</u> — For an additional charge, the total death benefit payable may be increased based on the increases in account value in the Contracts.

<u>Guaranteed Minimum Accumulation Benefit</u> — For an additional charge, the Company will guarantee that the contract value will not be less than a guaranteed minimum amount at the end of a specified number of years.

The table below represents the range of effective annual rates for each respective charge for the year ended December 31, 2022:

---

| | | |
|:---|:---|:---|
| Mortality and Expense Risk | 0.50 | % - 1.60% |
| Administrative | 0.15 | % - 0.25% |
| Optional Death Benefit Rider | 0.15 | % - 0.30% |
| Guaranteed Minimum Accumulation Benefit | 1.50 | % |

---

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**5. EXPENSES AND RELATED PARTY TRANSACTIONS — (Concluded)**

The above referenced charges may not necessarily correspond to the costs associated with providing the services or benefits indicated by the designation of the charge or associated with a particular contract. The range of effective rates disclosed above excludes any waivers granted to certain Sub-Accounts.

The following optional rider charges paid to the Company are charged at each contract anniversary date through the redemption of units and are recorded as contract charges in the accompanying statements of changes in net assets of the applicable Sub-Accounts:

<u>Guaranteed Minimum Accumulation Benefit</u> — For an additional charge, the Company will guarantee that the contract value will not be less than a guaranteed minimum amount at the end of a specified number of years.

<u>Lifetime Withdrawal Guarantee</u> — For an additional charge, the Company will guarantee minimum withdrawals for life regardless of market conditions.

<u>Guaranteed Withdrawal Benefit</u> — For an additional charge, the Company will guarantee minimum withdrawals regardless of market conditions.

<u>Guaranteed Minimum Income Benefit/Lifetime Income Solution</u> — For an additional charge, the company will guarantee a minimum payment regardless of market conditions.

<u>Enhanced Guaranteed Withdrawal Benefit</u> — For an additional charge, the Company will guarantee that at least the entire amount of purchase payments will be returned through a series of withdrawals without annuitizing.

The table below represents the range of effective annual rates for each respective charge for the year ended December 31, 2022:

---

| | | |
|:---|:---|:---|
| Guaranteed Minimum Accumulation Benefit | 0.75 | % |
| Lifetime Withdrawal Guarantee | 0.50 | % - 1.80% |
| Guaranteed Withdrawal Benefit | 0.25 | % - 1.40% |
| Guaranteed Minimum Income Benefit/Lifetime Income Solution | 0.50 | % - 1.50% |
| Enhanced Guaranteed Withdrawal Benefit | 0.55 | % |

---

The above referenced charges may not necessarily correspond to the costs associated with providing the services or benefits indicated by the designation of the charge or associated with a particular contract.

A contract maintenance fee ranging from $30 to $50 is assessed on an annual basis for Contracts with a value of less than $50,000 to $75,000. A transfer fee of $25 may be deducted after twelve transfers are made in a contract year or, if less, 2% of the amount transferred from the contract value. In addition, most Contracts impose a surrender charge which ranges from 0% to 9% if the contract is partially or fully surrendered within the specified surrender charge period. These charges are paid to the Company, assessed through the redemption of units, and are recorded as contract charges in the accompanying statements of changes in net assets of the applicable Sub-Accounts.

BHFTI and BHFTII currently offer shares of their portfolios only to separate accounts established by the Company and other affiliated life insurance companies, along with separate accounts of Metropolitan Life Insurance Company and its affiliated insurance companies. BHFTI and BHFTII portfolios are managed by Brighthouse Investment Advisers, LLC ("Brighthouse Advisers"), an affiliate of the Company. Brighthouse Advisers is also the investment adviser to the portfolios of BHFTI and BHFTII.

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**6. STATEMENTS OF INVESTMENTS**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **As of December 31, 2022**  | **As of December 31, 2022**  | **For the year ended**<br> **December 31, 2022** | **For the year ended**<br> **December 31, 2022** |
| | **Shares** | **Cost ($)** | **Cost of**<br> **Purchases ($)** | **Proceeds**<br> **from Sales ($)** |
| American Funds<sup>®</sup> Global Growth Sub-Account | 700404 | 19183022 | 3576636 | 1744603 |
| American Funds<sup>®</sup> Global Small Capitalization Sub-Account | 205017 | 4003709 | 1639190 | 298546 |
| American Funds<sup>®</sup> Growth Sub-Account | 511189 | 38491169 | 7509029 | 3230452 |
| American Funds<sup>®</sup> Growth-Income Sub-Account | 458173 | 20541721 | 3446271 | 4008908 |
| American Funds<sup>®</sup> The Bond Fund of America Sub-Account | 751336 | 8098306 | 1159965 | 1763065 |
| BHFTI AB Global Dynamic Allocation Sub-Account | 10061130 | 105138985 | 12019974 | 11075104 |
| BHFTI AB International Bond Sub-Account | 178948 | 1765701 | 366665 | 178691 |
| BHFTI Allspring Mid Cap Value Sub-Account | 1342345 | 16341728 | 3371085 | 3046240 |
| BHFTI American Funds<sup>®</sup> Balanced Allocation Sub-Account | 23717912 | 220635844 | 35731024 | 16737117 |
| BHFTI American Funds<sup>®</sup> Growth Allocation Sub-Account | 13978515 | 125870498 | 25041823 | 11352235 |
| BHFTI American Funds<sup>®</sup> Growth Sub-Account | 8982464 | 91942936 | 28779560 | 4735035 |
| BHFTI American Funds<sup>®</sup> Moderate Allocation Sub-Account | 12089620 | 113394606 | 20168946 | 8017443 |
| BHFTI BlackRock Global Tactical Strategies Sub-Account | 20747530 | 202783758 | 12211627 | 21385807 |
| BHFTI BlackRock High Yield Sub-Account | 7957326 | 60564511 | 8376554 | 7549025 |
| BHFTI Brighthouse Asset Allocation 100 Sub-Account | 9056731 | 102285216 | 12125365 | 7886326 |
| BHFTI Brighthouse Balanced Plus Sub-Account | 40111227 | 411914627 | 48769404 | 43981322 |
| BHFTI Brighthouse Small Cap Value Sub-Account | 1798297 | 25364880 | 5729072 | 3481888 |
| BHFTI Brighthouse/abrdn Emerging Markets Equity <br>Sub-Account | 2658061 | 26316891 | 5763132 | 2172186 |
| BHFTI Brighthouse/Eaton Vance Floating Rate Sub-Account | 1308945 | 13007992 | 4208777 | 2506775 |
| BHFTI Brighthouse/Franklin Low Duration Total Return <br>Sub-Account | 1505898 | 14255408 | 1971660 | 4272466 |
| BHFTI Brighthouse/Templeton International Bond <br>Sub-Account | 309101 | 3099084 | 37193 | 426512 |
| BHFTI Brighthouse/Wellington Large Cap Research <br>Sub-Account | 131808 | 1592466 | 438584 | 213415 |
| BHFTI CBRE Global Real Estate Sub-Account | 1503301 | 16672430 | 3040360 | 2067801 |
| BHFTI Harris Oakmark International Sub-Account | 3888293 | 49807101 | 6036785 | 4634087 |
| BHFTI Invesco Balanced-Risk Allocation Sub-Account | 4157931 | 40427623 | 9004810 | 5638250 |
| BHFTI Invesco Comstock Sub-Account | 2266601 | 28731880 | 7493420 | 7091026 |
| BHFTI Invesco Global Equity Sub-Account | 168256 | 3438330 | 853516 | 158600 |
| BHFTI Invesco Small Cap Growth Sub-Account | 5874074 | 59599796 | 19970171 | 2167577 |
| BHFTI JPMorgan Core Bond Sub-Account | 3125190 | 32310931 | 2238075 | 4645066 |
| BHFTI JPMorgan Global Active Allocation Sub-Account | 5567638 | 62249601 | 12136651 | 8875124 |
| BHFTI JPMorgan Small Cap Value Sub-Account | 292360 | 3854458 | 1270474 | 600219 |
| BHFTI Loomis Sayles Global Allocation Sub-Account | 1343978 | 19856177 | 3226729 | 1666491 |
| BHFTI Loomis Sayles Growth Sub-Account | 4237777 | 53926010 | 6736679 | 3416969 |
| BHFTI MetLife Multi-Index Targeted Risk Sub-Account | 4079842 | 47887647 | 5735382 | 6629104 |
| BHFTI MFS<sup>®</sup> Research International Sub-Account | 2278683 | 25933621 | 3592747 | 2524508 |
| BHFTI Morgan Stanley Discovery Sub-Account | 2981074 | 25028923 | 9238256 | 568007 |
| BHFTI PanAgora Global Diversified Risk Sub-Account | 12840002 | 108921854 | 109217772 | 5289566 |
| BHFTI PIMCO Inflation Protected Bond Sub-Account | 5245259 | 55358663 | 6153292 | 7661842 |
| BHFTI PIMCO Total Return Sub-Account | 10658569 | 124040131 | 5907755 | 14485021 |
| BHFTI Schroders Global Multi-Asset Sub-Account | 2946180 | 34412021 | 2903002 | 3392472 |
| BHFTI SSGA Emerging Markets Enhanced Index <br>Sub-Account | 92325 | 990737 | 323412 | 65867 |
| BHFTI SSGA Growth and Income ETF Sub-Account | 8825466 | 95379972 | 18905644 | 6521674 |
| BHFTI SSGA Growth ETF Sub-Account | 4703409 | 51344176 | 10247568 | 4201613 |
| BHFTI T. Rowe Price Large Cap Value Sub-Account | 1954445 | 54370666 | 11442641 | 9305559 |
| BHFTI T. Rowe Price Mid Cap Growth Sub-Account | 7624597 | 68107341 | 14435855 | 4579486 |
| BHFTI Victory Sycamore Mid Cap Value Sub-Account | 908803 | 15693618 | 3531823 | 3348000 |
| BHFTI Western Asset Management Government Income <br>Sub-Account | 3080398 | 32522879 | 6164207 | 8518829 |

---

(a) For the period April 29, 2022 to December 31, 2022.

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**6. STATEMENTS OF INVESTMENTS — (Continued)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **As of December 31, 2022**  | **As of December 31, 2022**  | **For the year ended**<br> **December 31, 2022** | **For the year ended**<br> **December 31, 2022** |
| | **Shares** | **Cost ($)** | **Cost of**<br> **Purchases ($)** | **Proceeds**<br> **from Sales ($)** |
| BHFTII Baillie Gifford International Stock Sub-Account | 1262753 | 13680829 | 2910096 | 1405676 |
| BHFTII BlackRock Bond Income Sub-Account | 177703 | 18792053 | 2637471 | 2721595 |
| BHFTII BlackRock Capital Appreciation Sub-Account | 575205 | 20819734 | 7863471 | 801581 |
| BHFTII BlackRock Ultra-Short Term Bond Sub-Account | 439686 | 44136943 | 16353852 | 19409026 |
| BHFTII Brighthouse Asset Allocation 20 Sub-Account | 1285886 | 13631048 | 2762840 | 1608962 |
| BHFTII Brighthouse Asset Allocation 40 Sub-Account | 22750820 | 262701888 | 21132431 | 30026425 |
| BHFTII Brighthouse Asset Allocation 60 Sub-Account | 40885061 | 489896669 | 46355822 | 42093847 |
| BHFTII Brighthouse Asset Allocation 80 Sub-Account | 28306169 | 367800223 | 39230219 | 39348608 |
| BHFTII Brighthouse/Artisan Mid Cap Value Sub-Account | 56074 | 11714046 | 2440561 | 2476378 |
| BHFTII Brighthouse/Dimensional International Small <br>Company Sub-Account | 456702 | 5633057 | 771278 | 608921 |
| BHFTII Brighthouse/Wellington Core Equity Opportunities <br>Sub-Account | 2369265 | 70262082 | 16776006 | 15291945 |
| BHFTII Frontier Mid Cap Growth Sub-Account | 588521 | 14623511 | 5112429 | 1044968 |
| BHFTII Jennison Growth Sub-Account | 6742894 | 92645308 | 26081225 | 3351658 |
| BHFTII Loomis Sayles Small Cap Core Sub-Account | 3825 | 832649 | 168289 | 63922 |
| BHFTII Loomis Sayles Small Cap Growth Sub-Account | 52733 | 559292 | 144964 | 50033 |
| BHFTII MetLife Aggregate Bond Index Sub-Account | 3293624 | 35376402 | 4404393 | 5421717 |
| BHFTII MetLife Mid Cap Stock Index Sub-Account | 713189 | 11945106 | 4215036 | 1700907 |
| BHFTII MetLife MSCI EAFE<sup>®</sup> Index Sub-Account | 671121 | 8401022 | 1348518 | 1179902 |
| BHFTII MetLife Russell 2000<sup>®</sup> Index Sub-Account | 854217 | 15227112 | 4255700 | 1157403 |
| BHFTII MetLife Stock Index Sub-Account | 1572046 | 73806006 | 18659136 | 10866589 |
| BHFTII MFS<sup>®</sup> Total Return Sub-Account | 38136 | 5667586 | 727124 | 933793 |
| BHFTII MFS<sup>®</sup> Value Sub-Account | 1783479 | 26309107 | 7230134 | 4218329 |
| BHFTII Neuberger Berman Genesis Sub-Account | 583152 | 10177764 | 2330357 | 2444058 |
| BHFTII T. Rowe Price Large Cap Growth Sub-Account | 3080961 | 62519699 | 20105965 | 3652996 |
| BHFTII T. Rowe Price Small Cap Growth Sub-Account | 24608 | 417829 | 101497 | 32277 |
| BHFTII VanEck Global Natural Resources Sub-Account | 259423 | 2667882 | 468140 | 1519246 |
| BHFTII Western Asset Management Strategic Bond <br>Opportunities Sub-Account | 5016576 | 64506253 | 8494671 | 10364228 |
| BHFTII Western Asset Management U.S. Government <br>Sub-Account | 2375303 | 27746949 | 4446509 | 7371095 |
| BlackRock Global Allocation V.I. Sub-Account | 430215 | 6519605 | 767973 | 230972 |
| Fidelity<sup>®</sup> VIP Contrafund<sup>®</sup> Sub-Account | 463099 | 16239438 | 2330124 | 2094406 |
| Fidelity<sup>®</sup> VIP Equity-Income Sub-Account | 620 | 13333 | 740 | 1422 |
| Fidelity<sup>®</sup> VIP Mid Cap Sub-Account | 354460 | 11454734 | 1322833 | 1796249 |
| FTVIPT Franklin Income VIP Sub-Account | 1118580 | 16962213 | 2129926 | 3084037 |
| FTVIPT Franklin Mutual Shares VIP Sub-Account | 143148 | 2404078 | 426968 | 447446 |
| FTVIPT Franklin Small Cap Value VIP Sub-Account | 219614 | 3233959 | 770223 | 622082 |
| FTVIPT Templeton Foreign VIP Sub-Account | 779683 | 11050135 | 602576 | 1599889 |
| FTVIPT Templeton Global Bond VIP Sub-Account | 467051 | 7665430 | 278786 | 1213909 |
| Invesco V.I. Equity and Income Sub-Account | 753685 | 12193854 | 2191818 | 2689818 |
| Invesco V.I. EQV International Equity Sub-Account | 223650 | 6849776 | 1236706 | 787281 |
| Invesco V.I. Main Street Small Cap<sup>®</sup> Sub-Account | 124120 | 2797007 | 463063 | 614086 |
| Janus Henderson Global Sustainable Equity Sub-Account (a) | 1418 | 12978 | 13044 | 62 |
| LMPVET ClearBridge Variable Appreciation Sub-Account | 444149 | 16804539 | 2287095 | 3598845 |
| LMPVET ClearBridge Variable Dividend Strategy <br>Sub-Account | 592901 | 9831466 | 1821057 | 1789601 |
| LMPVET ClearBridge Variable Large Cap Growth <br>Sub-Account | 8352 | 195205 | 28169 | 11915 |
| LMPVET ClearBridge Variable Large Cap Value <br>Sub-Account | 10992 | 198879 | 19776 | 35728 |

---

(a) For the period April 29, 2022 to December 31, 2022.

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**6. STATEMENTS OF INVESTMENTS — (Concluded)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **As of December 31, 2022**  | **As of December 31, 2022**  | **For the year ended**<br> **December 31, 2022** | **For the year ended**<br> **December 31, 2022** |
| | **Shares** | **Cost ($)** | **Cost of**<br> **Purchases ($)** | **Proceeds**<br> **from Sales ($)** |
| LMPVET ClearBridge Variable Small Cap Growth <br>Sub-Account | 240972 | 6411632 | 1334729 | 669558 |
| LMPVET Franklin Multi-Asset Variable Conservative <br>Growth Sub-Account | 82745 | 1118818 | 124074 | 293640 |
| LMPVET Franklin Multi-Asset Variable Growth <br>Sub-Account | 88921 | 1165781 | 131920 | 98420 |
| LMPVET Franklin Multi-Asset Variable Moderate Growth <br>Sub-Account | 2424 | 30472 | 2760 | 2292 |
| LMPVIT Western Asset Variable Global High Yield Bond <br>Sub-Account | 1076762 | 7985573 | 1032342 | 865855 |
| PIMCO VIT High Yield Sub-Account | 10240 | 75397 | 3788 | 5067 |
| PIMCO VIT Low Duration Sub-Account | 4162 | 42621 | 680 | 889 |
| Pioneer Mid Cap Value VCT Sub-Account | 149723 | 2140203 | 794352 | 309063 |
| Putnam VT Large Cap Value Sub-Account | 589 | 11850 | 1571 | 116 |
| Putnam VT Sustainable Leaders Sub-Account | 10792 | 339064 | 68392 | 7528 |
| TAP 1919 Variable Socially Responsive Balanced <br>Sub-Account | 7132 | 206644 | 11770 | 3503 |

---

(a) For the period April 29, 2022 to December 31, 2022.

------

This page is intentionally left blank.

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**7. SCHEDULES OF UNITS<br>For the years ended December 31, 2022 and 2021:**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **American Funds<sup>®</sup>** <br> **Global Growth** <br> **Sub-Account** | **American Funds<sup>®</sup>** <br> **Global Growth** <br> **Sub-Account** | **American Funds<sup>®</sup>** <br> **Global Small Capitalization** <br> **Sub-Account** | **American Funds<sup>®</sup>** <br> **Global Small Capitalization** <br> **Sub-Account** | **American Funds<sup>®</sup> Growth** <br> **Sub-Account (b)** | **American Funds<sup>®</sup> Growth** <br> **Sub-Account (b)** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 992510 | 734379 | 89285 | 78876 | 167146 | 203565 |
| Units issued and transferred<br>from other funding options | 283016 | 510877 | 20115 | 26372 | 24769 | 222043 |
| Units redeemed and transferred to <br>other funding options | (117676) | (252746) | (9458) | (15963) | (28444) | (258462) |
| Units end of year | 1157850 | 992510 | 99942 | 89285 | 163471 | 167146 |
|  | **BHFTI AB**<br> **International Bond**<br> **Sub-Account** | **BHFTI AB**<br> **International Bond**<br> **Sub-Account** | **BHFTI Allspring** <br> **Mid Cap Value** <br> **Sub-Account** | **BHFTI Allspring** <br> **Mid Cap Value** <br> **Sub-Account** | **BHFTI American Funds<sup>®</sup>** **Balanced Allocation**<br> **Sub-Account** | **BHFTI American Funds<sup>®</sup>** **Balanced Allocation**<br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 154592 | 94140 | 528782 | 621225 | 11574421 | 12122651 |
| Units issued and transferred<br>from other funding options | 25272 | 70316 | 16329 | 16273 | 616949 | 884133 |
| Units redeemed and transferred to <br>other funding options | (20700) | (9864) | (87940) | (108716) | (1082653) | (1432363) |
| Units end of year | 159164 | 154592 | 457171 | 528782 | 11108717 | 11574421 |
|  | **BHFTI BlackRock Global** <br> **Tactical Strategies**<br> **Sub-Account** | **BHFTI BlackRock Global** <br> **Tactical Strategies**<br> **Sub-Account** | **BHFTI BlackRock** <br> **High Yield** <br> **Sub-Account** | **BHFTI BlackRock** <br> **High Yield** <br> **Sub-Account** | **BHFTI Brighthouse** <br> **Asset Allocation 100** <br> **Sub-Account** | **BHFTI Brighthouse** <br> **Asset Allocation 100** <br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 14666019 | 16183955 | 4744372 | 2663226 | 4088833 | 4447639 |
| Units issued and transferred<br>from other funding options | 163736 | 340981 | 1331666 | 2844329 | 131066 | 181716 |
| Units redeemed and transferred to <br>other funding options | (1489347) | (1858917) | (1242002) | (763183) | (315850) | (540522) |
| Units end of year | 13340408 | 14666019 | 4834036 | 4744372 | 3904049 | 4088833 |
|  | **BHFTI Brighthouse/Eaton**<br> **Vance Floating Rate**<br> **Sub-Account** | **BHFTI Brighthouse/Eaton**<br> **Vance Floating Rate**<br> **Sub-Account** | **BHFTI Brighthouse/Franklin** <br> **Low Duration Total Return** <br> **Sub-Account** | **BHFTI Brighthouse/Franklin** <br> **Low Duration Total Return** <br> **Sub-Account** | **BHFTI Brighthouse/Templeton** <br> **International Bond** <br> **Sub-Account** | **BHFTI Brighthouse/Templeton** <br> **International Bond** <br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 883825 | 752487 | 1646433 | 1468500 | 263952 | 240718 |
| Units issued and transferred<br>from other funding options | 370402 | 251036 | 214872 | 669107 | 11536 | 42870 |
| Units redeemed and transferred to <br>other funding options | (257975) | (119698) | (477313) | (491174) | (45635) | (19636) |
| Units end of year | 996252 | 883825 | 1383992 | 1646433 | 229853 | 263952 |

---

(a) For the period April 29, 2022 to December 31, 2022.

(b) During 2021, the Separate Account effectuated a 1-for-10 unit change to certain contract owners in the American Funds<sup>®</sup> Growth Sub-Account, resulting in a broader range of unit values. The unit value and number of units outstanding for the impacted contract owners were retroactively adjusted to reflect this change in each period presented prior to 2022. There was no change to the total net assets of the fund or to any contract owner's investment in the fund for any period presented prior to 2022.

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **American Funds<sup>®</sup>** <br> **Growth-Income** <br> **Sub-Account** | **American Funds<sup>®</sup>** <br> **Growth-Income** <br> **Sub-Account** | **American Funds<sup>®</sup>** <br> **The Bond Fund of America**<br> **Sub-Account** | **American Funds<sup>®</sup>** <br> **The Bond Fund of America**<br> **Sub-Account** | **BHFTI AB Global** <br> **Dynamic Allocation** <br> **Sub-Account** | **BHFTI AB Global** <br> **Dynamic Allocation** <br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 1108656 | 906040 | 2385576 | 1767691 | 7604691 | 8406848 |
| Units issued and transferred<br>from other funding options | 331579 | 485980 | 585763 | 1078967 | 93143 | 116935 |
| Units redeemed and transferred to <br>other funding options | (138532) | (283364) | (548065) | (461082) | (777481) | (919092) |
| Units end of year | 1301703 | 1108656 | 2423274 | 2385576 | 6920353 | 7604691 |
|  | **BHFTI American Funds<sup>®</sup>** <br> **Growth Allocation** <br> **Sub-Account** | **BHFTI American Funds<sup>®</sup>** <br> **Growth Allocation** <br> **Sub-Account** | **BHFTI American Funds<sup>®</sup>** <br> **Growth** <br> **Sub-Account** | **BHFTI American Funds<sup>®</sup>** <br> **Growth** <br> **Sub-Account** | **BHFTI American Funds<sup>®</sup>** <br> **Moderate Allocation** <br> **Sub-Account** | **BHFTI American Funds<sup>®</sup>** <br> **Moderate Allocation** <br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 6000642 | 6030618 | 5365191 | 4894166 | 6141812 | 6377750 |
| Units issued and transferred<br>from other funding options | 385223 | 914757 | 1488052 | 1619717 | 556882 | 441234 |
| Units redeemed and transferred to <br>other funding options | (643503) | (944733) | (819804) | (1148692) | (534592) | (677172) |
| Units end of year | 5742362 | 6000642 | 6033439 | 5365191 | 6164102 | 6141812 |
|  | **BHFTI Brighthouse** <br> **Balanced Plus** <br> **Sub-Account** | **BHFTI Brighthouse** <br> **Balanced Plus** <br> **Sub-Account** | **BHFTI Brighthouse** <br> **Small Cap Value** <br> **Sub-Account** | **BHFTI Brighthouse** <br> **Small Cap Value** <br> **Sub-Account** | **BHFTI Brighthouse/abrdn** <br> **Emerging Markets Equity** <br> **Sub-Account** | **BHFTI Brighthouse/abrdn** <br> **Emerging Markets Equity** <br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 23834679 | 26280061 | 726526 | 864071 | 2139801 | 2232694 |
| Units issued and transferred<br>from other funding options | 636931 | 574782 | 58677 | 72521 | 343279 | 314286 |
| Units redeemed and transferred to <br>other funding options | (2692106) | (3020164) | (110772) | (210066) | (310998) | (407179) |
| Units end of year | 21779504 | 23834679 | 674431 | 726526 | 2172082 | 2139801 |
|  | **BHFTI Brighthouse/Wellington** <br> **Large Cap Research** <br> **Sub-Account** | **BHFTI Brighthouse/Wellington** <br> **Large Cap Research** <br> **Sub-Account** | **BHFTI CBRE** <br> **Global Real Estate** <br> **Sub-Account** | **BHFTI CBRE** <br> **Global Real Estate** <br> **Sub-Account** | **BHFTI Harris**<br> **Oakmark International**<br> **Sub-Account** | **BHFTI Harris**<br> **Oakmark International**<br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 60472 | 66113 | 773224 | 912650 | 1624824 | 1793726 |
| Units issued and transferred<br>from other funding options | 2474 | 170 | 80850 | 55254 | 205349 | 190196 |
| Units redeemed and transferred to <br>other funding options | (6709) | (5811) | (119305) | (194680) | (244560) | (359098) |
| Units end of year | 56237 | 60472 | 734769 | 773224 | 1585613 | 1624824 |

---

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**7. SCHEDULES OF UNITS — (Continued)<br>For the years ended December 31, 2022 and 2021:**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTI Invesco**<br> **Balanced-Risk Allocation**<br> **Sub-Account** | **BHFTI Invesco**<br> **Balanced-Risk Allocation**<br> **Sub-Account** | **BHFTI Invesco Comstock** <br> **Sub-Account** | **BHFTI Invesco Comstock** <br> **Sub-Account** | **BHFTI Invesco Global Equity** <br> **Sub-Account** | **BHFTI Invesco Global Equity** <br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 24747537 | 26870316 | 1281182 | 1508027 | 77634 | 82182 |
| Units issued and transferred<br>from other funding options | 4034229 | 1633165 | 180537 | 184084 | 12461 | 7697 |
| Units redeemed and transferred to <br>other funding options | (4497549) | (3755944) | (339165) | (410929) | (6166) | (12245) |
| Units end of year | 24284217 | 24747537 | 1122554 | 1281182 | 83929 | 77634 |
|  | **BHFTI JPMorgan**<br> **Small Cap Value**<br> **Sub-Account** | **BHFTI JPMorgan**<br> **Small Cap Value**<br> **Sub-Account** | **BHFTI Loomis** <br> **Sayles Global Allocation** <br> **Sub-Account** | **BHFTI Loomis** <br> **Sayles Global Allocation** <br> **Sub-Account** | **BHFTI Loomis** <br> **Sayles Growth** <br> **Sub-Account** | **BHFTI Loomis** <br> **Sayles Growth** <br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 135026 | 162370 | 752458 | 724959 | 1911338 | 1620817 |
| Units issued and transferred<br>from other funding options | 5813 | 8158 | 54311 | 137846 | 205127 | 614550 |
| Units redeemed and transferred to <br>other funding options | (23274) | (35502) | (84802) | (110347) | (212234) | (324029) |
| Units end of year | 117565 | 135026 | 721967 | 752458 | 1904231 | 1911338 |
|  | **BHFTI PanAgora**<br> **Global Diversified Risk**<br> **Sub-Account** | **BHFTI PanAgora**<br> **Global Diversified Risk**<br> **Sub-Account** | **BHFTI PIMCO Inflation**<br> **Protected Bond**<br> **Sub-Account** | **BHFTI PIMCO Inflation**<br> **Protected Bond**<br> **Sub-Account** | **BHFTI PIMCO Total Return** <br> **Sub-Account** | **BHFTI PIMCO Total Return** <br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 4339888 | 4058719 | 3589130 | 3419774 | 6708999 | 6422062 |
| Units issued and transferred<br>from other funding options | 73308841 | 1179234 | 425933 | 771857 | 478142 | 1414536 |
| Units redeemed and transferred to <br>other funding options | (5929416) | (898065) | (692378) | (602501) | (1050581) | (1127599) |
| Units end of year | 71719313 | 4339888 | 3322685 | 3589130 | 6136560 | 6708999 |
|  | **BHFTI SSGA Growth ETF**<br> **Sub-Account** | **BHFTI SSGA Growth ETF**<br> **Sub-Account** | **BHFTI T. Rowe Price** <br> **Large Cap Value** <br> **Sub-Account** | **BHFTI T. Rowe Price** <br> **Large Cap Value** <br> **Sub-Account** | **BHFTI T. Rowe Price** <br> **Mid Cap Growth** <br> **Sub-Account** | **BHFTI T. Rowe Price** <br> **Mid Cap Growth** <br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 2260653 | 2409539 | 502926 | 552845 | 1809374 | 1820476 |
| Units issued and transferred<br>from other funding options | 67148 | 61116 | 54286 | 53474 | 212361 | 241538 |
| Units redeemed and transferred to <br>other funding options | (183880) | (210002) | (97730) | (103393) | (231341) | (252640) |
| Units end of year | 2143921 | 2260653 | 459482 | 502926 | 1790394 | 1809374 |

---

(a) For the period April 29, 2022 to December 31, 2022.

(b) During 2021, the Separate Account effectuated a 1-for-10 unit change to certain contract owners in the American Funds<sup>®</sup> Growth Sub-Account, resulting in a broader range of unit values. The unit value and number of units outstanding for the impacted contract owners were retroactively adjusted to reflect this change in each period presented prior to 2022. There was no change to the total net assets of the fund or to any contract owner's investment in the fund for any period presented prior to 2022.

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTI Invesco** <br> **Small Cap Growth** <br> **Sub-Account** | **BHFTI Invesco** <br> **Small Cap Growth** <br> **Sub-Account** | **BHFTI JPMorgan Core Bond** <br> **Sub-Account** | **BHFTI JPMorgan Core Bond** <br> **Sub-Account** | **BHFTI JPMorgan** <br> **Global Active Allocation** <br> **Sub-Account** | **BHFTI JPMorgan** <br> **Global Active Allocation** <br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 765164 | 734094 | 2920833 | 2661284 | 39075024 | 40758747 |
| Units issued and transferred<br>from other funding options | 222507 | 197339 | 270026 | 641819 | 2774649 | 5497894 |
| Units redeemed and transferred to <br>other funding options | (115735) | (166269) | (516158) | (382270) | (5973301) | (7181617) |
| Units end of year | 871936 | 765164 | 2674701 | 2920833 | 35876372 | 39075024 |
|  | **BHFTI MetLife** <br> **Multi-Index Targeted Risk** <br> **Sub-Account** | **BHFTI MetLife** <br> **Multi-Index Targeted Risk** <br> **Sub-Account** | **BHFTI MFS<sup>®</sup> Research** <br> **International** <br> **Sub-Account** | **BHFTI MFS<sup>®</sup> Research** <br> **International** <br> **Sub-Account** | **BHFTI Morgan** <br> **Stanley Discovery** <br> **Sub-Account** | **BHFTI Morgan** <br> **Stanley Discovery** <br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 28930911 | 30858661 | 1319738 | 1424172 | 221149 | 271611 |
| Units issued and transferred<br>from other funding options | 1373784 | 2529686 | 132351 | 90217 | 142984 | 53380 |
| Units redeemed and transferred to <br>other funding options | (4201461) | (4457436) | (171306) | (194651) | (44646) | (103842) |
| Units end of year | 26103234 | 28930911 | 1280783 | 1319738 | 319487 | 221149 |
|  | **BHFTI Schroders** <br> **Global Multi-Asset** <br> **Sub-Account** | **BHFTI Schroders** <br> **Global Multi-Asset** <br> **Sub-Account** | **BHFTI SSGA Emerging** <br> **Markets Enhanced Index** <br> **Sub-Account** | **BHFTI SSGA Emerging** <br> **Markets Enhanced Index** <br> **Sub-Account** | **BHFTI SSGA** <br> **Growth and Income ETF**<br> **Sub-Account** | **BHFTI SSGA** <br> **Growth and Income ETF**<br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 24183311 | 28178777 | 65053 | 21007 | 4329542 | 4610993 |
| Units issued and transferred<br>from other funding options | 611417 | 1007756 | 33237 | 51661 | 199900 | 253664 |
| Units redeemed and transferred to <br>other funding options | (2408253) | (5003222) | (7548) | (7615) | (340397) | (535115) |
| Units end of year | 22386475 | 24183311 | 90742 | 65053 | 4189045 | 4329542 |
|  | **BHFTI Victory Sycamore** <br> **Mid Cap Value** <br> **Sub-Account** | **BHFTI Victory Sycamore** <br> **Mid Cap Value** <br> **Sub-Account** | **BHFTI Western Asset**<br> **Management**<br> **Government Income**<br> **Sub-Account** | **BHFTI Western Asset**<br> **Management**<br> **Government Income**<br> **Sub-Account** | **BHFTII Baillie Gifford**<br> **International Stock**<br> **Sub-Account** | **BHFTII Baillie Gifford**<br> **International Stock**<br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 325975 | 377683 | 3055180 | 3438704 | 712522 | 747852 |
| Units issued and transferred<br>from other funding options | 32445 | 36038 | 627260 | 607066 | 163954 | 116762 |
| Units redeemed and transferred to <br>other funding options | (67018) | (87746) | (865548) | (990590) | (132278) | (152092) |
| Units end of year | 291402 | 325975 | 2816892 | 3055180 | 744198 | 712522 |

---

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**7. SCHEDULES OF UNITS — (Continued)<br>For the years ended December 31, 2022 and 2021:**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTII BlackRock** <br> **Bond Income** <br> **Sub-Account** | **BHFTII BlackRock** <br> **Bond Income** <br> **Sub-Account** | **BHFTII BlackRock** <br> **Capital Appreciation** <br> **Sub-Account** | **BHFTII BlackRock** <br> **Capital Appreciation** <br> **Sub-Account** | **BHFTII BlackRock** <br> **Ultra-Short Term Bond** <br> **Sub-Account** | **BHFTII BlackRock** <br> **Ultra-Short Term Bond** <br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 273225 | 219703 | 174283 | 149933 | 6139612 | 5445123 |
| Units issued and transferred<br>from other funding options | 44257 | 85482 | 46620 | 40635 | 3367365 | 5810592 |
| Units redeemed and transferred to <br>other funding options | (50788) | (31960) | (12338) | (16285) | (3050110) | (5116103) |
| Units end of year | 266694 | 273225 | 208565 | 174283 | 6456867 | 6139612 |
|  | **BHFTII Brighthouse** <br> **Asset Allocation 80** <br> **Sub-Account** | **BHFTII Brighthouse** <br> **Asset Allocation 80** <br> **Sub-Account** | **BHFTII Brighthouse/Artisan** <br> **Mid Cap Value** <br> **Sub-Account** | **BHFTII Brighthouse/Artisan** <br> **Mid Cap Value** <br> **Sub-Account** | **BHFTII** <br> **Brighthouse/Dimensional** <br> **International Small Company** <br> **Sub-Account** | **BHFTII** <br> **Brighthouse/Dimensional** <br> **International Small Company** <br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 15464361 | 16910512 | 450461 | 515775 | 188151 | 205282 |
| Units issued and transferred<br>from other funding options | 319856 | 440649 | 30138 | 34059 | 12372 | 15965 |
| Units redeemed and transferred to <br>other funding options | (1670283) | (1886800) | (89854) | (99373) | (26600) | (33096) |
| Units end of year | 14113934 | 15464361 | 390745 | 450461 | 173923 | 188151 |
|  | **BHFTII Loomis Sayles** <br> **Small Cap Core** <br> **Sub-Account** | **BHFTII Loomis Sayles** <br> **Small Cap Core** <br> **Sub-Account** | **BHFTII Loomis Sayles** <br> **Small Cap Growth** <br> **Sub-Account** | **BHFTII Loomis Sayles** <br> **Small Cap Growth** <br> **Sub-Account** | **BHFTII MetLife** <br> **Aggregate Bond Index** <br> **Sub-Account** | **BHFTII MetLife** <br> **Aggregate Bond Index** <br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 9768 | 11843 | 13797 | 14903 | 2091257 | 1777483 |
| Units issued and transferred<br>from other funding options | 238 | 120 | 1158 | 1362 | 320490 | 632656 |
| Units redeemed and transferred to <br>other funding options | (704) | (2195) | (1589) | (2468) | (417780) | (318882) |
| Units end of year | 9302 | 9768 | 13366 | 13797 | 1993967 | 2091257 |
|  | **BHFTII MetLife** <br> **Stock Index** <br> **Sub-Account** | **BHFTII MetLife** <br> **Stock Index** <br> **Sub-Account** | **BHFTII MFS<sup>®</sup> Total Return** <br> **Sub-Account** | **BHFTII MFS<sup>®</sup> Total Return** <br> **Sub-Account** | **BHFTII MFS<sup>®</sup> Value**<br> **Sub-Account** | **BHFTII MFS<sup>®</sup> Value**<br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 2083501 | 2078635 | 76609 | 82987 | 671025 | 711871 |
| Units issued and transferred<br>from other funding options | 332056 | 362702 | 861 | 3149 | 97010 | 75096 |
| Units redeemed and transferred to <br>other funding options | (319231) | (357836) | (10104) | (9527) | (121371) | (115942) |
| Units end of year | 2096326 | 2083501 | 67366 | 76609 | 646664 | 671025 |

---

(a) For the period April 29, 2022 to December 31, 2022.

(b) During 2021, the Separate Account effectuated a 1-for-10 unit change to certain contract owners in the American Funds<sup>®</sup> Growth Sub-Account, resulting in a broader range of unit values. The unit value and number of units outstanding for the impacted contract owners were retroactively adjusted to reflect this change in each period presented prior to 2022. There was no change to the total net assets of the fund or to any contract owner's investment in the fund for any period presented prior to 2022.

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTII Brighthouse** <br> **Asset Allocation 20** <br> **Sub-Account** | **BHFTII Brighthouse** <br> **Asset Allocation 20** <br> **Sub-Account** | **BHFTII Brighthouse** <br> **Asset Allocation 40** <br> **Sub-Account** | **BHFTII Brighthouse** <br> **Asset Allocation 40** <br> **Sub-Account** | **BHFTII Brighthouse**<br> **Asset Allocation 60**<br> **Sub-Account** | **BHFTII Brighthouse**<br> **Asset Allocation 60**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 861410 | 766288 | 14048161 | 15661755 | 22078453 | 24020879 |
| Units issued and transferred<br>from other funding options | 154302 | 203957 | 520569 | 345089 | 517242 | 797472 |
| Units redeemed and transferred to <br>other funding options | (113544) | (108835) | (1657809) | (1958683) | (2093661) | (2739898) |
| Units end of year | 902168 | 861410 | 12910921 | 14048161 | 20502034 | 22078453 |
|  | **BHFTII** <br> **Brighthouse/Wellington** <br> **Core Equity Opportunities** <br> **Sub-Account** | **BHFTII** <br> **Brighthouse/Wellington** <br> **Core Equity Opportunities** <br> **Sub-Account** | **BHFTII** <br> **Frontier Mid Cap Growth** <br> **Sub-Account** | **BHFTII** <br> **Frontier Mid Cap Growth** <br> **Sub-Account** | **BHFTII Jennison Growth**<br> **Sub-Account** | **BHFTII Jennison Growth**<br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 2403692 | 2426127 | 286056 | 300679 | 1409992 | 1380663 |
| Units issued and transferred<br>from other funding options | 370382 | 377681 | 56082 | 37467 | 323793 | 315308 |
| Units redeemed and transferred to <br>other funding options | (529174) | (400116) | (39004) | (52090) | (183941) | (285979) |
| Units end of year | 2244900 | 2403692 | 303134 | 286056 | 1549844 | 1409992 |
|  | **BHFTII MetLife** <br> **Mid Cap Stock Index** <br> **Sub-Account** | **BHFTII MetLife** <br> **Mid Cap Stock Index** <br> **Sub-Account** | **BHFTII MetLife** <br> **MSCI EAFE<sup>®</sup> Index** <br> **Sub-Account** | **BHFTII MetLife** <br> **MSCI EAFE<sup>®</sup> Index** <br> **Sub-Account** | **BHFTII MetLife**<br> **Russell 2000<sup>®</sup> Index**<br> **Sub-Account** | **BHFTII MetLife**<br> **Russell 2000<sup>®</sup> Index**<br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 236049 | 244010 | 541578 | 565388 | 316964 | 324150 |
| Units issued and transferred<br>from other funding options | 59966 | 60753 | 67880 | 57142 | 60019 | 84068 |
| Units redeemed and transferred to <br>other funding options | (46319) | (68714) | (81896) | (80952) | (41673) | (91254) |
| Units end of year | 249696 | 236049 | 527562 | 541578 | 335310 | 316964 |
|  | **BHFTII** <br> **Neuberger Berman Genesis** <br> **Sub-Account** | **BHFTII** <br> **Neuberger Berman Genesis** <br> **Sub-Account** | **BHFTII T. Rowe**<br> **Price Large Cap Growth**<br> **Sub-Account** | **BHFTII T. Rowe**<br> **Price Large Cap Growth**<br> **Sub-Account** | **BHFTII T. Rowe Price** <br> **Small Cap Growth**<br> **Sub-Account** | **BHFTII T. Rowe Price** <br> **Small Cap Growth**<br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 285422 | 323232 | 1060820 | 1133729 | 7733 | 8025 |
| Units issued and transferred<br>from other funding options | 20342 | 28313 | 342201 | 143781 | 519 | 362 |
| Units redeemed and transferred to <br>other funding options | (63128) | (66123) | (184439) | (216690) | (650) | (654) |
| Units end of year | 242636 | 285422 | 1218582 | 1060820 | 7602 | 7733 |

---

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**7. SCHEDULES OF UNITS — (Continued)<br>For the years ended December 31, 2022 and 2021:**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **BHFTII VanEck** <br> **Global Natural Resources** <br> **Sub-Account** | **BHFTII VanEck** <br> **Global Natural Resources** <br> **Sub-Account** | **BHFTII** <br> **Western Asset Management** <br> **Strategic Bond Opportunities** <br> **Sub-Account** | **BHFTII** <br> **Western Asset Management** <br> **Strategic Bond Opportunities** <br> **Sub-Account** | **BHFTII** <br> **Western Asset Management** <br> **U.S. Government** <br> **Sub-Account** | **BHFTII** <br> **Western Asset Management** <br> **U.S. Government** <br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 302329 | 383974 | 1866465 | 1798940 | 1671665 | 1492144 |
| Units issued and transferred<br>from other funding options | 41740 | 35624 | 256310 | 665230 | 312012 | 680918 |
| Units redeemed and transferred to <br>other funding options | (112473) | (117269) | (390764) | (597705) | (499817) | (501397) |
| Units end of year | 231596 | 302329 | 1732011 | 1866465 | 1483860 | 1671665 |
|  | **Fidelity<sup>®</sup> VIP Mid Cap** <br> **Sub-Account** | **Fidelity<sup>®</sup> VIP Mid Cap** <br> **Sub-Account** | **FTVIPT Franklin Income VIP** <br> **Sub-Account** | **FTVIPT Franklin Income VIP** <br> **Sub-Account** | **FTVIPT**<br> **Franklin Mutual Shares VIP** <br> **Sub-Account** | **FTVIPT**<br> **Franklin Mutual Shares VIP** <br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 130081 | 160157 | 241149 | 261627 | 65286 | 76910 |
| Units issued and transferred<br>from other funding options | 10284 | 14515 | 17394 | 21988 | 11010 | 5168 |
| Units redeemed and transferred to <br>other funding options | (21946) | (44591) | (40908) | (42466) | (18607) | (16792) |
| Units end of year | 118419 | 130081 | 217635 | 241149 | 57689 | 65286 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Invesco V.I. Equity and Income** <br> **Sub-Account** | **Invesco V.I. Equity and Income** <br> **Sub-Account** | **Invesco V.I. EQV**<br> **International Equity** <br> **Sub-Account** | **Invesco V.I. EQV**<br> **International Equity** <br> **Sub-Account** | **Invesco V.I.** <br> **Main Street Small Cap<sup>®</sup>** **Sub-Account** | **Invesco V.I.** <br> **Main Street Small Cap<sup>®</sup>** **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 447558 | 532338 | 188793 | 207344 | 71486 | 82071 |
| Units issued and transferred<br>from other funding options | 22932 | 68321 | 23113 | 25414 | 8073 | 25545 |
| Units redeemed and transferred to <br>other funding options | (90736) | (153101) | (30905) | (43965) | (18027) | (36130) |
| Units end of year | 379754 | 447558 | 181001 | 188793 | 61532 | 71486 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **LMPVET ClearBridge** <br> **Variable Large Cap Growth** <br> **Sub-Account** | **LMPVET ClearBridge** <br> **Variable Large Cap Growth** <br> **Sub-Account** | **LMPVET ClearBridge** <br> **Variable Large Cap Value** <br> **Sub-Account** | **LMPVET ClearBridge** <br> **Variable Large Cap Value** <br> **Sub-Account** | **LMPVET ClearBridge** <br> **Variable Small Cap Growth** <br> **Sub-Account** | **LMPVET ClearBridge** <br> **Variable Small Cap Growth** <br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 5141 | 5460 | 6536 | 6994 | 1401886 | 1180360 |
| Units issued and transferred<br>from other funding options | 240 | 224 | 603 | 153 | 566167 | 503045 |
| Units redeemed and transferred to <br>other funding options | (168) | (543) | (1221) | (611) | (178060) | (281519) |
| Units end of year | 5213 | 5141 | 5918 | 6536 | 1789993 | 1401886 |

---

(a) For the period April 29, 2022 to December 31, 2022.

(b) During 2021, the Separate Account effectuated a 1-for-10 unit change to certain contract owners in the American Funds<sup>®</sup> Growth Sub-Account, resulting in a broader range of unit values. The unit value and number of units outstanding for the impacted contract owners were retroactively adjusted to reflect this change in each period presented prior to 2022. There was no change to the total net assets of the fund or to any contract owner's investment in the fund for any period presented prior to 2022.

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **BlackRock** <br> **Global Allocation V.I.** <br> **Sub-Account** | **BlackRock** <br> **Global Allocation V.I.** <br> **Sub-Account** | **Fidelity<sup>®</sup> VIP Contrafund<sup>®</sup>** <br> **Sub-Account** | **Fidelity<sup>®</sup> VIP Contrafund<sup>®</sup>** <br> **Sub-Account** | **Fidelity<sup>®</sup> VIP Equity-Income**<br> **Sub-Account** | **Fidelity<sup>®</sup> VIP Equity-Income**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 179596 | 102362 | 1819064 | 1300739 | 117 | 126 |
| Units issued and transferred<br>from other funding options | 28005 | 92547 | 740020 | 887732 |  |  |
| Units redeemed and transferred to <br>other funding options | (9187) | (15313) | (153886) | (369407) | (9) | (9) |
| Units end of year | 198414 | 179596 | 2405198 | 1819064 | 108 | 117 |
|  | **FTVIPT** <br> **Franklin Small Cap Value VIP** <br> **Sub-Account** | **FTVIPT** <br> **Franklin Small Cap Value VIP** <br> **Sub-Account** | **FTVIPT** <br> **Templeton Foreign VIP** <br> **Sub-Account** | **FTVIPT** <br> **Templeton Foreign VIP** <br> **Sub-Account** | **FTVIPT**<br> **Templeton Global Bond VIP**<br> **Sub-Account** | **FTVIPT**<br> **Templeton Global Bond VIP**<br> **Sub-Account** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 129320 | 165400 | 477665 | 487698 | 425295 | 457384 |
| Units issued and transferred<br>from other funding options | 15446 | 13635 | 25762 | 39794 | 37014 | 125023 |
| Units redeemed and transferred to <br>other funding options | (28917) | (49715) | (70403) | (49827) | (90216) | (157112) |
| Units end of year | 115849 | 129320 | 433024 | 477665 | 372093 | 425295 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Janus** <br> **Henderson**<br> **Global**<br> **Sustainable** <br> **Equity**<br> **Sub-Account** | **LMPVET ClearBridge** <br> **Variable Appreciation** <br> **Sub-Account** | **LMPVET ClearBridge** <br> **Variable Appreciation** <br> **Sub-Account** | **LMPVET ClearBridge** <br> **Variable Dividend Strategy**<br> **Sub-Account** | **LMPVET ClearBridge** <br> **Variable Dividend Strategy**<br> **Sub-Account** |
| | **2022 (a)** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year |  | 3911044 | 3227268 | 356164 | 411937 |
| Units issued and transferred<br>from other funding options | 13314 | 621679 | 1249216 | 38375 | 34374 |
| Units redeemed and transferred to <br>other funding options |  | (409435) | (565440) | (64873) | (90147) |
| Units end of year | 13314 | 4123288 | 3911044 | 329666 | 356164 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **LMPVET Franklin Multi-Asset** <br> **Variable Conservative Growth**<br> **Sub-Account** | **LMPVET Franklin Multi-Asset** <br> **Variable Conservative Growth**<br> **Sub-Account** | **LMPVET Franklin**<br> **Multi-Asset Variable Growth**<br> **Sub-Account** | **LMPVET Franklin**<br> **Multi-Asset Variable Growth**<br> **Sub-Account** | **LMPVET Franklin Multi-Asset**<br> **Variable Moderate Growth**<br> **Sub-Account** | **LMPVET Franklin Multi-Asset**<br> **Variable Moderate Growth**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 45437 | 54797 | 38862 | 40369 | 1152 | 1523 |
| Units issued and transferred<br>from other funding options | 1400 | 1301 | 346 | 350 |  |  |
| Units redeemed and transferred to <br>other funding options | (9398) | (10661) | (2873) | (1857) | (68) | (371) |
| Units end of year | 37439 | 45437 | 36335 | 38862 | 1084 | 1152 |

---

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**7. SCHEDULES OF UNITS — (Concluded)<br>For the years ended December 31, 2022 and 2021:**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **LMPVIT Western Asset** <br> **Variable Global High Yield Bond**<br> **Sub-Account** | **LMPVIT Western Asset** <br> **Variable Global High Yield Bond**<br> **Sub-Account** | **PIMCO VIT High Yield** <br> **Sub-Account** | **PIMCO VIT High Yield** <br> **Sub-Account** | **PIMCO VIT Low Duration** <br> **Sub-Account** | **PIMCO VIT Low Duration** <br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 2450122 | 1612960 | 3064 | 2835 | 2856 | 2796 |
| Units issued and transferred<br>from other funding options | 537224 | 954901 | 7 | 285 | 4 | 167 |
| Units redeemed and transferred to <br>other funding options | (256928) | (117739) | (168) | (56) | (25) | (107) |
| Units end of year | 2730418 | 2450122 | 2903 | 3064 | 2835 | 2856 |

---

---

| | | |
|:---|:---|:---|
| | **TAP 1919** <br> **Variable Socially** <br> **Responsive Balanced** <br> **Sub-Account** | **TAP 1919** <br> **Variable Socially** <br> **Responsive Balanced** <br> **Sub-Account** |
| | **2022** | **2021** |
| Units beginning of year | 3253 | 3254 |
| Units issued and transferred<br>from other funding options |  |  |
| Units redeemed and transferred to <br>other funding options |  | (1) |
| Units end of year | 3253 | 3253 |

---

(a) For the period April 29, 2022 to December 31, 2022.

(b) During 2021, the Separate Account effectuated a 1-for-10 unit change to certain contract owners in the American Funds<sup>®</sup> Growth Sub-Account, resulting in a broader range of unit values. The unit value and number of units outstanding for the impacted contract owners were retroactively adjusted to reflect this change in each period presented prior to 2022. There was no change to the total net assets of the fund or to any contract owner's investment in the fund for any period presented prior to 2022.

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Pioneer Mid Cap Value VCT** <br> **Sub-Account** | **Pioneer Mid Cap Value VCT** <br> **Sub-Account** | **Putnam VT** <br> **Large Cap Value** <br> **Sub-Account** | **Putnam VT** <br> **Large Cap Value** <br> **Sub-Account** | **Putnam VT** <br> **Sustainable Leaders**<br> **Sub-Account** | **Putnam VT** <br> **Sustainable Leaders**<br> **Sub-Account** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Units beginning of year | 29537 | 32642 | 288 | 1836 | 16128 | 15844 |
| Units issued and transferred<br>from other funding options | 729 | 4404 |  |  | 284 | 408 |
| Units redeemed and transferred to <br>other funding options | (4372) | (7509) |  | (1548) | (86) | (124) |
| Units end of year | 25894 | 29537 | 288 | 288 | 16326 | 16128 |

---

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**8. FINANCIAL HIGHLIGHTS**

The Company sells a number of variable annuity products which have unique combinations of features and fees, some of which directly affect the unit values of the Sub-Accounts. Differences in the fee structures result in a variety of unit values, expense ratios, and total returns.

The following table is a summary of unit values and units outstanding for the Contracts, net investment income ratios, and expense ratios, excluding expenses for the underlying fund, portfolio, or series, for the respective stated periods in the five years ended December 31, 2022:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **As of December 31** | **As of December 31** | **As of December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
| | | **Units** | **Unit Value<br>Lowest to<br>Highest ($)** | **Net<br>Assets ($)** | **Investment<sup>1</sup><br>Income<br>Ratio (%)** | **Expense Ratio<sup>2</sup><br>Lowest to<br>Highest (%)** | **Total Return<sup>3</sup><br>Lowest to<br>Highest (%)** |
| American Funds<sup>®</sup> Global | 2022 | 1157850 | 1.55 - 80.81 | 20852156 | 0.65 | 0.75 - 1.90 | (26.15) - (25.30) |
| Growth Sub-Account | 2021 | 992510 | 2.10 - 108.18 | 28858261 | 0.33 | 0.75 - 1.90 | 14.23 - 15.55 |
|  | 2020 | 734379 | 1.84 - 93.62 | 27729220 | 0.34 | 0.75 - 1.90 | 28.00 - 29.49 |
|  | 2019 | 757371 | 1.43 - 72.30 | 24833450 | 1.09 | 0.75 - 1.90 | 32.73 - 34.27 |
|  | 2018 | 666508 | 1.08 - 53.85 | 21025810 | 0.64 | 0.75 - 1.90 | (10.77) - (9.73) |
| American Funds<sup>®</sup> Global | 2022 | 99942 | 1.21 - 57.13 | 3136672 |  | 0.75 - 1.65 | (30.77) - (30.08) |
| Small Capitalization | 2021 | 89285 | 1.75 - 81.70 | 4181623 |  | 0.75 - 1.65 | 4.79 - 5.94 |
| Sub-Account | 2020 | 78876 | 1.67 - 77.12 | 4652746 | 0.17 | 0.75 - 1.65 | 27.39 - 28.75 |
|  | 2019 | 93529 | 1.31 - 59.90 | 4367370 | 0.15 | 0.75 - 1.65 | 29.23 - 30.54 |
|  | 2018 | 106255 | 1.01 - 45.89 | 4080500 | 0.08 | 0.75 - 1.65 | (12.19) - (11.22) |
| American Funds<sup>®</sup> Growth | 2022 | 163471 | 58.16 - 641.01 | 38543614 | 0.32 | 0.75 - 1.90 | (31.25) - (30.46) |
| Sub-Account<sup>4</sup> | 2021 | 167146 | 84.01 - 923.63 | 57848449 | 0.19 | 0.75 - 1.90 | 19.69 - 21.08 |
|  | 2020 | 203565 | 69.70-764.36 | 58175312 | 0.31 | 0.75 - 1.90 | 49.21 - 50.94 |
|  | 2019 | 264864 | 46.38-507.41 | 49108591 | 0.73 | 0.75 - 1.90 | 28.31 - 29.80 |
|  | 2018 | 310552 | 35.90-352.76 | 44466876 | 0.41 | 0.75 - 1.90 | (2.14) - (1.00) |
| American Funds<sup>®</sup> | 2022 | 1301703 | 1.49 - 362.20 | 22633122 | 1.22 | 0.95 - 1.90 | (18.06) - (17.28) |
| Growth-Income  | 2021 | 1108656 | 1.82 - 437.86 | 31034165 | 1.10 | 0.95 - 1.90 | 21.76 - 22.92 |
| Sub-Account | 2020 | 906040 | 1.49 - 356.21 | 28417461 | 1.34 | 0.95 - 1.90 | 11.40 - 12.47 |
|  | 2019 | 875000 | 1.34 - 316.72 | 28423083 | 1.64 | 0.95 - 1.90 | 23.76 - 24.94 |
|  | 2018 | 455519 | 1.08 - 253.49 | 24805980 | 1.34 | 0.95 - 1.90 | (3.65) - (2.72) |
| American Funds<sup>®</sup> The Bond | 2022 | 2423274 | 0.96 - 20.06 | 6955769 | 2.76 | 0.95 - 1.65 | (14.09) - (13.41) |
| Fund of America  | 2021 | 2385576 | 1.12 - 23.16 | 8989242 | 1.39 | 0.95 - 1.65 | (2.12) - (1.25) |
| Sub-Account | 2020 | 1767691 | 1.15 - 23.46 | 8872094 | 2.04 | 0.95 - 1.65 | 7.69 - 8.69 |
|  | 2019 | 1698951 | 1.06 - 21.58 | 9071314 | 2.53 | 0.95 - 1.65 | 7.40 - 8.32 |
|  | 2018 | 1102843 | 0.99 - 19.92 | 8850710 | 2.38 | 0.95 - 1.65 | (2.42) - (1.66) |
| BHFTI AB Global Dynamic | 2022 | 6920353 | 12.33 - 14.19 | 90348898 | 4.30 | 0.75 - 1.95 | (21.96) - (21.02) |
| Allocation Sub-Account | 2021 | 7604691 | 15.80 - 17.96 | 126581307 | 0.22 | 0.75 - 1.95 | 7.17 - 8.46 |
|  | 2020 | 8406848 | 14.74 - 16.56 | 129945316 | 1.77 | 0.75 - 1.95 | 4.03 - 5.29 |
|  | 2019 | 9188003 | 14.17 - 15.73 | 135837547 | 3.44 | 0.75 - 1.95 | 15.79 - 17.19 |
|  | 2018 | 10217872 | 12.19 - 13.42 | 129847013 | 1.66 | 0.75 - 2.00 | (8.82) - (7.67) |
| BHFTI AB International Bond | 2022 | 159164 | 8.54 - 8.62 | 1370733 | 11.15 | 1.30 - 1.55 | (16.94) - (16.73) |
| Sub-Account | 2021 | 154592 | 10.28 - 10.35 | 1598987 | 0.02 | 1.30 - 1.55 | (3.63) - (3.39) |
| (Commenced 4/29/2019) | 2020 | 94140 | 10.66 - 10.71 | 1007910 | 2.19 | 1.30 - 1.55 | 2.78 - 3.03 |
|  | 2019 | 13144 | 10.38 - 10.39 | 136536 |  | 1.30 - 1.55 | 3.79 - 3.97 |
| BHFTI Allspring Mid Cap | 2022 | 457171 | 33.18 - 37.47 | 16121537 | 0.38 | 1.30 - 1.95 | (6.80) - (6.19) |
| Value Sub-Account | 2021 | 528782 | 35.60 - 39.94 | 19946993 | 0.64 | 1.30 - 1.95 | 26.46 - 27.28 |
|  | 2020 | 621225 | 28.15 - 31.38 | 18466288 | 0.89 | 1.30 - 1.95 | 0.73 - 1.38 |
|  | 2019 | 690833 | 27.95 - 30.95 | 20317543 | 0.66 | 1.30 - 1.95 | 32.92 - 33.78 |
|  | 2018 | 798082 | 21.03 - 23.13 | 17592214 | 0.97 | 1.30 - 1.95 | (14.98) - (14.42) |

---

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**8. FINANCIAL HIGHLIGHTS — (Continued)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **As of December 31** | **As of December 31** | **As of December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
| | | **Units** | **Unit Value<br>Lowest to<br>Highest ($)** | **Net<br>Assets ($)** | **Investment<sup>1</sup><br>Income<br>Ratio (%)** | **Expense Ratio<sup>2</sup><br>Lowest to<br>Highest (%)** | **Total Return<sup>3</sup><br>Lowest to<br>Highest (%)** |
| BHFTI American Funds<sup>®</sup> | 2022 | 11108717 | 16.62 - 19.40 | 196621444 | 1.41 | 0.90 - 1.95 | (18.37) - (17.51) |
| Balanced Allocation | 2021 | 11574421 | 20.36 - 23.51 | 249625501 | 1.18 | 0.90 - 1.95 | 9.98 - 11.14 |
| Sub-Account | 2020 | 12122651 | 18.52 - 21.16 | 236408038 | 1.71 | 0.90 - 1.95 | 13.33 - 14.53 |
|  | 2019 | 12672640 | 16.34 - 18.47 | 216959616 | 1.80 | 0.90 - 1.95 | 17.22 - 18.46 |
|  | 2018 | 13364606 | 13.94 - 15.59 | 194218216 | 1.46 | 0.90 - 1.95 | (6.17) - (5.17) |
| BHFTI American Funds<sup>®</sup> | 2022 | 5742362 | 18.23 - 20.51 | 110709810 | 1.07 | 1.15 - 1.95 | (20.10) - (19.45) |
| Growth Allocation  | 2021 | 6000642 | 22.82 - 25.46 | 144066425 | 0.81 | 1.15 - 1.95 | 13.67 - 14.58 |
| Sub-Account | 2020 | 6030618 | 20.08 - 22.22 | 126663430 | 1.57 | 1.15 - 1.95 | 14.66 - 15.59 |
|  | 2019 | 6279397 | 17.51 - 19.23 | 114487890 | 1.67 | 1.15 - 1.95 | 7.84 - 22.22 |
|  | 2018 | 6617229 | 14.44 - 15.73 | 99054005 | 1.22 | 1.15 - 1.95 | (7.60) - (6.85) |
| BHFTI American Funds<sup>®</sup> | 2022 | 6033439 | 1.79 - 31.51 | 76530552 | 0.56 | 0.95 - 1.95 | (31.51) - (30.82) |
| Growth Sub-Account | 2021 | 5365191 | 2.61 - 45.63 | 101719282 |  | 0.95 - 1.95 | 19.27 - 20.47 |
|  | 2020 | 4894166 | 2.18 - 37.96 | 89226532 | 0.83 | 0.95 - 1.95 | 48.70 - 50.20 |
|  | 2019 | 5136432 | 1.46 - 25.32 | 62976175 | 0.43 | 0.95 - 1.95 | 27.82 - 29.11 |
|  | 2018 | 4491476 | 1.14 - 19.34 | 48010018 | 0.39 | 0.95 - 1.95 | (2.43) - (1.44) |
| BHFTI American Funds<sup>®</sup> | 2022 | 6164102 | 15.05 - 17.56 | 98772154 | 1.74 | 0.90 - 1.95 | (16.27) - (15.39) |
| Moderate Allocation | 2021 | 6141812 | 17.97 - 20.75 | 116777131 | 1.53 | 0.90 - 1.95 | 7.52 - 8.66 |
| Sub-Account | 2020 | 6377750 | 16.72 - 19.10 | 112094413 | 1.89 | 0.90 - 1.95 | 10.80 - 11.98 |
|  | 2019 | 6568015 | 15.09 - 17.06 | 103603783 | 1.97 | 0.90 - 1.95 | 13.91 - 15.12 |
|  | 2018 | 7025392 | 13.24 - 14.82 | 96769646 | 1.73 | 0.90 - 1.95 | (5.29) - (4.29) |
| BHFTI BlackRock Global | 2022 | 13340408 | 12.06 - 13.87 | 170129685 | 2.32 | 0.75 - 1.95 | (20.45) - (19.49) |
| Tactical Strategies | 2021 | 14666019 | 15.16 - 17.23 | 234000158 | 1.36 | 0.75 - 1.95 | 7.67 - 8.97 |
| Sub-Account | 2020 | 16183955 | 14.08 - 15.81 | 238675464 | 1.57 | 0.75 - 1.95 | 2.29 - 3.53 |
|  | 2019 | 17655618 | 13.76 - 15.27 | 253291322 | 0.20 | 0.75 - 1.95 | 18.30 - 19.72 |
|  | 2018 | 19774509 | 11.59 - 12.76 | 238743384 | 1.42 | 0.75 - 2.00 | (9.03) - (7.88) |
| BHFTI BlackRock High Yield | 2022 | 4834036 | 1.08 - 37.40 | 53734601 | 5.03 | 0.75 - 1.95 | (12.06) - (11.00) |
| Sub-Account | 2021 | 4744372 | 1.22 - 42.02 | 62139037 | 3.87 | 0.75 - 1.95 | 3.14 - 4.39 |
|  | 2020 | 2663226 | 1.18 - 40.26 | 43168060 | 5.09 | 0.75 - 1.95 | 5.42 - 6.70 |
|  | 2019 | 1950758 | 1.12 - 37.73 | 28165526 | 5.79 | 0.75 - 1.95 | 12.64 - 13.99 |
|  | 2018 | 1287335 | 0.99 - 33.10 | 20122403 | 4.80 | 0.75 - 1.95 | (4.76) - (3.60) |
| BHFTI Brighthouse Asset | 2022 | 3904049 | 22.43 - 27.90 | 92559747 | 1.35 | 0.75 - 1.95 | (21.69) - (20.75) |
| Allocation 100  | 2021 | 4088833 | 28.65 - 35.20 | 123439722 | 1.12 | 0.75 - 1.95 | 15.85 - 17.24 |
| Sub-Account | 2020 | 4447639 | 24.73 - 30.02 | 115444844 | 1.16 | 0.75 - 1.95 | 16.61 - 18.02 |
|  | 2019 | 4772123 | 21.20 - 25.44 | 105927507 | 1.51 | 0.75 - 1.95 | 25.02 - 26.53 |
|  | 2018 | 5260585 | 16.96 - 20.10 | 93121684 | 1.02 | 0.75 - 1.95 | (11.81) - (10.74) |
| BHFTI Brighthouse Balanced | 2022 | 21779504 | 14.25 - 16.40 | 329714238 | 2.43 | 0.75 - 1.95 | (23.31) - (22.39) |
| Plus Sub-Account | 2021 | 23834679 | 18.58 - 21.13 | 468035055 | 2.32 | 0.75 - 1.95 | 5.47 - 6.74 |
|  | 2020 | 26280061 | 17.62 - 19.79 | 486748752 | 2.34 | 0.75 - 1.95 | 10.34 - 11.68 |
|  | 2019 | 28468889 | 15.97 - 17.72 | 475407587 | 2.02 | 0.75 - 1.95 | 21.18 - 22.64 |
|  | 2018 | 30748386 | 13.13 - 14.45 | 421451230 | 1.67 | 0.75 - 2.00 | (9.21) - (8.06) |
| BHFTI Brighthouse Small Cap | 2022 | 674431 | 33.39 - 49.39 | 24116100 | 0.61 | 1.15 - 1.95 | (14.77) - (14.08) |
| Value Sub-Account | 2021 | 726526 | 39.18 - 57.51 | 30335558 | 0.83 | 1.30 - 1.95 | 29.23 - 30.29 |
|  | 2020 | 864071 | 30.32 - 44.14 | 27796792 | 1.41 | 1.30 - 1.95 | (2.50) - (1.71) |
|  | 2019 | 910026 | 31.09 - 44.91 | 29864040 | 0.89 | 1.30 - 1.95 | 26.29 - 27.27 |
|  | 2018 | 990586 | 24.62 - 35.28 | 25659573 | 1.03 | 1.30 - 1.95 | (16.88) - (16.16) |

---

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**8. FINANCIAL HIGHLIGHTS — (Continued)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **As of December 31** | **As of December 31** | **As of December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
| | | **Units** | **Unit Value<br>Lowest to<br>Highest ($)** | **Net<br>Assets ($)** | **Investment<sup>1</sup><br>Income<br>Ratio (%)** | **Expense Ratio<sup>2</sup><br>Lowest to<br>Highest (%)** | **Total Return<sup>3</sup><br>Lowest to<br>Highest (%)** |
| BHFTI Brighthouse/abrdn | 2022 | 2172082 | 9.54 - 20.02 | 22036110 | 0.73 | 0.75 - 1.95 | (27.24) - (26.36) |
| Emerging Markets Equity | 2021 | 2139801 | 13.11 - 27.28 | 29675089 | 0.17 | 0.75 - 1.95 | (6.90) - (5.77) |
| Sub-Account | 2020 | 2232694 | 14.08 - 29.06 | 33117310 | 1.99 | 0.75 - 1.95 | 24.83 - 26.35 |
|  | 2019 | 2588376 | 11.28 - 23.08 | 30651301 | 1.64 | 0.75 - 1.95 | 18.42 - 19.85 |
|  | 2018 | 2880148 | 9.53 - 19.35 | 28704578 | 2.59 | 0.75 - 1.95 | (15.85) - (14.83) |
| BHFTI Brighthouse/Eaton | 2022 | 996252 | 11.57 - 12.81 | 12290962 | 3.57 | 1.15 - 1.95 | (3.50) - (2.73) |
| Vance Floating Rate | 2021 | 883825 | 11.99 - 13.16 | 11241971 | 3.04 | 1.15 - 1.95 | 1.50 - 2.31 |
| Sub-Account | 2020 | 752487 | 11.81 - 12.87 | 9359795 | 4.73 | 1.15 - 1.95 | 0.09 - 0.89 |
|  | 2019 | 726357 | 11.80 - 12.57 | 8963538 | 4.54 | 1.30 - 1.95 | 1.11 - 5.65 |
|  | 2018 | 646814 | 11.24 - 11.90 | 7538932 | 3.60 | 1.30 - 1.95 | (1.64) - (0.99) |
| BHFTI Brighthouse/Franklin | 2022 | 1383992 | 8.92 - 10.27 | 12905500 | 2.67 | 0.75 - 1.95 | (6.57) - (5.45) |
| Low Duration Total Return | 2021 | 1646433 | 9.55 - 10.86 | 16378251 | 1.87 | 0.75 - 1.95 | (1.66) - (0.47) |
| Sub-Account | 2020 | 1468500 | 9.71 - 10.91 | 14779460 | 3.35 | 0.75 - 1.95 | 0.15 - 1.36 |
|  | 2019 | 1626120 | 9.70 - 10.76 | 16321879 | 3.38 | 0.75 - 1.95 | 1.06 - 3.85 |
|  | 2018 | 1653824 | 9.45 - 10.36 | 16098194 | 1.73 | 0.75 - 1.95 | (1.51) - (0.32) |
| BHFTI Brighthouse/Templeton | 2022 | 229853 | 9.45 - 11.06 | 2290416 |  | 0.75 - 1.90 | (6.42) - (5.34) |
| International Bond | 2021 | 263952 | 10.10 - 11.69 | 2798658 |  | 0.75 - 1.90 | (6.80) - (5.72) |
| Sub-Account | 2020 | 240718 | 10.84 - 12.40 | 2725886 | 6.34 | 0.75 - 1.90 | (7.68) - (6.61) |
|  | 2019 | 217145 | 11.74 - 13.28 | 2653379 | 8.18 | 0.75 - 1.90 | (0.74) - 0.41 |
|  | 2018 | 205255 | 11.83 - 13.22 | 2518417 |  | 0.75 - 1.90 | (0.91) - 0.24 |
| BHFTI | 2022 | 56237 | 26.12 - 33.43 | 1517054 | 0.56 | 0.75 - 1.90 | (20.64) - (19.81) |
| Brighthouse/Wellington Large | 2021 | 60472 | 32.91 - 41.69 | 2054177 | 0.75 | 0.75 - 1.90 | 21.86 - 23.10 |
| Cap Research Sub-Account | 2020 | 66113 | 27.01 - 33.87 | 1845036 | 0.99 | 0.75 - 1.90 | 19.80 - 21.12 |
|  | 2019 | 71956 | 22.54 - 27.96 | 1672902 | 1.02 | 0.75 - 1.90 | 29.35 - 30.72 |
|  | 2018 | 82238 | 17.43 - 21.39 | 1485745 | 0.87 | 0.75 - 1.90 | (8.07) - (7.10) |
| BHFTI CBRE Global Real | 2022 | 734769 | 18.25 - 37.17 | 14341988 | 4.08 | 0.75 - 1.95 | (26.44) - (25.55) |
| Estate Sub-Account | 2021 | 773224 | 24.81 - 50.07 | 20437475 | 2.86 | 0.75 - 1.95 | 31.83 - 33.42 |
|  | 2020 | 912650 | 18.82 - 37.70 | 18222815 | 4.48 | 0.75 - 1.95 | (6.86) - (5.73) |
|  | 2019 | 871120 | 20.21 - 40.15 | 18605549 | 3.06 | 0.75 - 1.95 | 22.40 - 23.88 |
|  | 2018 | 1046491 | 16.51 - 32.55 | 18205217 | 5.92 | 0.75 - 1.95 | (10.42) - (9.33) |
| BHFTI Harris Oakmark | 2022 | 1585613 | 24.38 - 29.58 | 42520364 | 2.20 | 1.15 - 1.95 | (17.62) - (16.96) |
| International Sub-Account | 2021 | 1624824 | 29.50 - 35.99 | 52648951 | 0.64 | 1.10 - 1.95 | 6.35 - 7.25 |
|  | 2020 | 1793726 | 27.67 - 34.54 | 54424155 | 3.27 | 0.95 - 1.95 | 3.08 - 4.12 |
|  | 2019 | 1759844 | 26.77 - 32.27 | 51536041 | 2.21 | 1.10 - 1.95 | 22.11 - 23.16 |
|  | 2018 | 1871869 | 21.85 - 26.21 | 44695497 | 1.70 | 0.95 - 1.95 | (25.45) - (24.81) |
| BHFTI Invesco Balanced-Risk | 2022 | 24284217 | 1.24 - 13.37 | 32681301 | 6.37 | 0.75 - 1.95 | (14.10) - (13.06) |
| Allocation Sub-Account | 2021 | 24747537 | 1.44 - 15.46 | 38583524 | 2.96 | 0.75 - 1.95 | 7.57 - 8.87 |
|  | 2020 | 26870316 | 1.34 - 14.28 | 38662468 | 5.37 | 0.75 - 1.95 | 8.00 - 9.31 |
|  | 2019 | 28935666 | 1.24 - 13.14 | 38350427 |  | 0.75 - 1.95 | 13.05 - 14.42 |
|  | 2018 | 34047720 | 1.10 - 11.55 | 39391891 | 1.17 | 0.75 - 2.00 | (8.30) - (7.14) |
| BHFTI Invesco Comstock | 2022 | 1122554 | 25.98 - 42.87 | 31709682 | 1.85 | 0.75 - 1.95 | (1.30) - (0.11) |
| Sub-Account | 2021 | 1281182 | 26.33 - 43.01 | 36405122 | 1.87 | 0.75 - 1.95 | 30.61 - 32.19 |
|  | 2020 | 1508027 | 20.16 - 32.60 | 32671738 | 2.22 | 0.75 - 1.95 | (2.43) - (1.25) |
|  | 2019 | 1499605 | 20.66 - 33.08 | 33155293 | 2.11 | 0.75 - 1.95 | 22.54 - 24.02 |
|  | 2018 | 1664588 | 16.86 - 19.87 | 29916589 | 0.63 | 0.75 - 1.95 | (13.86) - (12.81) |

---

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**8. FINANCIAL HIGHLIGHTS — (Continued)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **As of December 31** | **As of December 31** | **As of December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
| | | **Units** | **Unit Value<br>Lowest to<br>Highest ($)** | **Net<br>Assets ($)** | **Investment<sup>1</sup><br>Income<br>Ratio (%)** | **Expense Ratio<sup>2</sup><br>Lowest to<br>Highest (%)** | **Total Return<sup>3</sup><br>Lowest to<br>Highest (%)** |
| BHFTI Invesco Global Equity | 2022 | 83929 | 32.27 - 44.00 | 3132896 |  | 0.75 - 1.95 | (33.16) - (32.35) |
| Sub-Account | 2021 | 77634 | 48.27 - 65.04 | 4292087 |  | 0.75 - 1.95 | 13.24 - 14.61 |
|  | 2020 | 82182 | 42.63 - 56.75 | 4017630 | 0.69 | 0.75 - 1.95 | 25.11 - 26.63 |
|  | 2019 | 102972 | 34.07 - 44.82 | 3980202 | 0.79 | 0.75 - 1.95 | 29.03 - 30.58 |
|  | 2018 | 116549 | 26.41 - 34.32 | 3478836 | 0.99 | 0.75 - 1.95 | (14.83) - (13.80) |
| BHFTI Invesco Small Cap | 2022 | 871936 | 35.73 - 42.35 | 34367420 |  | 0.95 - 1.95 | (36.40) - (35.89) |
| Growth Sub-Account | 2021 | 765164 | 56.18 - 68.79 | 47064073 |  | 0.95 - 1.95 | 4.87 - 5.92 |
|  | 2020 | 734094 | 53.57 - 64.94 | 42548622 |  | 0.95 - 1.95 | 53.73 - 55.28 |
|  | 2019 | 771088 | 34.85 - 41.82 | 28722701 |  | 0.95 - 1.95 | 22.01 - 23.23 |
|  | 2018 | 782123 | 28.56 - 32.51 | 23720987 |  | 1.20 - 1.95 | (10.81) - (10.14) |
| BHFTI JPMorgan Core Bond | 2022 | 2674701 | 9.69 - 10.69 | 27532900 | 2.45 | 1.15 - 1.95 | (14.55) - (13.87) |
| Sub-Account | 2021 | 2920833 | 11.25 - 12.43 | 34982963 | 2.31 | 1.15 - 1.95 | (3.36) - (2.59) |
|  | 2020 | 2661284 | 11.55 - 12.78 | 32791435 | 3.20 | 1.15 - 1.95 | 5.80 - 6.66 |
|  | 2019 | 2477440 | 10.83 - 12.00 | 28682200 | 4.44 | 1.15 - 1.95 | 6.13 - 6.98 |
|  | 2018 | 2542779 | 10.48 - 11.23 | 27623106 | 2.69 | 1.30 - 1.95 | (1.92) - (1.28) |
| BHFTI JPMorgan Global | 2022 | 35876372 | 1.36 - 14.60 | 52280070 | 2.46 | 0.90 - 1.95 | (19.14) - (18.28) |
| Active Allocation  | 2021 | 39075024 | 1.68 - 17.94 | 70080994 | 0.48 | 0.90 - 1.95 | 7.52 - 8.66 |
| Sub-Account | 2020 | 40758747 | 1.57 - 16.58 | 67548179 | 2.27 | 0.75 - 1.95 | 10.05 - 11.39 |
|  | 2019 | 43285628 | 1.42 - 14.97 | 64742260 | 2.75 | 0.75 - 1.95 | 14.66 - 16.04 |
|  | 2018 | 47476683 | 1.24 - 12.97 | 61598686 | 1.59 | 0.75 - 2.00 | (9.04) - (7.88) |
| BHFTI JPMorgan Small Cap | 2022 | 117565 | 26.57 - 31.18 | 3225562 | 1.14 | 0.75 - 1.90 | (14.84) - (14.15) |
| Value Sub-Account | 2021 | 135026 | 31.20 - 36.32 | 4338893 | 1.12 | 0.75 - 1.90 | 30.51 - 31.75 |
|  | 2020 | 162370 | 23.90 - 27.57 | 3990830 | 1.41 | 0.75 - 1.90 | 4.34 - 5.32 |
|  | 2019 | 157392 | 22.91 - 26.18 | 3698007 | 1.32 | 0.75 - 1.90 | 17.28 - 18.26 |
|  | 2018 | 171486 | 19.53 - 22.13 | 3434677 | 1.31 | 0.75 - 1.90 | (15.39) - (14.55) |
| BHFTI Loomis Sayles Global | 2022 | 721967 | 22.23 - 25.40 | 17095364 |  | 1.15 - 1.95 | (24.78) - (24.17) |
| Allocation Sub-Account | 2021 | 752458 | 29.55 - 33.50 | 23557056 | 0.83 | 1.15 - 1.95 | 12.05 - 12.95 |
|  | 2020 | 724959 | 26.37 - 29.23 | 20068595 | 0.68 | 1.25 - 1.95 | 12.57 - 13.36 |
|  | 2019 | 759526 | 23.43 - 25.78 | 18565513 | 1.49 | 1.25 - 1.95 | 25.06 - 25.94 |
|  | 2018 | 840133 | 18.73 - 20.47 | 16345790 | 1.83 | 1.25 - 1.95 | (7.23) - (6.57) |
| BHFTI Loomis Sayles Growth | 2022 | 1904231 | 17.22 - 291.56 | 43988393 |  | 0.75 - 1.95 | (29.39) - (28.54) |
| Sub-Account | 2021 | 1911338 | 24.24 - 410.49 | 62332152 | 0.07 | 0.75 - 1.95 | 15.99 - 17.54 |
|  | 2020 | 1620817 | 20.77 - 351.34 | 41866619 | 0.64 | 0.75 - 1.95 | 29.67 - 32.17 |
|  | 2019 | 2307131 | 15.92 - 269.23 | 44736528 | 0.81 | 0.75 - 1.95 | 21.18 - 22.65 |
|  | 2018 | 2525710 | 13.06 - 220.81 | 40211767 | 0.59 | 0.75 - 1.95 | (8.86) - (7.76) |
| BHFTI MetLife Multi-Index | 2022 | 26103234 | 1.28 - 13.64 | 37616111 | 1.77 | 0.90 - 1.95 | (22.61) - (21.80) |
| Targeted Risk Sub-Account | 2021 | 28930911 | 1.66 - 18.41 | 54133667 | 1.78 | 0.75 - 1.95 | 7.60 - 8.90 |
|  | 2020 | 30858661 | 1.54 - 16.91 | 53394741 | 2.19 | 0.75 - 1.95 | 4.49 - 5.76 |
|  | 2019 | 32319545 | 1.47 - 15.99 | 52615574 | 2.06 | 0.75 - 1.95 | 19.36 - 20.80 |
|  | 2018 | 32838193 | 1.23 - 13.24 | 44448246 | 1.78 | 0.75 - 2.00 | (9.03) - (7.88) |
| BHFTI MFS<sup>®</sup> Research | 2022 | 1280783 | 18.04 - 29.92 | 24998786 | 1.79 | 0.75 - 1.95 | (19.16) - (18.18) |
| International Sub-Account | 2021 | 1319738 | 22.31 - 36.69 | 31678004 | 0.95 | 0.75 - 1.95 | 9.56 - 10.88 |
|  | 2020 | 1424172 | 20.36 - 33.22 | 31070983 | 2.23 | 0.75 - 1.95 | 10.83 - 12.17 |
|  | 2019 | 1554900 | 18.37 - 29.75 | 30470897 | 1.33 | 0.75 - 1.95 | 25.84 - 27.36 |
|  | 2018 | 1665206 | 14.60 - 23.44 | 25834571 | 1.94 | 0.75 - 1.95 | (15.67) - (14.64) |

---

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**8. FINANCIAL HIGHLIGHTS — (Continued)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **As of December 31** | **As of December 31** | **As of December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
| | | **Units** | **Unit Value<br>Lowest to<br>Highest ($)** | **Net<br>Assets ($)** | **Investment<sup>1</sup><br>Income<br>Ratio (%)** | **Expense Ratio<sup>2</sup><br>Lowest to<br>Highest (%)** | **Total Return<sup>3</sup><br>Lowest to<br>Highest (%)** |
| BHFTI Morgan Stanley | 2022 | 319487 | 23.62 - 30.71 | 8373705 |  | 0.75 - 1.95 | (63.25) - (62.80) |
| Discovery Sub-Account | 2021 | 221149 | 64.26 - 82.57 | 15658926 |  | 0.75 - 1.95 | (12.50) - (11.45) |
|  | 2020 | 271611 | 73.44 - 93.24 | 21703101 |  | 0.75 - 1.95 | 148.23 - 151.22 |
|  | 2019 | 361933 | 29.58 - 37.11 | 11737864 |  | 0.75 - 1.95 | 37.42 - 39.08 |
|  | 2018 | 440192 | 21.53 - 26.69 | 10359704 |  | 0.75 - 1.95 | 8.01 - 9.32 |
| BHFTI PanAgora Global | 2022 | 71719313 | 1.04 - 11.10 | 78195574 | 16.70 | 0.75 - 1.95 | (27.10) - (26.22) |
| Diversified Risk  | 2021 | 4339888 | 1.43 - 15.13 | 6608809 |  | 0.75 - 1.90 | 4.39 - 5.60 |
| Sub-Account | 2020 | 4058719 | 1.37 - 14.40 | 5912597 | 3.18 | 0.75 - 1.90 | 9.74 - 11.01 |
|  | 2019 | 3676013 | 1.25 - 13.05 | 4799922 | 3.33 | 0.75 - 1.90 | 19.70 - 21.08 |
|  | 2018 | 3544530 | 1.04 - 10.83 | 3847826 |  | 0.75 - 2.00 | (9.43) - (8.29) |
| BHFTI PIMCO Inflation | 2022 | 3322685 | 13.63 - 17.27 | 48728411 | 6.26 | 0.75 - 1.95 | (13.58) - (12.53) |
| Protected Bond Sub-Account | 2021 | 3589130 | 15.78 - 19.74 | 60507516 | 0.73 | 0.75 - 1.95 | 3.38 - 4.63 |
|  | 2020 | 3419774 | 15.26 - 18.87 | 55434901 | 2.68 | 0.75 - 1.95 | 9.38 - 10.71 |
|  | 2019 | 3570836 | 13.95 - 17.04 | 52681910 | 3.40 | 0.75 - 1.95 | 3.20 - 7.46 |
|  | 2018 | 3976454 | 13.14 - 15.86 | 55026070 | 1.58 | 0.75 - 1.95 | (4.30) - (3.14) |
| BHFTI PIMCO Total Return | 2022 | 6136560 | 15.02 - 19.51 | 100619358 | 2.94 | 0.75 - 1.95 | (16.21) - (15.20) |
| Sub-Account | 2021 | 6708999 | 17.93 - 23.01 | 130688648 | 1.81 | 0.75 - 1.95 | (3.30) - (2.13) |
|  | 2020 | 6422062 | 18.54 - 23.51 | 128631465 | 3.65 | 0.75 - 1.95 | 6.41 - 7.70 |
|  | 2019 | 6719811 | 17.42 - 21.83 | 125479864 | 2.89 | 0.75 - 1.95 | 6.37 - 7.65 |
|  | 2018 | 7156264 | 16.38 - 20.28 | 124952104 | 1.35 | 0.75 - 1.95 | (2.17) - (0.98) |
| BHFTI Schroders Global | 2022 | 22386475 | 1.24 - 13.34 | 29726905 | 1.40 | 0.75 - 1.95 | (21.71) - (20.77) |
| Multi-Asset Sub-Account | 2021 | 24183311 | 1.59 - 16.93 | 40928882 | 0.32 | 0.75 - 1.95 | 9.27 - 10.59 |
|  | 2020 | 28178777 | 1.45 - 15.40 | 43330188 | 1.77 | 0.75 - 1.95 | 0.13 - 1.34 |
|  | 2019 | 30051102 | 1.45 - 15.28 | 45838902 | 1.46 | 0.75 - 1.95 | 19.15 - 20.58 |
|  | 2018 | 34002282 | 1.21 - 12.74 | 43309580 | 1.66 | 0.75 - 2.00 | (11.23) - (10.10) |
| BHFTI SSGA Emerging Markets | 2022 | 90742 | 8.97 - 9.11 | 821679 | 2.42 | 1.15 - 1.55 | (21.54) - (21.23) |
| Enhanced Index Sub-Account | 2021 | 65053 | 11.43 - 11.56 | 748995 | 1.19 | 1.15 - 1.55 | (1.23) - (0.84) |
| (Commenced 4/29/2019) | 2020 | 21007 | 11.58 - 11.66 | 244296 | 2.63 | 1.15 - 1.55 | 12.87 - 13.33 |
|  | 2019 | 12728 | 10.26 - 10.28 | 130752 |  | 1.30 - 1.55 | 2.60 - 2.78 |
| BHFTI SSGA Growth and | 2022 | 4189045 | 17.33 - 21.31 | 78281836 | 3.02 | 0.75 - 1.95 | (17.01) - (16.01) |
| Income ETF Sub-Account | 2021 | 4329542 | 20.88 - 25.38 | 96981286 | 1.78 | 0.75 - 1.95 | 11.19 - 12.53 |
|  | 2020 | 4610993 | 18.78 - 22.55 | 92267877 | 2.67 | 0.75 - 1.95 | 7.70 - 9.00 |
|  | 2019 | 4769378 | 17.43 - 20.69 | 88116882 | 2.32 | 0.75 - 1.95 | 17.30 - 18.72 |
|  | 2018 | 5040707 | 14.86 - 17.43 | 79002382 | 2.31 | 0.75 - 1.95 | (8.34) - (7.22) |
| BHFTI SSGA Growth ETF | 2022 | 2143921 | 18.54 - 22.81 | 43083189 | 2.76 | 0.75 - 1.95 | (17.50) - (16.50) |
| Sub-Account | 2021 | 2260653 | 22.48 - 27.32 | 54751208 | 1.46 | 0.75 - 1.95 | 15.33 - 16.73 |
|  | 2020 | 2409539 | 19.49 - 23.41 | 50378450 | 2.40 | 0.75 - 1.95 | 8.60 - 9.92 |
|  | 2019 | 2597644 | 17.94 - 21.29 | 49729593 | 1.96 | 0.75 - 1.95 | 20.08 - 21.53 |
|  | 2018 | 2681123 | 14.94 - 17.52 | 42553669 | 2.01 | 0.75 - 1.95 | (10.52) - (9.43) |
| BHFTI T. Rowe Price Large | 2022 | 459482 | 70.60 - 158.00 | 55541055 | 1.60 | 0.75 - 1.95 | (6.98) - (5.86) |
| Cap Value Sub-Account | 2021 | 502926 | 75.79 - 167.83 | 64790307 | 1.87 | 0.75 - 1.95 | 23.55 - 25.04 |
|  | 2020 | 552845 | 61.25 - 134.22 | 56950224 | 2.43 | 0.75 - 1.95 | 0.88 - 2.10 |
|  | 2019 | 558436 | 60.61 - 131.46 | 56504655 | 2.07 | 0.75 - 1.95 | 24.07 - 25.57 |
|  | 2018 | 601200 | 48.79 - 104.69 | 48727954 | 1.78 | 0.75 - 1.95 | (10.92) - (9.84) |

---

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**8. FINANCIAL HIGHLIGHTS — (Continued)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **As of December 31** | **As of December 31** | **As of December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
| | | **Units** | **Unit Value<br>Lowest to<br>Highest ($)** | **Net<br>Assets ($)** | **Investment<sup>1</sup><br>Income<br>Ratio (%)** | **Expense Ratio<sup>2</sup><br>Lowest to<br>Highest (%)** | **Total Return<sup>3</sup><br>Lowest to<br>Highest (%)** |
| BHFTI T. Rowe Price Mid Cap | 2022 | 1790394 | 27.08 - 32.23 | 53143407 |  | 1.15 - 1.95 | (24.02) - (23.42) |
| Growth Sub-Account | 2021 | 1809374 | 35.64 - 42.09 | 70219983 |  | 1.15 - 1.95 | 12.76 - 13.66 |
|  | 2020 | 1820476 | 31.61 - 37.03 | 62126898 | 0.03 | 1.15 - 1.95 | 21.52 - 22.50 |
|  | 2019 | 1818189 | 26.01 - 30.23 | 50530533 | 0.03 | 1.15 - 1.95 | 28.54 - 29.57 |
|  | 2018 | 1928897 | 20.24 - 22.66 | 41420635 |  | 1.30 - 1.95 | (4.09) - (3.46) |
| BHFTI Victory Sycamore Mid | 2022 | 291402 | 54.75 - 74.24 | 17809400 | 1.65 | 0.75 - 1.95 | (4.57) - (3.43) |
| Cap Value Sub-Account | 2021 | 325975 | 57.37 - 76.87 | 20768085 | 1.11 | 0.75 - 1.95 | 29.25 - 30.81 |
|  | 2020 | 377683 | 44.39 - 58.76 | 18525969 | 1.46 | 0.75 - 1.95 | 5.55 - 6.83 |
|  | 2019 | 385188 | 42.05 - 55.00 | 17797016 | 1.08 | 0.75 - 1.95 | 26.49 - 28.02 |
|  | 2018 | 433096 | 33.24 - 42.96 | 15744266 | 0.55 | 0.75 - 1.95 | (11.89) - (10.82) |
| BHFTI Western Asset | 2022 | 2816892 | 9.25 - 10.64 | 27754339 | 2.34 | 0.75 - 1.95 | (16.32) - (15.32) |
| Management  | 2021 | 3055180 | 11.05 - 12.57 | 35766498 | 2.14 | 0.75 - 1.95 | (3.87) - (2.71) |
| Government Income | 2020 | 3438704 | 11.50 - 12.92 | 41607571 | 2.40 | 0.75 - 1.95 | 5.59 - 6.87 |
| Sub-Account | 2019 | 3474529 | 10.89 - 12.09 | 39631125 | 2.73 | 0.75 - 1.95 | 5.42 - 6.69 |
|  | 2018 | 3791273 | 10.29 - 11.33 | 40819022 | 2.80 | 0.75 - 2.00 | (2.05) - (0.82) |
| BHFTII Baillie Gifford | 2022 | 744198 | 10.68 - 17.89 | 11036432 | 0.84 | 1.30 - 1.95 | (30.19) - (29.73) |
| International Stock | 2021 | 712522 | 15.30 - 25.49 | 14988798 | 0.74 | 1.30 - 1.95 | (2.91) - (2.27) |
| Sub-Account | 2020 | 747852 | 15.76 - 26.11 | 16093061 | 1.82 | 1.30 - 1.95 | 23.82 - 24.63 |
|  | 2019 | 816882 | 12.73 - 20.97 | 14010380 | 1.08 | 1.30 - 1.95 | 10.44 - 30.70 |
|  | 2018 | 937037 | 9.80 - 16.06 | 12270605 | 0.91 | 1.30 - 1.95 | (18.80) - (18.27) |
| BHFTII BlackRock Bond | 2022 | 266694 | 49.47 - 74.85 | 15688342 | 2.70 | 0.75 - 1.90 | (15.88) - (15.00) |
| Income Sub-Account | 2021 | 273225 | 58.81 - 88.05 | 18997191 | 2.59 | 0.75 - 1.90 | (2.47) - (1.43) |
|  | 2020 | 219703 | 60.30 - 89.34 | 15513039 | 3.24 | 0.75 - 1.90 | 6.40 - 7.52 |
|  | 2019 | 170143 | 56.67 - 83.08 | 11162312 | 3.54 | 0.75 - 1.90 | 7.60 - 8.73 |
|  | 2018 | 146429 | 52.67 - 76.41 | 8806036 | 3.27 | 0.75 - 1.90 | (2.40) - (1.36) |
| BHFTII BlackRock Capital | 2022 | 208565 | 3.56 - 104.79 | 12954595 |  | 0.75 - 1.90 | (38.78) - (38.08) |
| Appreciation Sub-Account | 2021 | 174283 | 5.79 - 169.22 | 16610613 |  | 0.75 - 1.90 | 18.92 - 20.30 |
|  | 2020 | 149933 | 4.84 - 140.67 | 11092077 |  | 0.75 - 1.90 | 38.01 - 39.61 |
|  | 2019 | 107037 | 3.49 - 100.76 | 4300435 | 0.10 | 0.75 - 1.90 | 30.29 - 31.86 |
|  | 2018 | 91092 | 2.66 - 76.41 | 2291502 | 0.11 | 0.75 - 1.90 | (4.42) - 1.66 |
| BHFTII BlackRock | 2022 | 6456867 | 0.96 - 22.83 | 44371907 |  | 0.75 - 1.95 | (0.77) - 0.43 |
| Ultra-Short Term Bond | 2021 | 6139612 | 0.96 - 22.83 | 46921730 | 0.08 | 0.75 - 1.95 | (2.37) - (1.19) |
| Sub-Account | 2020 | 5445123 | 0.98 - 23.19 | 49729047 | 1.65 | 0.75 - 1.95 | (1.75) - (0.56) |
|  | 2019 | 5161657 | 1.00 - 23.42 | 47748304 | 1.53 | 0.75 - 1.95 | (0.09) - 1.12 |
|  | 2018 | 5290563 | 0.99 - 23.25 | 49931627 | 0.73 | 0.75 - 1.95 | (0.42) - 0.79 |
| BHFTII Brighthouse Asset | 2022 | 902168 | 1.03 - 17.18 | 11945834 | 3.08 | 0.75 - 1.95 | (14.37) - (13.34) |
| Allocation 20 Sub-Account | 2021 | 861410 | 1.20 - 19.83 | 13105640 | 3.03 | 0.75 - 1.95 | 1.68 - 2.91 |
|  | 2020 | 766288 | 1.18 - 19.26 | 11254493 | 2.91 | 0.75 - 1.95 | 7.40 - 8.70 |
|  | 2019 | 811835 | 1.09 - 16.84 | 9365830 | 2.17 | 1.10 - 1.95 | 9.58 - 10.51 |
|  | 2018 | 629209 | 0.99 - 15.98 | 7821074 | 2.23 | 0.75 - 1.95 | (4.50) - (3.34) |
| BHFTII Brighthouse Asset | 2022 | 12910921 | 1.11 - 19.62 | 214540163 | 2.57 | 0.75 - 1.95 | (15.50) - (14.48) |
| Allocation 40 Sub-Account | 2021 | 14048161 | 1.31 - 22.94 | 279716525 | 2.66 | 0.75 - 1.95 | 5.35 - 6.62 |
|  | 2020 | 15661755 | 1.24 - 21.52 | 294980895 | 2.67 | 0.75 - 1.95 | 8.89 - 10.21 |
|  | 2019 | 17118149 | 1.13 - 19.53 | 294316953 | 2.16 | 0.75 - 1.95 | 13.36 - 14.73 |
|  | 2018 | 19202713 | 1.00 - 17.02 | 290842062 | 2.01 | 0.75 - 1.95 | (6.26) - (5.12) |

---

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**8. FINANCIAL HIGHLIGHTS — (Continued)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **As of December 31** | **As of December 31** | **As of December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
| | | **Units** | **Unit Value<br>Lowest to<br>Highest ($)** | **Net<br>Assets ($)** | **Investment<sup>1</sup><br>Income<br>Ratio (%)** | **Expense Ratio<sup>2</sup><br>Lowest to<br>Highest (%)** | **Total Return<sup>3</sup><br>Lowest to<br>Highest (%)** |
| BHFTII Brighthouse Asset | 2022 | 20502034 | 1.20 - 23.21 | 398629294 | 2.14 | 0.75 - 1.95 | (16.96) - (15.96) |
| Allocation 60 Sub-Account | 2021 | 22078453 | 1.44 - 27.62 | 514442119 | 2.11 | 0.75 - 1.95 | 8.76 - 10.08 |
|  | 2020 | 24020879 | 1.32 - 25.09 | 512822909 | 2.18 | 0.75 - 2.00 | 11.59 - 13.00 |
|  | 2019 | 25803127 | 1.18 - 22.21 | 491164015 | 1.96 | 0.75 - 2.00 | 17.06 - 18.53 |
|  | 2018 | 27892903 | 1.00 - 18.73 | 455682989 | 1.64 | 0.75 - 2.00 | (7.99) - (6.83) |
| BHFTII Brighthouse Asset | 2022 | 14113934 | 1.28 - 26.15 | 298346941 | 1.79 | 0.75 - 1.95 | (19.55) - (18.58) |
| Allocation 80 Sub-Account | 2021 | 15464361 | 1.59 - 32.12 | 406629576 | 1.67 | 0.75 - 1.95 | 12.50 - 13.85 |
|  | 2020 | 16910512 | 1.41 - 28.21 | 394297503 | 1.80 | 0.75 - 1.95 | 14.34 - 15.72 |
|  | 2019 | 18822400 | 1.22 - 24.38 | 382529406 | 1.74 | 0.75 - 1.95 | 21.34 - 22.80 |
|  | 2018 | 21038503 | 1.01 - 19.85 | 350798313 | 1.31 | 0.75 - 1.95 | (9.90) - (8.80) |
| BHFTII Brighthouse/Artisan | 2022 | 390745 | 26.75 - 70.19 | 11294323 | 0.70 | 1.15 - 1.95 | (14.52) - (13.83) |
| Mid Cap Value Sub-Account | 2021 | 450461 | 31.29 - 81.45 | 15132904 | 0.76 | 1.15 - 1.95 | 24.14 - 25.14 |
|  | 2020 | 515775 | 25.20 - 65.09 | 13888228 | 0.73 | 1.15 - 1.95 | 3.93 - 4.77 |
|  | 2019 | 506338 | 24.25 - 27.33 | 13046116 | 0.50 | 1.30 - 1.95 | 21.06 - 21.84 |
|  | 2018 | 539932 | 20.03 - 22.43 | 11443229 | 0.38 | 1.30 - 1.95 | (15.10) - (14.54) |
| BHFTII | 2022 | 173923 | 23.05 - 26.57 | 4247298 | 2.33 | 0.95 - 1.95 | (19.29) - (18.48) |
| Brighthouse/Dimensional | 2021 | 188151 | 28.56 - 32.59 | 5661149 | 1.55 | 0.95 - 1.95 | 11.66 - 12.78 |
| International Small Company | 2020 | 205282 | 25.58 - 28.89 | 5507052 | 2.45 | 0.95 - 1.95 | 6.68 - 7.76 |
| Sub-Account | 2019 | 220370 | 23.98 - 26.81 | 5518448 | 1.05 | 0.95 - 1.95 | 20.66 - 21.87 |
|  | 2018 | 231385 | 19.87 - 22.45 | 4778583 | 2.50 | 0.75 - 1.95 | (22.11) - (21.16) |
| BHFTII | 2022 | 2244900 | 1.72 - 125.60 | 70228400 | 1.31 | 0.75 - 1.95 | (7.13) - (5.79) |
| Brighthouse/Wellington Core | 2021 | 2403692 | 1.85 - 133.31 | 88101053 | 1.29 | 0.75 - 1.95 | 21.71 - 23.50 |
| Equity Opportunities | 2020 | 2426127 | 1.51 - 107.95 | 78950561 | 1.48 | 0.75 - 1.95 | 8.82 - 10.44 |
| Sub-Account | 2019 | 2453821 | 1.38 - 97.75 | 78887115 | 1.48 | 0.75 - 1.95 | 28.12 - 29.96 |
|  | 2018 | 2755106 | 1.07 - 75.21 | 70656698 | 1.63 | 0.75 - 1.95 | (2.29) - (0.84) |
| BHFTII Frontier Mid Cap | 2022 | 303134 | 28.66 - 118.15 | 9392763 |  | 1.15 - 1.95 | (29.72) - (29.15) |
| Growth Sub-Account | 2021 | 286056 | 40.78 - 45.75 | 12498190 |  | 1.30 - 1.95 | 12.17 - 12.91 |
|  | 2020 | 300679 | 36.35 - 40.52 | 11638346 |  | 1.30 - 1.95 | 28.84 - 29.68 |
|  | 2019 | 289669 | 28.22 - 31.24 | 8613331 |  | 1.30 - 1.95 | 30.27 - 31.12 |
|  | 2018 | 313432 | 21.66 - 23.83 | 7109711 |  | 1.30 - 1.95 | (7.73) - (7.12) |
| BHFTII Jennison Growth | 2022 | 1549844 | 16.89 - 48.62 | 60088385 |  | 0.75 - 1.95 | (40.20) - (39.48) |
| Sub-Account | 2021 | 1409992 | 28.07 - 80.62 | 90717151 |  | 0.75 - 1.95 | 14.65 - 16.04 |
|  | 2020 | 1380663 | 24.34 - 69.72 | 76620517 | 0.01 | 0.75 - 1.95 | 53.35 - 55.20 |
|  | 2019 | 1464589 | 15.78 - 45.08 | 52230907 | 0.20 | 0.75 - 1.95 | 29.94 - 31.51 |
|  | 2018 | 1620381 | 12.07 - 34.40 | 43831631 | 0.12 | 0.75 - 1.95 | (1.83) - (0.64) |
| BHFTII Loomis Sayles Small | 2022 | 9302 | 75.14 - 79.58 | 716056 |  | 1.70 - 1.90 | (16.87) - (16.70) |
| Cap Core Sub-Account | 2021 | 9768 | 90.39 - 95.54 | 904077 |  | 1.70 - 1.90 | 19.35 - 19.59 |
|  | 2020 | 11843 | 75.73 - 79.89 | 917124 |  | 1.70 - 1.90 | 9.68 - 9.90 |
|  | 2019 | 11774 | 69.05 - 72.69 | 833345 |  | 1.70 - 1.90 | 22.87 - 23.12 |
|  | 2018 | 11832 | 56.20 - 59.04 | 681029 |  | 1.70 - 1.90 | (12.98) - (12.80) |
| BHFTII Loomis Sayles Small | 2022 | 13366 | 29.57 - 34.79 | 420271 |  | 0.75 - 1.50 | (24.24) - (23.67) |
| Cap Growth Sub-Account | 2021 | 13797 | 39.03 - 45.58 | 571469 |  | 0.75 - 1.50 | 8.11 - 8.92 |
|  | 2020 | 14903 | 36.10 - 41.85 | 569459 |  | 0.75 - 1.50 | 32.04 - 33.04 |
|  | 2019 | 16179 | 27.34 - 31.45 | 468283 |  | 0.75 - 1.50 | 24.63 - 25.56 |
|  | 2018 | 19502 | 21.94 - 25.05 | 451260 |  | 0.75 - 1.50 | (1.22) - (0.47) |

---

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**8. FINANCIAL HIGHLIGHTS — (Continued)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **As of December 31** | **As of December 31** | **As of December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
| | | **Units** | **Unit Value<br>Lowest to<br>Highest ($)** | **Net<br>Assets ($)** | **Investment<sup>1</sup><br>Income<br>Ratio (%)** | **Expense Ratio<sup>2</sup><br>Lowest to<br>Highest (%)** | **Total Return<sup>3</sup><br>Lowest to<br>Highest (%)** |
| BHFTII MetLife Aggregate | 2022 | 1993967 | 1.69 - 17.98 | 29840192 | 2.49 | 0.75 - 1.95 | (15.00) - (13.98) |
| Bond Index Sub-Account | 2021 | 2091257 | 1.97 - 20.90 | 36310567 | 2.36 | 0.75 - 1.95 | (4.15) - (2.99) |
|  | 2020 | 1777483 | 2.04 - 21.54 | 31538770 | 2.55 | 0.75 - 1.95 | 4.82 - 6.09 |
|  | 2019 | 1145343 | 1.93 - 20.31 | 19134533 | 2.93 | 0.75 - 1.95 | 6.25 - 7.53 |
|  | 2018 | 1062730 | 1.80 - 18.88 | 16435910 | 2.82 | 0.75 - 2.00 | (2.47) - (1.24) |
| BHFTII MetLife Mid Cap | 2022 | 249696 | 38.73 - 47.96 | 10797641 | 0.83 | 1.00 - 1.95 | (15.17) - (14.36) |
| Stock Index Sub-Account | 2021 | 236049 | 45.65 - 56.00 | 11895616 | 0.87 | 1.00 - 1.95 | 21.62 - 22.78 |
|  | 2020 | 244010 | 37.54 - 45.61 | 9989114 | 1.22 | 1.00 - 1.95 | 10.88 - 11.94 |
|  | 2019 | 242817 | 33.86 - 40.75 | 8858249 | 1.11 | 1.00 - 1.95 | 23.12 - 24.29 |
|  | 2018 | 247006 | 27.50 - 32.79 | 7240467 | 0.99 | 1.00 - 1.95 | (13.28) - (12.45) |
| BHFTII MetLife MSCI EAFE<sup>®</sup> | 2022 | 527562 | 1.81 - 17.44 | 8395699 | 3.48 | 1.00 - 1.95 | (16.31) - (15.51) |
| Index Sub-Account | 2021 | 541578 | 2.14 - 19.97 | 10196923 | 1.52 | 1.00 - 1.95 | 8.22 - 9.25 |
|  | 2020 | 565388 | 1.96 - 18.33 | 9602086 | 2.96 | 1.00 - 1.95 | 5.44 - 6.44 |
|  | 2019 | 514486 | 1.84 - 17.28 | 8199643 | 2.43 | 1.00 - 1.95 | 19.23 - 20.37 |
|  | 2018 | 499779 | 1.53 - 14.40 | 6606006 | 2.76 | 1.00 - 1.95 | (15.79) - (14.98) |
| BHFTII MetLife Russell 2000<sup>®</sup> | 2022 | 335310 | 4.17 - 40.22 | 12531329 | 0.77 | 1.00 - 1.95 | (22.00) - (21.26) |
| Index Sub-Account | 2021 | 316964 | 5.30 - 51.16 | 15078874 | 0.78 | 1.00 - 1.95 | 11.99 - 13.06 |
|  | 2020 | 324150 | 4.68 - 45.31 | 13538340 | 1.14 | 1.00 - 1.95 | 16.95 - 18.07 |
|  | 2019 | 339156 | 3.97 - 37.24 | 11955820 | 0.88 | 1.00 - 1.95 | 22.78 - 23.96 |
|  | 2018 | 324847 | 3.20 - 30.13 | 9215132 | 0.82 | 1.00 - 1.95 | (12.93) - (12.09) |
| BHFTII MetLife Stock Index | 2022 | 2096326 | 13.54 - 128.91 | 77419177 | 1.07 | 1.00 - 1.95 | (20.08) - (19.32) |
| Sub-Account | 2021 | 2083501 | 16.78 - 160.01 | 95740312 | 1.35 | 1.00 - 1.95 | 25.57 - 26.77 |
|  | 2020 | 2078635 | 13.24 - 124.24 | 75354201 | 1.71 | 1.00 - 1.95 | 15.54 - 16.65 |
|  | 2019 | 1905561 | 11.35 - 106.79 | 59292658 | 1.97 | 1.00 - 1.95 | 28.28 - 29.50 |
|  | 2018 | 1931296 | 8.76 - 82.65 | 46327633 | 1.61 | 1.00 - 2.90 | (7.43) - (5.78) |
| BHFTII MFS<sup>®</sup> Total Return | 2022 | 67366 | 24.44 - 107.20 | 5553324 | 1.62 | 0.75 - 1.90 | (11.52) - (10.54) |
| Sub-Account | 2021 | 76609 | 27.50 - 119.84 | 7162535 | 1.70 | 0.75 - 1.90 | 11.85 - 13.08 |
|  | 2020 | 82987 | 24.48 - 105.97 | 6902823 | 2.24 | 0.75 - 1.90 | 7.47 - 8.67 |
|  | 2019 | 88865 | 22.67 - 97.52 | 6814865 | 2.18 | 0.75 - 1.90 | 17.87 - 19.17 |
|  | 2018 | 107850 | 19.15 - 81.83 | 6561057 | 2.10 | 0.75 - 1.90 | (7.55) - (6.52) |
| BHFTII MFS<sup>®</sup> Value | 2022 | 646664 | 35.70 - 47.87 | 26171943 | 1.52 | 0.75 - 1.95 | (8.03) - (6.92) |
| Sub-Account | 2021 | 671025 | 38.81 - 51.43 | 29380024 | 1.37 | 0.75 - 1.95 | 22.88 - 24.36 |
|  | 2020 | 711871 | 31.59 - 41.36 | 25233003 | 1.82 | 0.75 - 1.95 | 1.65 - 2.88 |
|  | 2019 | 684570 | 31.07 - 40.20 | 23660739 | 1.75 | 0.75 - 1.95 | 27.34 - 28.88 |
|  | 2018 | 729098 | 24.40 - 31.19 | 19648433 | 1.30 | 0.75 - 1.95 | (11.98) - (10.92) |
| BHFTII Neuberger Berman | 2022 | 242636 | 32.34 - 50.08 | 9821648 |  | 0.75 - 1.95 | (20.88) - (19.92) |
| Genesis Sub-Account | 2021 | 285422 | 40.83 - 62.55 | 14525048 |  | 0.75 - 1.95 | 15.83 - 17.23 |
|  | 2020 | 323232 | 35.21 - 53.35 | 14100494 |  | 0.75 - 1.95 | 22.34 - 23.82 |
|  | 2019 | 362615 | 28.75 - 43.09 | 12847737 |  | 0.75 - 1.95 | 26.91 - 28.44 |
|  | 2018 | 383584 | 22.63 - 33.55 | 10646038 | 0.10 | 0.75 - 1.95 | (8.79) - (7.68) |
| BHFTII T. Rowe Price Large | 2022 | 1218582 | 14.44 - 42.14 | 41326279 |  | 1.15 - 1.95 | (41.81) - (41.29) |
| Cap Growth Sub-Account | 2021 | 1060820 | 24.82 - 71.84 | 60930950 |  | 1.15 - 1.95 | 17.64 - 18.58 |
|  | 2020 | 1133729 | 21.10 - 60.58 | 54629722 | 0.02 | 1.15 - 1.95 | 34.00 - 35.08 |
|  | 2019 | 1072500 | 15.75 - 44.75 | 36415233 | 0.18 | 1.30 - 1.95 | 28.07 - 29.17 |
|  | 2018 | 1050180 | 12.30 - 34.65 | 26765258 | 0.20 | 1.30 - 1.95 | (3.07) - (2.32) |

---

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**8. FINANCIAL HIGHLIGHTS — (Continued)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **As of December 31** | **As of December 31** | **As of December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
| | | **Units** | **Unit Value<br>Lowest to<br>Highest ($)** | **Net<br>Assets ($)** | **Investment<sup>1</sup><br>Income<br>Ratio (%)** | **Expense Ratio<sup>2</sup><br>Lowest to<br>Highest (%)** | **Total Return<sup>3</sup><br>Lowest to<br>Highest (%)** |
| BHFTII T. Rowe Price Small | 2022 | 7602 | 45.27 - 51.52 | 356808 |  | 1.40 - 1.90 | (23.80) - (23.42) |
| Cap Growth Sub-Account | 2021 | 7733 | 59.41 - 67.28 | 475763 |  | 1.40 - 1.90 | 9.26 - 9.81 |
|  | 2020 | 8025 | 54.38 - 61.27 | 451123 |  | 1.40 - 1.90 | 21.70 - 22.32 |
|  | 2019 | 8927 | 44.68 - 50.09 | 412112 |  | 1.40 - 1.90 | 30.34 - 30.99 |
|  | 2018 | 11317 | 34.28 - 38.24 | 400874 |  | 1.40 - 1.90 | (8.55) - (8.08) |
| BHFTII VanEck Global | 2022 | 231596 | 13.44 - 15.94 | 3271292 | 2.45 | 0.75 - 1.95 | 5.90 - 7.17 |
| Natural Resources  | 2021 | 302329 | 12.69 - 14.87 | 4017036 | 0.98 | 0.75 - 1.95 | 16.22 - 17.62 |
| Sub-Account | 2020 | 383974 | 10.92 - 12.64 | 4376253 | 1.23 | 0.75 - 1.95 | 18.83 - 20.27 |
|  | 2019 | 431638 | 9.19 - 10.51 | 4127141 | 0.35 | 0.75 - 1.95 | 10.18 - 11.51 |
|  | 2018 | 402320 | 8.34 - 9.43 | 3479021 |  | 0.75 - 1.95 | (30.24) - (29.39) |
| BHFTII Western Asset | 2022 | 1732011 | 3.49 - 39.53 | 53472697 | 5.87 | 0.75 - 1.95 | (18.53) - (17.28) |
| Management Strategic Bond | 2021 | 1866465 | 4.24 - 47.78 | 70323605 | 3.67 | 0.75 - 1.95 | 0.63 - 2.05 |
| Opportunities Sub-Account | 2020 | 1798940 | 4.17 - 46.82 | 67109029 | 5.78 | 0.75 - 1.95 | 4.55 - 6.11 |
|  | 2019 | 1839569 | 3.95 - 44.12 | 65273070 | 4.79 | 0.75 - 1.95 | 12.03 - 13.63 |
|  | 2018 | 2028696 | 27.43 - 38.83 | 64242084 | 5.26 | 0.75 - 1.95 | (5.89) - (4.52) |
| BHFTII Western Asset | 2022 | 1483860 | 14.25 - 18.88 | 24326686 | 1.97 | 0.95 - 1.95 | (10.92) - (10.02) |
| Management U.S. Government | 2021 | 1671665 | 15.99 - 20.99 | 30424239 | 2.50 | 0.95 - 1.95 | (3.66) - (2.70) |
| Sub-Account | 2020 | 1492144 | 16.38 - 21.57 | 27878573 | 2.80 | 0.95 - 2.00 | 2.83 - 3.92 |
|  | 2019 | 1312674 | 15.93 - 20.76 | 23768953 | 2.51 | 0.95 - 2.00 | 3.69 - 4.78 |
|  | 2018 | 1481884 | 15.37 - 19.81 | 25701077 | 2.07 | 0.95 - 2.00 | (1.31) - (0.26) |
| BlackRock Global Allocation | 2022 | 198414 | 24.54 - 26.49 | 5106643 |  | 1.15 - 1.55 | (17.36) - (17.03) |
| V.I. Sub-Account | 2021 | 179596 | 29.70 - 31.07 | 5579066 | 0.91 | 1.30 - 1.55 | 4.78 - 5.04 |
|  | 2020 | 102362 | 28.34 - 29.58 | 3026611 | 1.68 | 1.30 - 1.55 | 18.85 - 19.15 |
|  | 2019 | 52374 | 23.85 - 24.83 | 1299249 | 2.25 | 1.30 - 1.55 | 15.94 - 16.23 |
|  | 2018 | 9262 | 20.57 - 21.36 | 197767 | 1.26 | 1.30 - 1.55 | (7.68) - (7.53) |
| Fidelity<sup>®</sup> VIP Contrafund<sup>®</sup> | 2022 | 2405198 | 1.53 - 131.57 | 17299560 | 0.37 | 0.95 - 1.85 | (27.73) - (27.08) |
| Sub-Account | 2021 | 1819064 | 2.12 - 180.43 | 24440517 | 0.05 | 0.95 - 1.85 | 25.37 - 26.50 |
|  | 2020 | 1300739 | 1.68 - 142.63 | 21397993 | 0.14 | 0.95 - 1.85 | 28.03 - 29.19 |
|  | 2019 | 1001771 | 1.31 - 110.40 | 19110902 | 0.34 | 0.95 - 1.85 | 29.04 - 30.21 |
|  | 2018 | 812628 | 1.02 - 84.79 | 17097852 | 0.57 | 0.95 - 1.85 | (8.21) - (7.38) |
| Fidelity<sup>®</sup> VIP | 2022 | 108 | 130.24 | 14071 | 1.65 | 1.50 | (6.65) |
| Equity-Income Sub-Account | 2021 | 117 | 139.52 | 16364 | 1.62 | 1.50 | 22.75 |
|  | 2020 | 126 | 113.66 | 14351 | 1.69 | 1.50 | 4.85 |
|  | 2019 | 123 | 27.39 - 108.40 | 13301 | 2.07 | 1.40 - 1.50 | 25.21 - 25.34 |
|  | 2018 | 1307 | 21.85 - 86.57 | 36464 | 1.93 | 1.40 - 1.50 | (9.91) - (9.82) |
| Fidelity<sup>®</sup> VIP Mid Cap | 2022 | 118419 | 87.83 - 103.91 | 11059110 | 0.26 | 0.95 - 1.65 | (16.36) - (15.77) |
| Sub-Account | 2021 | 130081 | 105.00 - 123.36 | 14493913 | 0.34 | 0.95 - 1.65 | 23.26 - 24.12 |
|  | 2020 | 160157 | 85.19 - 99.39 | 14462567 | 0.40 | 0.95 - 1.65 | 15.93 - 16.75 |
|  | 2019 | 168355 | 73.48 - 85.13 | 13094588 | 0.66 | 0.95 - 1.65 | 21.16 - 22.01 |
|  | 2018 | 197251 | 60.65 - 69.77 | 12632647 | 0.39 | 0.95 - 1.65 | (16.18) - (15.58) |
| FTVIPT Franklin Income VIP | 2022 | 217635 | 68.21 - 92.58 | 16476647 | 4.75 | 0.95 - 1.85 | (7.20) - (6.37) |
| Sub-Account | 2021 | 241149 | 73.51 - 98.87 | 19608039 | 4.62 | 0.95 - 1.85 | 14.62 - 15.65 |
|  | 2020 | 261627 | 64.14 - 85.49 | 18542366 | 5.79 | 0.95 - 1.85 | (1.16) - (0.26) |
|  | 2019 | 266046 | 64.89 - 85.72 | 19093371 | 5.39 | 0.95 - 1.85 | 13.93 - 14.96 |
|  | 2018 | 294051 | 56.95 - 74.56 | 18485748 | 4.79 | 0.95 - 1.85 | (6.07) - (5.21) |

---

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**8. FINANCIAL HIGHLIGHTS — (Continued)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **As of December 31** | **As of December 31** | **As of December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
| | | **Units** | **Unit Value<br>Lowest to<br>Highest ($)** | **Net<br>Assets ($)** | **Investment<sup>1</sup><br>Income<br>Ratio (%)** | **Expense Ratio<sup>2</sup><br>Lowest to<br>Highest (%)** | **Total Return<sup>3</sup><br>Lowest to<br>Highest (%)** |
| FTVIPT Franklin Mutual | 2022 | 57689 | 35.12 - 42.18 | 2170096 | 1.79 | 0.95 - 1.65 | (8.94) - (8.30) |
| Shares VIP Sub-Account | 2021 | 65286 | 38.57 - 46.00 | 2686509 | 2.83 | 0.95 - 1.65 | 17.22 - 18.04 |
|  | 2020 | 76910 | 32.91 - 37.58 | 2689215 | 2.78 | 1.10 - 1.65 | (6.60) - (6.09) |
|  | 2019 | 80076 | 35.23 - 40.02 | 2993280 | 1.78 | 1.10 - 1.65 | 20.57 - 21.23 |
|  | 2018 | 93265 | 29.22 - 33.01 | 2885952 | 2.30 | 0.95 - 1.65 | (10.56) - (10.07) |
| FTVIPT Franklin Small Cap | 2022 | 115849 | 21.1 - 52.43 | 2751742 | 0.96 | 0.95 - 1.55 | (11.45) - (10.91) |
| Value VIP Sub-Account | 2021 | 129320 | 23.82 - 59.06 | 3489074 | 1.00 | 0.95 - 1.55 | 23.44 - 24.18 |
|  | 2020 | 165400 | 19.29 - 47.73 | 3423174 | 1.48 | 0.95 - 1.55 | 3.57 - 4.19 |
|  | 2019 | 171679 | 18.61 - 45.97 | 3350116 | 1.05 | 0.95 - 1.55 | 24.40 - 25.15 |
|  | 2018 | 196488 | 14.95 - 36.86 | 3044422 | 0.89 | 0.95 - 1.55 | (14.22) - (13.70) |
| FTVIPT Templeton Foreign | 2022 | 433024 | 13.43 - 34.87 | 9492173 | 3.03 | 1.30 - 1.90 | (9.34) - (8.67) |
| VIP Sub-Account | 2021 | 477665 | 14.78 - 38.23 | 11647608 | 1.81 | 1.30 - 1.90 | 2.20 - 2.98 |
|  | 2020 | 487698 | 14.42 - 37.19 | 11676903 | 3.42 | 1.30 - 1.90 | (3.02) - (2.30) |
|  | 2019 | 452328 | 14.84 - 38.12 | 11164052 | 1.72 | 1.30 - 1.90 | 10.41 - 11.27 |
|  | 2018 | 465043 | 13.40 - 34.32 | 10188360 | 2.66 | 1.30 - 1.90 | (17.04) - (16.45) |
| FTVIPT Templeton Global | 2022 | 372093 | 15.05 - 17.39 | 5828771 |  | 0.95 - 1.55 | (6.41) - (5.85) |
| Bond VIP Sub-Account | 2021 | 425295 | 16.09 - 18.47 | 7114458 |  | 0.95 - 1.55 | (6.45) - (5.89) |
|  | 2020 | 457384 | 17.20 - 19.62 | 8175465 | 8.35 | 0.95 - 1.55 | (6.74) - (6.18) |
|  | 2019 | 465524 | 18.44 - 20.91 | 8916190 | 7.13 | 0.95 - 1.55 | 0.44 - 1.05 |
|  | 2018 | 518656 | 18.36 - 20.70 | 9876862 |  | 0.95 - 1.55 | 0.36 - 0.97 |
| Invesco V.I. Equity and | 2022 | 379754 | 30.35 - 34.83 | 12081549 | 1.39 | 0.95 - 1.65 | (9.22) - (8.58) |
| Income Sub-Account | 2021 | 447558 | 33.43 - 38.10 | 15671333 | 1.59 | 0.95 - 1.65 | 16.41 - 17.23 |
|  | 2020 | 532338 | 28.72 - 32.50 | 15978006 | 2.20 | 0.95 - 1.65 | 7.85 - 8.61 |
|  | 2019 | 604019 | 26.63 - 29.92 | 16792600 | 2.29 | 0.95 - 1.65 | 18.05 - 18.87 |
|  | 2018 | 667340 | 22.56 - 25.17 | 15704635 | 1.99 | 0.95 - 1.65 | (11.21) - (10.59) |
| Invesco V.I. EQV | 2022 | 181001 | 15.80 - 40.02 | 6357051 | 1.42 | 0.95 - 1.55 | (19.76) - (19.27) |
| International Equity | 2021 | 188793 | 19.61 - 49.57 | 8243783 | 1.05 | 0.95 - 1.55 | 3.98 - 4.61 |
| Sub-Account | 2020 | 207344 | 18.78 - 47.39 | 8708971 | 2.15 | 0.95 - 1.55 | 11.99 - 12.66 |
|  | 2019 | 233436 | 16.71 - 42.06 | 8769800 | 1.25 | 0.95 - 1.55 | 26.27 - 27.03 |
|  | 2018 | 280671 | 13.18 - 33.11 | 8360170 | 1.78 | 0.95 - 1.55 | (16.52) - (16.01) |
| Invesco V.I. Main Street | 2022 | 61532 | 43.72 - 49.74 | 2800129 | 0.24 | 0.95 - 1.55 | (17.33) - (16.84) |
| Small Cap<sup>®</sup> Sub-Account | 2021 | 71486 | 52.89 - 59.80 | 3929067 | 0.18 | 0.95 - 1.55 | 20.38 - 21.11 |
|  | 2020 | 82071 | 43.93 - 49.38 | 3742898 | 0.37 | 0.95 - 1.55 | 17.79 - 18.50 |
|  | 2019 | 87355 | 37.30 - 41.67 | 3377338 |  | 0.95 - 1.55 | 24.19 - 24.94 |
|  | 2018 | 100955 | 30.03 - 32.49 | 3142174 | 0.06 | 0.95 - 1.55 | (11.92) - (11.52) |
| Janus Henderson Global  | 2022 | 13314 | 0.91 | 12066 | 0.56 | 1.30 | (8.12) |
| Sustainable Equity  |  |  |  |  |  |  |  |
| Sub-Account  |  |  |  |  |  |  |  |
| (Commenced 4/29/2022) |  |  |  |  |  |  |  |
| LMPVET ClearBridge Variable | 2022 | 4123288 | 1.60 - 111.43 | 22295200 | 0.96 | 0.95 - 1.90 | (14.09) - (13.27) |
| Appreciation Sub-Account | 2021 | 3911044 | 1.87 - 128.49 | 28433313 | 0.56 | 0.95 - 1.90 | 21.33 - 22.49 |
|  | 2020 | 3227268 | 1.54 - 104.89 | 25378157 | 1.02 | 0.95 - 1.90 | 12.61 - 13.69 |
|  | 2019 | 2552956 | 1.36 - 92.27 | 24573880 | 1.33 | 0.95 - 1.90 | 27.42 - 28.64 |
|  | 2018 | 1932776 | 1.07 - 71.72 | 22409019 | 1.20 | 0.95 - 1.90 | (3.60) - (2.68) |

---

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Continued)**

**8. FINANCIAL HIGHLIGHTS — (Continued)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **As of December 31** | **As of December 31** | **As of December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
| | | **Units** | **Unit Value<br>Lowest to<br>Highest ($)** | **Net<br>Assets ($)** | **Investment<sup>1</sup><br>Income<br>Ratio (%)** | **Expense Ratio<sup>2</sup><br>Lowest to<br>Highest (%)** | **Total Return<sup>3</sup><br>Lowest to<br>Highest (%)** |
| LMPVET ClearBridge Variable | 2022 | 329666 | 27.22 - 42.61 | 12615091 | 1.21 | 0.95 - 1.90 | (9.91) - (9.10) |
| Dividend Strategy  | 2021 | 356164 | 30.13 - 46.88 | 15070095 | 1.31 | 0.95 - 1.90 | 24.29 - 25.42 |
| Sub-Account | 2020 | 411937 | 24.17 - 37.38 | 13952158 | 1.30 | 0.95 - 1.90 | 5.52 - 6.48 |
|  | 2019 | 442875 | 22.83 - 35.10 | 14150185 | 1.31 | 0.95 - 1.90 | 29.00 - 30.17 |
|  | 2018 | 521884 | 17.65 - 26.97 | 12903855 | 1.36 | 0.95 - 1.90 | (6.75) - (5.90) |
| LMPVET ClearBridge Variable | 2022 | 5213 | 41.14 - 45.41 | 226074 |  | 1.50 - 1.90 | (33.52) - (33.25) |
| Large Cap Growth  | 2021 | 5141 | 61.88 - 68.03 | 335131 |  | 1.50 - 1.90 | 19.65 - 20.13 |
| Sub-Account | 2020 | 5460 | 51.72 - 56.63 | 296447 | 0.02 | 1.50 - 1.90 | 28.27 - 28.79 |
|  | 2019 | 6040 | 40.32 - 43.97 | 255317 | 0.35 | 1.50 - 1.90 | 29.67 - 30.19 |
|  | 2018 | 6572 | 31.09 - 33.77 | 213754 | 0.28 | 1.50 - 1.90 | (1.88) - (1.48) |
| LMPVET ClearBridge Variable | 2022 | 5918 | 36.49 - 38.83 | 221468 | 1.30 | 1.50 - 1.90 | (8.19) - (7.96) |
| Large Cap Value Sub-Account | 2021 | 6536 | 39.74 - 42.19 | 266467 | 1.02 | 1.65 - 1.90 | 23.84 - 24.14 |
|  | 2020 | 6994 | 32.09 - 35.17 | 230188 | 1.18 | 1.50 - 1.90 | 3.26 - 3.68 |
|  | 2019 | 10912 | 31.08 - 33.92 | 352143 | 1.59 | 1.50 - 1.90 | 26.46 - 26.96 |
|  | 2018 | 14915 | 24.58 - 26.72 | 378407 | 1.53 | 1.50 - 1.90 | (10.60) - (10.24) |
| LMPVET ClearBridge Variable | 2022 | 1789993 | 1.57 - 57.23 | 5865900 |  | 0.95 - 1.90 | (30.18) - (29.52) |
| Small Cap Growth  | 2021 | 1401886 | 2.24 - 81.20 | 7585002 |  | 0.95 - 1.90 | 10.49 - 11.55 |
| Sub-Account | 2020 | 1180360 | 2.02 - 72.80 | 7174195 |  | 0.95 - 1.90 | 40.56 - 41.90 |
|  | 2019 | 1064009 | 1.44 - 51.30 | 5569386 |  | 0.95 - 1.90 | 24.49 - 25.67 |
|  | 2018 | 630981 | 1.15 - 40.82 | 4475137 |  | 0.95 - 1.90 | 1.48 - 2.45 |
| LMPVET Franklin Multi-Asset | 2022 | 37439 | 27.09 - 32.48 | 1064087 | 1.97 | 0.95 - 1.65 | (15.58) - (14.98) |
| Variable Conservative Growth | 2021 | 45437 | 32.09 - 38.21 | 1532607 | 3.11 | 0.95 - 1.65 | 9.64 - 10.41 |
| Sub-Account | 2020 | 54797 | 29.27 - 33.38 | 1679630 | 2.07 | 1.10 - 1.65 | 9.14 - 9.75 |
|  | 2019 | 61120 | 26.82 - 30.42 | 1715186 | 1.99 | 1.10 - 1.65 | 15.44 - 16.08 |
|  | 2018 | 78225 | 23.23 - 26.20 | 1917375 | 2.39 | 1.10 - 1.65 | (5.97) - (5.45) |
| LMPVET Franklin Multi-Asset | 2022 | 36335 | 27.87 - 30.12 | 1053702 | 3.10 | 1.35 - 1.65 | (16.19) - (15.94) |
| Variable Growth | 2021 | 38862 | 33.25 - 35.83 | 1342903 | 4.13 | 1.35 - 1.65 | 18.72 - 19.08 |
| Sub-Account | 2020 | 40369 | 28.00 - 30.09 | 1173882 | 1.63 | 1.35 - 1.65 | 9.41 - 9.74 |
|  | 2019 | 40975 | 25.60 - 28.05 | 1087531 | 1.52 | 1.25 - 1.65 | 20.57 - 21.05 |
|  | 2018 | 45503 | 21.23 - 23.17 | 1003940 | 2.33 | 1.25 - 1.65 | (9.56) - (9.19) |
| LMPVET Franklin Multi-Asset | 2022 | 1084 | 26.49 - 27.54 | 28956 | 1.78 | 1.50 - 1.65 | (15.76) - (15.63) |
| Variable Moderate Growth | 2021 | 1152 | 31.44 - 32.64 | 36572 | 3.96 | 1.50 - 1.65 | 14.76 - 14.93 |
| Sub-Account | 2020 | 1523 | 27.40 - 28.40 | 42386 | 1.75 | 1.50 - 1.65 | 9.25 - 9.41 |
|  | 2019 | 1525 | 25.08 - 25.96 | 38824 | 1.74 | 1.50 - 1.65 | 18.46 - 18.64 |
|  | 2018 | 1527 | 21.17 - 21.88 | 32802 | 2.17 | 1.50 - 1.65 | (7.82) - (7.68) |
| LMPVIT Western Asset | 2022 | 2730418 | 0.98 - 28.47 | 6316832 | 6.39 | 0.95 - 1.90 | (15.34) - (14.54) |
| Variable Global High Yield | 2021 | 2450122 | 1.15 - 33.31 | 7621275 | 4.48 | 0.95 - 1.90 | (0.58) - 0.37 |
| Bond Sub-Account | 2020 | 1612960 | 1.16 - 33.19 | 7213023 | 3.98 | 0.95 - 1.90 | 5.29 - 6.30 |
|  | 2019 | 1076821 | 1.10 - 31.22 | 7144096 | 5.18 | 0.95 - 1.90 | 12.23 - 13.30 |
|  | 2018 | 755929 | 0.98 - 27.55 | 7196680 | 4.97 | 0.95 - 1.90 | (5.74) - (4.83) |
| PIMCO VIT High Yield | 2022 | 2903 | 23.53 - 24.72 | 69319 | 5.04 | 1.30 - 1.50 | (11.62) - (11.44) |
| Sub-Account | 2021 | 3064 | 26.62 - 27.92 | 82769 | 4.45 | 1.30 - 1.50 | 2.09 - 2.29 |
|  | 2020 | 2835 | 26.08 - 27.29 | 74875 | 4.83 | 1.30 - 1.50 | 4.17 - 4.38 |
|  | 2019 | 2812 | 25.04 - 26.15 | 71192 | 4.97 | 1.30 - 1.50 | 13.02 - 13.24 |
|  | 2018 | 4444 | 22.15 - 23.09 | 99197 | 5.09 | 1.30 - 1.50 | (4.11) - (3.91) |

---

------

**BRIGHTHOUSE VARIABLE ANNUITY ACCOUNT B<br>OF BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY<br>NOTES TO THE FINANCIAL STATEMENTS — (Concluded)**

**8. FINANCIAL HIGHLIGHTS — (Concluded)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **As of December 31** | **As of December 31** | **As of December 31** | **For the year ended December 31** | **For the year ended December 31** | **For the year ended December 31** |
| | | **Units** | **Unit Value<br>Lowest to<br>Highest ($)** | **Net<br>Assets ($)** | **Investment<sup>1</sup><br>Income<br>Ratio (%)** | **Expense Ratio<sup>2</sup><br>Lowest to<br>Highest (%)** | **Total Return<sup>3</sup><br>Lowest to<br>Highest (%)** |
| PIMCO VIT Low Duration | 2022 | 2835 | 13.80 - 14.11 | 39450 | 1.68 | 1.40 - 1.50 | (7.14) - (7.05) |
| Sub-Account | 2021 | 2856 | 14.87 - 15.17 | 42782 | 0.52 | 1.40 - 1.50 | (2.40) - (2.30) |
|  | 2020 | 2796 | 15.23 - 15.53 | 42932 | 1.20 | 1.40 - 1.50 | 1.45 - 1.56 |
|  | 2019 | 2824 | 15.01 - 15.30 | 42724 | 2.77 | 1.40 - 1.50 | 2.48 - 2.58 |
|  | 2018 | 2982 | 14.65 - 14.91 | 44020 | 1.88 | 1.40 - 1.50 | (1.16) - (1.06) |
| Pioneer Mid Cap Value VCT | 2022 | 25894 | 61.92 - 75.25 | 1694835 | 1.38 | 0.95 - 1.65 | (7.42) - (6.77) |
| Sub-Account | 2021 | 29537 | 66.89 - 80.72 | 2088943 | 0.72 | 0.95 - 1.65 | 27.26 - 28.15 |
|  | 2020 | 32642 | 52.56 - 62.99 | 1807815 | 0.95 | 0.95 - 1.65 | 0.20 - 0.91 |
|  | 2019 | 33435 | 52.46 - 62.43 | 1849005 | 1.09 | 0.95 - 1.65 | 25.99 - 26.87 |
|  | 2018 | 39747 | 41.64 - 49.20 | 1745896 | 0.46 | 0.95 - 1.65 | (20.82) - (20.26) |
| Putnam VT Large Cap Value | 2022 | 288 | 55.34 | 15929 | 1.46 | 0.75 | (3.85) |
| Sub-Account | 2021 | 288 | 51.03 - 57.56 | 16568 | 1.10 | 0.75 - 1.40 | 25.53 - 26.35 |
|  | 2020 | 1836 | 40.65 - 45.56 | 76063 | 1.65 | 0.75 - 1.40 | 4.33 - 5.01 |
|  | 2019 | 1760 | 38.97 - 43.38 | 69846 | 2.19 | 0.75 - 1.40 | 28.59 - 29.43 |
|  | 2018 | 2446 | 30.30 - 33.52 | 75058 | 0.69 | 0.75 - 1.40 | (9.77) - (9.18) |
| Putnam VT Sustainable | 2022 | 16326 | 22.52 | 367684 | 0.82 | 1.40 | (23.79) |
| Leaders Sub-Account | 2021 | 16128 | 29.55 | 476628 | 0.33 | 1.40 | 22.12 |
|  | 2020 | 15844 | 24.20 | 383422 | 0.62 | 1.40 | 27.27 |
|  | 2019 | 15640 | 19.02 | 297395 | 0.67 | 1.40 | 34.82 |
|  | 2018 | 15235 | 14.10 | 214887 | 0.01 | 1.40 | (2.66) |
| TAP 1919 Variable Socially | 2022 | 3253 | 60.51 - 63.35 | 197474 | 0.70 | 1.50 - 1.65 | (22.23) - (22.11) |
| Responsive Balanced | 2021 | 3253 | 77.80 - 81.34 | 253927 | 0.36 | 1.50 - 1.65 | 16.59 - 16.76 |
| Sub-Account | 2020 | 3254 | 66.73 - 69.66 | 217805 | 0.79 | 1.50 - 1.65 | 20.92 - 21.10 |
|  | 2019 | 3255 | 55.19 - 57.53 | 180142 | 1.11 | 1.50 - 1.65 | 24.63 - 24.82 |
|  | 2018 | 322 | 44.28 - 46.09 | 14651 | 1.01 | 1.50 - 1.65 | (2.57) - (2.42) |

---

1 These amounts represent the dividends, excluding distributions of capital gains, received by the Sub-Account from the underlying fund, portfolio, or series net of management fees assessed by the fund manager, divided by the average net assets, regardless of share class, if any. These ratios exclude those expenses, such as mortality and expense risk charges, that are assessed against contract owner accounts either through reductions in the unit values or the redemption of units. The investment income ratio is calculated for each period indicated or from the effective date through the end of the reporting period. The recognition of investment income by the Sub-Account is affected by the timing of the declaration of dividends by the underlying fund, portfolio, or series in which the Sub-Account invests. The investment income ratio is calculated as a weighted average ratio since the Sub-Account may invest in two or more share classes, within the underlying fund, portfolio, or series of the trusts which may have unique investment income ratios.

2 These amounts represent annualized contract expenses of each of the applicable Sub-Accounts, consisting primarily of mortality and expense risk charges, for each period indicated. The ratios include only those expenses that result in a direct reduction to unit values. Charges made directly to contract owner accounts through the redemption of units and expenses of the underlying fund, portfolio, or series have been excluded.

3 These amounts represent the total return for the period indicated, including changes in the value of the underlying fund, portfolio, or series and expenses assessed through the reduction of unit values. These ratios do not include any expenses assessed through the redemption of units. The total return is calculated for each period indicated or from the effective date through the end of the reporting period. The total return is presented as a range of minimum to maximum returns, based on the minimum and maximum returns within each product grouping of the applicable Sub-Account.

4 During 2021, the Separate Account effectuated a 1-for-10 unit change to certain contract owners in the American Funds<sup>®</sup> Growth Sub-Account, resulting in a broader range of unit values. The unit value and number of units outstanding for the impacted contract owners were retroactively adjusted to reflect this change in each period presented prior to 2022. There was no change to the total net assets of the fund or to any contract owner's investment in the fund for any period presented prior to 2022.

------

This page is intentionally left blank.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Index to Financial Statements, Notes and Schedules**

---

| | |
|:---|:---|
| | **Page** |
| Report of Independent Registered Public Accounting Firm | 2 |
| Financial Statements at December 31, 2022 and 2021 and for the Years Ended December 31, 2022, 2021<br>and 2020: | Financial Statements at December 31, 2022 and 2021 and for the Years Ended December 31, 2022, 2021<br>and 2020: |
| Balance Sheets | 5 |
| Statements of Operations | 6 |
| Statements of Comprehensive Income (Loss) | 7 |
| Statements of Stockholder's Equity | 8 |
| Statements of Cash Flows | 9 |
| Notes to the Financial Statements | Notes to the Financial Statements |
| Note 1 — Business, Basis of Presentation and Summary of Significant Accounting Policies | 10 |
| Note 2 — Segment Information | 18 |
| Note 3 — Insurance | 21 |
| Note 4 — Deferred Policy Acquisition Costs and Deferred Sales Inducements | 24 |
| Note 5 — Reinsurance | 24 |
| Note 6 — Investments | 28 |
| Note 7 — Derivatives | 35 |
| Note 8 — Fair Value | 39 |
| Note 9 — Short-term Debt | 48 |
| Note 10 — Equity | 48 |
| Note 11 — Other Revenues and Other Expenses | 51 |
| Note 12 — Income Tax | 51 |
| Note 13 — Contingencies, Commitments and Guarantees | 54 |
| Note 14 — Related Party Transactions | 55 |
| Note 15 — Subsequent Events | 56 |
| Financial Statement Schedules at December 31, 2022 and 2021 and for the Years Ended December 31,<br>2022, 2021 and 2020: | Financial Statement Schedules at December 31, 2022 and 2021 and for the Years Ended December 31,<br>2022, 2021 and 2020: |
| Schedule I — Summary of Investments — Other Than Investments in Related Parties | 57 |
| Schedule III — Supplementary Insurance Information | 58 |
| Schedule IV — Reinsurance | 60 |

---

------

**REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

To the stockholders and the Board of Directors of Brighthouse Life Insurance Company of NY

**Opinion on the Financial Statements**

We have audited the accompanying balance sheets of Brighthouse Life Insurance Company of NY (the "Company") as of December 31, 2022 and 2021, the related statements of operations, comprehensive income (loss), stockholder's equity, and cash flows for each of the three years in the period ended December 31, 2022, and the related notes and the schedules listed in the Index to Financial Statements, Notes and Schedules (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.

**Basis for Opinion**

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

**Critical Audit Matters**

The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

***Liability for Future Policy Benefits — Refer to Notes 1 and 3 to the financial statements***

*Critical Audit Matter Description*

As of December 31, 2022, the liability for future policy benefits totaled $857 million, and included benefits related to variable annuity contracts with guaranteed benefit riders. Management regularly reviews its assumptions supporting the estimates of these actuarial liabilities and differences between actual experience and the assumptions used in pricing the policies and guarantees may require a change to the assumptions recorded at inception as well as an adjustment to the related liabilities. Updating such assumptions can result in variability of profits or the recognition of losses.

Given the future policy benefit obligation for these contracts is sensitive to changes in the assumptions related to general account and separate account investment returns, and policyholder behavior including mortality, benefit election and utilization, and withdrawals, auditing management's selection of these assumptions involves an especially high degree of estimation.

------

*How the Critical Audit Matter Was Addressed in the Audit*

Our audit procedures related to the updating of assumptions by management included the following, among others:

• We tested the effectiveness of management's controls over the assumption review process, including those over the selection of the significant assumptions used related to general account and separate account investment returns, and policyholder behavior including mortality, benefit election and utilization, and withdrawals.

• With the assistance of our actuarial specialists, we evaluated the appropriateness of the significant assumptions used, developed an independent estimate of the future policy benefit liability for a sample of policies, and compared our estimates to management's estimates.

• We tested the completeness and accuracy of the underlying data that served as the basis for the actuarial analysis, including experience studies, to test that the inputs to the actuarial estimate were reasonable.

• We evaluated the methods and significant assumptions used by management to identify potential bias.

• We evaluated whether the significant assumptions used were consistent with evidence obtained in other areas of the audit.

***Deferred Policy Acquisition Costs (DAC) — Refer to Notes 1 and 4 to the financial statements***

*Critical Audit Matter Description*

The Company incurs and defers certain costs in connection with acquiring new and renewal insurance business. These deferred costs, amounting to $325 million as of December 31, 2022, are amortized over the expected life of the policy contract in proportion to actual and expected future gross profits, premiums or margins. For deferred annuity contracts, expected future gross profits utilized in the amortization calculation are derived using assumptions such as separate account and general account investment returns, mortality, in-force or persistency, benefit elections and utilization, and withdrawals. The assumptions used in the calculation of expected future gross profits are reviewed at least annually.

Given the significance of the estimates and uncertainty associated with the long-term assumptions utilized in the determination of expected future gross profits, auditing management's determination of the appropriateness of the assumptions used in the calculation of DAC amortization involves an especially high degree of estimation.

*How the Critical Audit Matter Was Addressed in the Audit*

Our audit procedures related to management's determination of DAC amortization included the following, among others:

• We tested the effectiveness of management's controls related to the determination of expected future gross profits, including those over management's review that the significant assumptions utilized related to separate account and general account investment returns, mortality, in-force or persistency, benefit elections and utilization, and withdrawals represented a reasonable estimate.

• With assistance from our actuarial specialists, we evaluated the data included in the estimate provided by the Company's actuaries and the methodology utilized, and evaluated the process used by the Company to determine whether the significant assumptions used were reasonable estimates based on the Company's own experience and industry studies.

• We inquired of the Company's actuarial specialists whether there were any changes in the methodology utilized during the year in the determination of expected future gross profits.

• We inspected supporting documentation underlying the Company's experience studies and, utilizing our actuarial specialists, independently recalculated the amortization for a sample of policies, and compared our estimates to management's estimates.

• We evaluated whether the significant assumptions used by the Company were consistent with evidence obtained in other areas of the audit and to identify potential bias.

• We evaluated the sufficiency of the Company's disclosures related to DAC amortization.

------

***Embedded Derivative Liabilities Related to Variable Annuity Guarantees — Refer to Notes 1, 7, and 8 to the financial statements.***

*Critical Audit Matter Description*

The Company sells index-linked annuities and variable annuity products with guaranteed minimum benefits, some of which are embedded derivatives that are required to be bifurcated from the host contract, separately accounted for, and measured at fair value. As of December 31, 2022, the fair value of the embedded derivative liability associated with certain of the Company's annuity contracts was $508 million. Management utilizes various assumptions in order to measure the embedded liability including expectations concerning policyholder behavior, mortality and risk margins, as well as changes in the Company's own nonperformance risk. These assumptions are reviewed at least annually by management, and if they change significantly, the estimated fair value is adjusted by a cumulative charge or credit to net income.

Given the embedded derivative liability is sensitive to changes in these assumptions, auditing management's selection of these assumptions involves an especially high degree of estimation.

*How the Critical Audit Matter Was Addressed in the Audit*

Our audit procedures related to the assumptions selected by management for the embedded derivative liability included the following, among others:

• We tested the effectiveness of management's controls over the embedded derivative liability, including those over the selection of the significant assumptions related to policyholder behavior, mortality, risk margins and the Company's nonperformance risk.

• With the assistance of our actuarial specialists, we evaluated the appropriateness of the significant assumptions, tested the completeness and accuracy of the underlying data and the mathematical accuracy of the Company's valuation model.

• We evaluated the reasonableness of the Company's assumptions by comparing those selected by management to those independently derived by our actuarial specialists, drawing upon standard actuarial and industry practice.

• We evaluated the methods and assumptions used by management to identify potential bias in the determination of the embedded liability.

• We evaluated whether the assumptions used were consistent with evidence obtained in other areas of the audit.

/s/ DELOITTE & TOUCHE LLP

Charlotte, North Carolina

March 24, 2023

We have served as the Company's auditor since 2000.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Balance Sheets<br>December 31, 2022 and 2021**

**(In millions, except share and per share data)**

---

| | | |
|:---|:---|:---|
| | **2022** | **2021** |
| **Assets** | **Assets** | **Assets** |
| Investments: | Investments: | Investments: |
| Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $4,605 and $4,464, <br>respectively; allowance for credit losses of $0 and $0, respectively) | $4025 | $4697 |
| Equity securities, at estimated fair value | 4 | 3 |
| Mortgage loans (net of allowance for credit losses of $5 and $2, respectively) | 1218 | 811 |
| Limited liability companies | 7 |  |
| Short-term investments, principally at estimated fair value |  | 13 |
| Other invested assets, principally at estimated fair value | 266 | 342 |
| Total investments | 5520 | 5866 |
| Cash and cash equivalents | 559 | 535 |
| Accrued investment income | 40 | 56 |
| Premiums, reinsurance and other receivables | 996 | 1122 |
| Deferred policy acquisition costs | 325 | 224 |
| Deferred income tax asset | 168 |  |
| Other assets | 21 | 26 |
| Separate account assets | 3922 | 5149 |
| Total assets | $11551 | $12978 |
| **Liabilities and Stockholder's Equity** | **Liabilities and Stockholder's Equity** | **Liabilities and Stockholder's Equity** |
| **Liabilities** | **Liabilities** | **Liabilities** |
| Future policy benefits | $857 | $846 |
| Policyholder account balances | 4828 | 4360 |
| Other policy-related balances | 13 | 12 |
| Payables for collateral under derivative transactions | 194 | 331 |
| Short-term debt | 125 |  |
| Current income tax payable | 94 | 35 |
| Deferred income tax liability |  | 107 |
| Other liabilities | 921 | 987 |
| Separate account liabilities | 3922 | 5149 |
| Total liabilities | 10954 | 11827 |
| **Contingencies, Commitments and Guarantees (Note 13)** | **Contingencies, Commitments and Guarantees (Note 13)** | **Contingencies, Commitments and Guarantees (Note 13)** |
| **Stockholder's Equity** | **Stockholder's Equity** | **Stockholder's Equity** |
| Common stock, par value $10 per share; 200,000 shares authorized, issued and outstanding | 2 | 2 |
| Additional paid-in capital | 591 | 491 |
| Retained earnings (deficit) | 417 | 523 |
| Accumulated other comprehensive income (loss) | (413) | 135 |
| Total stockholder's equity | 597 | 1151 |
| Total liabilities and stockholder's equity | $11551 | $12978 |

---

**See accompanying notes to the financial statements.**

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Statements of Operations<br>For the Years Ended December 31, 2022, 2021 and 2020**

**(In millions)**

---

| | | | |
|:---|:---|:---|:---|
| | **2022** | **2021** | **2020** |
| **Revenues** | **Revenues** | **Revenues** | **Revenues** |
| Premiums | $8 | $13 | $22 |
| Universal life and investment-type product policy fees | 90 | 105 | 93 |
| Net investment income | 188 | 157 | 134 |
| Other revenues | (81) | (96) | (83) |
| Net investment gains (losses) | (12) | (3) | 13 |
| Net derivative gains (losses) | (137) | (76) | 129 |
| Total revenues | 56 | 100 | 308 |
| **Expenses** | **Expenses** | **Expenses** | **Expenses** |
| Policyholder benefits and claims | 30 | (11) | 23 |
| Interest credited to policyholder account balances | 63 | 60 | 38 |
| Amortization of deferred policy acquisition costs | 26 | (2) | 38 |
| Other expenses | 81 | 77 | 77 |
| Total expenses | 200 | 124 | 176 |
| Income (loss) before provision for income tax | (144) | (24) | 132 |
| Provision for income tax expense (benefit) | (38) | (6) | 25 |
| Net income (loss) | $(106) | $(18) | $107 |

---

**See accompanying notes to the financial statements.**

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Statements of Comprehensive Income (Loss)<br>For the Years Ended December 31, 2022, 2021 and 2020**

**(In millions)**

---

| | | | |
|:---|:---|:---|:---|
| | **2022** | **2021** | **2020** |
| Net income (loss) | $(106) | $(18) | $107 |
| Other comprehensive income (loss): | Other comprehensive income (loss): | Other comprehensive income (loss): | Other comprehensive income (loss): |
| Unrealized investment gains (losses), net of related offsets | (706) | (161) | 177 |
| Unrealized gains (losses) on derivatives | 12 | 6 | (5) |
| Other comprehensive income (loss), before income tax | (694) | (155) | 172 |
| Income tax (expense) benefit related to items of other comprehensive income (loss) | 146 | 32 | (36) |
| Other comprehensive income (loss), net of income tax | (548) | (123) | 136 |
| Comprehensive income (loss) | $(654) | $(141) | $243 |

---

**See accompanying notes to the financial statements.**

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Statements of Stockholder's Equity<br>For the Years Ended December 31, 2022, 2021 and 2020**

**(In millions)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Common**<br> **Stock** | **Additional**<br> **Paid-in**<br> **Capital** | **Retained**<br> **Earnings**<br> **(Deficit)** | **Accumulated**<br> **Other**<br> **Comprehensive**<br> **Income (Loss)** | **Total**<br> **Stockholder's**<br> **Equity** |
| Balance at December 31, 2019 | $2 | $491 | $434 | $122 | $1049 |
| Net income (loss) |  |  | 107 |  | 107 |
| Other comprehensive income (loss), net of income tax |  |  |  | 136 | 136 |
| Balance at December 31, 2020 | 2 | 491 | 541 | 258 | 1292 |
| Net income (loss) |  |  | (18) |  | (18) |
| Other comprehensive income (loss), net of income tax |  |  |  | (123) | (123) |
| Balance at December 31, 2021 | 2 | 491 | 523 | 135 | 1151 |
| Capital contribution |  | 100 |  |  | 100 |
| Net income (loss) |  |  | (106) |  | (106) |
| Other comprehensive income (loss), net of income tax |  |  |  | (548) | (548) |
| Balance at December 31, 2022 | $2 | $591 | $417 | $(413) | $597 |

---

**See accompanying notes to the financial statements.**

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Statements of Cash Flows<br>For the Years Ended December 31, 2022, 2021 and 2020**

**(In millions)**

---

| | | | |
|:---|:---|:---|:---|
| | **2022** | **2021** | **2020** |
| **Cash flows from operating activities** | **Cash flows from operating activities** | **Cash flows from operating activities** | **Cash flows from operating activities** |
| Net income (loss) | $(106) | $(18) | $107 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |
| Amortization of premiums and accretion of discounts associated with investments, net |  | (2) | 1 |
| (Gains) losses on investments, net | 12 | 3 | (13) |
| (Gains) losses on derivatives, net | 130 | 37 | (124) |
| Interest credited to policyholder account balances | 63 | 60 | 38 |
| Universal life and investment-type product policy fees | (90) | (105) | (93) |
| Change in accrued investment income | 7 | (27) | (3) |
| Change in premiums, reinsurance and other receivables | 28 | (23) | (35) |
| Change in deferred policy acquisition costs | (29) | (60) | (4) |
| Change in income tax | (71) | (5) |  |
| Change in other assets | 87 | 98 | 90 |
| Change in future policy benefits and other policy-related balances | 47 | 6 | 68 |
| Change in other liabilities | (66) | 7 | (37) |
| Net cash provided by (used in) operating activities | 12 | (29) | (5) |
| **Cash flows from investing activities** | **Cash flows from investing activities** | **Cash flows from investing activities** | **Cash flows from investing activities** |
| Sales, maturities and repayments of: | Sales, maturities and repayments of: | Sales, maturities and repayments of: | Sales, maturities and repayments of: |
| Fixed maturity securities | 699 | 490 | 480 |
| Mortgage loans | 42 | 77 | 60 |
| Purchases of: | Purchases of: | Purchases of: | Purchases of: |
| Fixed maturity securities | (815) | (1499) | (1023) |
| Equity securities | (1) | (3) |  |
| Mortgage loans | (457) | (249) | (80) |
| Cash received in connection with freestanding derivatives | 110 | 466 | 313 |
| Cash paid in connection with freestanding derivatives | (437) | (119) | (231) |
| Net change in short-term investments | 13 | 58 | (20) |
| Net change in other invested assets |  |  | 1 |
| Net cash provided by (used in) investing activities | (846) | (779) | (500) |
| **Cash flows from financing activities** | **Cash flows from financing activities** | **Cash flows from financing activities** | **Cash flows from financing activities** |
| Policyholder account balances: | Policyholder account balances: | Policyholder account balances: | Policyholder account balances: |
| Deposits | 947 | 980 | 672 |
| Withdrawals | (182) | (106) | (100) |
| Net change in payables for collateral under derivative transactions | (137) | 194 | 52 |
| Short-term debt issued | 125 |  | 100 |
| Short-term debt repaid |  |  | (100) |
| Capital contribution | 100 |  |  |
| Financing element on certain derivative instruments and other derivative related transactions, net | 5 |  | 8 |
| Net cash provided by (used in) financing activities | 858 | 1068 | 632 |
| Change in cash, cash equivalents and restricted cash | 24 | 260 | 127 |
| Cash, cash equivalents and restricted cash, beginning of year | 535 | 275 | 148 |
| **Cash, cash equivalents and restricted cash, end of year** | $559 | $535 | $275 |
| **Supplemental disclosures of cash flow information** | **Supplemental disclosures of cash flow information** | **Supplemental disclosures of cash flow information** | **Supplemental disclosures of cash flow information** |
| Net cash paid (received) for: | Net cash paid (received) for: | Net cash paid (received) for: | Net cash paid (received) for: |
| Interest | $2 | $— | $1 |
| Income tax | $33 | $(5) | $25 |

---

**See accompanying notes to the financial statements.**

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements**

**1. Business, Basis of Presentation and Summary of Significant Accounting Policies**

***Business***

"BLNY" and the "Company" refer to Brighthouse Life Insurance Company of NY, a New York domiciled life insurance company. Brighthouse Life Insurance Company of NY is a wholly-owned subsidiary of Brighthouse Life Insurance Company, which is an indirect wholly-owned subsidiary of Brighthouse Financial, Inc. ("BHF" and together with its subsidiaries, "Brighthouse Financial"). The Company is licensed to transact business in the state of New York.

The Company markets or administers a range of annuity and life insurance products to individuals. The Company is organized into two segments: Annuities and Life. In addition, the Company reports certain of its results of operations in Corporate & Other.

***Basis of Presentation***

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company's business and operations. Actual results could differ from these estimates.

***Summary of Significant Accounting Policies***

***<u>Insurance</u>***

*<u>Future Policy Benefit Liabilities and Policyholder Account Balances</u>*

The Company establishes liabilities for future amounts payable under insurance policies. Insurance liabilities are generally equal to the present value of future expected benefits to be paid, reduced by the present value of future expected net premiums. Assumptions used to measure the liability are based on the Company's experience and include a margin for adverse deviation. The most significant assumptions used in the establishment of liabilities for future policy benefits are mortality, benefit election and utilization, withdrawals, policy lapse, and investment returns as appropriate to the respective product type.

For traditional long-duration insurance contracts (term life insurance and income annuities), assumptions are determined at issuance of the policy and are not updated unless a premium deficiency exists. A premium deficiency exists when the liability for future policy benefits plus the present value of expected future gross premiums are less than expected future benefits and expenses (based on current assumptions). When a premium deficiency exists, the Company will reduce any deferred acquisition costs and may also establish an additional liability to eliminate the deficiency. To assess whether a premium deficiency exists, the Company groups insurance contracts based on the manner acquired, serviced and measured for profitability. In applying the profitability criteria, groupings are limited by segment.

The Company is also required to reflect the effect of investment gains and losses in its premium deficiency testing. When a premium deficiency exists related to unrealized gains and losses, any reductions in deferred acquisition costs or increases in insurance liabilities are recorded to other comprehensive income (loss) ("OCI").

Policyholder account balances relate to customer deposits on deferred annuity contracts and are equal to the sum of deposits, plus interest credited, less charges and withdrawals. The Company may also hold additional liabilities for certain guaranteed benefits related to these contracts.

The Company issues directly, certain variable annuity products with guaranteed minimum benefits that provide the policyholder a minimum return based on their initial deposit (i.e., the benefit base) less withdrawals. These guarantees are accounted for as insurance liabilities or as embedded derivatives depending on how and when the benefit is paid. Specifically, a guarantee is accounted for as an embedded derivative if a guarantee is paid without requiring (i) the occurrence of specific insurable event, or (ii) the policyholder to annuitize. Alternatively, a guarantee is accounted for as an insurance liability if the guarantee is paid only upon either (i) the occurrence of a specific insurable event, or (ii) annuitization. In certain cases, a guarantee may have elements of both an insurance liability and an embedded derivative and in such cases the guarantee is split and accounted for under both models.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)**

Guarantees accounted for as insurance liabilities in future policy benefits include guaranteed minimum death benefits ("GMDB"), the portion of guaranteed minimum income benefits ("GMIB") that require annuitization, and the life contingent portion of guaranteed minimum withdrawal benefits ("GMWB").

Guarantees accounted for as embedded derivatives in policyholder account balances include the non-life contingent portion of GMWBs, guaranteed minimum accumulation benefits ("GMAB") and the portion of GMIBs that do not require annuitization. At inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent "excess" fees and are reported in universal life and investment-type product policy fees.

*<u>Recognition of Insurance Revenues and Deposits</u>*

Premiums related to traditional life insurance and annuity contracts are recognized as revenues when due from policyholders. When premiums for income annuities are due over a significantly shorter period than the period over which policyholder benefits are incurred, any excess profit is deferred and recognized into earnings in proportion to the amount of expected future benefit payments.

Deposits related to deferred annuities are credited to policyholder account balances. Revenues from such contracts consist of asset-based investment management fees, risk charges, policy administration fees and surrender charges. These fees, which are included in universal life and investment-type product policy fees, are recognized when assessed to the contract holder.

Premiums, policy fees, policyholder benefits and expenses are reported net of reinsurance.

***<u>Deferred Policy Acquisition Costs and Deferred Sales Inducements</u>***

The Company incurs significant costs in connection with acquiring new and renewal insurance business. Costs that are related directly to the successful acquisition or renewal of insurance contracts are capitalized as deferred policy acquisition costs ("DAC"). These costs mainly consist of commissions and include the portion of employees' compensation and benefits related to time spent selling, underwriting or processing the issuance of new insurance contracts. All other acquisition-related costs are expensed as incurred.

The Company amortizes DAC related to term life insurance over the appropriate premium paying period in proportion to the actual and expected future gross premiums that were set at contract issue. The expected premiums are based upon the premium requirement of each policy and assumptions for mortality, persistency and investment returns at policy issuance, include provisions for adverse deviation, and are consistent with the assumptions used to calculate future policy benefit liabilities. These assumptions are not revised after policy issuance or acquisition unless the DAC balance is deemed to be unrecoverable from future expected profits.

The Company amortizes DAC on deferred annuities over the estimated lives of the contracts in proportion to actual and expected future gross profits. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The amount of future gross profits is dependent principally upon investment returns in excess of the amounts credited to policyholders, mortality, in-force or persistency, benefit elections and utilization, and withdrawals. When significant negative gross profits are expected in future periods, the Company substitutes the amount of insurance in-force for expected future gross profits as the amortization basis for DAC.

Assumptions for DAC are reviewed at least annually, and if they change significantly, the cumulative DAC amortization is re-estimated and adjusted by a cumulative charge or credit to net income. When expected future gross profits are below those previously estimated, the DAC amortization will increase, resulting in a current period charge to net income. The opposite result occurs when the expected future gross profits are above the previously estimated expected future gross profits.

The Company updates expected future gross profits to reflect the actual gross profits for each period, including changes to its nonperformance risk related to embedded derivatives and the actual amount of business remaining in-force. When actual gross profits exceed those previously estimated, the DAC amortization will increase, resulting in a current period charge to net income. The opposite result occurs when the actual gross profits are below the previously expected future gross profits.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)**

DAC balances on deferred annuities are also adjusted to reflect the effect of investment gains and losses and certain embedded derivatives (including changes in nonperformance risk). These adjustments can create fluctuations in net income from period to period. Changes in DAC balances related to unrealized gains and losses are recorded to OCI.

DAC balances and amortization for variable annuities can be significantly impacted by changes in expected future gross profits related to projected separate account rates of return. The Company's practice of determining changes in separate account returns assumes that long-term appreciation in equity markets is only changed when sustained interim deviations are expected. The Company monitors these events and only changes the assumption when its long-term expectation changes.

Periodically, the Company modifies product benefits, features, rights or coverages that occur by the exchange of an existing contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage within a contract. If a modification is considered to have substantially changed the contract, the associated DAC is written off immediately as net income and any new acquisition costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed.

The Company also has intangible assets representing deferred sales inducements ("DSI") which are included in other assets. The Company defers sales inducements and amortizes them over the life of the policy using the same methodology and assumptions used to amortize DAC. The amortization of DSI is included in policyholder benefits and claims. Each year, or more frequently if circumstances indicate a possible impairment exists, the Company reviews DSI to determine whether the assets are impaired.

***<u>Reinsurance</u>***

The Company enters into reinsurance arrangements pursuant to which it cedes certain insurance risks to unaffiliated and related party reinsurers. Cessions under reinsurance agreements do not discharge the Company's obligations as the primary insurer. The accounting for reinsurance arrangements depends on whether the arrangement provides indemnification against loss or liability relating to insurance risk in accordance with GAAP.

For ceded reinsurance of existing in-force blocks of insurance contracts that transfer significant insurance risk, premiums, benefits and the amortization of DAC are reported net of reinsurance ceded. Amounts recoverable from reinsurers related to incurred claims and ceded reserves are included in premiums, reinsurance and other receivables and amounts payable to reinsurers included in other liabilities.

If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in other liabilities and deposits made are included in premiums, reinsurance and other receivables. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as other revenues or other expenses, as appropriate.

The funds withheld liability represents amounts withheld by the Company in accordance with the terms of the reinsurance agreements. Under certain reinsurance agreements, the Company withholds the funds rather than transferring the underlying investments and, as a result, records a funds withheld liability in other liabilities. The Company recognizes interest on funds withheld, included in other expenses, at rates defined by the terms of the agreement which may be contractually specified or directly related to the investment portfolio. Certain funds withheld arrangements may also contain embedded derivatives measured at fair value that are related to the investment return on the assets withheld.

The Company cedes the risk associated with the variable annuities with guaranteed minimum benefits to Brighthouse Life Insurance Company. Certain features of the ceded guarantees are accounted for as an embedded derivative and measured at fair value.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)**

***<u>Index-linked Annuities</u>***

The Company issues index-linked annuities. The crediting rate associated with index-linked annuities is accounted for at fair value as an embedded derivative. The estimated fair value is determined using a combination of an option pricing model and an option-budget approach. Under this approach, the Company estimates the cost of funding the crediting rate using option pricing and establishes that cost on the balance sheet as a reduction to the initial deposit amount. In subsequent periods, the embedded derivative is remeasured at fair value while the reduction in initial deposit is accreted back up to the initial deposit over the estimated life of the contract.

***<u>Investments</u>***

*<u>Net Investment Income and Net Investment Gains (Losses)</u>*

Income from investments is reported in net investment income, unless otherwise stated herein. Gains and losses on sales of investments, impairment losses and changes in valuation allowances are reported in net investment gains (losses), unless otherwise stated herein.

*<u>Fixed Maturity Securities Available-For-Sale</u>*

The Company's fixed maturity securities are classified as available-for-sale and are reported at their estimated fair value. Unrealized investment gains and losses on these securities are recorded as a separate component of OCI, net of policy-related amounts and deferred income taxes. Publicly-traded security transactions are recorded on a trade date basis, while privately-placed and bank loan security transactions are recorded on a settlement date basis. Investment gains and losses on sales are determined on a specific identification basis.

Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts and is based on the estimated economic life of the securities, which for residential mortgage-backed securities ("RMBS"), commercial mortgage-backed securities ("CMBS") and asset-backed securities ("ABS") (collectively, "Structured Securities") considers the estimated timing and amount of prepayments of the underlying loans. The amortization of premium and accretion of discount of fixed maturity securities also takes into consideration call and maturity dates.

Amortization of premium and accretion of discount on Structured Securities considers the estimated timing and amount of prepayments of the underlying loans. Actual prepayment experience is periodically reviewed, and effective yields are recalculated when differences arise between the originally anticipated and the actual prepayments received and currently anticipated. Prepayment assumptions for Structured Securities are estimated using inputs obtained from third-party specialists and based on management's knowledge of the current market. For credit-sensitive Structured Securities and certain prepayment-sensitive securities, the effective yield is recalculated on a prospective basis. For all other Structured Securities, the effective yield is recalculated on a retrospective basis.

The Company regularly evaluates fixed maturity securities for declines in fair value to determine if a credit loss exists. This evaluation is based on management's case by case evaluation of the underlying reasons for the decline in fair value including, but not limited to an analysis of the gross unrealized losses by severity and financial condition of the issuer.

For fixed maturity securities in an unrealized loss position, when the Company has the intent to sell the security, or it is more likely than not that the Company will be required to sell the security before recovery, the amortized cost basis of the security is written down to fair value through net investment gains (losses).

For fixed maturity securities that do not meet the aforementioned criteria, management evaluates whether the decline in estimated fair value has resulted from credit losses or other factors. If the Company determines the decline in estimated fair value is due to credit losses, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an allowance through net investment gains (losses). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of the allowance related to other-than-credit factors is recorded in OCI.

Once a security specific allowance for credit losses is established, the present value of cash flows expected to be collected from the security continues to be reassessed. Any changes in the security specific allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in net investment gains (losses).

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)**

Fixed maturity securities are also evaluated to determine whether any amounts have become uncollectible. When all, or a portion, of a security is deemed uncollectible, the uncollectible portion is written-off with an adjustment to amortized cost and a corresponding reduction to the allowance for credit losses.

*<u>Mortgage Loans</u>*

Mortgage loans are stated at unpaid principal balance, adjusted for any unamortized premium or discount, and any deferred fees or expenses, and net of an allowance for credit losses. Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts. The allowance for credit losses for mortgage loans represents the Company's best estimate of expected credit losses over the remaining life of the loans and is determined using relevant available information from internal and external sources, relating to past events, current conditions, and a reasonable and supportable forecast.

*<u>Limited Liability Companies</u>*

The Company uses the equity method of accounting for investments when it has more than a minor ownership interest or more than a minor influence over the investee's operations; when the Company has virtually no influence over the investee's operations the investment is carried at estimated fair value. The Company generally recognizes its share of the equity method investee's earnings on a three-month lag in instances where the investee's financial information is not sufficiently timely or when the investee's reporting period differs from the Company's reporting period; while distributions on investments carried at estimated fair value are recognized as earned or received.

*<u>Short-term Investments</u>*

Short-term investments include securities and other investments with remaining maturities of one year or less, but greater than three months, at the time of purchase and are stated at estimated fair value or amortized cost, which approximates estimated fair value. The Company's short-term investments generally involve large dollar amounts that turn over quickly and have short maturities. For the year ended December 31, 2022, gross cash receipts from sales and purchases of short-term investments were $14 million and $1 million, respectively.

*<u>Other Invested Assets</u>*

Other invested assets consist principally of freestanding derivatives with positive estimated fair values which are described in "— Derivatives" below.

***<u>Derivatives</u>***

*<u>Freestanding Derivatives</u>*

Freestanding derivatives are carried at estimated fair value on the Company's balance sheet either as assets in other invested assets or as liabilities in other liabilities. The Company does not offset the estimated fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement.

If a derivative is not designated or did not qualify as an accounting hedge, changes in the estimated fair value of the derivative are reported in net derivative gains (losses).

The Company generally reports cash received or paid for a derivative in the investing activity section of the statement of cash flows except for cash flows of certain derivative options with deferred premiums, which are reported in the financing activity section of the statement of cash flows.

*<u>Hedge Accounting</u>*

The Company primarily designates derivatives as a hedge of a forecasted transaction or a variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in fair value are recorded in OCI and subsequently reclassified into the statement of operations when the Company's earnings are affected by the variability in cash flows of the hedged item.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)**

To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument's effectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship.

The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative or hedged item expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument.

When hedge accounting is discontinued the derivative is carried at its estimated fair value on the balance sheet, with changes in its estimated fair value recognized in the current period as net derivative gains (losses). The changes in estimated fair value of derivatives previously recorded in OCI related to discontinued cash flow hedges are released into the statement of operations when the Company's earnings are affected by the variability in cash flows of the hedged item. When the hedged item matures or is sold, or the forecasted transaction is not probable of occurring, the Company immediately reclassifies any remaining balances in OCI to net derivative gains (losses).

*<u>Embedded Derivatives</u>*

The Company has certain insurance and reinsurance contracts that contain embedded derivatives which are required to be separated from their host contracts and reported as derivatives. These host contracts include: variable annuities with guaranteed minimum benefits; index-linked annuities that are directly written; and ceded reinsurance of variable annuity with guaranteed minimum benefits. Embedded derivatives within asset host contracts are reported in premiums, reinsurance and other receivables. Embedded derivatives within liability host contracts are reported in policyholder account balances. Changes in the estimated fair value of the embedded derivative are reported in net derivative gains (losses).

See "— Variable Annuity Guarantees," "— Index-Linked Annuities" and "— Reinsurance" for additional information on the accounting policies for embedded derivatives bifurcated from variable annuity and reinsurance host contracts.

***<u>Fair Value</u>***

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In most cases, the exit price and the transaction (or entry) price will be the same at initial recognition.

In determining the estimated fair value of the Company's investments, fair values are based on unadjusted quoted prices for identical investments in active markets that are readily and regularly obtainable. When such quoted prices are not available, fair values are based on quoted prices in markets that are not active, quoted prices for similar but not identical investments, or other observable inputs. If these inputs are not available, or observable inputs are not determinable, unobservable inputs and/or adjustments to observable inputs requiring management judgment are used to determine the estimated fair value of investments.

***<u>Separate Accounts</u>***

Separate accounts underlying the Company's variable life and annuity contracts are reported at fair value. Assets in separate accounts supporting the contract liabilities are legally insulated from the Company's general account liabilities. Investments in these separate accounts are directed by the contract holder and all investment performance, net of contract fees and assessments, is passed through to the contract holder. Investment performance and the corresponding amounts credited to contract holders of such separate accounts are offset in the same line on the statements of operations.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)**

Separate accounts that do not pass all investment performance to the contract holder, including those underlying certain index-linked annuities, are combined on a line-by-line basis with the Company's general account assets, liabilities, revenues and expenses. The accounting for investments in these separate accounts is consistent with the methodologies described herein for similar financial instruments held in the general account.

The Company receives asset-based distribution and service fees from mutual funds available to the annuity contract holders as investment options in its separate accounts. These fees are recognized in the period in which the related services are performed and are included in other revenues.

***<u>Income Tax</u>***

The Company's income tax provision was prepared following the modified separate return method. The modified separate return method applies the Accounting Standards Codification 740 — Income Taxes ("ASC 740") to the standalone financial statements of each member of the consolidated group as if the member were a separate taxpayer and a standalone enterprise, after providing benefits for losses. The Company's accounting for income taxes represents management's best estimate of various events and transactions. Current and deferred income taxes included herein and attributable to periods up until the Company's separation from MetLife, Inc. ("Separation") have been allocated to the Company in a manner that is systematic, rational and consistent with the asset and liability method prescribed by ASC 740.

Deferred tax assets and liabilities resulting from temporary differences between the financial reporting and tax bases of assets and liabilities are measured at the balance sheet date using enacted tax rates expected to apply to taxable income in the years the temporary differences are expected to reverse.

The realization of deferred tax assets depends upon the existence of sufficient taxable income within the carryback or carryforward periods under the tax law in the applicable tax jurisdiction. Valuation allowances are established when management determines, based on available information, that it is more likely than not that deferred income tax assets will not be realized. Significant judgment is required in determining whether valuation allowances should be established, as well as the amount of such allowances. When making such determination, the Company considers many factors, including the jurisdiction in which the deferred tax asset was generated, the length of time that carryforward can be utilized in the various taxing jurisdictions, future taxable income exclusive of reversing temporary differences and carryforwards, future reversals of existing taxable temporary differences, taxable income in prior carryback years, tax planning strategies and the nature, frequency, and amount of cumulative financial reporting income and losses in recent years.

On August 16, 2022, the Inflation Reduction Act was signed into law by President Biden. The Inflation Reduction Act establishes a 15% corporate alternative minimum tax ("CAMT") for corporations whose average annual adjusted financial statement income for any consecutive three-tax year period ending after December 31, 2021, and preceding the tax year exceeds $1 billion. The provision is effective for tax years beginning after December 31, 2022. The Company elects not to consider any future effects resulting from potential applicability of the CAMT when assessing the valuation allowance for regular deferred taxes.

The Company may be required to change its provision for income taxes when estimates used in determining valuation allowances on deferred tax assets significantly change or when receipt of new information indicates the need for adjustment in valuation allowances. Additionally, the effect of changes in tax laws, tax regulations, or interpretations of such laws or regulations, is recognized in net income tax expense (benefit) in the period of change.

The Company determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded on the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likely of being realized upon settlement. Unrecognized tax benefits due to tax uncertainties that do not meet the threshold are included in other liabilities and are charged to earnings in the period that such determination is made.

The Company classifies interest recognized as interest expense and penalties recognized as a component of income tax expense.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)**

***<u>Litigation and Other Loss Contingencies</u>***

The Company may be a party to or involved in legal disputes, including litigation matters and disputes or other matters involving third parties (e.g., vendors, reinsurers or tax or other authorities), and are subject in the ordinary course to a number of regulatory examinations and investigations. The Company reviews relevant information with respect to litigation and other loss contingencies related to these matters and establishes liabilities when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Legal costs are recognized as incurred.

In matters where it is not probable, but it is reasonably possible that a loss will be incurred and the amount of loss can be reasonably estimated, such losses or range of losses are disclosed, and no accrual is made. In the absence of sufficient information to support an assessment of a reasonably possible loss or range of loss, no accrual is made and no loss or range of loss is disclosed.

***<u>Other Accounting Policies</u>***

*<u>Cash and Cash Equivalents</u>*

The Company considers all highly liquid securities and other investments purchased with an original or remaining maturity of three months or less at the date of purchase to be cash equivalents. Cash equivalents are stated at estimated fair value or amortized cost, which approximates estimated fair value.

*<u>Employee Benefit Plans</u>*

Brighthouse Services, LLC ("ServiceCo"), an affiliate, sponsors qualified and non-qualified defined contribution plans, and New England Life Insurance Company, an affiliate, sponsors certain frozen defined benefit pension and postretirement plans. Within its statement of operations, the Company has included expenses associated with its participants in these plans.

***Adoption of New Accounting Pronouncements***

Changes to GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of accounting standards updates ("ASU") to the FASB Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. There were no significant ASUs adopted as of December 31, 2022.

***Future Adoption of New Accounting Pronouncements***

In August 2018, the FASB issued new guidance on long-duration contracts (ASU 2018-12, Financial Services-Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts ("LDTI")). LDTI is effective for fiscal years beginning after January 1, 2023. LDTI will result in significant changes to the measurement, presentation and disclosure requirements for long-duration insurance contracts. A summary of the most significant changes is provided below:

(1) Guaranteed benefits associated with variable annuity and certain fixed annuity contracts will be classified and reported separately on the balance sheets as market risk benefits ("MRB"). MRBs will be measured at fair value through net income and reported separately on the statements of operations, except for instrument-specific credit risk changes, which will be recognized in OCI.

(2) Cash flow assumptions used to measure the liability for future policy benefits on traditional long-duration contracts (including term life insurance and immediate annuities) will be updated on an annual basis using a retrospective method. The resulting remeasurement gain or loss will be reported separately on the statements of operations along with the remeasurement gain or loss on universal life-type contract liabilities.

(3) The discount rate assumption used to measure the liability for traditional long-duration contracts will be based on an upper-medium grade fixed income yield, updated quarterly, with changes recognized in OCI.

(4) DAC for all insurance products are required to be amortized on a constant-level basis over the expected term of the contracts, using amortization methods that are not a function of revenue or profit emergence. Changes in assumptions used to amortize DAC will be recognized as a revision to future amortization amounts.

(5) There will be a significant increase in required disclosures, including disaggregated roll-forwards of insurance contract assets and liabilities supplemented by qualitative and quantitative information regarding the cash flows, assumptions, methods and judgements used to measure those balances.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)**

LDTI will be applied to the earliest period reported in the financial statements, making the transition date January 1, 2021. The MRB changes are required to be applied on a retrospective basis, while the changes for insurance liability assumption updates and DAC amortization will be applied to existing carrying amounts on the transition date.

LDTI will have a significant impact on the Company's financial statements. The most significant impact will be the requirement that all variable annuity guarantees be considered MRBs and measured at fair value, because a significant amount of variable annuity guarantees are classified as insurance liabilities under current GAAP. The impacts to the financial statements are highly dependent on market conditions, especially interest rates.

The Company estimates the impact of LDTI adoption to total stockholder's equity as of December 31, 2021 to be a reduction of less than $200 million. The changes from the adoption of LDTI are primarily driven by the MRB changes and to a lesser extent the requirement to update the discount rate quarterly in the measurement of the liability for traditional long-duration contracts. Based on prevailing interest rates at December 31, 2022, the Company expects the impact of LDTI to total stockholder's equity as of December 31, 2022 to be significantly lower as compared to such impact as of December 31, 2021.

The Company has made significant progress toward adopting the new guidance, including updating systems, validating computations, establishing proper controls, finalizing accounting policies and preparing financial disclosures. Implementation remains in process as of December 31, 2022 as the Company continues to refine its internal controls and processes in advance of formal implementation in 2023.

**2. Segment Information**

The Company is organized into two segments: Annuities and Life. In addition, the Company reports certain of its results of operations in Corporate & Other.

***Annuities***

The Annuities segment consists of a variety of variable, fixed, index-linked and income annuities designed to address contract holders' needs for protected wealth accumulation on a tax-deferred basis, wealth transfer and income security.

***Life***

The Life segment consists of insurance products and services, mainly term life insurance, designed to address policyholders' needs for financial security and protected wealth transfer, which may be on a tax-advantaged basis.

***Corporate & Other***

Corporate & Other contains the excess capital not allocated to the segments and expenses associated with certain legal proceedings and income tax audit issues.

***Financial Measures and Segment Accounting Policies***

Adjusted earnings is a financial measure used by management to evaluate performance and facilitate comparisons to industry results. Consistent with GAAP guidance for segment reporting, adjusted earnings is also used to measure segment performance. The Company believes the presentation of adjusted earnings, as the Company measures it for management purposes, enhances the understanding of its performance by contract holders by highlighting the results of operations and the underlying profitability drivers of the business.

Adjusted earnings, which may be positive or negative, focuses on the Company's primary businesses by excluding the impact of market volatility, which could distort trends.

The following are significant items excluded from total revenues in calculating adjusted earnings:

• Net investment gains (losses);

• Net derivative gains (losses) except earned income and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment; and

• Certain variable annuity GMIB fees ("GMIB Fees").

The following are significant items excluded from total expenses in calculating adjusted earnings:

• Amounts associated with benefits related to GMIBs ("GMIB Costs");

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**2. Segment Information (continued)**

• Amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets; and

• Amortization of DAC related to (i) net investment gains (losses), (ii) net derivative gains (losses) and (iii) GMIB Fees and GMIB Costs.

The tax impact of the adjustments discussed above is calculated net of the statutory tax rate, which could differ from the Company's effective tax rate.

The segment accounting policies are the same as those used to prepare the Company's financial statements, except for the adjustments to calculate adjusted earnings described above. In addition, segment accounting policies include the methods of capital allocation described below.

Segment investment and capitalization targets are based on statutory oriented risk principles and metrics. Segment invested assets backing liabilities are based on net statutory liabilities plus excess capital. For the variable annuity business, the excess capital held is based on the target statutory total asset requirement consistent with the Company's variable annuity risk management strategy. For insurance businesses other than variable annuities, excess capital held is based on a percentage of required statutory risk-based capital ("RBC"). Assets in excess of those allocated to the segments, if any, are held in Corporate & Other. Segment net investment income reflects the performance of each segment's respective invested assets.

Operating results by segment, as well as Corporate & Other, were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Year Ended December 31, 2022** | **Year Ended December 31, 2022** | **Year Ended December 31, 2022** | **Year Ended December 31, 2022** |
| | **Annuities** | **Life** | **Corporate** <br> **& Other** | **Total** |
| | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** |
| Pre-tax adjusted earnings | $14 | $7 | $(2) | $19 |
| Provision for income tax expense (benefit) | 1 | 1 | (6) | (4) |
| Adjusted earnings | $13 | $6 | $4 | 23 |
| Adjustments for: | Adjustments for: | Adjustments for: | Adjustments for: | Adjustments for: |
| Net investment gains (losses) |  |  |  | (12) |
| Net derivative gains (losses) |  |  |  | (137) |
| Other adjustments to net income (loss) |  |  |  | (14) |
| Provision for income tax (expense) benefit |  |  |  | 34 |
| Net income (loss) |  |  |  | $(106) |
| Interest revenue | $153 | $33 | $2 |  |
| Interest expense | $— | $— | $3 |  |

---

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**2. Segment Information (continued)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Year Ended December 31, 2021** | **Year Ended December 31, 2021** | **Year Ended December 31, 2021** | **Year Ended December 31, 2021** |
| | **Annuities** | **Life** | **Corporate** <br> **& Other** | **Total** |
| | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** |
| Pre-tax adjusted earnings | $(22) | $16 | $4 | $(2) |
| Provision for income tax expense (benefit) | (6) | 4 | 1 | (1) |
| Adjusted earnings | $(16) | $12 | $3 | (1) |
| Adjustments for: | Adjustments for: | Adjustments for: | Adjustments for: | Adjustments for: |
| Net investment gains (losses) |  |  |  | (3) |
| Net derivative gains (losses) |  |  |  | (76) |
| Other adjustments to net income (loss) |  |  |  | 57 |
| Provision for income tax (expense) benefit |  |  |  | 5 |
| Net income (loss) |  |  |  | $(18) |
| Interest revenue | $121 | $35 | $1 |  |
|  | **Year Ended December 31, 2020** | **Year Ended December 31, 2020** | **Year Ended December 31, 2020** | **Year Ended December 31, 2020** |
|  | **Annuities** | **Life** | **Corporate** <br> **& Other** | **Total** |
|  | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** |
| Pre-tax adjusted earnings | $(11) | $33 | $(6) | $16 |
| Provision for income tax expense (benefit) | (4) | 7 | (2) | 1 |
| Adjusted earnings | $(7) | $26 | $(4) | 15 |
| Adjustments for: | Adjustments for: | Adjustments for: | Adjustments for: | Adjustments for: |
| Net investment gains (losses) |  |  |  | 13 |
| Net derivative gains (losses) |  |  |  | 129 |
| Other adjustments to net income (loss) |  |  |  | (26) |
| Provision for income tax (expense) benefit |  |  |  | (24) |
| Net income (loss) |  |  |  | $107 |
| Interest revenue | $97 | $36 | $1 |  |

---

Total revenues by segment, as well as Corporate & Other, were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| | **(In millions)** | **(In millions)** | **(In millions)** |
| Annuities | $156 | $125 | $104 |
| Life | 34 | 39 | 48 |
| Corporate & Other | 2 | 2 | 2 |
| Adjustments | (136) | (66) | 154 |
| Total | $56 | $100 | $308 |

---

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**2. Segment Information (continued)**

Total assets by segment, as well as Corporate & Other, were as follows at:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| | **2022** | **2021** |
| | **(In millions)** | **(In millions)** |
| Annuities | $9165 | $10745 |
| Life | 1767 | 1863 |
| Corporate & Other | 619 | 370 |
| Total | $11551 | $12978 |

---

Total premiums, universal life and investment-type product policy fees and other revenues by major product group were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| | **(In millions)** | **(In millions)** | **(In millions)** |
| Annuity products | $16 | $16 | $20 |
| Life insurance products | 1 | 6 | 12 |
| Total | $17 | $22 | $32 |

---

All of the Company's premiums, universal life and investment-type product policy fees and other revenues originated in the U.S.

Revenues derived from any individual customer did not exceed 10% of premiums, universal life and investment-type product policy fees and other revenues for the years ended December 31, 2022, 2021 and 2020.

**3. Insurance**

***Insurance Liabilities***

Insurance liabilities are comprised of future policy benefits, policyholder account balances and other policy-related balances included on the balance sheets.

***Assumptions for Future Policyholder Benefits and Policyholder Account Balances***

For term life insurance, assumptions for mortality and persistency are based upon the Company's experience. Interest rate assumptions for the aggregate future policy benefit liabilities range from 3% to 5%. The liability for single premium immediate annuities is based on the present value of expected future payments using the Company's experience for mortality assumptions, with interest rate assumptions used in establishing such liabilities ranging from 1% to 8%.

Policyholder account balances liabilities for deferred annuities have interest credited rates ranging from 1% to 6%.

***Guarantees***

The Company issues variable annuity contracts with guaranteed minimum benefits. GMDBs, the life contingent portion of GMWBs and certain portions of GMIBs are accounted for as insurance liabilities in future policyholder benefits, while other guarantees are accounted for in whole or in part as embedded derivatives in policyholder account balances and are further discussed in Note 7. The most significant assumptions for variable annuity guarantees included in future policyholder benefits are projected general account and separate account investment returns, and policyholder behavior including mortality, benefit election and utilization, and withdrawals.

See Note 1 for more information on guarantees accounted for as insurance liabilities.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**3. Insurance (continued)**

Information regarding the liabilities for guarantees (excluding policyholder account balances and embedded derivatives) relating to variable annuity contracts was as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Variable Annuity Contracts** | **Variable Annuity Contracts** | |
| | **GMDBs** | **GMIBs** |<br>**Total** |
| | **(In millions)** | **(In millions)** | **(In millions)** |
| **Direct** | **Direct** | **Direct** | **Direct** |
| Balance at January 1, 2020 | $14 | $202 | $216 |
| Incurred guaranteed benefits | (1) | 64 | 63 |
| Paid guaranteed benefits | (1) |  | (1) |
| Balance at December 31, 2020 | 12 | 266 | 278 |
| Incurred guaranteed benefits | 6 | (8) | (2) |
| Paid guaranteed benefits |  |  |  |
| Balance at December 31, 2021 | 18 | 258 | 276 |
| Incurred guaranteed benefits | 7 | 37 | 44 |
| Paid guaranteed benefits | 1 |  | 1 |
| Balance at December 31, 2022 | $26 | $295 | $321 |
| **Ceded** | **Ceded** | **Ceded** | **Ceded** |
| Balance at January 1, 2020 | $12 | $74 | $86 |
| Incurred guaranteed benefits |  | 34 | 34 |
| Paid guaranteed benefits | (1) |  | (1) |
| Balance at December 31, 2020 | 11 | 108 | 119 |
| Incurred guaranteed benefits | 5 | (2) | 3 |
| Paid guaranteed benefits |  |  |  |
| Balance at December 31, 2021 | 16 | 106 | 122 |
| Incurred guaranteed benefits | 10 | 14 | 24 |
| Paid guaranteed benefits | (2) | 1 | (1) |
| Balance at December 31, 2022 | $24 | $121 | $145 |
| **Net** | **Net** | **Net** | **Net** |
| Balance at January 1, 2020 | $2 | $128 | $130 |
| Incurred guaranteed benefits | (1) | 30 | 29 |
| Paid guaranteed benefits |  |  |  |
| Balance at December 31, 2020 | 1 | 158 | 159 |
| Incurred guaranteed benefits | 1 | (6) | (5) |
| Paid guaranteed benefits |  |  |  |
| Balance at December 31, 2021 | 2 | 152 | 154 |
| Incurred guaranteed benefits | (3) | 23 | 20 |
| Paid guaranteed benefits | 3 | (1) | 2 |
| Balance at December 31, 2022 | $2 | $174 | $176 |

---

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**3. Insurance (continued)**

Information regarding the Company's guarantee exposure was as follows at:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| | **2022** | **2022** | **2022** | **2022** | **2021** | **2021** | **2021** | **2021** |
| | **In the** <br> **Event of Death** | **In the** <br> **Event of Death** | **At**<br> **Annuitization** | **At**<br> **Annuitization** | **In the** <br> **Event of Death** | **In the** <br> **Event of Death** | **At**<br> **Annuitization** | **At**<br> **Annuitization** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| ***Annuity Contracts (1), (2)*** | ***Annuity Contracts (1), (2)*** | ***Annuity Contracts (1), (2)*** | ***Annuity Contracts (1), (2)*** | ***Annuity Contracts (1), (2)*** | ***Annuity Contracts (1), (2)*** | ***Annuity Contracts (1), (2)*** | ***Annuity Contracts (1), (2)*** | ***Annuity Contracts (1), (2)*** |
| **Variable Annuity Guarantees** | **Variable Annuity Guarantees** | **Variable Annuity Guarantees** | **Variable Annuity Guarantees** | **Variable Annuity Guarantees** | **Variable Annuity Guarantees** | **Variable Annuity Guarantees** | **Variable Annuity Guarantees** | **Variable Annuity Guarantees** |
| Total account value (3) | $3924 |  | $2814 |  | $5154 |  | $3799 |  |
| Separate account value | $3919 |  | $2814 |  | $5146 |  | $3796 |  |
| Net amount at risk | $396 | (4) | $271 | (5) | $4 | (4) | $319 | (5) |
| Average attained age of contract holders | 70 years |  | 70 years |  | 70 years |  | 69 years |  |

---

(1) The Company's annuity contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive.

(2) Includes direct business, but excludes offsets from hedging or reinsurance, if any. Therefore, the net amount at risk reported reflects the economic exposures of living and death benefit guarantees associated with variable annuities, but not necessarily their impact on the Company. See Note 5 for a discussion of guaranteed minimum benefits which have been reinsured.

(3) Includes the contract holder's investments in the general account and separate account, if applicable.

(4) Defined as the death benefit less the total account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death.

(5) Defined as the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company's potential economic exposure to such guarantees in the event all contract holders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contract holders have achieved.

Account balances of contracts with guarantees were invested in separate account asset classes as follows at:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| | **2022** | **2021** |
| | **(In millions)** | **(In millions)** |
| Fund Groupings: | Fund Groupings: | Fund Groupings: |
| Balanced | $2330 | $3095 |
| Equity | 1118 | 1471 |
| Bond | 474 | 583 |
| Total | $3922 | $5149 |

---

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**4. Deferred Policy Acquisition Costs and Deferred Sales Inducements**

See Note 1 for a description of capitalized acquisition costs.

Information regarding DAC was as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| | **(In millions)** | **(In millions)** | **(In millions)** |
| **DAC:** | **DAC:** | **DAC:** | **DAC:** |
| Balance at January 1, | $224 | $160 | $175 |
| Capitalizations | 55 | 58 | 42 |
| Amortization related to net investment gains (losses) and net derivative gains (losses) | 3 | 34 | 18 |
| All other amortization | (29) | (32) | (56) |
| Total amortization | (26) | 2 | (38) |
| Unrealized investment gains (losses) | 72 | 4 | (19) |
| Balance at December 31, | $325 | $224 | $160 |

---

Information regarding DSI was as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| | **(In millions)** | **(In millions)** | **(In millions)** |
| **DSI:** | **DSI:** | **DSI:** | **DSI:** |
| Balance at January 1, | $18 | $18 | $25 |
| Amortization | (2) |  | (7) |
| Balance at December 31, | $16 | $18 | $18 |

---

**5. Reinsurance**

The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products. The Company participates in reinsurance activities in order to limit losses, minimize exposure to significant risks and provide additional capacity for future growth.

Accounting for reinsurance requires extensive use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company periodically reviews actual and anticipated experience compared to the aforementioned assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance and evaluates the financial strength of counterparties to its reinsurance agreements using criteria similar to that evaluated in the security impairment process discussed in Note 6.

***Annuities***

For annuities, the Company currently reinsures to its parent, Brighthouse Life Insurance Company, 100% of certain variable annuity risks or 100% of the living and death benefit guarantees issued in connection with variable annuities. Under the benefit guarantee reinsurance agreements, the Company pays a reinsurance premium generally based on fees associated with the guarantees collected from policyholders and receives reimbursement for benefits paid or accrued in excess of account values, subject to certain limitations.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**5. Reinsurance (continued)**

***Life***

For its individual life insurance products, the Company has historically reinsured the mortality risk primarily on an excess of retention basis or on a quota share basis. The Company currently retains up to $100,000 per life and reinsures 100% of amounts in excess of the amount the Company retains. In addition to reinsuring mortality risk as described above, the Company reinsures other risks, as well as specific coverages. Placement of reinsurance is done primarily on an automatic basis and also on a facultative basis for risks with specified characteristics. The Company evaluates its reinsurance programs routinely and may increase or decrease its retention at any time.

***Catastrophe Coverage***

The Company has exposure to catastrophes which could contribute to significant fluctuations in the Company's results of operations. The Company uses excess of retention and quota share reinsurance agreements to provide greater diversification of risk and minimize exposure to larger risks.

***Reinsurance Recoverables***

The Company reinsures its business through a diversified group of primarily highly rated reinsurers. The Company analyzes recent trends in arbitration and litigation outcomes in disputes, if any, with its reinsurers and monitors ratings and the financial strength of its reinsurers. In addition, the reinsurance recoverable balance due from each reinsurer and the recoverability of such balance is evaluated as part of this overall monitoring process.

The Company generally secures large reinsurance recoverable balances with various forms of collateral, including secured trusts, funds withheld accounts, and irrevocable letters of credit. These reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance, which at both December 31, 2022 and 2021, were not significant. The Company had $20 million and $19 million of unsecured reinsurance recoverable balances with third-party reinsurers at December 31, 2022 and 2021, respectively.

At December 31, 2022, the Company had $449 million of net ceded reinsurance recoverables with third-party reinsurers. Of this total, $446 million, or 99%, were with the Company's five largest ceded reinsurers, including $17 million of net ceded reinsurance recoverables which were unsecured. At December 31, 2021, the Company had $454 million of net ceded reinsurance recoverables with third-party reinsurers. Of this total, $451 million, or 99%, were with the Company's five largest ceded reinsurers, including $16 million of net ceded reinsurance recoverables which were unsecured.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**5. Reinsurance (continued)**

The amounts on the statements of operations include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| | **(In millions)** | **(In millions)** | **(In millions)** |
| **Premiums** | **Premiums** | **Premiums** | **Premiums** |
| Direct premiums | $71 | $75 | $82 |
| Reinsurance ceded | (63) | (62) | (60) |
| Net premiums | $8 | $13 | $22 |
| **Universal life and investment-type product policy fees** | **Universal life and investment-type product policy fees** | **Universal life and investment-type product policy fees** | **Universal life and investment-type product policy fees** |
| Direct universal life and investment-type product policy fees | $94 | $109 | $97 |
| Reinsurance ceded | (4) | (4) | (4) |
| Net universal life and investment-type product policy fees | $90 | $105 | $93 |
| **Other revenues** | **Other revenues** | **Other revenues** | **Other revenues** |
| Direct other revenues | $12 | $16 | $13 |
| Reinsurance ceded | (93) | (112) | (96) |
| Net other revenues | $(81) | $(96) | $(83) |
| **Policyholder benefits and claims** | **Policyholder benefits and claims** | **Policyholder benefits and claims** | **Policyholder benefits and claims** |
| Direct policyholder benefits and claims | $129 | $71 | $149 |
| Reinsurance ceded | (99) | (82) | (126) |
| Net policyholder benefits and claims | $30 | $(11) | $23 |
| **Other expenses** | **Other expenses** | **Other expenses** | **Other expenses** |
| Direct other expenses | $83 | $80 | $80 |
| Reinsurance ceded | (2) | (3) | (3) |
| Net other expenses | $81 | $77 | $77 |

---

The amounts on the balance sheets include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows at:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| | **2022** | **2022** | **2022** | **2021** | **2021** | **2021** |
| | **Direct** | **Ceded** | **Total**<br> **Balance**<br> **Sheet** | **Direct** | **Ceded** | **Total**<br> **Balance**<br> **Sheet** |
| | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** |
| **Assets** | **Assets** | **Assets** | **Assets** | **Assets** | **Assets** | **Assets** |
| Premiums, reinsurance and other receivables | $18 | $978 | $996 | $22 | $1100 | $1122 |
| **Liabilities** | **Liabilities** | **Liabilities** | **Liabilities** | **Liabilities** | **Liabilities** | **Liabilities** |
| Other liabilities | $239 | $682 | $921 | $197 | $790 | $987 |

---

Reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss from insurance risk are recorded using the deposit method of accounting. The deposit assets on reinsurance were $438 million and $445 million at December 31, 2022 and 2021, respectively. There were no deposit liabilities on reinsurance at both December 31, 2022 and 2021.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**5. Reinsurance (continued)**

***Related Party Reinsurance Transactions***

Information regarding the significant effects of ceded related party reinsurance included on the statements of operations was as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| | **(In millions)** | **(In millions)** | **(In millions)** |
| Premiums | $(47) | $(45) | $(43) |
| Universal life and investment-type product policy fees | $(3) | $(3) | $(4) |
| Other revenues | $(93) | $(112) | $(96) |
| Policyholder benefits and claims | $(90) | $(76) | $(120) |
| Other expenses | $(7) | $(8) | $(7) |

---

Information regarding the significant effects of ceded related party reinsurance included on the balance sheets was as follows at:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| | **2022** | **2021** |
| | **(In millions)** | **(In millions)** |
| **Assets** | **Assets** | **Assets** |
| Premiums, reinsurance and other receivables | $523 | $637 |
| **Liabilities** | **Liabilities** | **Liabilities** |
| Other liabilities | $248 | $347 |

---

The Company cedes risks to Brighthouse Life Insurance Company related to guaranteed minimum benefit guarantees written directly by the Company. These ceded reinsurance agreements contain embedded derivatives and changes in their estimated fair value are included within net derivative gains (losses). The embedded derivatives associated with the cessions are included within premiums, reinsurance and other receivables and were $255 million and $351 million at December 31, 2022 and 2021, respectively. Net derivative gains (losses) associated with the embedded derivatives were ($98) million, ($128) million and $138 million for the years ended December 31, 2022, 2021 and 2020, respectively.

The Company has secured certain reinsurance recoverable balances with various forms of collateral, including secured trusts. The Company had no unsecured related party reinsurance recoverable balances at both December 31, 2022 and 2021.

Related party reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss from insurance risk are recorded using the deposit method of accounting. The deposit assets on related party reinsurance were $3 million at both December 31, 2022 and 2021. There were no deposit liabilities on related party reinsurance at both December 31, 2022 and 2021.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**6. Investments**

See Notes 1 and 8 for a description of the Company's accounting policies for investments and the fair value hierarchy for investments and the related valuation methodologies.

***Fixed Maturity Securities Available-for-sale***

***<u>Fixed Maturity Securities by Sector</u>***

Fixed maturity securities by sector were as follows at:

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2022** | **December 31, 2022** | **December 31, 2022** | **December 31, 2022** | **December 31, 2022** | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** |
| | | | **Gross Unrealized** | **Gross Unrealized** | | | | **Gross Unrealized** | **Gross Unrealized** | |
| | **Amortized**<br>**Cost** | **Allowance**<br> **for Credit**<br>**Losses** | **Gains** | **Losses** | **Estimated**<br> **Fair**<br>**Value** | **Amortized**<br>**Cost** | **Allowance**<br> **for Credit**<br>**Losses** | **Gains** | **Losses** | **Estimated**<br> **Fair**<br>**Value** |
| | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** |
| U.S. corporate | $2349 | $— | $2 | $321 | $2030 | $2315 | $— | $143 | $15 | $2443 |
| Foreign corporate | 779 |  | 1 | 109 | 671 | 669 |  | 31 | 7 | 693 |
| CMBS | 358 |  |  | 41 | 317 | 333 |  | 18 | 2 | 349 |
| ABS | 295 |  |  | 14 | 281 | 312 |  | 1 |  | 313 |
| RMBS | 304 |  | 2 | 31 | 275 | 270 |  | 11 | 2 | 279 |
| State and political subdivision | 298 |  | 1 | 54 | 245 | 290 |  | 15 | 2 | 303 |
| U.S. government and agency | 205 |  |  | 13 | 192 | 252 |  | 40 |  | 292 |
| Foreign government | 17 |  |  | 3 | 14 | 23 |  | 2 |  | 25 |
| Total fixed maturity securities | $4605 | $— | $6 | $586 | $4025 | $4464 | $— | $261 | $28 | $4697 |

---

The Company did not hold any non-income producing fixed maturity securities at December 31, 2022 or December 31, 2021.

***<u>Maturities of Fixed Maturity Securities</u>***

The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at December 31, 2022:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Due in One**<br> **Year or Less** | **Due After One**<br> **Year Through**<br> **Five Years** | **Due After Five**<br> **Years**<br> **Through Ten**<br> **Years** | **Due After Ten**<br> **Years** | **Structured**<br> **Securities** | **Total Fixed**<br> **Maturity**<br> **Securities** |
| | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** |
| Amortized cost | $72 | $1022 | $1411 | $1143 | $957 | $4605 |
| Estimated fair value | $71 | $951 | $1220 | $910 | $873 | $4025 |

---

Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. Structured Securities are shown separately, as they are not due at a single maturity.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**6. Investments (continued)**

***<u>Continuous Gross Unrealized Losses for Fixed Maturity Securities by Sector</u>***

The estimated fair value and gross unrealized losses of fixed maturity securities in an unrealized loss position, by sector and by length of time that the securities have been in a continuous unrealized loss position, were as follows at:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2022** | **December 31, 2022** | **December 31, 2022** | **December 31, 2022** | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** |
| | **Less than 12 Months** | **Less than 12 Months** | **12 Months or Greater** | **12 Months or Greater** | **Less than 12 Months** | **Less than 12 Months** | **12 Months or Greater** | **12 Months or Greater** |
| | **Estimated**<br> **Fair**<br> **Value** | **Gross**<br> **Unrealized**<br> **Losses** | **Estimated**<br> **Fair**<br> **Value** | **Gross**<br> **Unrealized**<br> **Losses** | **Estimated**<br> **Fair**<br> **Value** | **Gross**<br> **Unrealized**<br> **Losses** | **Estimated**<br> **Fair**<br> **Value** | **Gross**<br> **Unrealized**<br> **Losses** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| U.S. corporate | $1605 | $217 | $362 | $104 | $583 | $13 | $21 | $2 |
| Foreign corporate | 500 | 64 | 160 | 45 | 193 | 5 | 11 | 2 |
| CMBS | 254 | 26 | 63 | 15 | 72 | 2 | 10 |  |
| ABS | 164 | 8 | 107 | 6 | 138 |  | 2 |  |
| RMBS | 165 | 16 | 79 | 15 | 114 | 2 |  |  |
| State and political subdivision | 139 | 33 | 85 | 21 | 107 | 2 |  |  |
| U.S. government and agency | 178 | 13 |  |  |  |  |  |  |
| Foreign government | 13 | 2 | 1 | 1 | 6 |  | 2 |  |
| Total fixed maturity securities | $3018 | $379 | $857 | $207 | $1213 | $24 | $46 | $4 |
| Total number of securities in an <br>unrealized loss position | 1293 |  | 497 |  | 602 |  | 20 |  |

---

***<u>Allowance for Credit Losses for Fixed Maturity Securities</u>***

*<u>Evaluation and Measurement Methodologies</u>*

For fixed maturity securities in an unrealized loss position, management first assesses whether the Company intends to sell, or whether it is more likely than not it will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security's amortized cost basis is written down to estimated fair value through net investment gains (losses). For fixed maturity securities that do not meet the aforementioned criteria, management evaluates whether the decline in estimated fair value has resulted from credit losses or other factors. Inherent in management's evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used in the allowance for credit loss evaluation process include, but are not limited to: (i) the extent to which estimated fair value is less than amortized cost; (ii) any changes to the rating of the security by a rating agency; (iii) adverse conditions specifically related to the security, industry or geographic area; and (iv) payment structure of the fixed maturity security and the likelihood of the issuer being able to make payments in the future or the issuer's failure to make scheduled interest and principal payments. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss is deemed to exist and an allowance for credit losses is recorded, limited by the amount that the estimated fair value is less than the amortized cost basis, with a corresponding charge to net investment gains (losses). Any unrealized losses that have not been recorded through an allowance for credit losses are recognized in OCI.

Once a security specific allowance for credit losses is established, the present value of cash flows expected to be collected from the security continues to be reassessed. Any changes in the security specific allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in net investment gains (losses).

Fixed maturity securities are also evaluated to determine whether any amounts have become uncollectible. When all, or a portion, of a security is deemed uncollectible, the uncollectible portion is written-off with an adjustment to amortized cost and a corresponding reduction to the allowance for credit losses.

Accrued interest receivables are presented separate from the amortized cost basis of fixed maturity securities. An allowance for credit losses is not estimated on an accrued interest receivable, rather receivable balances 90-days past due are deemed uncollectible and are written off with a corresponding reduction to net investment income. The accrued interest receivable on fixed maturity securities totaled $32 million and $30 million at December 31, 2022 and 2021, respectively, and is included in accrued investment income.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**6. Investments (continued)**

Fixed maturity securities are also evaluated to determine if they qualify as purchased financial assets with credit deterioration ("PCD"). To determine if the credit deterioration experienced since origination is more than insignificant, both (i) the extent of the credit deterioration and (ii) any rating agency downgrades are evaluated. For securities categorized as PCD assets, the present value of cash flows expected to be collected from the security are compared to the par value of the security. If the present value of cash flows expected to be collected is less than the par value, credit losses are embedded in the purchase price of the PCD asset. In this situation, both an allowance for credit losses and amortized cost gross-up is recorded, limited by the amount that the estimated fair value is less than the grossed-up amortized cost basis. Any difference between the purchase price and the present value of cash flows is amortized or accreted into net investment income over the life of the PCD asset. Any subsequent PCD asset allowance for credit losses is evaluated in a manner similar to the process described above for fixed maturity securities.

*<u>Current Period Evaluation</u>*

Based on the Company's current evaluation of its fixed maturity securities in an unrealized loss position and the current intent or requirement to sell, the Company recorded an allowance for credit losses of less than $1 million on three fixed maturity securities at December 31, 2022. Management concluded that for all other fixed maturity securities in an unrealized loss position, the unrealized loss was not due to issuer specific credit-related factors and as a result was recognized in OCI. Where unrealized losses have not been recognized into income, it is primarily because the securities' bond issuer(s) are of high credit quality, management does not intend to sell and it is likely that management will not be required to sell the securities prior to their anticipated recovery, and the decline in estimated fair value is largely due to changes in interest rates and non-issuer-specific credit spreads. These issuers continued to make timely principal and interest payments and the estimated fair value is expected to recover as the securities approach maturity.

***Mortgage Loans***

***<u>Mortgage Loans by Portfolio Segment</u>***

Mortgage loans are summarized as follows at:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| | **2022** | **2022** | **2021** | **2021** |
| | **Carrying**<br> **Value** | **% of**<br> **Total** | **Carrying**<br> **Value** | **% of**<br> **Total** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Commercial | $940 | 77.2% | $593 | 73.1% |
| Agricultural | 283 | 23.2 | 220 | 27.1 |
| Total mortgage loans | 1223 | 100.4 | 813 | 100.2 |
| Allowance for credit losses | (5) | (0.4) | (2) | (0.2) |
| Total mortgage loans, net | $1218 | 100.0% | $811 | 100.0% |

---

***<u>Allowance for Credit Losses for Mortgage Loans</u>***

*<u>Evaluation and Measurement Methodologies</u>*

The allowance for credit losses is a valuation account that is deducted from the mortgage loan's amortized cost basis to present the net amount expected to be collected on the mortgage loan. The loan balance, or a portion of the loan balance, is written-off against the allowance when management believes this amount is uncollectible.

Accrued interest receivables are presented separate from the amortized cost basis of mortgage loans. An allowance for credit losses is generally not estimated on an accrued interest receivable, rather when a loan is placed in nonaccrual status the associated accrued interest receivable balance is written off with a corresponding reduction to net investment income. The accrued interest receivable on mortgage loans is included in accrued investment income and totaled $6 million and $4 million at December 31, 2022 and 2021, respectively.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**6. Investments (continued)**

The allowance for credit losses is estimated using relevant available information, from internal and external sources, relating to past events, current conditions, and a reasonable and supportable forecast. Historical credit loss experience provides the basis for estimating expected credit losses. Adjustments to historical loss information are made for differences in current loan-specific risk characteristics and environmental conditions. A reasonable and supportable forecast period of two-years is used with an input reversion period of one-year.

Mortgage loans are evaluated in both portfolio segments to determine the allowance for credit losses. The loan-level loss rates are determined using individual loan terms and characteristics, risk pools/internal ratings, national economic forecasts, prepayment speeds, and estimated default and loss severity. The resulting loss rates are applied to the mortgage loan's amortized cost to generate an allowance for credit losses. In certain situations, the allowance for credit losses is measured as the difference between the loan's amortized cost and liquidation value of the collateral. These situations include collateral dependent loans, expected troubled debt restructurings ("TDR"), foreclosure probable loans, and loans with dissimilar risk characteristics.

*<u>Rollforward of the Allowance for Credit Losses for Mortgage Loans by Portfolio Segment</u>*

The changes in the allowance for credit losses by portfolio segment were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Commercial** | **Agricultural** | **Total** |
| | **(In millions)** | **(In millions)** | **(In millions)** |
| Balance at January 1, 2020 | $1 | $1 | $2 |
| Current period provision |  |  |  |
| Balance at December 31, 2020 | 1 | 1 | 2 |
| Current period provision |  |  |  |
| Balance at December 31, 2021 | 1 | 1 | 2 |
| Current period provision | 3 |  | 3 |
| Balance at December 31, 2022 | $4 | $1 | $5 |

---

***<u>Credit Quality of Mortgage Loans by Portfolio Segment</u>***

The amortized cost of mortgage loans by year of origination and credit quality indicator was as follows at:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **2022** | **2021** | **2020** | **2019** | **2018** | **Prior** | **Total** |
| | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** |
| **December 31, 2022** |  |  |  |  |  |  |  |
| **Commercial mortgage loans** |  |  |  |  |  |  |  |
| Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: |
| Less than 65% | $345 | $171 | $31 | $108 | $10 | $135 | $800 |
| 65% to 75% | 37 |  |  | 25 | 13 | 41 | 116 |
| 76% to 80% |  |  |  | 5 |  |  | 5 |
| Greater than 80% |  |  |  | 10 | 5 | 4 | 19 |
| Total commercial mortgage loans | 382 | 171 | 31 | 148 | 28 | 180 | 940 |
| **Agricultural mortgage loans** |  |  |  |  |  |  |  |
| Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: |
| Less than 65% | 48 | 41 | 43 | 31 | 16 | 36 | 215 |
| 65% to 75% | 26 | 34 |  | 7 | 1 |  | 68 |
| Total agricultural mortgage loans | 74 | 75 | 43 | 38 | 17 | 36 | 283 |
| Total | $456 | $246 | $74 | $186 | $45 | $216 | $1223 |

---

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**6. Investments (continued)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **2021** | **2020** | **2019** | **2018** | **2017** | **Prior** | **Total** |
| | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** |
| **December 31, 2021** |  |  |  |  |  |  |  |
| **Commercial mortgage loans** |  |  |  |  |  |  |  |
| Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: |
| Less than 65% | $121 | $31 | $100 | $16 | $13 | $158 | $439 |
| 65% to 75% | 50 |  | 52 | 13 | 7 | 16 | 138 |
| 76% to 80% |  |  |  |  |  | 1 | 1 |
| Greater than 80% |  |  |  | 5 |  | 10 | 15 |
| Total commercial mortgage loans | 171 | 31 | 152 | 34 | 20 | 185 | 593 |
| **Agricultural mortgage loans** |  |  |  |  |  |  |  |
| Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: | Loan-to-value ratios: |
| Less than 65% | 42 | 45 | 33 | 17 | 6 | 35 | 178 |
| 65% to 75% | 34 |  | 7 | 1 |  |  | 42 |
| Total agricultural mortgage loans | 76 | 45 | 40 | 18 | 6 | 35 | 220 |
| Total | $247 | $76 | $192 | $52 | $26 | $220 | $813 |

---

The loan-to-value ratio is a measure commonly used to assess the quality of commercial and agricultural mortgage loans. The loan-to-value ratio compares the amount of the loan to the estimated fair value of the underlying property collateralizing the loan and is commonly expressed as a percentage. A loan-to-value ratio less than 100% indicates an excess of collateral value over the loan amount. Loan-to-value ratios greater than 100% indicate that the loan amount exceeds the collateral value. Performing status is a measure commonly used to assess the quality of residential mortgage loans. A loan is considered performing when the borrower makes consistent and timely payments.

The amortized cost of commercial mortgage loans by debt-service coverage ratio was as follows at:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| | **2022** | **2022** | **2021** | **2021** |
| | **Amortized**<br> **Cost** | **% of**<br> **Total** | **Amortized**<br> **Cost** | **% of**<br> **Total** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Debt service coverage ratios: | Debt service coverage ratios: | Debt service coverage ratios: | Debt service coverage ratios: | Debt service coverage ratios: |
| Greater than 1.20x | $894 | 95.1% | $510 | 86.0% |
| 1.00x - 1.20x | 21 | 2.2 | 46 | 7.8 |
| Less than 1.00x | 25 | 2.7 | 37 | 6.2 |
| Total | $940 | 100.0% | $593 | 100.0% |

---

The debt-service coverage ratio compares a property's net operating income to its debt-service payments. Debt-service coverage ratios less than 1.00 times indicate that property operations do not generate enough income to cover the loan's current debt payments. A debt-service coverage ratio greater than 1.00 times indicates an excess of net operating income over the debt-service payments.

***<u>Past Due Mortgage Loans by Portfolio Segment</u>***

The Company has a high-quality, well performing mortgage loan portfolio, with all mortgage loans classified as performing at both December 31, 2022 and 2021. Delinquency is defined consistent with industry practice, when mortgage loans are past due as follows: commercial mortgage loans — 60 days and agricultural mortgage loans — 90 days.

At both December 31, 2022 and 2021 the Company did not have any mortgage loans past due.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**6. Investments (continued)**

***<u>Mortgage Loans in Nonaccrual Status by Portfolio Segment</u>***

Mortgage loans are placed in a nonaccrual status if there are concerns regarding collectability of future payments or the loan is past due, unless the past due loan is well collateralized.

The Company did not have any mortgage loans in a nonaccrual status at either December 31, 2022 or 2021.

***<u>Modified Mortgage Loans by Portfolio Segment</u>***

Under certain circumstances, modifications are granted to nonperforming mortgage loans. Each modification is evaluated to determine if a TDR has occurred. A modification is a TDR when the borrower is in financial difficulty and the creditor makes concessions. Generally, the types of concessions may include reducing the amount of debt owed, reducing the contractual interest rate, extending the maturity date at an interest rate lower than current market interest rates and/or reducing accrued interest. The Company did not have any mortgage loans modified in a TDR during both years ended December 31, 2022 and 2021.

***Net Unrealized Investment Gains (Losses)***

Unrealized investment gains (losses) on fixed maturity securities and the effect on DAC and future policy benefits, that would result from the realization of the unrealized gains (losses), are included in net unrealized investment gains (losses) in accumulated other comprehensive income (loss) ("AOCI").

The components of net unrealized investment gains (losses), included in AOCI, were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| | **(In millions)** | **(In millions)** | **(In millions)** |
| Fixed maturity securities | $(580) | $233 | $383 |
| Derivatives | 19 | 7 | 1 |
| Subtotal | (561) | 240 | 384 |
| Amounts allocated from: | Amounts allocated from: | Amounts allocated from: | Amounts allocated from: |
| Future policy benefits |  | (35) | (20) |
| DAC | 38 | (34) | (38) |
| Subtotal | 38 | (69) | (58) |
| Deferred income tax benefit (expense) | 110 | (36) | (68) |
| Net unrealized investment gains (losses) | $(413) | $135 | $258 |

---

The changes in net unrealized investment gains (losses) were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| | **(In millions)** | **(In millions)** | **(In millions)** |
| Balance at January 1, | $135 | $258 | $122 |
| Unrealized investment gains (losses) during the year | (801) | (144) | 208 |
| Unrealized investment gains (losses) relating to: | Unrealized investment gains (losses) relating to: | Unrealized investment gains (losses) relating to: | Unrealized investment gains (losses) relating to: |
| Future policy benefits | 35 | (15) | (17) |
| DAC | 72 | 4 | (19) |
| Deferred income tax benefit (expense) | 146 | 32 | (36) |
| Balance at December 31, | $(413) | $135 | $258 |
| Change in net unrealized investment gains (losses) | $(548) | $(123) | $136 |

---

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**6. Investments (continued)**

***Concentrations of Credit Risk***

There were no investments in any counterparty that were greater than 10% of the Company's equity, other than the U.S. government and its agencies, at both December 31, 2022 and 2021.

***Invested Assets on Deposit and Pledged as Collateral***

Invested assets on deposit and pledged as collateral at estimated fair value were as follows at:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| | **2022** | **2021** |
| | **(In millions)** | **(In millions)** |
| Invested assets on deposit (regulatory deposits) | $1 | $2 |
| Invested assets pledged as collateral (1) | 236 | 161 |
| Total invested assets on deposit and pledged as collateral (2) | $237 | $163 |

---

(1) The Company has pledged invested assets in connection with derivative transactions (see Note 7).

(2) The Company did not hold any restricted cash and cash equivalents at either December 31, 2022 or 2021.

***Variable Interest Entities***

The Company has invested in legal entities that are variable interest entities ("VIE"). VIEs are consolidated when the investor is the primary beneficiary. A primary beneficiary is the variable interest holder in a VIE with both (i) the power to direct the activities of the VIE that most significantly impact the economic performance of the VIE and (ii) the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE.

There were no material VIEs for which the Company has concluded that it is the primary beneficiary at either December 31, 2022 or 2021.

The carrying amount and maximum exposure to loss related to the VIEs for which the Company has concluded that it holds a variable interest, but is not the primary beneficiary, were as follows at:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| | **2022** | **2022** | **2021** | **2021** |
| | **Carrying**<br> **Amount** | **Maximum**<br> **Exposure**<br> **to Loss** | **Carrying**<br> **Amount** | **Maximum**<br> **Exposure**<br> **to Loss** |
| | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** |
| Fixed maturity securities | $342 | $373 | $326 | $308 |

---

The Company's investments in unconsolidated VIEs are described below.

***<u>Fixed Maturity Securities</u>***

The Company invests in U.S. corporate bonds, foreign corporate bonds and Structured Securities issued by VIEs. The Company is not obligated to provide any financial or other support to these VIEs, other than the original investment. The Company's involvement with these entities is limited to that of a passive investor. The Company has no unilateral right to appoint or remove the servicer, special servicer, or investment manager, which are generally viewed as having the power to direct the activities that most significantly impact the economic performance of the VIE, nor does the Company function in any of these roles. The Company does not have the obligation to absorb losses or the right to receive benefits from the entity that could potentially be significant to the entity; as a result, the Company has determined it is not the primary beneficiary, or consolidator, of the VIE. The Company's maximum exposure to loss on these fixed maturity securities is limited to the amortized cost of these investments. See "— Fixed Maturity Securities Available-for-sale" for information on these securities.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**6. Investments (continued)**

***Net Investment Income***

The components of net investment income were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| | **(In millions)** | **(In millions)** | **(In millions)** |
| Investment income: | Investment income: | Investment income: | Investment income: |
| Fixed maturity securities | $149 | $135 | $112 |
| Mortgage loans | 40 | 26 | 26 |
| Cash, cash equivalents and short-term investments | 6 |  | 1 |
| Other | 2 | 2 | 1 |
| Total investment income | 197 | 163 | 140 |
| Less: Investment expenses | 9 | 6 | 6 |
| Net investment income | $188 | $157 | $134 |

---

***Net Investment Gains (Losses)***

***<u>Components of Net Investment Gains (Losses)</u>***

The components of net investment gains (losses) were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| | **(In millions)** | **(In millions)** | **(In millions)** |
| Fixed maturity securities | $(10) | $(2) | $13 |
| Mortgage loans | (2) |  |  |
| Other |  | (1) |  |
| Total net investment gains (losses) | $(12) | $(3) | $13 |

---

***<u>Sales or Disposals of Fixed Maturity Securities</u>***

Investment gains and losses on sales of securities are determined on a specific identification basis. Proceeds from sales or disposals of fixed maturity securities and the components of fixed maturity securities net investment gains (losses) were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| | **(In millions)** | **(In millions)** | **(In millions)** |
| Proceeds | $459 | $153 | $321 |
| Gross investment gains | $7 | $1 | $14 |
| Gross investment losses | (17) | (3) | (1) |
| Net investment gains (losses) | $(10) | $(2) | $13 |

---

**7. Derivatives**

***Accounting for Derivatives***

See Note 1 for a description of the Company's accounting policies for derivatives and Note 8 for information about the fair value hierarchy for derivatives.

***Derivative Strategies***

The Company maintains an overall risk management strategy that incorporates the use of derivative instruments to minimize its exposure to various market risks, including interest rate, foreign currency exchange rate and equity market.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**7. Derivatives (continued)**

Derivatives are financial instruments with values derived from interest rates, foreign currency exchange rates and/or financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter ("OTC") market. The Company's OTC derivatives are settled bilateral contracts between two counterparties ("OTC-bilateral").

***<u>Interest Rate Derivatives</u>***

Interest rate caps: The Company uses interest rate caps to protect against interest rate exposure arising from mismatches between assets and liabilities. Interest rate caps are used in non-qualifying hedging relationships.

***<u>Foreign Currency Exchange Rate Derivatives</u>***

Foreign currency swaps: The Company uses foreign currency swaps to convert foreign currency denominated cash flows to U.S. dollars to reduce cash flow fluctuations due to changes in currency exchange rates. Foreign currency swaps are used in cash flow and non-qualifying hedging relationships.

***<u>Equity Market Derivatives</u>***

Equity index options: The Company uses equity index options to hedge index-linked annuity products against adverse changes in equity markets. Equity index options are used in non-qualifying hedging relationships.

Equity total return swaps: The Company uses equity total return swaps to hedge index-linked annuity products against adverse changes in equity markets. Equity total return swaps are used in non-qualifying hedging relationships.

***Primary Risks Managed by Derivatives***

The primary underlying risk exposure, gross notional amount and estimated fair value of derivatives held were as follows at:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| | | **2022** | **2022** | **2022** | **2021** | **2021** | **2021** |
| | | | **Estimated Fair Value** | **Estimated Fair Value** | | **Estimated Fair Value** | **Estimated Fair Value** |
| |<br><br>**Primary Underlying Risk Exposure** | **Gross**<br> **Notional**<br>**Amount** | **Assets** | **Liabilities** | **Gross**<br> **Notional**<br>**Amount** | **Assets** | **Liabilities** |
| | | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** |
| **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** |
| Cash flow hedges: | Cash flow hedges: | Cash flow hedges: | Cash flow hedges: | Cash flow hedges: | Cash flow hedges: | Cash flow hedges: | Cash flow hedges: |
| Foreign currency swaps | Foreign currency exchange rate | $164 | $19 | $— | $125 | $7 | $1 |
| Total qualifying hedges |  | 164 | 19 |  | 125 | 7 | 1 |
| **Derivatives Not Designated or Not Qualifying as Hedging Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging Instruments:** |
| Interest rate caps | Interest rate | 800 | 12 |  | 800 | 2 |  |
| Foreign currency swaps | Foreign currency exchange rate | 16 | 4 |  | 16 | 4 |  |
| Equity index options | Equity market | 2761 | 171 | 72 | 2576 | 268 | 137 |
| Equity total return swaps | Equity market | 2392 | 59 | 35 | 2089 | 61 | 3 |
| Total non-designated or non-qualifying derivatives |  | 5969 | 246 | 107 | 5481 | 335 | 140 |
| **Embedded derivatives:** | **Embedded derivatives:** | **Embedded derivatives:** | **Embedded derivatives:** | **Embedded derivatives:** | **Embedded derivatives:** | **Embedded derivatives:** | **Embedded derivatives:** |
| Ceded guaranteed minimum <br>income benefits | Other | N/A | 255 |  | N/A | 351 |  |
| Direct guaranteed minimum <br>benefits | Other | N/A |  | (21) | N/A |  | (30) |
| Direct index-linked annuities | Other | N/A |  | 529 | N/A |  | 792 |
| Total embedded derivatives | Other | N/A | 255 | 508 | N/A | 351 | 762 |
| Total |  | $6133 | $520 | $615 | $5606 | $693 | $903 |

---

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**7. Derivatives (continued)**

The amount and location of gains (losses), including earned income, recognized for derivatives and gains (losses) pertaining to hedged items reported in net derivative gains (losses) were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Year Ended December 31, 2022** | **Year Ended December 31, 2022** | **Year Ended December 31, 2022** | **Year Ended December 31, 2022** |
| | **Net Derivative**<br> **Gains (Losses)**<br> **Recognized for**<br> **Derivatives** | **Net Derivative**<br> **Gains (Losses)**<br> **Recognized for**<br> **Hedged Items** | **Net**<br> **Investment** <br> **Income** | **Amount of**<br> **Gains (Losses)**<br> **Deferred in**<br> **AOCI** |
| | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** |
| **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** |
| Cash flow hedges: | Cash flow hedges: | Cash flow hedges: | Cash flow hedges: | Cash flow hedges: |
| Foreign currency exchange rate | $— | $— | $2 | $12 |
| Total cash flow hedges |  |  | 2 | 12 |
| **Derivatives Not Designated or Not Qualifying as Hedging** <br> **Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging** <br> **Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging** <br> **Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging** <br> **Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging** <br> **Instruments:** |
| Interest rate | 10 |  |  |  |
| Foreign currency exchange rate | 1 | (1) |  |  |
| Equity market | (426) |  |  |  |
| Embedded | 279 |  |  |  |
| Total non-qualifying hedges | (136) | (1) |  |  |
| Total | $(136) | $(1) | $2 | $12 |
|  | **Year Ended December 31, 2021** | **Year Ended December 31, 2021** | **Year Ended December 31, 2021** | **Year Ended December 31, 2021** |
|  | **Net Derivative**<br> **Gains (Losses)**<br> **Recognized for**<br> **Derivatives** | **Net Derivative**<br> **Gains (Losses)**<br> **Recognized for**<br> **Hedged Items** | **Net**<br> **Investment**<br> **Income** | **Amount of**<br> **Gains (Losses)**<br> **Deferred in**<br> **AOCI** |
|  | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** |
| **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** |
| Cash flow hedges: | Cash flow hedges: | Cash flow hedges: | Cash flow hedges: | Cash flow hedges: |
| Foreign currency exchange rate | $— | $— | $1 | $6 |
| Total cash flow hedges |  |  | 1 | 6 |
| **Derivatives Not Designated or Not Qualifying as Hedging** <br> **Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging** <br> **Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging** <br> **Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging** <br> **Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging** <br> **Instruments:** |
| Interest rate | 1 |  |  |  |
| Foreign currency exchange rate |  |  |  |  |
| Equity market | 368 |  |  |  |
| Embedded | (445) |  |  |  |
| Total non-qualifying hedges | (76) |  |  |  |
| Total | $(76) | $— | $1 | $6 |

---

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**7. Derivatives (continued)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Year Ended December 31, 2020** | **Year Ended December 31, 2020** | **Year Ended December 31, 2020** | **Year Ended December 31, 2020** |
| | **Net Derivative**<br> **Gains (Losses)**<br> **Recognized for**<br> **Derivatives** | **Net Derivative**<br> **Gains (Losses)**<br> **Recognized for**<br> **Hedged Items** | **Net**<br> **Investment**<br> **Income** | **Amount of**<br> **Gains (Losses)**<br> **Deferred in**<br> **AOCI** |
| | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** |
| **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** |
| Cash flow hedges: | Cash flow hedges: | Cash flow hedges: | Cash flow hedges: | Cash flow hedges: |
| Foreign currency exchange rate | $— | $— | $1 | $(5) |
| Total cash flow hedges |  |  | 1 | (5) |
| **Derivatives Not Designated or Not Qualifying as Hedging** <br> **Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging** <br> **Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging** <br> **Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging** <br> **Instruments:** | **Derivatives Not Designated or Not Qualifying as Hedging** <br> **Instruments:** |
| Interest rate | (1) |  |  |  |
| Foreign currency exchange rate | 1 |  |  |  |
| Equity market | 195 |  |  |  |
| Embedded | (66) |  |  |  |
| Total non-qualifying hedges | 129 |  |  |  |
| Total | $129 | $— | $1 | $(5) |

---

At December 31, 2022 and 2021, the balance in AOCI associated with cash flow hedges was $19 million and $7 million, respectively.

***Counterparty Credit Risk***

The Company may be exposed to credit-related losses in the event of counterparty nonperformance on derivative instruments. Generally, the credit exposure is the fair value at the reporting date less any collateral received from the counterparty.

The Company manages its credit risk by: (i) entering into derivative transactions with creditworthy counterparties governed by master netting agreements; (ii) trading through regulated exchanges and central clearing counterparties; (iii) obtaining collateral, such as cash and securities, when appropriate; and (iv) setting limits on single party credit exposures which are subject to periodic management review.

See Note 8 for a description of the impact of credit risk on the valuation of derivatives.

The estimated fair values of net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | **Gross Amounts Not Offset on the**<br> **Balance Sheets** | **Gross Amounts Not Offset on the**<br> **Balance Sheets** | | | |
| |<br>**Gross Amount**<br> **Recognized** | **Financial**<br> **Instruments (1)** | **Collateral**<br> **Received/Pledged** <br> **(2)** |<br>**Net Amount** |<br>**Securities**<br> **Collateral**<br> **Received/Pledged** <br> **(3)** |<br>**Net Amount**<br> **After Securities**<br> **Collateral** |
| | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** |
| **December 31, 2022** | **December 31, 2022** | **December 31, 2022** | **December 31, 2022** | **December 31, 2022** | **December 31, 2022** | **December 31, 2022** |
| Derivative assets | $260 | $(65) | $(189) | $6 | $(5) | $1 |
| Derivative liabilities | $111 | $(65) | $— | $46 | $(45) | $1 |
| **December 31, 2021** | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** |
| Derivative assets | $342 | $(33) | $(305) | $4 | $(3) | $1 |
| Derivative liabilities | $141 | $(33) | $— | $108 | $(108) | $— |

---

(1) Represents amounts subject to an enforceable master netting agreement or similar agreement.

(2) The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreement.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**7. Derivatives (continued)**

(3) Securities collateral received from counterparties is not reported on the balance sheets and may not be sold or re-pledged unless the counterparty is in default. Amounts do not include excess of collateral pledged or received.

The Company's collateral arrangements generally require the counterparty in a net liability position, after considering the effect of netting agreements, to pledge collateral when the amount owed by that counterparty reaches a minimum transfer amount. Certain of these arrangements also include credit-contingent provisions which permit the party with positive fair value to terminate the derivative at the current fair value or demand immediate full collateralization from the party in a net liability position, in the event that the financial strength or credit rating of the party in a net liability position falls below a certain level.

The aggregate estimated fair values of derivatives in a net liability position containing such credit contingent provisions and the aggregate estimated fair value of assets posted as collateral for such instruments were as follows at:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| | **2022** | **2021** |
| | **(In millions)** | **(In millions)** |
| Estimated fair value of derivatives in a net liability position (1) | $46 | $108 |
| Estimated Fair Value of Collateral Provided (2): | Estimated Fair Value of Collateral Provided (2): | Estimated Fair Value of Collateral Provided (2): |
| Fixed maturity securities | $235 | $162 |

---

(1) After taking into consideration the existence of netting agreements.

(2) Substantially all of the Company's collateral arrangements provide for daily posting of collateral for the full value of the derivative contract. As a result, if the credit-contingent provisions of derivative contracts in a net liability position were triggered, minimal additional assets would be required to be posted as collateral or needed to settle the instruments immediately. Additionally, the Company is required to pledge initial margin for certain new OTC-bilateral derivative transactions to third-party custodians.

**8. Fair Value**

When developing estimated fair values, the Company considers three broad valuation techniques: (i) the market approach, (ii) the income approach, and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given what is being measured and the availability of sufficient inputs, giving priority to observable inputs. The Company categorizes its assets and liabilities measured at estimated fair value into a three level hierarchy, based on the significant input with the lowest level in its valuation. The input levels are as follows:

Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities. The Company defines active markets based on average trading volume for equity securities. The size of the bid/ask spread is used as an indicator of market activity for fixed maturity securities.

Level 2 Quoted prices in markets that are not active or inputs that are observable either directly or indirectly. These inputs can include quoted prices for similar assets or liabilities other than quoted prices in Level 1, quoted prices in markets that are not active, or other significant inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 Unobservable inputs that are supported by little or no market activity and are significant to the determination of estimated fair value of the assets or liabilities. Unobservable inputs reflect the reporting entity's own assumptions about the assumptions that market participants would use in pricing the asset or liability.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**8. Fair Value (continued)**

***Recurring Fair Value Measurements***

The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy are presented in the tables below. Investments that do not have a readily determinable fair value and are measured at net asset value (or equivalent) as a practical expedient to estimated fair value are excluded from the fair value hierarchy.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2022** | **December 31, 2022** | **December 31, 2022** | **December 31, 2022** |
| | **Fair Value Hierarchy** | **Fair Value Hierarchy** | **Fair Value Hierarchy** | |
| | **Level 1** | **Level 2** | **Level 3** |<br>**Total Estimated** <br> **Fair Value** |
| | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** |
| **Assets** | **Assets** | **Assets** | **Assets** | **Assets** |
| Fixed maturity securities: | Fixed maturity securities: | Fixed maturity securities: | Fixed maturity securities: | Fixed maturity securities: |
| U.S. corporate | $— | $2015 | $15 | $2030 |
| Foreign corporate |  | 649 | 22 | 671 |
| CMBS |  | 317 |  | 317 |
| ABS |  | 270 | 11 | 281 |
| RMBS |  | 275 |  | 275 |
| State and political subdivision |  | 245 |  | 245 |
| U.S. government and agency | 144 | 48 |  | 192 |
| Foreign government |  | 13 | 1 | 14 |
| Total fixed maturity securities | 144 | 3832 | 49 | 4025 |
| Equity securities |  |  | 4 | 4 |
| Short-term investments |  |  |  |  |
| Derivative assets: (1) | Derivative assets: (1) | Derivative assets: (1) | Derivative assets: (1) | Derivative assets: (1) |
| Interest rate |  | 12 |  | 12 |
| Foreign currency exchange rate |  | 23 |  | 23 |
| Equity market |  | 230 |  | 230 |
| Total derivative assets |  | 265 |  | 265 |
| Embedded derivatives within asset host contracts (2) |  |  | 255 | 255 |
| Separate account assets |  | 3922 |  | 3922 |
| Total assets | $144 | $8019 | $308 | $8471 |
| **Liabilities** | **Liabilities** | **Liabilities** | **Liabilities** | **Liabilities** |
| Derivative liabilities: (1) | Derivative liabilities: (1) | Derivative liabilities: (1) | Derivative liabilities: (1) | Derivative liabilities: (1) |
| Foreign currency exchange rate | $— | $— | $— | $— |
| Equity market |  | 107 |  | 107 |
| Total derivative liabilities |  | 107 |  | 107 |
| Embedded derivatives within liability host contracts (2) |  |  | 508 | 508 |
| Total liabilities | $— | $107 | $508 | $615 |

---

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**8. Fair Value (continued)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** |
| | **Fair Value Hierarchy** | **Fair Value Hierarchy** | **Fair Value Hierarchy** | |
| | **Level 1** | **Level 2** | **Level 3** |<br>**Total Estimated**<br> **Fair Value** |
| | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** |
| **Assets** | **Assets** | **Assets** | **Assets** | **Assets** |
| Fixed maturity securities: | Fixed maturity securities: | Fixed maturity securities: | Fixed maturity securities: | Fixed maturity securities: |
| U.S. corporate | $— | $2422 | $21 | $2443 |
| Foreign corporate |  | 679 | 14 | 693 |
| CMBS |  | 349 |  | 349 |
| ABS |  | 303 | 10 | 313 |
| RMBS |  | 279 |  | 279 |
| State and political subdivision |  | 303 |  | 303 |
| U.S. government and agency | 148 | 144 |  | 292 |
| Foreign government |  | 23 | 2 | 25 |
| Total fixed maturity securities | 148 | 4502 | 47 | 4697 |
| Equity securities |  |  | 3 | 3 |
| Short-term investments | 13 |  |  | 13 |
| Derivative assets: (1) | Derivative assets: (1) | Derivative assets: (1) | Derivative assets: (1) | Derivative assets: (1) |
| Interest rate |  | 2 |  | 2 |
| Foreign currency exchange rate |  | 11 |  | 11 |
| Equity market |  | 329 |  | 329 |
| Total derivative assets |  | 342 |  | 342 |
| Embedded derivatives within asset host contracts (2) |  |  | 351 | 351 |
| Separate account assets |  | 5149 |  | 5149 |
| Total assets | $161 | $9993 | $401 | $10555 |
| **Liabilities** | **Liabilities** | **Liabilities** | **Liabilities** | **Liabilities** |
| Derivative liabilities: (1) | Derivative liabilities: (1) | Derivative liabilities: (1) | Derivative liabilities: (1) | Derivative liabilities: (1) |
| Foreign currency exchange rate | $— | $1 | $— | $1 |
| Equity market |  | 140 |  | 140 |
| Total derivative liabilities |  | 141 |  | 141 |
| Embedded derivatives within liability host contracts (2) |  |  | 762 | 762 |
| Total liabilities | $— | $141 | $762 | $903 |

---

(1) Derivative assets are reported in other invested assets and derivative liabilities are reported in other liabilities. The amounts are presented gross in the tables above to reflect the presentation on the balance sheets.

(2) Embedded derivatives within asset host contracts are reported in premiums, reinsurance and other receivables. Embedded derivatives within liability host contracts are reported in policyholder account balances.

***<u>Valuation Controls and Procedures</u>***

The Company monitors and provides oversight of valuation controls and policies for securities, mortgage loans and derivatives, which are primarily executed by its valuation service providers. The valuation methodologies used to determine fair values prioritize the use of observable market prices and market-based parameters and determines that judgmental valuation adjustments, when applied, are based upon established policies and are applied consistently over time. The valuation methodologies for securities, mortgage loans and derivatives are reviewed on an ongoing basis and revised when necessary. In addition, the Chief Accounting Officer periodically reports to the Audit Committee of Brighthouse Financial's Board of Directors regarding compliance with fair value accounting standards.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**8. Fair Value (continued)**

The fair value of financial assets and financial liabilities is based on quoted market prices, where available. Prices received are assessed to determine if they represent a reasonable estimate of fair value. Several controls are performed, including certain monthly controls, which include, but are not limited to, analysis of portfolio returns to corresponding benchmark returns, comparing a sample of executed prices of securities sold to the fair value estimates, reviewing the bid/ask spreads to assess activity, comparing prices from multiple independent pricing services and ongoing due diligence to confirm that independent pricing services use market-based parameters. The process includes a determination of the observability of inputs used in estimated fair values received from independent pricing services or brokers by assessing whether these inputs can be corroborated by observable market data. Independent non-binding broker quotes, also referred to herein as "consensus pricing," are used for a non-significant portion of the portfolio. Prices received from independent brokers are assessed to determine if they represent a reasonable estimate of fair value by considering such pricing relative to the current market dynamics and current pricing for similar financial instruments.

A formal process is also applied to challenge any prices received from independent pricing services that are not considered representative of estimated fair value. If prices received from independent pricing services are not considered reflective of market activity or representative of estimated fair value, independent non-binding broker quotations are obtained. If obtaining an independent non-binding broker quotation is unsuccessful, the last available price will be used.

Additional controls are performed, such as, balance sheet analytics to assess reasonableness of period to period pricing changes, including any price adjustments. Price adjustments are applied if prices or quotes received from independent pricing services or brokers are not considered reflective of market activity or representative of estimated fair value. The Company did not have significant price adjustments during the year ended December 31, 2022.

***<u>Determination of Fair Value</u>***

*<u>Fixed Maturity Securities</u>*

The fair values for actively traded marketable bonds, primarily U.S. government and agency securities, are determined using the quoted market prices and are classified as Level 1 assets. For fixed maturity securities classified as Level 2 assets, fair values are determined using either a market or income approach and are valued based on a variety of observable inputs as described below.

*U.S. corporate and foreign corporate securities:* Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, benchmark yields, spreads off benchmark yields, new issuances, issuer rating, trades of identical or comparable securities, or duration. Privately-placed securities are valued using the additional key inputs: market yield curve, call provisions, observable prices and spreads for similar public or private securities that incorporate the credit quality and industry sector of the issuer, and delta spread adjustments to reflect specific credit-related issues.

*U.S. government and agency, state and political subdivision and foreign government securities:* Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, benchmark U.S. Treasury yield or other yields, spread off the U.S. Treasury yield curve for the identical security, issuer ratings and issuer spreads, broker-dealer quotes, and comparable securities that are actively traded.

*Structured Securities:* Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, spreads for actively traded securities, spreads off benchmark yields, expected prepayment speeds and volumes, current and forecasted loss severity, ratings, geographic region, weighted average coupon and weighted average maturity, average delinquency rates and debt-service coverage ratios. Other issuance-specific information is also used, including, but not limited to; collateral type, structure of the security, vintage of the loans, payment terms of the underlying asset, payment priority within tranche, and deal performance.

*<u>Equity Securities and Short-term Investments</u>*

The fair value for actively traded equity securities and short-term investments are determined using quoted market prices and are classified as Level 1 assets. For financial instruments classified as Level 2 assets, fair values are determined using a market approach and are valued based on a variety of observable inputs as described below.

*Equity securities and short-term investments:* Fair value is determined using third-party commercial pricing services, with the primary input being quoted prices in markets that are not active.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**8. Fair Value (continued)**

*<u>Derivatives</u>*

The fair values for OTC-bilateral derivatives classified as Level 2 assets or liabilities are determined using the income approach. Valuations of non-option-based derivatives utilize present value techniques, whereas valuations of option-based derivatives utilize option pricing models which are based on market standard valuation methodologies and a variety of observable inputs.

The significant inputs to the pricing models for most OTC-bilateral derivatives are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Certain OTC-bilateral derivatives may rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and management believes they are consistent with what other market participants would use when pricing such instruments.

Most inputs for OTC-bilateral derivatives are mid-market inputs but, in certain cases, liquidity adjustments are made when they are deemed more representative of exit value. Market liquidity, as well as the use of different methodologies, assumptions and inputs, may have a material effect on the estimated fair values of the Company's derivatives and could materially affect net income.

The credit risk of both the counterparty and the Company are considered in determining the estimated fair value for all OTC-bilateral derivatives, and any potential credit adjustment is based on the net exposure by counterparty after taking into account the effects of netting agreements and collateral arrangements. The Company values its OTC-bilateral derivatives using standard swap curves which may include a spread to the risk-free rate, depending upon specific collateral arrangements. This credit spread is appropriate for those parties that execute trades at pricing levels consistent with similar collateral arrangements. As the Company and its significant derivative counterparties generally execute trades at such pricing levels and hold sufficient collateral, additional credit risk adjustments are not currently required in the valuation process. The Company's ability to consistently execute at such pricing levels is in part due to the netting agreements and collateral arrangements that are in place with all of its significant derivative counterparties. An evaluation of the requirement to make additional credit risk adjustments is performed by the Company each reporting period.

*<u>Embedded Derivatives</u>*

Embedded derivatives principally include certain direct variable annuity guarantees and certain affiliated ceded reinsurance agreements related to such variable annuity guarantees and equity crediting rates within index-linked annuity contracts. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income.

The Company issues variable annuity products with guaranteed minimum benefits. GMABs, the non-life contingent portion of GMWBs and certain portions of GMIBs are accounted for as embedded derivatives and measured at estimated fair value separately from the host variable annuity contract. These embedded derivatives are classified in policyholder account balances, with changes in estimated fair value reported in net derivative gains (losses).

The Company determines the fair value of these embedded derivatives by estimating the present value of projected future benefits minus the present value of projected future fees using actuarial and capital markets assumptions including expectations of policyholder behavior. The calculation is based on in-force business and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk-free rates. The percentage of fees included in the initial fair value measurement is not updated in subsequent periods.

Capital markets assumptions, such as risk-free rates and implied volatilities, are based on market prices for publicly-traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**8. Fair Value (continued)**

The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital markets inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for BHF's debt. These observable spreads are then adjusted to reflect the priority of these liabilities and claims-paying ability of the issuing insurance subsidiaries as compared to BHF's overall financial strength.

Risk margins are established to capture the non-capital markets risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees.

*<u>Transfers Into or Out of Level 3:</u>*

Assets and liabilities are transferred into Level 3 when a significant input cannot be corroborated with market observable data. This occurs when market activity decreases significantly and underlying inputs cannot be observed, current prices are not available, and/or when there are significant variances in quoted prices, thereby affecting transparency. Assets and liabilities are transferred out of Level 3 when circumstances change such that a significant input can be corroborated with market observable data. This may be due to a significant increase in market activity, a specific event, or one or more significant input(s) becoming observable.

***<u>Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3)</u>***

Certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) were as follows at:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | | **December 31, 2022** | **December 31, 2022** | **December 31, 2021** | **December 31, 2021** | |
| |<br>**Valuation**<br> **Techniques** |<br>**Significant**<br> **Unobservable Inputs** | **Range** | **Range** | **Range** | **Range** | **Impact of**<br> **Increase in Input**<br>**on Estimated**<br> **Fair Value** |
| **Embedded derivatives** | **Embedded derivatives** | **Embedded derivatives** | **Embedded derivatives** | **Embedded derivatives** | **Embedded derivatives** | **Embedded derivatives** | **Embedded derivatives** |
| Direct, assumed and ceded guaranteed <br>minimum benefits | • Option pricing <br>techniques | • Mortality rates | 0.03 | % - 12.62% | 0.03 | % - 12.62% | Decrease (1) |
|  |  | • Lapse rates | 0.30 | % - 14.50% | 0.30 | % - 14.50% | Decrease (2) |
|  |  | • Utilization rates | 0.00 | % - 25.00% | 0.00 | % - 25.00% | Increase (3) |
|  |  | • Withdrawal rates | 0.25 | % - 10.00% | 0.25 | % - 10.00% | (4) |
|  |  | • Long-term equity<br>volatilities | 16.46 | % - 22.01% | 16.44 | % - 22.16% | Increase (5) |
|  |  | • Nonperformance<br>risk spread | 0.00 | % - 1.98% | (0.38 |)% - 1.49% | Decrease (6) |

---

(1) Mortality rates vary by age and by demographic characteristics such as gender. The range shown reflects the mortality rate for policyholders between 35 and 90 years old, which represents the majority of the business with living benefits. Mortality rate assumptions are set based on company experience and include an assumption for mortality improvement.

(2) The range shown reflects base lapse rates for major product categories for duration 1-20, which represents majority of business with living benefit riders. Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in-the-money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**8. Fair Value (continued)**

(3) The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible in a given year. The range shown represents the floor and cap of the GMIB dynamic election rates across varying levels of in-the-money. For lifetime withdrawal guarantee riders, the assumption is that everyone will begin withdrawals once account value reaches zero which is equivalent to a 100% utilization rate. Utilization rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract's withdrawal history and by the age of the policyholder.

(4) The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.

(5) Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(6) Nonperformance risk spread varies by duration. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.

The Company does not develop unobservable inputs used in measuring fair value for all other assets and liabilities classified within Level 3; therefore, these are not included in the table above. The other Level 3 assets and liabilities primarily included fixed maturity securities and derivatives. For fixed maturity securities valued based on non-binding broker quotes, an increase (decrease) in credit spreads would result in a higher (lower) fair value. For derivatives valued based on third-party pricing models, an increase (decrease) in credit spreads would generally result in a higher (lower) fair value.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**8. Fair Value (continued)**

The changes in assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3) were summarized as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Fair Value Measurements Using Significant Unobservable Inputs (Level 3)** | **Fair Value Measurements Using Significant Unobservable Inputs (Level 3)** | **Fair Value Measurements Using Significant Unobservable Inputs (Level 3)** | **Fair Value Measurements Using Significant Unobservable Inputs (Level 3)** | **Fair Value Measurements Using Significant Unobservable Inputs (Level 3)** |
| | **Fixed Maturity Securities** | **Fixed Maturity Securities** | **Fixed Maturity Securities** | | |
| | **Corporate (1)** | **Structured**<br> **Securities** | **Foreign Government** |<br>**Equity**<br> **Securities** |<br>**Net Embedded**<br> **Derivatives (2)** |
| | | | **(In millions)** | | |
| Balance, January 1, 2021 | $26 | $6 | $— | $— | $70 |
| Total realized/unrealized gains (losses) <br>included in net income (loss) (3) (4) |  |  |  |  | (445) |
| Total realized/unrealized gains (losses) <br>included in AOCI |  |  |  |  |  |
| Purchases (5) | 19 | 10 | 2 | 3 |  |
| Sales (5) |  | (3) |  |  |  |
| Issuances (5) |  |  |  |  |  |
| Settlements (5) |  |  |  |  | (36) |
| Transfers into Level 3 (6) | 6 |  |  |  |  |
| Transfers out of Level 3 (6) | (16) | (3) |  |  |  |
| Balance, December 31, 2021 | 35 | 10 | 2 | 3 | (411) |
| Total realized/unrealized gains (losses) <br>included in net income (loss) (3) (4) |  |  |  |  | 279 |
| Total realized/unrealized gains (losses) <br>included in AOCI | (6) |  | (1) |  |  |
| Purchases (5) | 15 | 1 |  | 1 |  |
| Sales (5) | (5) |  |  |  |  |
| Issuances (5) |  |  |  |  |  |
| Settlements (5) |  |  |  |  | (121) |
| Transfers into Level 3 (6) | 4 |  |  |  |  |
| Transfers out of Level 3 (6) | (6) |  |  |  |  |
| Balance, December 31, 2022 | $37 | $11 | $1 | $4 | $(253) |
| Changes in unrealized gains (losses) <br>included in net income (loss) for the <br>instruments still held at December 31, <br>2020 (7) | $— | $— | $— | $— | $(111) |
| Changes in unrealized gains (losses) <br>included in net income (loss) for the <br>instruments still held at December 31, <br>2021 (7) | $— | $— | $— | $— | $(475) |
| Changes in unrealized gains (losses) <br>included in net income (loss) for the <br>instruments still held at December 31, <br>2022 (7) | $— | $— | $— | $— | $154 |
| Changes in unrealized gains (losses) <br>included in OCI for the instruments still <br>held at December 31, 2020 (7) | $— | $— | $— | $— | $— |
| Changes in unrealized gains (losses) <br>included in OCI for the instruments still <br>held at December 31, 2021 (7) | $— | $— | $— | $— | $— |
| Changes in unrealized gains (losses) <br>included in OCI for the instruments still <br>held at December 31, 2022 (7) | $(6) | $— | $— | $— | $— |
| Gains (Losses) Data for the year ended <br>December 31, 2020: | Gains (Losses) Data for the year ended <br>December 31, 2020: | Gains (Losses) Data for the year ended <br>December 31, 2020: | Gains (Losses) Data for the year ended <br>December 31, 2020: | Gains (Losses) Data for the year ended <br>December 31, 2020: | Gains (Losses) Data for the year ended <br>December 31, 2020: |
| Total realized/unrealized gains (losses) <br>included in net income (loss) (3) (4) | $— | $— | $— | $— | $(66) |
| Total realized/unrealized gains (losses) <br>included in AOCI | $— | $— | $— | $— | $— |

---

(1) Comprised of U.S. and foreign corporate securities.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**8. Fair Value (continued)**

(2) Embedded derivative assets and liabilities are reported net for purposes of the rollforward.

(3) Amortization of premium/accretion of discount is included in net investment income. Changes in the allowance for credit losses and direct write offs are charged to net income (loss) on securities are included in net investment gains (losses). Lapses associated with net embedded derivatives are included in net derivative gains (losses). Substantially all realized/ unrealized gains (losses) included in net income (loss) for net embedded derivatives are reported in net derivative gains (losses).

(4) Interest accruals, as well as cash interest coupons received, are excluded from the rollforward.

(5) Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements.

(6) Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.

(7) Changes in unrealized gains (losses) included in net income (loss) for fixed maturities are reported in either net investment income or net investment gains (losses). Substantially all changes in unrealized gains (losses) included in net income (loss) for net embedded derivatives are reported in net derivative gains (losses).

***Fair Value of Financial Instruments Carried at Other Than Fair Value***

The following tables provide fair value information for financial instruments that are carried on the balance sheet at amounts other than fair value. These tables exclude the following financial instruments: cash and cash equivalents, accrued investment income and payables for collateral under derivative transactions. The estimated fair value of the excluded financial instruments, which are primarily classified in Level 2, approximates carrying value as they are short-term in nature such that the Company believes there is minimal risk of material changes in interest rates or credit quality. All remaining balance sheet amounts excluded from the tables below are not considered financial instruments subject to this disclosure.

The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **December 31, 2022** | **December 31, 2022** | **December 31, 2022** | **December 31, 2022** | **December 31, 2022** |
| | | **Fair Value Hierarchy** | **Fair Value Hierarchy** | **Fair Value Hierarchy** | |
| |<br>**Carrying**<br> **Value** | **Level 1** | **Level 2** | **Level 3** |<br>**Total**<br> **Estimated**<br> **Fair Value** |
| | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** |
| **Assets** | **Assets** | **Assets** | **Assets** | **Assets** | **Assets** |
| Mortgage loans | $1218 | $— | $— | $1078 | $1078 |
| Premiums, reinsurance and other receivables | $440 | $— | $2 | $438 | $440 |
| **Liabilities** | **Liabilities** | **Liabilities** | **Liabilities** | **Liabilities** | **Liabilities** |
| Policyholder account balances | $784 | $— | $— | $764 | $764 |
| Short term debt | $125 | $— | $— | $125 | $125 |
| Other liabilities | $478 | $— | $49 | $429 | $478 |

---

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**8. Fair Value (continued)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** |
| | | **Fair Value Hierarchy** | **Fair Value Hierarchy** | **Fair Value Hierarchy** | |
| |<br>**Carrying**<br> **Value** | **Level 1** | **Level 2** | **Level 3** |<br>**Total**<br> **Estimated**<br> **Fair Value** |
| | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** | **(In millions)** |
| **Assets** | **Assets** | **Assets** | **Assets** | **Assets** | **Assets** |
| Mortgage loans | $811 | $— | $— | $839 | $839 |
| Premiums, reinsurance and other receivables | $448 | $— | $3 | $445 | $448 |
| **Liabilities** | **Liabilities** | **Liabilities** | **Liabilities** | **Liabilities** | **Liabilities** |
| Policyholder account balances | $853 | $— | $— | $845 | $845 |
| Other liabilities | $438 | $— | $2 | $436 | $438 |

---

**9. Short-term Debt**

***Intercompany Liquidity Facilities***

BHF has established an intercompany liquidity facility with certain of its insurance and non-insurance subsidiaries to provide short-term liquidity within and across the combined group of companies. Under the facility, which is comprised of a series of revolving loan agreements among BHF and its participating subsidiaries, each company may lend to or borrow from each other, subject to certain maximum limits for a term of up to 364 days, depending on the agreement.

On May 16, 2022, BLNY issued a $125 million promissory note to Brighthouse Holdings, LLC (the "May 2022 Promissory Note"), which bore interest at a fixed rate of 2.5363%. Upon maturity on August 16, 2022, the May 2022 Promissory Note was replaced with a new promissory note which bore interest at a fixed rate of 4.0466% (the "August 2022 Promissory Note"). Upon maturity on November 16, 2022, the August 2022 Promissory Note was replaced by a new promissory note that bears interest at a fixed rate of 5.4504% and matures on February 16, 2023 (the "November 2022 Promissory Note"). See Note 15 for more information.

Interest expense related to the affiliated short-term debt above of $3 million, $0 and $1 million for the years ended December 31, 2022, 2021 and 2020, respectively, is included in other expenses.

**10. Equity**

***Capital Contributions***

During the years ended December 31, 2022, 2021 and 2020, the Company received cash capital contributions of $100 million, $0 and $0, respectively, from Brighthouse Life Insurance Company.

See Note 15 for capital contributions approved subsequent to December 31, 2022.

***Statutory Financial Information***

The state of New York imposes RBC requirements that were developed by the National Association of Insurance Commissioners ("NAIC"). The requirements are used by regulators to assess the minimum amount of statutory capital needed for an insurance company to support its operations, based on its size and risk profile. RBC is based on the statutory financial statements and is calculated in a manner prescribed by the NAIC, with the RBC ratio equal to the total adjusted capital ("TAC") divided by the applicable company action level. Companies below minimum RBC ratios are subject to corrective action. The RBC ratio for the Company was in excess of such minimums for all periods presented.

The Company prepares statutory-basis financial statements in accordance with statutory accounting practices prescribed or permitted by the New York State Department of Financial Services ("NYDFS"). The NAIC has adopted standardized accounting guidance ("NAIC SAP"), which in most cases has been adopted by the NYDFS. However, statutory accounting principles continue to be established or modified by New York state laws and regulations.

Statutory accounting principles differ from GAAP primarily by charging policy acquisition costs to expense as incurred, establishing future policy benefit liabilities using different actuarial assumptions, reporting of reinsurance agreements and valuing investments and deferred tax assets on a different basis.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**10. Equity (continued)**

New York has adopted certain prescribed accounting practices that differ from NAIC SAP. These prescribed accounting practices primarily consist of the continuous Commissioners' Annuity Reserve Valuation Method, which impacts deferred annuities, NYDFS Circular Letter No 11, which impacts deferred premiums, and NYDFS Seventh Amendment to Regulation 172, which impacts admitted unearned reinsurance premiums. The collective impact of these prescribed accounting practices (increased) decreased the statutory capital and surplus of the Company for the years ended December 31, 2022 and 2021 by an amount of ($1) million and $143 million, respectively, relative to statutory surplus determined under NAIC SAP.

The tables below present amounts from the Company, which are derived from the statutory-basis financial statements as filed with the NYDFS.

Statutory net income (loss) was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
|<br>**Company** |<br>**State of Domicile** | **2022** | **2021** | **2020** |
|  |  | **(In millions)** | **(In millions)** | **(In millions)** |
| Brighthouse Life Insurance Company of NY | New York | $(152) | $(52) | $(390) |

---

Statutory capital and surplus was as follows at:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
|<br>**Company** | **2022** | **2021** |
|  | **(In millions)** | **(In millions)** |
| Brighthouse Life Insurance Company of NY | $223 | $357 |

---

***Dividend Restrictions***

The Company is permitted to pay $22 million of dividends in 2023 to its parent without insurance regulatory approval from the NYDFS. The Company did not pay any dividends during the years ended December 31, 2022, 2021 and 2020,

Under New York Insurance Laws, the Company is permitted, without prior insurance regulatory clearance, to pay stockholder dividends to its parent in any calendar year based on one of two standards. Under one standard, the Company is permitted, without prior insurance regulatory clearance, to pay dividends out of earned surplus (defined as positive "unassigned funds (surplus)"), excluding 85% of the change in net unrealized capital gains or losses (less capital gains tax), for the immediately preceding calendar year), in an amount up to the greater of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year, or (ii) its statutory net gain from operations for the immediately preceding calendar year (excluding realized capital gains), not to exceed 30% of surplus to policyholders as of the end of the immediately preceding calendar year. In addition, under this standard, the Company may not, without prior insurance regulatory clearance, pay any dividends in any calendar year immediately following a calendar year for which its net gain from operations, excluding realized capital gains, was negative. Under the second standard, if dividends are paid out of other than earned surplus, the Company may, without prior insurance regulatory clearance, pay an amount up to the lesser of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year, or (ii) its statutory net gain from operations for the immediately preceding calendar year (excluding realized capital gains). In addition, the Company will be permitted to pay a dividend to its parent in excess of the amounts allowed under both standards only if it files notice of its intention to declare such a dividend and the amount thereof with the New York Superintendent of Financial Services (the "NY Superintendent") and the NY Superintendent either approves the distribution of the dividend or does not disapprove the dividend within 30 days of its filing.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**10. Equity (continued)**

***Accumulated Other Comprehensive Income (Loss)***

Information regarding changes in the balances of each component of AOCI was as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Unrealized**<br> **Investment Gains**<br> **(Losses), Net of**<br> **Related Offsets (1)** | **Unrealized**<br> **Gains (Losses)**<br> **on Derivatives** | **Total** |
| | **(In millions)** | **(In millions)** | **(In millions)** |
| Balance at December 31, 2019 | $116 | $6 | $122 |
| OCI before reclassifications | 190 | (5) | 185 |
| Deferred income tax benefit (expense) (2) | (40) | 1 | (39) |
| AOCI before reclassifications, net of income tax | 266 | 2 | 268 |
| Amounts reclassified from AOCI | (13) |  | (13) |
| Deferred income tax benefit (expense) (2) | 3 |  | 3 |
| Amounts reclassified from AOCI, net of income tax | (10) |  | (10) |
| Balance at December 31, 2020 | 256 | 2 | 258 |
| OCI before reclassifications | (163) | 6 | (157) |
| Deferred income tax benefit (expense) (2) | 33 | (1) | 32 |
| AOCI before reclassifications, net of income tax | 126 | 7 | 133 |
| Amounts reclassified from AOCI | 2 |  | 2 |
| Amounts reclassified from AOCI, net of income tax | 2 |  | 2 |
| Balance at December 31, 2021 | 128 | 7 | 135 |
| OCI before reclassifications | (717) | 12 | (705) |
| Deferred income tax benefit (expense) (2) | 151 | (3) | 148 |
| AOCI before reclassifications, net of income tax | (438) | 16 | (422) |
| Amounts reclassified from AOCI | 11 |  | 11 |
| Deferred income tax benefit (expense) (2) | (2) |  | (2) |
| Amounts reclassified from AOCI, net of income tax | 9 |  | 9 |
| Balance at December 31, 2022 | $(429) | $16 | $(413) |

---

(1) See Note 6 for information on offsets to investments related to future policy benefits and DAC.

(2) The effects of income taxes on amounts recorded in AOCI are also recognized in AOCI. These income tax effects are released from AOCI when the related activity is reclassified into results from operations.

Information regarding amounts reclassified out of each component of AOCI was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **AOCI Components** | **Amounts Reclassified from AOCI** | **Amounts Reclassified from AOCI** | **Amounts Reclassified from AOCI** | **Statements of Operations**<br> **Locations** |
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** | |
|  | **2022** | **2021** | **2020** |  |
|  | **(In millions)** | **(In millions)** | **(In millions)** |  |
| Net unrealized investment gains (losses): | Net unrealized investment gains (losses): | Net unrealized investment gains (losses): | Net unrealized investment gains (losses): | Net unrealized investment gains (losses): |
| Net unrealized investment gains (losses) | $(11) | $(2) | $13 | Net investment gains (losses) |
| Net unrealized investment gains (losses), before income tax | (11) | (2) | 13 |  |
| Income tax (expense) benefit | 2 |  | (3) |  |
| Net unrealized investment gains (losses), net of income tax | (9) | (2) | 10 |  |
| Total reclassifications, net of income tax | $(9) | $(2) | $10 |  |

---

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**11. Other Revenues and Other Expenses**

***Other Revenues***

The Company has entered into contracts with mutual funds, fund managers, and their affiliates (collectively, the "Funds") whereby the Company is paid monthly or quarterly fees ("12b-1 fees") for providing certain services to customers and distributors of the Funds. The 12b-1 fees are generally equal to a fixed percentage of the average daily balance of the customer's investment in a fund. The percentage is specified in the contract between the Company and the Funds. Payments are generally collected when due and are neither refundable nor able to offset future fees.

To earn these fees, the Company performs services such as responding to phone inquiries, maintaining records, providing information to distributors and shareholders about fund performance and providing training to account managers and sales agents. The passage of time reflects the satisfaction of the Company's performance obligations to the Funds and is used to recognize revenue associated with 12b-1 fees.

Direct other revenues consisted primarily of 12b-1 fees of $12 million, $14 million and $13 million for the years ended December 31, 2022, 2021 and 2020, respectively, of which all were reported in the Annuities segment.

***Other Expenses***

Information on other expenses was as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| | **(In millions)** | **(In millions)** | **(In millions)** |
| Compensation | $24 | $24 | $20 |
| Contracted services and other labor costs | 18 | 16 | 16 |
| Transition services agreements | 3 | 6 | 6 |
| Establishment costs | 3 | 4 | 8 |
| Premium and other taxes, licenses and fees | 4 | 2 |  |
| Volume related costs, excluding compensation, net of DAC capitalization | 23 | 25 | 22 |
| Other | 6 |  | 5 |
| Total other expenses | $81 | $77 | $77 |

---

***Capitalization of DAC***

See Note 4 for additional information on the capitalization of DAC.

***Related Party Expenses***

See Note 14 for a discussion of related party expenses included in the table above.

**12. Income Tax**

The provision for income tax was as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| | **(In millions)** | **(In millions)** | **(In millions)** |
| Current: | Current: | Current: | Current: |
| Federal | $92 | $32 | $(3) |
| Deferred: | Deferred: | Deferred: | Deferred: |
| Federal | (130) | (38) | 28 |
| Provision for income tax expense (benefit) | $(38) | $(6) | $25 |

---

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**12. Income Tax (continued)**

The reconciliation of the income tax provision at the statutory tax rate to the provision for income tax as reported was as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Tax provision at statutory rate | $(30) | $(5) | $28 |
| Tax effect of: | Tax effect of: | Tax effect of: | Tax effect of: |
| Resolution of prior years | (4) |  |  |
| Dividends received deduction | (2) | (1) | (2) |
| Change in uncertain tax benefits | (1) |  |  |
| Tax credits | (1) | (1) | (1) |
| Change in valuation allowance |  | 1 |  |
| Provision for income tax expense (benefit) | $(38) | $(6) | $25 |
| Effective tax rate | 26% | 25% | 19% |

---

Deferred income tax represents the tax effect of the differences between the book and tax bases of assets and liabilities. Net deferred income tax assets and liabilities consisted of the following at:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| | **2022** | **2021** |
| | **(In millions)** | **(In millions)** |
| Deferred income tax assets: | Deferred income tax assets: | Deferred income tax assets: |
| Net unrealized investment losses | $110 | $— |
| Net operating loss carryforwards | 61 | 61 |
| Investments, including derivatives | 51 |  |
| Tax credit carryforwards | 8 | 7 |
| Other | 26 | 1 |
| Total deferred income tax assets | 256 | 69 |
| Less: Valuation allowance | 1 | 1 |
| Total net deferred income tax assets | 255 | 68 |
| Deferred income tax liabilities: | Deferred income tax liabilities: | Deferred income tax liabilities: |
| DAC | 51 | 45 |
| Policyholder liabilities and receivables | 35 | 44 |
| Intangibles | 1 | 1 |
| Investments, including derivatives |  | 49 |
| Net unrealized investment gains |  | 36 |
| Total deferred income tax liabilities | 87 | 175 |
| Net deferred income tax asset (liability) | $168 | $(107) |

---

At December 31, 2022, the Company had net operating loss carryforwards of approximately $290 million, all of which is carried forward indefinitely.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**12. Income Tax (continued)**

The following table sets forth the foreign tax credits available for carryforward for tax purposes at December 31, 2022.

---

| | |
|:---|:---|
| | **Foreign Tax Credits**<br> **Carryforwards** |
| | **(In millions)** |
| **Expiration** | **Expiration** |
| 2023-2026 | $1 |
| 2027-2031 | 6 |
| 2032-2036 | 1 |
| 2037-2041 |  |
| Indefinite |  |
|  | $8 |

---

The Company believes that it is more likely than not that the benefit from certain tax credit carryforwards will not be realized. Accordingly, a valuation allowance of $1 million has been established on the deferred tax assets related to the tax credit carryforwards at December 31, 2022.

The Company's liability for unrecognized tax benefits may increase or decrease in the next 12 months. A reasonable estimate of the increase or decrease cannot be made at this time. However, the Company continues to believe that the ultimate resolution of the pending issues will not result in a material change to its financial statements, although the resolution of income tax matters could impact the Company's effective tax rate in the future.

The ending balance for unrecognized tax benefits that, if recognized, would impact the effective rate is $0, $1 million and $1 million for each of the years ended December 31, 2022, 2021 and 2020. The Company classifies interest accrued related to unrecognized tax benefits in interest expense, included in other expenses, while penalties are included in income tax expense. Interest related to unrecognized tax benefits was not significant. The Company had no penalties for each of the years ended December 31, 2022, 2021 and 2020.

The Company is subject to examination by the Internal Revenue Service and other tax authorities in jurisdictions in which the Company has significant business operations. The income tax years under examination vary by jurisdiction and subsidiary. The Company is no longer subject to federal, state or local income tax examinations for years prior to 2017. Management believes it has established adequate tax liabilities, and final resolution of any audits for the years 2017 and forward is not expected to have a material impact on the Company's financial statements.

***<u>Tax Sharing Agreements</u>***

For the periods prior to the Separation, the Company was included in a consolidated federal life and non-life income tax return in accordance with the provisions of the Internal Revenue Code of 1986, as amended. Current taxes (and the benefits of tax attributes such as losses) are allocated to the Company under the consolidated tax return regulations and a tax sharing agreement with MetLife, Inc. This tax sharing agreement states that federal taxes will be computed on a modified separate return basis with benefits for losses.

For periods after the Separation, Brighthouse Life Insurance Company and any directly owned life insurance and reinsurance subsidiaries (including the Company and Brighthouse Reinsurance Company of Delaware) entered in a tax sharing agreement to join a life consolidated federal income tax return. The non-life subsidiaries of Brighthouse Life Insurance Company will file their own federal income tax returns. The tax sharing agreements state that federal taxes are computed on a modified separate return basis with benefit for losses.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**12. Income Tax (continued)**

***<u>Income Tax Transactions with Former Parent</u>***

The Company entered into a tax separation agreement with MetLife, Inc. Among other things, the tax separation agreement governs the allocation between MetLife, Inc. and the Company of the responsibility for the taxes of the MetLife, Inc. group. The tax separation agreement also allocates rights, obligations and responsibilities in connection with certain administrative matters relating to the preparation of tax returns and control of tax audits and other proceedings relating to taxes. For the years ended December 31, 2022, 2021 and 2020, MetLife, Inc. paid $2 million, $3 million and $0, respectively, to the Company under the tax separation agreement. At December 31, 2022 and 2021, the current income tax payable included $0 and $3 million, respectively, payable to MetLife, Inc. related to this agreement.

**13. Contingencies, Commitments and Guarantees**

***Contingencies***

***<u>Litigation</u>***

*<u>Sales Practices Claims</u>*

Over the past several years, the Company has faced claims and regulatory inquiries and investigations, alleging improper marketing or sales of individual life insurance policies, annuities or other products. The Company continues to defend vigorously against the claims in these matters. The Company believes adequate provision has been made in its financial statements for all probable and reasonably estimable losses for sales practices matters.

*<u>Summary</u>*

Various litigations, claims and assessments against the Company, in addition to those discussed previously and those otherwise provided for in the Company's financial statements, have arisen in the course of the Company's business, including, but not limited to, in connection with its activities as an insurer, investor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company's compliance with applicable insurance and other laws and regulations.

It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings. In some of the matters referred to previously, large or indeterminate amounts, including punitive and treble damages, are sought. Although, in light of these considerations, it is possible that an adverse outcome in certain cases could have a material effect upon the Company's financial position, based on information currently known by the Company's management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company's net income or cash flows in particular quarterly or annual periods.

***<u>Other Loss Contingencies</u>***

The Company considers establishing liabilities for loss contingencies associated with disputes or other matters involving third parties, including counterparties to contractual arrangements entered into by the Company (e.g., third-party vendors and reinsurers), as well as with tax or other authorities ("other loss contingencies"). The Company establishes liabilities for such other loss contingencies when it is probable that a loss will be incurred and the amount of the loss can be reasonably estimated. In matters where it is not probable, but is reasonably possible that a loss will be incurred and the amount of loss can be reasonably estimated, such losses or range of losses are disclosed, and no accrual is made. In the absence of sufficient information to support an assessment of the reasonably possible loss or range of loss, no accrual is made and no loss or range of loss is disclosed.

On a quarterly basis, the Company reviews relevant information with respect to other loss contingencies and, when applicable, updates its accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**13. Contingencies, Commitments and Guarantees (continued)**

***Commitments***

***<u>Mortgage Loan Commitments</u>***

The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $1 million and $161 million at December 31, 2022 and 2021, respectively.

***<u>Commitments to Fund Private Corporate Bond Investments</u>***

The Company commits to lend funds under private corporate bond investments. The amounts of these unfunded commitments were less than $1 million and $16 million at December 31, 2022 and 2021, respectively.

***Guarantees***

In the normal course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties such that it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other specific liabilities and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemnifications to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third-party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. In some cases, the maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation, while in other cases such limitations are not specified or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future. Management believes that it is unlikely the Company will have to make any material payments under these indemnities, guarantees, or commitments.

In addition, the Company indemnifies its directors and officers as provided in its charters and bylaws. Also, the Company indemnifies its agents for liabilities incurred as a result of their representation of the Company's interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these indemnities in the future.

The Company did not have a liability for indemnities, guarantees and commitments at either December 31, 2022 or 2021.

**14. Related Party Transactions**

The Company has various existing arrangements with its Brighthouse Financial affiliates and had previous arrangements with MetLife, Inc. for services necessary to conduct its activities. Certain of the MetLife, Inc. services have continued, however, MetLife, Inc. ceased to be a related party in June 2018. See Note 11 for amounts related to continuing transition services.

The Company has related party reinsurance, debt and equity transactions (see Notes 5, 9 and 10). Other material arrangements between the Company and its related parties not disclosed elsewhere are as follows:

***<u>Shared Services and Overhead Allocations</u>***

ServiceCo currently provides the Company certain services which include, but are not limited to, treasury, financial planning and analysis, legal, human resources, tax planning, internal audit, financial reporting and information technology. When specific identification to a particular legal entity and/or product is not practicable, an allocation methodology based on various performance measures or activity-based costing, such as sales, new policies/contracts issued, reserves, and in-force policy counts is used. The bases for such charges are modified and adjusted by management when necessary or appropriate to reflect fairly and equitably the actual incidence of cost incurred by the Company and/or affiliate. Management believes that the methods used to allocate expenses under these arrangements are reasonable. Revenues received from an affiliate related to these agreements, recorded in universal life and investment-type product policy fees, were $11 million, $13 million and $11 million for the years ended December 31, 2022, 2021 and 2020, respectively. Costs incurred under these arrangements were $52 million, $54 million and $53 million for the years ended December 31, 2022, 2021 and 2020, respectively, and were recorded in other expenses.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Notes to the Financial Statements (continued)**

**14. Related Party Transactions (continued)**

Included in these costs were those incurred related to the establishment of services and infrastructure to replace those previously provided by MetLife, Inc. The Company incurred costs of $0, $0 and $3 million for the years ended December 31, 2022, 2021 and 2020, respectively. The Company has been charged a fee to reflect the value of the available infrastructure and services provided by these costs. While management believes the method used to allocate expenses under this arrangement has been reasonable, the allocated expenses may not have been indicative of those of a standalone entity. These establishment costs were fully allocated as of December 31, 2020.

The Company had net receivables from/(payables to) affiliates, related to the items discussed above, of ($55) million and ($18) million at December 31, 2022 and 2021, respectively.

***<u>Broker-Dealer Transactions</u>***

The related party expense for the Company was commissions paid on the sale of variable products and passed through to the broker-dealer affiliate. The related party revenue for the Company was fee income passed through the broker-dealer affiliate from trusts and mutual funds whose shares serve as investment options of policyholders of the Company. Fee income received related to these transactions and recorded in other revenues was $11 million, $13 million and $12 million for the years ended December 31, 2022, 2021 and 2020, respectively. Commission expenses incurred related to these transactions and recorded in other expenses was $83 million, $92 million and $71 million for the years ended December 31, 2022, 2021 and 2020, respectively. The Company also had related party fee income receivables of $1 million at both December 31, 2022 and 2021.

**15. Subsequent Events**

***Intercompany Liquidity Facilities***

Upon maturity on February 16, 2023, the November 2022 Promissory Note was replaced by a $125 million promissory note that bears interest at a fixed rate of 5.9937% and matures on May 16, 2023.

***Capital Contribution***

On March 24, 2023, Brighthouse Life Insurance Company approved a capital contribution of $100 million, which is expected to be paid during the first quarter of 2023.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Schedule I**

**Summary of Investments<br>Other Than Investments in Related Parties<br>December 31, 2022**

**(In millions)**

---

| | | | |
|:---|:---|:---|:---|
| **Types of Investments** | **Cost or**<br> **Amortized Cost (1)** | **Estimated Fair**<br> **Value** | **Amount at**<br> **Which Shown on**<br> **Balance Sheet** |
| Fixed maturity securities: | Fixed maturity securities: | Fixed maturity securities: | Fixed maturity securities: |
| Bonds: | Bonds: | Bonds: | Bonds: |
| State and political subdivision | $298 | $245 | $245 |
| U.S. government and agency | 205 | 192 | 192 |
| Public utilities | 122 | 104 | 104 |
| Foreign government | 17 | 14 | 14 |
| All other corporate bonds | 2995 | 2588 | 2588 |
| Total bonds | 3637 | 3143 | 3143 |
| Mortgage-backed and asset-backed securities | 957 | 873 | 873 |
| Redeemable preferred stock | 11 | 9 | 9 |
| Total fixed maturity securities | 4605 | 4025 | 4025 |
| Equity securities: | Equity securities: | Equity securities: | Equity securities: |
| Common stock: | Common stock: | Common stock: | Common stock: |
| Industrial, miscellaneous and all other | 1 | 1 | 1 |
| Non-redeemable preferred stock | 3 | 3 | 3 |
| Total equity securities | 4 | 4 | 4 |
| Mortgage loans | 1218 |  | 1218 |
| Limited liability companies | 7 |  | 7 |
| Other invested assets | 266 |  | 266 |
| Total investments | $6100 |  | $5520 |

---

(1) Cost or amortized cost for fixed maturity securities represents original cost reduced by impairments that are charged to earnings and adjusted for amortization of premiums or accretion of discounts; for mortgage loans, cost represents original cost reduced by repayments and valuation allowances and adjusted for amortization of premiums or accretion of discounts; for equity securities, cost represents original cost; for limited liability companies, cost represents original cost adjusted for equity in earnings and distributions.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Schedule III**

**Supplementary Insurance Information<br>December 31, 2022 and 2021**

**(In millions)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Segment** | **DAC** | **Future Policy**<br> **Benefits and Other**<br> **Policy-Related**<br> **Balances** | **Policyholder**<br> **Account**<br> **Balances** | **Unearned**<br> **Premiums (1), (2)** | **Unearned**<br> **Revenue (1)** |
| **2022** | **2022** | **2022** | **2022** | **2022** | **2022** |
| Annuities | $310  | $496  | $4817  | $—  | $2 |
| Life | 14 | 362 | 11 | 1 |  |
| Corporate & Other | 1 | 12 |  |  |  |
| Total | $325 | $870 | $4828 | $1 | $2 |
| **2021** | **2021** | **2021** | **2021** | **2021** | **2021** |
| Annuities | $208 | $461 | $4349 | $—  | $2 |
| Life | 16 | 386 | 11 | 1 |  |
| Corporate & Other |  | 11 |  |  |  |
| Total | $224 | $858 | $4360 | $1 | $2 |

---

(1) Amounts are included in the future policy benefits and other policy-related balances column.

(2) Includes premiums received in advance.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Schedule III**

**Supplementary Insurance Information (continued)<br>December 31, 2022, 2021 and 2020**

**(In millions)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Segment** | **Premiums and**<br> **Universal Life**<br> **and Investment-Type**<br> **Product Policy Fees** | **Net**<br> **Investment**<br> **Income (1)** | **Policyholder Benefits**<br> **and Claims and**<br> **Interest Credited**<br> **to Policyholder**<br> **Account Balances** | **Amortization of**<br> **DAC** | **Other**<br> **Expenses** |
| **2022** | **2022** | **2022** | **2022** | **2022** | **2022** |
| Annuities | $97 | $153 | $79 | $24 | $66 |
| Life | 1 | 33 | 15 | 2 | 10 |
| Corporate & Other |  | 2 | (1) |  | 5 |
| Total | $98 | $188 | $93 | $26 | $81 |
| **2021** | **2021** | **2021** | **2021** | **2021** | **2021** |
| Annuities | $113 | $121 | $42 | $(4) | $65 |
| Life | 4 | 35 | 10 | 2 | 11 |
| Corporate & Other | 1 | 1 | (3) |  | 1 |
| Total | $118 | $157 | $49 | $(2) | $77 |
| **2020** | **2020** | **2020** | **2020** | **2020** | **2020** |
| Annuities | $102 | $97 | $59 | $37 | $57 |
| Life | 12 | 36 | 2 | 1 | 12 |
| Corporate & Other | 1 | 1 |  |  | 8 |
| Total | $115 | $134 | $61 | $38 | $77 |

---

(1) See Note 2 of the Notes to the Financial Statements for the basis of allocation of net investment income.

------

**Brighthouse Life Insurance Company of NY<br>(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)**

**Schedule IV**

**Reinsurance<br>December 31, 2022, 2021 and 2020**

**(Dollars in millions)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Gross Amount** | **Ceded** | **Assumed** | **Net Amount** | **% Amount**<br> **Assumed to Net** |
| **2022** | **2022** | **2022** | **2022** | **2022** | **2022** |
| Life insurance in-force | $37212 | $32121 | $— | $5091 | —% |
| Life insurance premium (1) | $71 | $63 | $—  | $8 | —% |
| **2021** | **2021** | **2021** | **2021** | **2021** | **2021** |
| Life insurance in-force | $39572 | $33955 | $— | $5617 | —% |
| Life insurance premium (1) | $75 | $62 | $— | $13 | —% |
| **2020** | **2020** | **2020** | **2020** | **2020** | **2020** |
| Life insurance in-force | $41707 | $35792 | $— | $5915 | —% |
| Life insurance premium (1) | $82 | $60 | $—  | $22 | —% |

---

(1) Includes annuities with life contingencies.

For the years ended December 31, 2022, 2021 and 2020, reinsurance ceded included related party transactions for life insurance in-force of $24.5 billion, $25.8 billion and $27.0 billion, respectively, and life insurance premiums of $47 million, $45 million and $43 million, respectively. There were no related party transactions for assumed life insurance in-force and life insurance premiums for the years ended December 31, 2022, 2021 and 2020.

------